0001868420-21-000009.txt : 20210625 0001868420-21-000009.hdr.sgml : 20210625 20210625141808 ACCESSION NUMBER: 0001868420-21-000009 CONFORMED SUBMISSION TYPE: N-CSR PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20210430 FILED AS OF DATE: 20210625 DATE AS OF CHANGE: 20210625 EFFECTIVENESS DATE: 20210625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FRANKLIN STRATEGIC SERIES CENTRAL INDEX KEY: 0000872625 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: N-CSR SEC ACT: 1940 Act SEC FILE NUMBER: 811-06243 FILM NUMBER: 211046846 BUSINESS ADDRESS: STREET 1: ONE FRANKLIN PARKWAY CITY: SAN MATEO STATE: CA ZIP: 94403-1906 BUSINESS PHONE: 650-570-3000 MAIL ADDRESS: STREET 1: ONE FRANKLIN PARKWAY CITY: SAN MATEO STATE: CA ZIP: 94403-1906 FORMER COMPANY: FORMER CONFORMED NAME: FRANKLIN CALIFORNIA 250 GROWTH FUND DATE OF NAME CHANGE: 19911216 FORMER COMPANY: FORMER CONFORMED NAME: FRANKLIN CALIFORNIA 250 GROWTH INDEX FUND DATE OF NAME CHANGE: 19910917 0000872625 S000006878 FRANKLIN GROWTH OPPORTUNITIES FUND C000018615 CLASS A FGRAX C000018617 CLASS C FKACX C000018618 ADVISOR CLASS FRAAX C000018619 CLASS R FKARX C000128860 Class R6 FOPPX 0000872625 S000006879 FRANKLIN STRATEGIC INCOME FUND C000018620 CLASS A FRSTX C000018622 CLASS C FSGCX C000018623 ADVISOR CLASS FKSAX C000018624 CLASS R FKSRX C000128861 Class R6 FGKNX 0000872625 S000006882 FRANKLIN BIOTECHNOLOGY DISCOVERY FUND C000018631 CLASS A FBDIX C000081539 ADVISOR CLASS FTDZX C000128862 Class R6 FRBRX C000141458 Class C FBTDX 0000872625 S000006887 FRANKLIN NATURAL RESOURCES FUND C000018647 CLASS C FNCRX C000018648 CLASS A FRNRX C000018649 ADVISOR CLASS FNRAX C000132949 Class R6 FNCSX 0000872625 S000006888 FRANKLIN SMALL-MID CAP GROWTH FUND C000018650 CLASS A FRSGX C000018652 CLASS C FRSIX C000018653 ADVISOR CLASS FSGAX C000018654 CLASS R FSMRX C000128864 Class R6 FMGGX 0000872625 S000006889 FRANKLIN SMALL CAP GROWTH FUND C000018655 CLASS A FSGRX C000018657 CLASS C FCSGX C000018658 ADVISOR CLASS FSSAX C000018659 CLASS R FSSRX C000128865 Class R6 FSMLX N-CSR 1 primary-document.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM N-CSR
 
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES
 
Investment Company Act file number 811-06243
 
Franklin Strategic Series

(Exact name of registrant as specified in charter)
 
One Franklin Parkway, San Mateo, CA 94403-1906

(Address of principal executive offices) (Zip code)
 
Craig S. Tyle, One Franklin Parkway, San Mateo, CA 94403-1906

(Name and address of agent for service)
 
Registrant's telephone number, including area code: 650 312-2000
 
Date of fiscal year end: 4/30
 
Date of reporting period: 4/30/21
 
Item 1. Reports to Stockholders.
 
a.)
 
The following is a copy of the report transmitted to shareholders pursuant to Rule30e-1 under the Investment Company Act of 1940, as amended (the “1940 Act”) (17 CFR 270.30e-1.)


b.)
 
Include a copy of each notice transmitted to stockholders in reliance on Rule 30e-3 under the Act (17 CFR 270.30e-3) that contains disclosures specified by paragraph (c)(3) of that rule.
Not Applicable.
 
ANNUAL
REPORT
AND
SHAREHOLDER
LETTER
Franklin
Strategic
Series
April
30,
2021
Sign
up
for
electronic
delivery
at
franklintempleton.com/edelivery
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
franklintempleton.com
Not
part
of
the
annual
report
1
Shareholder
Letter
Dear
Shareholder:
During
the
12
months
ended
April
30,
2021,
the
novel
coronavirus
(COVID-19)
pandemic
caused
the
U.S.
economy
to
contract
in
2020’s
first
half.
For
the
remainder
of
2020,
the
economy
recovered
substantially
based
on
increased
business
and
residential
investment
and
consumer
spending.
U.S.
economic
growth
accelerated
during
2021’s
first
quarter
as
the
reopening
of
businesses,
widespread
COVID-19
vaccinations
and
federal
assistance
programs
boosted
consumer
spending.
Before
the
reporting
period,
the
U.S.
Federal
Reserve
(Fed),
in
its
efforts
to
support
U.S.
economic
activity,
lowered
the
target
range
for
the
federal
funds
rate
twice
in
March
2020
and
implemented
broad
quantitative
easing
measures
to
support
credit
markets.
During
the
reporting
period,
the
Fed
held
the
target
range
for
its
key
rate
unchanged
at
0.00–
0.25%,
but
it
continued
quantitative
easing
and
adjusted
its
policy
in
August
2020
to
allow
more
flexibility
to
keep
interest
rates
low,
while
maintaining
a
2%
average
inflation
target.
In
this
environment,
U.S.
stocks,
as
measured
by
the
Standard
&
Poor’s
®
500
Index,
posted
a
strong
positive
total
return
for
the
12-month
period.
We
are
committed
to
our
long-term
perspective
and
disciplined
investment
approach
as
we
conduct
a
rigorous,
fundamental
analysis
of
securities
with
a
regular
emphasis
on
investment
risk
management.
We
believe
active,
professional
investment
management
serves
investors
well.
We
also
recognize
the
important
role
of
financial
professionals
in
today’s
markets
and
encourage
investors
to
continue
to
seek
their
advice.
Amid
changing
markets
and
economic
conditions,
we
are
confident
investors
with
a
well-diversified
portfolio
and
a
patient,
long-term
outlook
should
be
well-positioned
for
the
years
ahead.
In
addition,
Franklin
Strategic
Series’
annual
report
includes
more
detail
about
prevailing
conditions
and
a
discussion
about
investment
decisions
during
the
period.
All
securities
markets
fluctuate,
as
do
mutual
fund
share
prices.
We
thank
you
for
investing
with
Franklin
Templeton,
welcome
your
questions
and
comments,
and
look
forward
to
serving
your
future
investment
needs.
Sincerely,
Edward
Perks,
CFA
President
and
Chief
Executive
Officer
Investment
Management
Franklin
Strategic
Series
This
letter
reflects
our
analysis
and
opinions
as
of
April
30,
2021,
unless
otherwise
indicated.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
CFA
®
is
a
trademark
owned
by
CFA
Institute.
franklintempleton.com
Annual
Report
2
Contents
Annual
Report
Economic
and
Market
Overview
3
Franklin
Growth
Opportunities
Fund
4
Franklin
Small
Cap
Growth
Fund
10
Franklin
Small-Mid
Cap
Growth
Fund
16
Financial
Highlights
and
Statements
of
Investments
22
Financial
Statements
54
Notes
to
Financial
Statements
59
Report
of
Independent
Registered
Public
Accounting
Firm
87
Tax
Information
88
Board
Members
and
Officers
89
Shareholder
Information
94
Visit
franklintempleton.com
for
fund
updates,
to
access
your
account,
or
to
find
helpful
financial
planning
tools.
3
franklintempleton.com
Annual
Report
ANNUAL
REPORT
Economic
and
Market
Overview
U.S.
equities,
as
measured
by
the
Standard
&
Poor’s
500
Index
(S&P
500
®
),
advanced
strongly
during
the
12
months
ended
April
30,
2021.
Equities
rose
amid
the
U.S.
recovery
from
the
initial
shock
of
the
novel
coronavirus
pandemic
and
related
restrictions.
The
phased
economic
reopening
of
many
states,
the
development
of
treatments
and
vaccines,
and
several
fiscal
stimulus
measures
that
included
direct
payments
to
many
individuals
and
programs
designed
to
help
small
businesses
keep
employees
on
the
payroll,
supported
stock
prices.
In
November
2020,
news
that
several
vaccines
showed
high
efficacy
rates
bolstered
investor
confidence.
Furthermore,
the
implementation
of
mass
vaccination
programs
in
early
2021,
a
significant
decline
in
the
U.S.
infection
rate
and
continued
economic
opening
led
U.S.
equities
to
reach
all-time
price
highs
in
April
2021.
The
U.S.
economy
was
severely
impacted
by
the
pandemic,
as
business
closures
and
restrictions
on
gatherings
disrupted
everyday
life.
As
a
result,
second-quarter
2020
gross
domestic
product
(GDP)
declined
at
a
record
annualized
rate,
and
mass
layoffs
drove
the
unemployment
rate
to
a
peak
of
14.8%
in
April.
1
However,
economic
conditions
improved
rapidly
thereafter,
with
the
GDP
rebounding
at
a
record
annualized
pace
in
2020’s
third
quarter
and
expanding
at
a
less
robust
pace
in
2020’s
fourth
quarter
and
2021’s
first
quarter.
Notably,
the
unemployment
rate
declined
to
6.1%
in
April
2021,
as
jobless
claims
fell
and
employment
openings
rose.
1
In
an
effort
to
support
the
economy,
the
U.S.
Federal
Reserve
(Fed)
kept
the
federal
funds
target
rate
at
a
record-low
range
of
0.00%–0.25%.
The
Fed
also
enacted
quantitative
easing
measures
aimed
at
ensuring
credit
flows
to
borrowers
and
supporting
credit
markets
with
open-
ended
bond
purchasing.
Furthermore,
the
Fed
signaled
that
interest
rates
would
potentially
remain
low,
even
if
inflation
moderately
exceeded
its
2%
target.
The
combination
of
stimulus
payments,
increasing
asset
prices
and
generally
rising
savings
during
lockdowns
led
to
the
strengthening
of
overall
household
balance
sheets.
The
higher
overall
household
wealth
and
pent-up
consumer
demand
led
to
stronger
consumer
spending
in
2021’s
first
quarter
that,
along
with
the
shortages
of
some
materials
and
supplies,
drove
many
investors’
inflation
expectations
to
increase
significantly
near
period-end.
The
foregoing
information
reflects
our
analysis
and
opinions
as
of
April
30,
2021.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
1.
Source:
Bureau
of
Labor
Statistics.
4
franklintempleton.com
Annual
Report
Franklin
Growth
Opportunities
Fund
This
annual
report
for
Franklin
Growth
Opportunities
Fund
covers
the
fiscal
year
ended
April
30,
2021.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
capital
appreciation.
Under
normal
conditions,
the
Fund
invests
predominantly
in
equity
securities
of
companies
demonstrating
accelerating
growth,
increasing
profitability,
or
above-average
growth
or
growth
potential
as
compared
with
the
overall
economy.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+50.64%
cumulative
total
return
for
the
12
months
under
review.
In
comparison,
the
Fund’s
narrow
benchmark,
the
Russell
3000
®
Growth
Index,
which
measures
performance
of
those
Russell
3000
®
Index
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
rates,
posted
a
+52.41%
total
return.
1
The
Fund’s
broad
benchmark,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
tracks
the
broad
U.S.
stock
market,
posted
a
+45.98%
total
return.
1
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
6
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236.
Investment
Strategy
We
use
fundamental,
bottom-up
research
to
seek
companies
meeting
our
criteria
of
growth
potential,
quality
and
valuation.
In
seeking
sustainable
growth
characteristics,
we
look
for
companies
we
believe
can
produce
sustainable
earnings
and
cash
flow
growth,
evaluating
the
long-term
market
opportunity
and
competitive
structure
of
an
industry
to
target
leaders
and
emerging
leaders.
We
define
quality
companies
as
those
with
strong
and
improving
competitive
positions
in
attractive
markets.
We
also
believe
important
attributes
of
quality
are
experienced
and
talented
management
teams
as
well
as
financial
strength
reflected
in
the
capital
structure,
gross
and
operating
margins,
free
cash
flow
generation
and
returns
on
capital
employed.
Our
valuation
analysis
includes
a
range
of
potential
outcomes
based
on
an
assessment
of
multiple
scenarios.
In
assessing
value,
we
consider
whether
security
prices
fully
reflect
the
balance
of
the
sustainable
growth
opportunities
relative
to
business
and
financial
risks.
Manager’s
Discussion
During
the
12
months
under
review,
nearly
all
sectors
represented
in
the
Fund’s
portfolio
posted
positive
returns
and
contributed
to
absolute
performance.
Relative
to
the
Russell
3000
®
Growth
Index,
stock
selection
in
the
health
care
sector,
stock
selection
and
an
underweighting
in
the
consumer
staples
sector
and
stock
selection
in
the
information
technology
(IT)
sector
contributed
to
Fund
performance.
Within
health
care,
the
development
of
a
novel
coronavirus
(COVID-19)
vaccine
candidate
bolstered
the
shares
of
vaccine
developer
Novavax.
In
consumer
staples,
our
investment
in
dog
and
cat
food
manufacturer
Freshpet
aided
relative
results.
Portfolio
Composition
4/30/21
%
of
Total
Net
Assets
Software
18.4%
IT
Services
14.1%
Internet
&
Direct
Marketing
Retail
9.7%
Capital
Markets
7.0%
Health
Care
Equipment
&
Supplies
6.6%
Interactive
Media
&
Services
3.9%
Professional
Services
3.9%
Semiconductors
&
Semiconductor
Equipment
3.8%
Technology
Hardware,
Storage
&
Peripherals
3.7%
Health
Care
Providers
&
Services
2.8%
Equity
Real
Estate
Investment
Trusts
(REITs)
2.4%
Biotechnology
2.3%
Hotels,
Restaurants
&
Leisure
2.1%
Automobiles
1.9%
Other
17.6%
Short-Term
Investments
&
Other
Net
Assets
(0.2)%
1.
Source:
Morningstar.
Frank
Russell
Company
is
the
source
and
owner
of
the
trademarks,
service
marks
and
copyrights
related
to
the
Russell
Indexes.
Russell
®
is
a
trademark
of
Frank
Russell
Company.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
27
.
Franklin
Growth
Opportunities
Fund
5
franklintempleton.com
Annual
Report
In
the
IT
sector,
Twilio
was
a
top
relative
contributor
as
the
COVID-19
pandemic
increased
the
demand
for
the
company’s
digital
communication
services
from
telehealth,
online
education,
remote
customer
care
and
food
delivery
companies,
among
others.
The
stocks
of
payment
solutions
provider
Bill.com
Holdings
and
video
conferencing
platform
provider
Zoom
Video
Communications
(not
held
at
period-
end)
also
posted
strong
returns.
Bill.com
benefited
from
smaller
companies’
growing
need
to
switch
to
cost-
and
time-saving
digital
bill
payment
technologies.
Zoom
Video
Communications’
share
price
reached
all-time
highs
as
digital
work
became
crucial
during
the
pandemic.
Another
notable
relative
contributor
included
our
investment
in
at-home
fitness
platform
Peloton
Interactive
(not
held
at
period-end).
In
contrast,
key
detractors
from
the
Fund’s
relative
performance
included
stock
selection
in
the
industrials
sector
as
well
as
stock
selection
and
overweightings
in
the
real
estate
and
financials
sectors.
Within
industrials,
shares
of
data
analytics
provider
Verisk
Analytics
and
commercial
real
estate
information,
analytics
and
online
marketplace
company
CoStar
Group
posted
positive
returns
but
underperformed
the
index,
and
our
overweighted
positions
hurt
relative
results.
In
the
real
estate
sector,
wireless
telecommunications
tower
operator
SBA
Communications
underperformed
the
index
after
strong
outperformance
earlier
in
the
period.
We
believe
the
company
is
an
attractive
long-term
investment
opportunity
given
the
tower
industry’s
strong
barriers
to
entry
and
increasing
mobile
carrier
spending
on
5G
network
upgrades.
There
were
no
financials
holdings
among
the
Fund’s
10
biggest
relative
detractors
during
the
period.
Other
key
detractors
from
the
Fund’s
relative
performance
included
our
positions
in
electronic
products
company
Apple,
electric
vehicle
manufacturer
Tesla
and
biopharmaceutical
company
Reata
Pharmaceuticals.
An
underweighting
in
the
strong-performing
shares
of
Apple
hurt
relative
performance.
Apple
saw
strong
demand
for
its
products
as
consumers
required
more
devices
at
home
to
support
various
streaming
needs
for
work,
school
and
entertainment
during
the
pandemic.
Similarly,
an
underweighting
in
Tesla
hindered
relative
results
as
its
shares
outperformed
the
index
amid
strong
vehicle
sales.
The
share
price
of
Reata
Pharmaceuticals
declined
as
the
company
faced
U.S.
Food
and
Drug
Administration
hurdles
for
its
neurological
disorder
treatment.
Thank
you
for
your
continued
participation
in
Franklin
Growth
Opportunities
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Grant
Bowers
Sara
Araghi,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
April
30,
2021,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Top
10
Holdings
4/30/21
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Amazon.com,
Inc.
8.6%
Internet
&
Direct
Marketing
Retail,
United
States
Mastercard
,
Inc.
4.2%
IT
Services,
United
States
Microsoft
Corp.
4.1%
Software,
United
States
Apple,
Inc.
3.7%
Technology
Hardware,
Storage
&
Peripherals,
United
States
Visa,
Inc.
3.2%
IT
Services,
United
States
Alphabet,
Inc.
2.7%
Interactive
Media
&
Services,
United
States
ServiceNow
,
Inc.
2.5%
Software,
United
States
CoStar
Group,
Inc.
2.0%
Professional
Services,
United
States
PayPal
Holdings,
Inc.
2.0%
IT
Services,
United
States
SBA
Communications
Corp.
2.0%
Equity
Real
Estate
Investment
Trusts
(REITs),
United
States
Performance
Summary
as
of
April
30,
2021
Franklin
Growth
Opportunities
Fund
6
franklintempleton.com
Annual
Report
The
performance
table
and
graphs
do
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
04
/3
0
/2
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236.
Share
Class
Cumulative
Total
Return
1
Average
Annual
Total
Return
2
A
3
1-Year
+50.64%
+42.37%
5-Year
+167.63%
+20.39%
10-Year
+295.33%
+14.09%
Advisor
1-Year
+51.01%
+51.01%
5-Year
+170.99%
+22.06%
10-Year
+306.06%
+15.04%
See
page
8
for
Performance
Summary
footnotes.
Franklin
Growth
Opportunities
Fund
Performance
Summary
7
franklintempleton.com
Annual
Report
See
page
8
for
Performance
Summary
footnotes.
Total
Return
Index
Comparison
for
a
Hypothetical
$10,000
Investment
Total
return
represents
the
change
in
value
of
an
investment
over
the
periods
shown.
It
includes
any
applicable
maximum
sales
charge,
Fund
expenses,
account
fees
and
reinvested
distributions.
The
unmanaged
indexes
include
reinvestment
of
any
income
or
distributions.
They
differ
from
the
Fund
in
composition
and
do
not
pay
management
fees
or
expenses.
One
cannot
invest
directly
in
an
index.
Class
A
(5/1/11–4/30/21)
Advisor
Class
(5/1/11–4/30/21)
Franklin
Growth
Opportunities
Fund
Performance
Summary
8
franklintempleton.com
Annual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Growth
stock
prices
reflect
projections
of
future
earnings
or
revenues,
and
can,
therefore,
fall
dramatically
if
the
company
fails
to
meet
those
projections.
To
the
extent
the
Fund
focuses
on
particular
countries,
regions,
industries,
sectors
or
types
of
investment
from
time
to
time,
it
may
be
subject
to
greater
risks
of
adverse
developments
in
such
areas
of
focus
than
a
fund
that
invests
in
a
wider
variety
of
countries,
regions,
industries,
sectors
or
investments.
Smaller,
midsized
and
relatively
new
or
unseasoned
companies
can
be
particularly
sensitive
to
changing
economic
conditions,
and
their
prospects
for
growth
are
less
certain
than
those
of
larger,
more
established
companies.
Historically,
these
securities
have
experienced
more
price
volatility
than
larger-company
stocks,
especially
over
the
short
term.
Events
such
as
the
spread
of
deadly
diseases,
disasters,
and
financial,
political
or
social
disruptions,
may
heighten
risks
and
adversely
affect
performance.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
2.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
3.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
4.
Source:
Morningstar.
The
Russell
3000
Growth
Index
is
market
capitalization
weighted
and
measures
performance
of
those
Russell
3000
Index
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
values.
The
S&P
500
is
a
market
capitalization-weighted
index
of
500
stocks
designed
to
measure
total
U.S.
equity
market
performance.
5.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Distributions
(5/1/20–4/30/21)
Share
Class
Short-Term
Capital
Gain
Long-Term
Capital
Gain
Total
A
$0.3049
$2.8182
$3.1231
C
$0.3049
$2.8182
$3.1231
R
$0.3049
$2.8182
$3.1231
R6
$0.3049
$2.8182
$3.1231
Advisor
$0.3049
$2.8182
$3.1231
Total
Annual
Operating
Expenses
5
Share
Class
A
0.95%
Advisor
0.70%
Your
Fund’s
Expenses
Franklin
Growth
Opportunities
Fund
9
franklintempleton.com
Annual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6
).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
181/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
11/1/20
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,207.25
$4.97
$1,020.29
$4.55
0.91%
C
$1,000
$1,202.87
$9.04
$1,016.58
$8.28
1.66%
R
$1,000
$1,205.92
$6.28
$1,019.10
$5.75
1.15%
R6
$1,000
$1,209.33
$3.13
$1,021.96
$2.87
0.57%
Advisor
$1,000
$1,208.89
$3.61
$1,021.53
$3.30
0.66%
10
franklintempleton.com
Annual
Report
Franklin
Small
Cap
Growth
Fund
This
annual
report
for
Franklin
Small
Cap
Growth
Fund
covers
the
fiscal
year
ended
April
30,
2021.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
long-term
capital
growth.
Under
normal
market
conditions,
the
Fund
invests
at
least
80%
of
its
net
assets
in
the
equity
securities
of
small-cap
companies.
For
this
Fund,
small-cap
companies
are
those
with
market
capitalizations
not
exceeding
$1.5
billion
or
the
highest
market
capitalization
in
the
Russell
2000
®
Index,
whichever
is
greater,
at
the
time
of
purchase.
1
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+76.43%
cumulative
total
return
for
the
12
months
under
review.
In
comparison,
the
Russell
2000
®
Growth
Index,
which
measures
performance
of
small-cap
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
rates,
posted
a
+69.15%
total
return.
2
The
Standard
&
Poor’s
500
Index
(S&P
500),
which
tracks
the
broad
U.S.
stock
market,
posted
a
+45.98%
total
return.
2
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
12
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
use
fundamental,
bottom-up
research
to
seek
companies
meeting
our
criteria
of
growth
potential,
quality
and
valuation.
In
seeking
sustainable
growth
characteristics,
we
look
for
companies
we
believe
can
produce
sustainable
earnings
and
cash
flow
growth,
evaluating
the
long-term
market
opportunity
and
competitive
structure
of
an
industry.
We
define
quality
companies
as
those
with
strong
and
improving
competitive
positions
in
attractive
markets.
We
also
believe
important
attributes
of
quality
are
experienced
and
talented
management
teams
as
well
as
financial
strength
reflected
in
the
capital
structure,
gross
and
operating
margins,
free
cash
flow
generation
and
returns
on
capital
employed.
Our
valuation
analysis
includes
a
range
of
potential
outcomes
based
on
an
assessment
of
multiple
scenarios.
In
assessing
value,
we
consider
whether
security
prices
fully
reflect
the
balance
of
the
sustainable
growth
opportunities
relative
to
business
and
financial
risks.
Manager’s
Discussion
During
the
12
months
under
review,
all
sectors
represented
in
the
Fund’s
portfolio
posted
positive
returns
and
contributed
to
absolute
performance.
Relative
to
the
Russell
2000
®
Growth
Index,
stock
selection
and
overweightings
in
the
consumer
discretionary
and
information
technology
(IT)
sectors,
as
well
as
stock
selection
and
an
underweighting
in
the
health
care
sector,
contributed
significantly
to
the
Fund’s
performance.
Portfolio
Composition
4/30/21
%
of
Total
Net
Assets
Biotechnology
9.8%
Specialty
Retail
8.6%
Software
8.0%
Semiconductors
&
Semiconductor
Equipment
6.0%
Health
Care
Equipment
&
Supplies
4.6%
Capital
Markets
4.3%
IT
Services
4.0%
Hotels,
Restaurants
&
Leisure
3.6%
Health
Care
Providers
&
Services
3.6%
Health
Care
Technology
3.3%
Food
Products
3.0%
Household
Durables
2.8%
Banks
2.7%
Trading
Companies
&
Distributors
2.7%
Other
30.0%
Short-Term
Investments
&
Other
Net
Assets
3.0%
1.
The
Russell
2000
Index
is
market
capitalization
weighted
and
measures
performance
of
the
2,000
smallest
companies
in
the
Russell
3000
Index,
which
represent
a
small
amount
of
the
total
market
capitalization
of
the
Russell
3000
Index.
2.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
37
.
Franklin
Small
Cap
Growth
Fund
11
franklintempleton.com
Annual
Report
Within
consumer
discretionary,
notable
relative
contributors
included
our
investments
in
digital
sports
entertainment
and
gaming
company
DraftKings
(not
part
of
the
index;
not
held
at
period-end)
and
lifestyle
clothing
retailer
American
Eagle
Outfitters.
DraftKings’
share
price
reached
record
highs
amid
positive
news
flow
that
included
the
announcement
of
an
exclusive
agreement
with
a
major
sports
media
company
to
provide
fantasy
sports
information.
American
Eagle
Outfitters
showed
solid
execution
during
the
period
as
it
continued
to
improve
its
business.
In
the
IT
sector,
our
investment
in
Israel-based
web-
building
platform
Wix.com
(not
part
of
the
index)
contributed
meaningfully
to
relative
results.
The
company’s
services
became
important
as
more
people
accessed
the
cloud
to
work
remotely
during
the
novel
coronavirus
(COVID-19)
shelter-in-place
directives.
In
the
health
care
sector,
our
holdings
in
digital
health
care
company
Livongo
Health
(not
held
at
period-end)
and
vaccine
developer
Novavax
(not
held
at
period-end)
aided
relative
results.
Livongo
Health’s
share
price
surged
as
social
distancing
measures
drove
up
demand
for
the
company’s
remote
monitoring
services.
The
development
of
a
COVID-19
vaccine
candidate
bolstered
the
shares
of
Novavax.
In
contrast,
stock
selection
in
the
industrials,
consumer
staples
and
materials
sectors
detracted
from
the
Fund’s
relative
performance.
There
were
no
consumer
staples
and
materials
holdings
among
the
Fund’s
10
biggest
relative
detractors.
Within
industrials,
technology-focused
aerospace
and
defense
company
Mercury
Systems
and
IT
and
technical
services
solutions
provider
ManTech
International
hindered
relative
returns.
Although
our
overall
health
care
holdings
contributed
to
relative
performance,
three
of
the
Fund’s
10
biggest
relative
detractors
came
from
the
sector,
namely
biopharmaceutical
company
Reata
Pharmaceuticals
and
biotechnology
firms
Global
Blood
Therapeutics
and
PTC
Therapeutics.
The
share
price
of
Reata
Pharmaceuticals
declined
as
the
company
faced
U.S.
Food
and
Drug
Administration
hurdles
for
its
neurological
disorder
treatment.
Global
Blood
Therapeutics
and
PTC
Therapeutics
faced
pandemic-related
headwinds.
Thank
you
for
your
continued
participation
in
Franklin
Small
Cap
Growth
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Michael
P.
McCarthy,
CFA
Bradley
T.
Carris,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
April
30,
2021,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Top
10
Holdings
4/30/21
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
American
Eagle
Outfitters,
Inc.
1.9%
Specialty
Retail,
United
States
Allegiant
Travel
Co.
1.8%
Airlines,
United
States
M/I
Homes,
Inc.
1.6%
Household
Durables,
United
States
Inspire
Medical
Systems,
Inc.
1.5%
Health
Care
Technology,
United
States
Beacon
Roofing
Supply,
Inc.
1.5%
Trading
Companies
&
Distributors,
United
States
Lattice
Semiconductor
Corp.
1.4%
Semiconductors
&
Semiconductor
Equipment,
United
States
Western
Alliance
Bancorp
1.4%
Banks,
United
States
Onto
Innovation,
Inc.
1.4%
Semiconductors
&
Semiconductor
Equipment,
United
States
Pinnacle
Financial
Partners,
Inc.
1.3%
Banks,
United
States
Five
Below,
Inc.
1.3%
Specialty
Retail,
United
States
Performance
Summary
as
of
April
30,
2021
Franklin
Small
Cap
Growth
Fund
12
franklintempleton.com
Annual
Report
The
performance
table
and
graphs
do
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
04
/3
0
/2
1
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class
:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
1-Year
+76.43%
+66.70%
5-Year
+17
4.98%
+21.05%
10-Year
+294.62%
+14.07%
Advisor
1-Year
+76.86%
+76.86%
5-Year
+178.38%
+22.72%
10-Year
+305.29%
+15.02%
See
page
14
for
Performance
Summary
footnotes.
Franklin
Small
Cap
Growth
Fund
Performance
Summary
13
franklintempleton.com
Annual
Report
See
page
14
for
Performance
Summary
footnotes.
Total
Return
Index
Comparison
for
a
Hypothetical
$10,000
Investment
1
Total
return
represents
the
change
in
value
of
an
investment
over
the
periods
shown.
It
includes
any
applicable
maximum
sales
charge,
Fund
expenses,
account
fees
and
reinvested
distributions.
The
unmanaged
indexes
include
reinvestment
of
any
income
or
distributions.
They
differ
from
the
Fund
in
composition
and
do
not
pay
management
fees
or
expenses.
One
cannot
invest
directly
in
an
index.
Class
A
(5/1/11–4/30/21)
Advisor
Class
(5/1/11–4/30/21)
Franklin
Small
Cap
Growth
Fund
Performance
Summary
14
franklintempleton.com
Annual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Smaller,
midsized
and
relatively
new
or
unseasoned
companies
can
be
particularly
sensitive
to
changing
economic
conditions,
and
their
prospects
for
growth
are
less
certain
than
those
of
larger,
more
established
companies.
Historically,
these
securities
have
experienced
more
price
volatility
than
larger-company
stocks,
especially
over
the
short
term.
Growth
stock
prices
reflect
projections
of
future
earnings
or
revenues,
and
can,
therefore,
fall
dramatically
if
the
company
fails
to
meet
those
projections.
To
the
extent
the
Fund
focuses
on
particular
countries,
regions,
industries,
sectors
or
types
of
investment
from
time
to
time,
it
may
be
subject
to
greater
risks
of
adverse
developments
in
such
areas
of
focus
than
a
fund
that
invests
in
a
wider
variety
of
countries,
regions,
industries,
sectors
or
investments.
From
time
to
time,
the
trading
market
for
a
particular
security
or
type
of
secu-
rity
in
which
the
Fund
invests
may
become
less
liquid
or
even
illiquid.
Events
such
as
the
spread
of
deadly
diseases,
disasters,
and
financial,
political
or
social
disruptions,
may
heighten
risks
and
adversely
affect
performance.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
waiver,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
5.
Source:
Morningstar.
The
Russell
2000
Growth
Index
is
market
capitalization
weighted
and
measures
performance
of
those
Russell
2000
Index
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
values.
The
S&P
500
is
a
market
capitalization-weighted
index
of
500
stocks
designed
to
measure
total
U.S.
equity
market
performance.
6.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Distributions
(5/1/20–4/30/21)
Share
Class
Short-Term
Capital
Gain
Long-Term
Capital
Gain
Total
A
$0.6140
$2.2158
$2.8298
C
$0.6140
$2.2158
$2.8298
R
$0.6140
$2.2158
$2.8298
R6
$0.6140
$2.2158
$2.8298
Advisor
$0.6140
$2.2158
$2.8298
Total
Annual
Operating
Expenses
6
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
1.07%
1.08%
Advisor
0.82%
0.83%
Your
Fund’s
Expenses
Franklin
Small
Cap
Growth
Fund
15
franklintempleton.com
Annual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration)
:
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6
).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
181/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
11/1/20
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
Ending
Account
Value
4/30/21
1,2
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,330.25
$5.80
$1,019.81
$5.03
1.00%
C
$1,000
$1,325.43
$10.10
$1,016.11
$8.76
1.75%
R
$1,000
$1,328.78
$7.24
$1,018.58
$6.27
1.25%
R6
$1,000
$1,332.90
$3.68
$1,021.64
$3.19
0.64%
Advisor
$1,000
$1,332.24
$4.37
$1,021.05
$3.79
0.76%
16
franklintempleton.com
Annual
Report
Franklin
Small-Mid
Cap
Growth
Fund
This
annual
report
for
Franklin
Small-Mid
Cap
Growth
Fund
covers
the
fiscal
year
ended
April
30,
2021.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
long-term
capital
growth.
Under
normal
market
conditions,
the
Fund
invests
at
least
80%
of
its
net
assets
in
the
equity
securities
of
small-cap
and
mid-
cap
companies.
For
this
Fund,
small-cap
companies
are
companies
within
the
market
capitalization
range
of
companies
in
the
Russell
2500
Index
at
the
time
of
purchase,
and
mid-cap
companies
are
companies
within
the
market
capitalization
range
of
companies
in
the
Russell
Midcap
®
Index
at
the
time
of
purchase.
1
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+68.37%
cumulative
total
return
for
the
12
months
under
review.
In
comparison,
the
Russell
Midcap
®
Growth
Index,
which
measures
performance
of
those
Russell
Midcap
®
Index
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
rates,
posted
a
+53.97%
total
return.
2
Also
in
comparison,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
tracks
the
broad
U.S.
stock
market,
posted
a
+45.98%
total
return.
2
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
18
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236.
Investment
Strategy
We
use
fundamental,
bottom-up
research
to
seek
companies
meeting
our
criteria
of
growth
potential,
quality
and
valuation.
In
seeking
sustainable
growth
characteristics,
we
look
for
companies
we
believe
can
produce
sustainable
earnings
and
cash
flow
growth,
evaluating
the
long-term
market
opportunity
and
competitive
structure
of
an
industry
to
target
leaders
and
emerging
leaders.
We
define
quality
companies
as
those
with
strong
and
improving
competitive
positions
in
attractive
markets.
We
also
believe
important
attributes
of
quality
are
experienced
and
talented
management
teams
as
well
as
financial
strength
reflected
in
the
capital
structure,
gross
and
operating
margins,
free
cash
flow
generation
and
returns
on
capital
employed.
Our
valuation
analysis
includes
a
range
of
potential
outcomes
based
on
an
assessment
of
multiple
scenarios.
In
assessing
value,
we
consider
whether
security
prices
fully
reflect
the
balance
of
the
sustainable
growth
opportunities
relative
to
business
and
financial
risks.
Manager’s
Discussion
During
the
12
months
under
review,
all
sectors
represented
in
the
Fund’s
portfolio
posted
positive
returns
and
contributed
to
absolute
performance.
Relative
to
the
Russell
Midcap
®
Growth
Index,
stock
selection
and
an
underweighting
in
the
information
technology
(IT)
sector,
stock
selection
and
an
overweighting
in
the
consumer
discretionary
sector
and
stock
selection
in
the
communication
services
sector
contributed
significantly
to
Fund
performance.
Portfolio
Composition
4/30/21
%
of
Total
Net
Assets
Software
18.0%
IT
Services
7.9%
Health
Care
Equipment
&
Supplies
7.2%
Semiconductors
&
Semiconductor
Equipment
6.3%
Professional
Services
5.8%
Capital
Markets
5.2%
Specialty
Retail
4.6%
Life
Sciences
Tools
&
Services
4.0%
Hotels,
Restaurants
&
Leisure
3.9%
Biotechnology
3.0%
Health
Care
Technology
2.5%
Entertainment
2.5%
Machinery
2.1%
Equity
Real
Estate
Investment
Trusts
(REITs)
2.1%
Other
21.4%
Short-Term
Investments
&
Other
Net
Assets
3.5%
1.
The
Russell
2500
Index
is
market
capitalization
weighted
and
measures
performance
of
the
2,500
smallest
companies
in
the
Russell
3000
Index,
which
represent
a
modest
amount
of
the
Russell
3000
Index’s
total
market
capitalization.
The
Russell
Midcap
Index
is
market
capitalization
weighted
and
measures
performance
of
the
smallest
companies
in
the
Russell
1000
Index,
which
represent
a
modest
amount
of
the
Russell
1000
Index’s
total
market
capitalization.
2.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
48
.
Franklin
Small-Mid
Cap
Growth
Fund
17
franklintempleton.com
Annual
Report
Within
IT,
our
investments
in
Twilio,
DocuSign
and
Cloudflare
were
leading
contributors
to
relative
returns.
The
novel
coronavirus
(COVID-19)
pandemic
increased
the
demand
for
Twilio’s
digital
communication
services
from
telehealth,
online
education,
remote
customer
care
and
food
delivery
companies,
among
others.
Subscription
revenue
and
billings
growth
were
positive
drivers
of
performance
for
electronic
signature
company
DocuSign.
While
the
company
is
benefiting
from
work-from-home-trends
in
the
near
term,
we
believe
there
is
a
large
and
underpenetrated
market
for
the
digital
transformation
of
contracts
and
other
types
of
agreements
that
require
e-signatures.
Shares
of
cloud-
security
specialist
Cloudflare,
which
provides
tools
that
enable
remote
work,
also
benefited
from
pandemic-related
shelter-in-place
mandates.
In
consumer
discretionary,
notable
relative
contributors
included
our
holdings
in
digital
sports
entertainment
and
gaming
company
DraftKings
(not
part
of
the
index)
and
Peloton
Interactive
(not
held
at
period-end).
DraftKings’
share
price
reached
record
highs
amid
positive
news
flow
that
included
the
announcement
of
an
exclusive
agreement
with
a
major
sports
media
company
to
provide
fantasy
sports
information.
Peloton
Interactive
saw
a
surge
in
demand
for
its
at-home,
connected
fitness
products.
In
the
communication
services
sector,
photo-sharing
website
operator
Pinterest
aided
relative
results.
In
contrast,
stock
selection
in
the
real
estate
and
industrials
sectors
detracted
from
the
Fund’s
relative
performance.
Within
real
estate,
wireless
telecommunications
tower
operator
SBA
Communications
underperformed
the
index
after
strong
outperformance
earlier
in
the
period.
We
believe
the
company
is
an
attractive
long-term
investment
opportunity
given
the
tower
industry’s
strong
barriers
to
entry
and
increasing
mobile
carrier
spending
on
5G
network
upgrades.
In
the
industrials
sector,
technology-focused
aerospace
and
defense
company
Mercury
Systems
faced
pandemic-driven
supply-side
headwinds
and
defense
budget
pressures.
Other
key
individual
detractors
from
the
Fund’s
relative
performance
included
our
positions
in
dentistry
products
manufacturer
Align
Technology,
biopharmaceutical
company
Reata
Pharmaceuticals
and
software,
data
and
analytics
solutions
provider
Black
Knight.
Align
Technology
faced
headwinds
during
closures
of
orthodontist
and
dentist
offices
during
the
pandemic
but
has
since
seen
strong
recovery
with
the
reopening
of
the
economy.
Its
shares
performed
strongly
during
the
period,
and
our
underweighting
hurt
relative
results.
The
share
price
of
Reata
Pharmaceuticals
declined
as
the
company
faced
U.S.
Food
and
Drug
Administration
hurdles
for
its
neurological
disorder
treatment.
Black
Knight
posted
positive
returns
that
underperformed
the
index,
and
our
overweighted
position
hindered
relative
results.
Thank
you
for
your
continued
participation
in
Franklin
Small-
Mid
Cap
Growth
Fund.
We
look
forward
to
serving
your
future
investment
needs.
John
P.
Scandalios,
CFA
Michael
P.
McCarthy,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
April
30,
2021,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Top
10
Holdings
4/30/21
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Synopsys,
Inc.
2.2%
Software,
United
States
IDEXX
Laboratories,
Inc.
2.1%
Health
Care
Equipment
&
Supplies,
United
States
DocuSign,
Inc.
1.8%
Software,
United
States
Verisk
Analytics,
Inc.
1.8%
Professional
Services,
United
States
CoStar
Group,
Inc.
1.8%
Professional
Services,
United
States
Okta
,
Inc.
1.7%
IT
Services,
United
States
MSCI,
Inc.
1.7%
Capital
Markets,
United
States
ANSYS,
Inc.
1.6%
Software,
United
States
SBA
Communications
Corp.
1.6%
Equity
Real
Estate
Investment
Trusts
(REITs),
United
States
Veeva
Systems,
Inc.
1.5%
Health
Care
Technology,
United
States
Performance
Summary
as
of
April
30,
2021
Franklin
Small-Mid
Cap
Growth
Fund
18
franklintempleton.com
Annual
Report
The
performance
table
and
graphs
do
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
04
/3
0
/2
1
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
1-Year
+68.37%
+59.11%
5-Year
+167.56%
+20.39%
10-Year
+265.08%
+13.18%
Advisor
1-Year
+68.77%
+68.77%
5-Year
+170.86%
+22.05%
10-Year
+274.29%
+14.11%
See
page
20
for
Performance
Summary
footnotes.
Franklin
Small-Mid
Cap
Growth
Fund
Performance
Summary
19
franklintempleton.com
Annual
Report
See
page
20
for
Performance
Summary
footnotes.
Total
Return
Index
Comparison
for
a
Hypothetical
$10,000
Investment
1
Total
return
represents
the
change
in
value
of
an
investment
over
the
periods
shown.
It
includes
any
applicable
maximum
sales
charge,
Fund
expenses,
account
fees
and
reinvested
distributions.
The
unmanaged
indexes
include
reinvestment
of
any
income
or
distributions.
They
differ
from
the
Fund
in
composition
and
do
not
pay
management
fees
or
expenses.
One
cannot
invest
directly
in
an
index.
Class
A
(5/1/11–4/30/21)
Advisor
Class
(5/1/11–4/30/21)
Franklin
Small-Mid
Cap
Growth
Fund
Performance
Summary
20
franklintempleton.com
Annual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Growth
stock
prices
reflect
projections
of
future
earnings
or
revenues,
and
can,
therefore,
fall
dramatically
if
the
company
fails
to
meet
those
projections.
Smaller,
midsized
and
relatively
new
or
unseasoned
companies
can
be
particularly
sensitive
to
changing
economic
conditions,
and
their
prospects
for
growth
are
less
certain
than
those
of
larger,
more
established
companies.
Historically,
these
securities
have
experienced
more
price
volatility
than
larger-company
stocks,
especially
over
the
short
term.
To
the
extent
the
Fund
focuses
on
particular
countries,
regions,
industries,
sectors
or
types
of
investment
from
time
to
time,
it
may
be
subject
to
greater
risks
of
adverse
developments
in
such
areas
of
focus
than
a
fund
that
invests
in
a
wider
variety
of
countries,
regions,
industries,
sectors
or
investments.
From
time
to
time,
the
trading
market
for
a
particular
security
or
type
of
security
in
which
the
Fund
invests
may
become
less
liquid
or
even
illiquid.
Events
such
as
the
spread
of
deadly
diseases,
disasters,
and
financial,
political
or
social
disruptions,
may
heighten
risks
and
adversely
affect
performance.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
waiver,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
5.
Source:
Morningstar.
The
Russell
Midcap
Growth
Index
is
market
capitalization
weighted
and
measures
performance
of
those
Russell
Midcap
Index
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
values.
The
S&P
500
is
a
market
capitalization-weighted
index
of
500
stocks
designed
to
measure
total
U.S.
equity
market
performance.
6.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Distributions
(5/1/20–4/30/21)
Share
Class
Short-Term
Capital
Gain
Long-Term
Capital
Gain
Total
A
$0.3626
$3.7786
$4.1412
C
$0.3626
$3.7786
$4.1412
R
$0.3626
$3.7786
$4.1412
R6
$0.3626
$3.7786
$4.1412
Advisor
$0.3626
$3.7786
$4.1412
Total
Annual
Operating
Expenses
6
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
0.88%
0.89%
Advisor
0.63%
0.64%
Your
Fund’s
Expenses
Franklin
Small-Mid
Cap
Growth
Fund
21
franklintempleton.com
Annual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6
).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
181/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
11/1/20
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,243.79
$4.73
$1,020.58
$4.26
0.85%
C
$1,000
$1,238.98
$8.82
$1,016.91
$7.95
1.59%
R
$1,000
$1,242.13
$5.93
$1,019.51
$5.34
1.07%
R6
$1,000
$1,245.84
$2.73
$1,022.41
$2.46
0.49%
Advisor
$1,000
$1,245.20
$3.32
$1,021.84
$2.99
0.60%
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
22
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$39.60
$39.57
$38.58
$34.81
$30.40
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.26)
(0.14)
(0.13)
(0.10)
(0.09)
Net
realized
and
unrealized
gains
(losses)
...........
20.03
3.59
5.29
7.03
5.14
Total
from
investment
operations
....................
19.77
3.45
5.16
6.93
5.05
Less
distributions
from:
Net
realized
gains
.............................
(3.12)
(3.42)
(4.17)
(3.16)
(0.64)
Net
asset
value,
end
of
year
.......................
$56.25
$39.60
$39.57
$38.58
$34.81
Total
return
c
...................................
50.64%
8.90%
15.91%
20.43%
16.88%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.91%
0.95%
0.94%
1.02%
1.05%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
0.91%
e
0.95%
e
0.94%
e
0.99%
0.97%
Net
investment
(loss)
............................
(0.51)%
(0.35)%
(0.32)%
(0.27)%
(0.30)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$4,203,693
$2,883,392
$2,819,007
$2,428,175
$2,272,831
Portfolio
turnover
rate
............................
17.54%
19.47%
24.21%
22.68%
47.75%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
23
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$31.61
$32.47
$32.67
$30.12
$26.59
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.50)
(0.35)
(0.35)
(0.33)
(0.29)
Net
realized
and
unrealized
gains
(losses)
...........
15.88
2.91
4.32
6.04
4.46
Total
from
investment
operations
....................
15.38
2.56
3.97
5.71
4.17
Less
distributions
from:
Net
realized
gains
.............................
(3.12)
(3.42)
(4.17)
(3.16)
(0.64)
Net
asset
value,
end
of
year
.......................
$43.87
$31.61
$32.47
$32.67
$30.12
Total
return
c
...................................
49.47%
8.10%
15.10%
19.53%
15.98%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.66%
1.70%
1.69%
1.77%
1.80%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
1.66%
e
1.70%
e
1.69%
e
1.74%
1.72%
Net
investment
(loss)
............................
(1.26)%
(1.10)%
(1.07)%
(1.02)%
(1.05)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$278,804
$216,757
$244,574
$400,295
$390,123
Portfolio
turnover
rate
............................
17.54%
19.47%
24.21%
22.68%
47.75%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
24
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$37.32
$37.57
$36.93
$33.52
$29.37
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.36)
(0.22)
(0.21)
(0.18)
(0.17)
Net
realized
and
unrealized
gains
(losses)
...........
18.85
3.39
5.02
6.75
4.96
Total
from
investment
operations
....................
18.49
3.17
4.81
6.57
4.79
Less
distributions
from:
Net
realized
gains
.............................
(3.12)
(3.42)
(4.17)
(3.16)
(0.64)
Net
asset
value,
end
of
year
.......................
$52.69
$37.32
$37.57
$36.93
$33.52
Total
return
....................................
50.26%
8.64%
15.66%
20.14%
16.62%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.15%
1.20%
1.19%
1.27%
1.30%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
1.15%
d
1.20%
d
1.19%
d
1.24%
1.22%
Net
investment
(loss)
............................
(0.75)%
(0.60)%
(0.57)%
(0.52)%
(0.55)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$40,396
$31,060
$37,105
$36,582
$50,429
Portfolio
turnover
rate
............................
17.54%
19.47%
24.21%
22.68%
47.75%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
25
In
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$43.97
$43.42
$41.78
$37.30
$32.39
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
....................
(0.10)
0.01
0.01
0.07
0.05
Net
realized
and
unrealized
gains
(losses)
...........
22.31
3.96
5.80
7.57
5.50
Total
from
investment
operations
....................
22.21
3.97
5.81
7.64
5.55
Less
distributions
from:
Net
realized
gains
.............................
(3.12)
(3.42)
(4.17)
(3.16)
(0.64)
Net
asset
value,
end
of
year
.......................
$63.06
$43.97
$43.42
$41.78
$37.30
Total
return
....................................
51.13%
9.34%
16.26%
20.98%
17.42%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.57%
0.59%
0.59%
0.58%
0.59%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.57%
d
0.59%
d
0.58%
0.55%
0.51%
Net
investment
income
(loss)
......................
(0.17)%
0.01%
0.04%
0.17%
0.16%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$563,918
$383,208
$418,174
$369,688
$291,825
Portfolio
turnover
rate
............................
17.54%
19.47%
24.21%
22.68%
47.75%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
26
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$43.31
$42.87
$41.34
$37.02
$32.20
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.14)
(0.04)
(0.03)
(0.01)
(0.02)
Net
realized
and
unrealized
gains
(losses)
...........
21.96
3.90
5.73
7.49
5.48
Total
from
investment
operations
....................
21.82
3.86
5.70
7.48
5.46
Less
distributions
from:
Net
realized
gains
.............................
(3.12)
(3.42)
(4.17)
(3.16)
(0.64)
Net
asset
value,
end
of
year
.......................
$62.01
$43.31
$42.87
$41.34
$37.02
Total
return
....................................
51.01%
9.20%
16.16%
20.71%
17.21%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.66%
0.70%
0.69%
0.77%
0.80%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.66%
d
0.70%
d
0.69%
d
0.74%
0.72%
Net
investment
(loss)
............................
(0.26)%
(0.10)%
(0.07)%
(0.02)%
(0.05)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$643,449
$467,727
$506,964
$583,509
$537,193
Portfolio
turnover
rate
............................
17.54
%
19.47%
24.21%
22.68%
47.75%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments,
April
30,
2021
Franklin
Growth
Opportunities
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
27
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
95.2%
Auto
Components
0.5%
a
Aptiv
plc
............................................
United
States
193,320
$
27,816,815
Automobiles
1.0%
a
Tesla,
Inc.
...........................................
United
States
80,258
56,938,235
Beverages
1.4%
Constellation
Brands,
Inc.,
A
.............................
United
States
189,213
45,471,668
a
Monster
Beverage
Corp.
................................
United
States
331,280
32,150,724
77,622,392
Biotechnology
2.3%
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
172,150
7,982,595
a
Heron
Therapeutics,
Inc.
................................
United
States
2,090,035
36,533,812
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
268,504
8,441,766
a
Novavax
,
Inc.
........................................
United
States
252,352
59,789,759
a
PTC
Therapeutics,
Inc.
.................................
United
States
466,661
19,231,100
131,979,032
Capital
Markets
7.0%
a,b,c,d
ArcLight
Clean
Transition
Corp.
...........................
United
States
477,500
7,563,276
a,b,c,d,e
Aspirational
Consumer
Lifestyle
Corp.
......................
Singapore
3,500,000
35,000,000
a,b,c,d
Churchill
Capital
Corp.
IV
...............................
United
States
2,167,003
32,505,045
a
Coinbase
Global,
Inc.,
A
................................
United
States
38,300
11,399,612
a
Dragoneer
Growth
Opportunities
Corp.
.....................
United
States
1,112,700
11,828,001
a,b,c,d
Dragoneer
Growth
Opportunities
Corp.
II
....................
United
States
416,700
4,167,000
Intercontinental
Exchange,
Inc.
...........................
United
States
334,839
39,413,899
MarketAxess
Holdings,
Inc.
..............................
United
States
85,572
41,798,499
MSCI,
Inc.
...........................................
United
States
203,644
98,924,146
S&P
Global,
Inc.
......................................
United
States
195,666
76,386,050
a
Soaring
Eagle
Acquisition
Corp.
..........................
United
States
1,160,400
12,543,924
a,f
Social
Capital
Hedosophia
Holdings
Corp.
V,
A
...............
United
States
1,385,827
23,559,059
a
TPG
Pace
Beneficial
II
Corp.,
A
...........................
United
States
662,600
6,692,260
401,780,771
Chemicals
1.3%
Ecolab,
Inc.
..........................................
United
States
126,472
28,344,905
Linde
plc
............................................
United
Kingdom
156,944
44,860,873
73,205,778
Commercial
Services
&
Supplies
0.8%
a,b,c
Legalzoom.com,
Inc.
...................................
United
States
1,673,284
26,204,625
Republic
Services,
Inc.
.................................
United
States
158,671
16,866,727
43,071,352
Electric
Utilities
0.5%
NextEra
Energy,
Inc.
...................................
United
States
336,418
26,075,759
Entertainment
0.6%
a
Walt
Disney
Co.
(The)
..................................
United
States
191,533
35,628,969
Equity
Real
Estate
Investment
Trusts
(REITs)
2.4%
American
Tower
Corp.
..................................
United
States
92,470
23,558,582
SBA
Communications
Corp.
.............................
United
States
377,164
113,043,594
136,602,176
Food
Products
1.5%
a
Freshpet
,
Inc.
........................................
United
States
207,987
38,440,157
Lamb
Weston
Holdings,
Inc.
.............................
United
States
359,009
28,900,224
a
Nomad
Foods
Ltd.
....................................
United
Kingdom
724,298
21,120,530
88,460,911
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
28
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Health
Care
Equipment
&
Supplies
6.6%
Danaher
Corp.
.......................................
United
States
276,594
$
70,238,280
a
Edwards
Lifesciences
Corp.
.............................
United
States
556,359
53,143,412
a
IDEXX
Laboratories,
Inc.
................................
United
States
98,571
54,114,493
a
Intuitive
Surgical,
Inc.
..................................
United
States
52,921
45,776,665
a
Nevro
Corp.
.........................................
United
States
279,993
48,385,590
West
Pharmaceutical
Services,
Inc.
........................
United
States
319,842
105,074,494
376,732,934
Health
Care
Providers
&
Services
2.3%
a
Guardant
Health,
Inc.
..................................
United
States
170,094
27,041,544
UnitedHealth
Group,
Inc.
................................
United
States
263,010
104,888,388
131,929,932
Health
Care
Technology
1.8%
a
Veeva
Systems,
Inc.,
A
.................................
United
States
366,940
103,642,203
Hotels,
Restaurants
&
Leisure
2.1%
a,f
Airbnb,
Inc.,
A
........................................
United
States
22,400
3,868,704
a
Booking
Holdings,
Inc.
.................................
United
States
13,169
32,475,807
a
Chipotle
Mexican
Grill,
Inc.
..............................
United
States
46,523
69,413,712
Starbucks
Corp.
......................................
United
States
133,795
15,318,190
121,076,413
Industrial
Conglomerates
1.5%
Honeywell
International,
Inc.
.............................
United
States
161,234
35,961,632
Roper
Technologies,
Inc.
................................
United
States
113,478
50,661,118
86,622,750
Interactive
Media
&
Services
3.9%
a
Alphabet,
Inc.,
C
......................................
United
States
65,168
157,062,700
a
Bumble,
Inc.,
A
.......................................
United
States
76,700
4,620,408
a
Facebook,
Inc.,
A
.....................................
United
States
142,781
46,415,248
a
ZoomInfo
Technologies,
Inc.,
A
...........................
United
States
302,278
15,676,137
223,774,493
Internet
&
Direct
Marketing
Retail
9.1%
a
Amazon.com,
Inc.
.....................................
United
States
141,519
490,705,811
a,f
Coupang
,
Inc.
........................................
South
Korea
452,500
18,959,750
b,c
Marqeta
,
Inc.
.........................................
United
States
1,196,245
11,524,036
521,189,597
IT
Services
13.8%
a
Black
Knight,
Inc.
.....................................
United
States
360,298
26,092,781
Mastercard
,
Inc.,
A
....................................
United
States
634,990
242,604,279
a
Okta
,
Inc.
...........................................
United
States
96,161
25,934,622
a
PayPal
Holdings,
Inc.
..................................
United
States
439,575
115,296,127
a
Shopify,
Inc.,
A
.......................................
Canada
50,064
59,201,181
a
Snowflake,
Inc.,
A
.....................................
United
States
132,704
30,732,919
a
Twilio
,
Inc.,
A
.........................................
United
States
295,928
108,842,318
Visa,
Inc.,
A
..........................................
United
States
784,241
183,167,328
791,871,555
Life
Sciences
Tools
&
Services
1.2%
a
Illumina,
Inc.
.........................................
United
States
69,033
27,118,924
a
Maravai
LifeSciences
Holdings,
Inc.,
A
.....................
United
States
131,900
5,132,229
a,g
Wuxi
Biologics
Cayman,
Inc.,
144A,
Reg
S
..................
China
2,794,182
39,224,154
71,475,307
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
29
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Media
0.7%
a
Liberty
Broadband
Corp.,
C
..............................
United
States
246,590
$
40,125,125
Pharmaceuticals
1.7%
AstraZeneca
plc,
ADR
..................................
United
Kingdom
648,172
34,398,488
a
Catalent
,
Inc.
........................................
United
States
345,883
38,901,461
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
114,500
11,610,300
Royalty
Pharma
plc,
A
..................................
United
States
325,046
14,302,024
99,212,273
Professional
Services
3.9%
a
CoStar
Group,
Inc.
....................................
United
States
135,573
115,837,639
TransUnion
..........................................
United
States
278,366
29,114,300
Verisk
Analytics,
Inc.
...................................
United
States
418,506
78,762,829
223,714,768
Road
&
Rail
0.9%
Union
Pacific
Corp.
....................................
United
States
243,411
54,059,149
Semiconductors
&
Semiconductor
Equipment
3.8%
Analog
Devices,
Inc.
...................................
United
States
250,576
38,378,220
Monolithic
Power
Systems,
Inc.
...........................
United
States
178,021
64,333,229
NVIDIA
Corp.
........................................
United
States
187,780
112,739,357
215,450,806
Software
16.6%
a
Adobe,
Inc.
..........................................
United
States
210,947
107,232,798
a
AppLovin
Corp.,
A
.....................................
United
States
175,800
10,198,158
a
Atlassian
Corp.
plc,
A
..................................
United
States
80,156
19,041,859
a
Autodesk,
Inc.
........................................
United
States
71,892
20,985,994
a
Avalara,
Inc.
.........................................
United
States
38,000
5,384,980
a,b,c,e
Avidxchange
,
Inc.
.....................................
United
States
255,039
13,792,310
a
Bill.com
Holdings,
Inc.
..................................
United
States
560,964
86,741,863
a
DocuSign,
Inc.
.......................................
United
States
138,218
30,814,321
Intuit,
Inc.
...........................................
United
States
89,127
36,734,584
Microsoft
Corp.
.......................................
United
States
932,532
235,165,920
a
Paycom
Software,
Inc.
.................................
United
States
66,255
25,469,085
a
PTC,
Inc.
...........................................
United
States
278,539
36,471,897
a
salesforce.com,
Inc.
...................................
United
States
200,696
46,224,303
a
ServiceNow
,
Inc.
......................................
United
States
277,265
140,398,678
a
Synopsys,
Inc.
.......................................
United
States
171,819
42,449,602
a
Tyler
Technologies,
Inc.
.................................
United
States
71,470
30,364,744
a,f
UiPath
,
Inc.,
A
........................................
United
States
60,300
4,341,600
a
Workday,
Inc.,
A
......................................
United
States
127,073
31,387,031
a
Zendesk
,
Inc.
........................................
United
States
185,645
27,132,017
950,331,744
Specialty
Retail
0.3%
a
Burlington
Stores,
Inc.
..................................
United
States
51,461
16,793,268
Technology
Hardware,
Storage
&
Peripherals
3.7%
Apple,
Inc.
..........................................
United
States
1,619,864
212,947,321
Textiles,
Apparel
&
Luxury
Goods
1.0%
a,b,c
Figs,
Inc.
............................................
United
States
230,802
20,963,721
NIKE,
Inc.,
B
.........................................
United
States
259,006
34,349,376
55,313,097
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
30
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Wireless
Telecommunication
Services
1.0%
a
T-Mobile
US,
Inc.
.....................................
United
States
434,596
$
57,423,169
Total
Common
Stocks
(Cost
$1,923,137,557)
....................................
5,452,868,094
Convertible
Preferred
Stocks
1.0%
Internet
&
Direct
Marketing
Retail
0.5%
a,b,c
Fanatics,
Inc.,
E
......................................
United
States
920,577
24,109,411
a,b,c
Fanatics,
Inc.,
F
......................................
United
States
109,362
3,748,614
27,858,025
Software
0.5%
a,b,c
Databricks
,
Inc.,
G
....................................
United
States
112,760
20,894,425
a,b,c
OneTrust
LLC,
C
......................................
United
States
517,056
10,139,623
31,034,048
Total
Convertible
Preferred
Stocks
(Cost
$49,869,857)
...........................
58,892,073
Preferred
Stocks
4.0%
Airlines
0.4%
a,b,c,e
Wheels
Up
Partners
LLC,
D
.............................
United
States
5,028,735
22,526,068
a
Automobiles
0.9%
a,b,c
Proterra
,
Inc.,
144A,
5
..................................
United
States
2,362,202
30,364,751
a,b,c
Proterra
,
Inc.,
144A,
6
..................................
United
States
596,775
7,671,200
a,b,c
Proterra
,
Inc.,
7
.......................................
United
States
780,667
10,035,026
a,b,c
Proterra
,
Inc.,
8
.......................................
United
States
289,016
3,715,135
51,786,112
Commercial
Services
&
Supplies
0.2%
a,b,c,e
Optoro
,
Inc.,
E
.......................................
United
States
509,182
12,164,900
a
Food
&
Staples
Retailing
0.3%
a,b,c
Sweetgreen
,
Inc.,
H
...................................
United
States
928,488
13,901,189
a,b,c
Sweetgreen
,
Inc.,
I
....................................
United
States
100,835
1,718,144
a,b,c
Sweetgreen
,
Inc.,
J
....................................
United
States
76,670
1,306,392
16,925,725
Health
Care
Providers
&
Services
0.5%
a,b,c,e
Tempus
Labs,
Inc.,
F
...................................
United
States
504,854
22,633,975
a,b,c,e
Tempus
Labs,
Inc.,
G
..................................
United
States
126,131
5,814,771
28,448,746
Internet
&
Direct
Marketing
Retail
0.1%
a,b,c
Marqeta
,
Inc.,
A
.......................................
United
States
181,494
1,748,424
a,b,c
Marqeta
,
Inc.,
B
......................................
United
States
19,136
184,347
1,932,771
IT
Services
0.3%
a,b,c,e
HashiCorp
,
Inc.,
E
.....................................
United
States
415,102
19,097,102
a
Software
1.3%
a,b,c,e
ClearMotion
,
Inc.,
C
...................................
United
States
2,610,594
7,703,411
a,b,c,e
ClearMotion
,
Inc.,
D
...................................
United
States
3,698,772
11,706,569
a,b,c
Confluent,
Inc.,
E
.....................................
United
States
642,459
10,233,034
a,b,c
Gitlab
,
Inc.,
E
........................................
United
States
201,294
8,909,283
a,b,c,e
Talkdesk
,
Inc.,
C
......................................
United
States
1,753,060
28,638,800
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
31
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
(continued)
Software
(continued)
a,b,c
Tanium,
Inc.,
G
.......................................
United
States
805,800
$
9,206,398
76,397,495
Total
Preferred
Stocks
(Cost
$141,131,271)
.....................................
229,278,919
Warrants
Warrants
0.0%
Food
&
Staples
Retailing
0.0%
a,b,c
Sweetgreen
,
Inc.,
1/20/26
...............................
United
States
23,001
Total
Warrants
(Cost
$—)
.....................................................
Total
Long
Term
Investments
(Cost
$2,114,138,685)
.............................
5,741,039,086
a
Short
Term
Investments
2.2%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
1.3%
h,i
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
74,672,064
74,672,064
Total
Money
Market
Funds
(Cost
$74,672,064)
..................................
74,672,064
a
a
a
a
a
j
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.9%
Money
Market
Funds
0.9%
h,i
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
50,044,540
50,044,540
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$50,044,540)
...........................................................
50,044,540
Total
Short
Term
Investments
(Cost
$124,716,604
)
...............................
124,716,604
a
Total
Investments
(Cost
$2,238,855,289)
102.4%
................................
$5,865,755,690
Other
Assets,
less
Liabilities
(2.4)%
...........................................
(135,495,857)
Net
Assets
100.0%
...........................................................
$5,730,259,833
See
Abbreviations
on
page
86
.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
11
regarding
fair
value
measurements.
c
See
Note
8
regarding
restricted
securities.
d
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1
(
c
).
e
See
Note
9
regarding
holdings
of
5%
voting
securities.
f
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2021.
See
Note
1
(
d
).
g
Security
was
purchased
pursuant
to
Rule
1
44A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
April
30,
2021,
the
aggregate
value
of
these
securities
was
$39,224,154,
representing
0.7%
of
net
assets.
h
See
Note
3
(
f
)
regarding
investments
in
affiliated
management
investment
companies.
i
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
j
See
Note
1
(
d
)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
32
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$18.85
$21.46
$23.01
$19.60
$16.37
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.18)
(0.11)
(0.15)
(0.13)
(0.11)
Net
realized
and
unrealized
gains
(losses)
...........
14.24
(1.07)
2.86
3.96
3.34
Total
from
investment
operations
....................
14.06
(1.18)
2.71
3.83
3.23
Less
distributions
from:
Net
realized
gains
.............................
(2.83)
(1.43)
(4.26)
(0.42)
Net
asset
value,
end
of
year
.......................
$30.08
$18.85
$21.46
$23.01
$19.60
Total
return
c
...................................
76.43%
(6.25)%
16.06%
19.71%
19.73%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.03%
1.07%
1.07%
1.11%
1.10%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
1.02%
1.06%
1.06%
1.10%
1.08%
Net
investment
(loss)
............................
(0.69)%
(0.51)%
(0.68)%
(0.61)%
(0.61)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$1,244,591
$686,791
$713,442
$665,251
$719,752
Portfolio
turnover
rate
............................
47.80%
35.29%
42.10%
29.82%
29.93%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
33
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$14.69
$17.15
$19.41
$16.71
$14.07
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.29)
(0.21)
(0.28)
(0.25)
(0.21)
Net
realized
and
unrealized
gains
(losses)
...........
11.00
(0.82)
2.28
3.37
2.85
Total
from
investment
operations
....................
10.71
(1.03)
2.00
3.12
2.64
Less
distributions
from:
Net
realized
gains
.............................
(2.83)
(1.43)
(4.26)
(0.42)
Net
asset
value,
end
of
year
.......................
$22.57
$14.69
$17.15
$19.41
$16.71
Total
return
c
...................................
75.13%
(6.97)%
15.31%
18.79%
18.76%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.78%
1.82%
1.82%
1.86%
1.85%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
1.77%
1.81%
1.81%
1.85%
1.83%
Net
investment
(loss)
............................
(1.43)%
(1.26)%
(1.43)%
(1.36)%
(1.36)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$86,394
$66,269
$90,513
$132,116
$142,539
Portfolio
turnover
rate
............................
47.80%
35.29%
42.10%
29.82%
29.93%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
34
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$17.58
$20.15
$21.93
$18.74
$15.70
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.23)
(0.15)
(0.20)
(0.17)
(0.15)
Net
realized
and
unrealized
gains
(losses)
...........
13.24
(0.99)
2.68
3.78
3.19
Total
from
investment
operations
....................
13.01
(1.14)
2.48
3.61
3.04
Less
distributions
from:
Net
realized
gains
.............................
(2.83)
(1.43)
(4.26)
(0.42)
Net
asset
value,
end
of
year
.......................
$27.76
$17.58
$20.15
$21.93
$18.74
Total
return
....................................
75.96%
(6.47)%
15.78%
19.37%
19.36%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.28%
1.32%
1.32%
1.36%
1.35%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
1.27%
1.31%
1.31%
1.35%
1.33%
Net
investment
(loss)
............................
(0.93)%
(0.76)%
(0.93)%
(0.86)%
(0.86)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$79,314
$54,369
$74,634
$71,398
$79,995
Portfolio
turnover
rate
............................
47.80%
35.29%
42.10%
29.82%
29.93%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
35
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$21.07
$23.73
$24.88
$21.06
$17.52
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.09)
(0.02)
(0.07)
(0.03)
(0.03)
Net
realized
and
unrealized
gains
(losses)
...........
15.99
(1.21)
3.18
4.27
3.57
Total
from
investment
operations
....................
15.90
(1.23)
3.11
4.24
3.54
Less
distributions
from:
Net
realized
gains
.............................
(2.83)
(1.43)
(4.26)
(0.42)
Net
asset
value,
end
of
year
.......................
$34.14
$21.07
$23.73
$24.88
$21.06
Total
return
....................................
77.13%
(5.86)%
16.50%
20.23%
20.21%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.65%
0.67%
0.67%
0.65%
0.63%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.64%
0.64%
0.64%
0.63%
0.61%
Net
investment
(loss)
............................
(0.31)%
(0.09)%
(0.26)%
(0.14)%
(0.14)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$2,149,795
$1,136,759
$1,084,442
$935,509
$858,972
Portfolio
turnover
rate
............................
47.80%
35.29%
42.10%
29.82%
29.93%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
36
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$20.70
$23.37
$24.61
$20.88
$17.41
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.13)
(0.06)
(0.10)
(0.08)
(0.07)
Net
realized
and
unrealized
gains
(losses)
...........
15.69
(1.18)
3.12
4.23
3.54
Total
from
investment
operations
....................
15.56
(1.24)
3.02
4.15
3.47
Less
distributions
from:
Net
realized
gains
.............................
(2.83)
(1.43)
(4.26)
(0.42)
Net
asset
value,
end
of
year
.......................
$33.43
$20.70
$23.37
$24.61
$20.88
Total
return
....................................
76.86%
(5.99)%
16.30%
19.97%
19.93%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.78%
0.82%
0.82%
0.86%
0.85%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.77%
0.81%
0.81%
0.85%
0.83%
Net
investment
(loss)
............................
(0.44
)%
(0.26)%
(0.43)%
(0.36)%
(0.36)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$739,985
$428,155
$725,622
$713,135
$805,661
Portfolio
turnover
rate
............................
47.80%
35.29%
42.10%
29.82%
29.93%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments,
April
30,
2021
Franklin
Small
Cap
Growth
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
37
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
93.0%
Aerospace
&
Defense
2.7%
a
Axon
Enterprise,
Inc.
...................................
United
States
114,200
$
17,313,862
BWX
Technologies,
Inc.
................................
United
States
753,600
50,430,912
a
Kratos
Defense
&
Security
Solutions,
Inc.
...................
United
States
690,264
18,457,659
a
Mercury
Systems,
Inc.
..................................
United
States
401,116
30,179,968
116,382,401
Airlines
1.8%
a
Allegiant
Travel
Co.
....................................
United
States
337,748
79,617,336
Banks
2.7%
Pinnacle
Financial
Partners,
Inc.
..........................
United
States
659,804
57,825,223
Western
Alliance
Bancorp
...............................
United
States
569,500
59,837,365
117,662,588
Biotechnology
9.8%
a,b
Alector
,
Inc.
..........................................
United
States
1,110,100
21,646,950
a
Arcutis
Biotherapeutics
,
Inc.
.............................
United
States
329,800
11,048,300
a
Ascendis
Pharma
A/S,
ADR
.............................
Denmark
178,900
25,935,133
a
Blueprint
Medicines
Corp.
...............................
United
States
203,800
19,630,016
a
Cullinan
Oncology,
Inc.
.................................
United
States
241,500
7,839,090
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
507,400
23,528,138
a
Dyne
Therapeutics,
Inc.
................................
United
States
377,400
7,427,232
a
Emergent
BioSolutions
,
Inc.
.............................
United
States
257,068
15,676,006
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
488,700
19,929,186
a
Harpoon
Therapeutics,
Inc.
..............................
United
States
493,300
11,168,312
a
Heron
Therapeutics,
Inc.
................................
United
States
1,775,508
31,035,880
a
Insmed
,
Inc.
.........................................
United
States
673,400
22,713,782
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
1,165,300
36,637,032
a
KalVista
Pharmaceuticals,
Inc.
...........................
United
States
378,900
9,461,133
a
Karuna
Therapeutics,
Inc.
...............................
United
States
88,900
9,868,789
a
Kura
Oncology,
Inc.
....................................
United
States
434,900
11,711,857
a
Mirati
Therapeutics,
Inc.
................................
United
States
205,495
34,157,379
a
PTC
Therapeutics,
Inc.
.................................
United
States
881,000
36,306,010
a
Rocket
Pharmaceuticals,
Inc.
............................
United
States
319,000
14,622,960
a
Sutro
Biopharma,
Inc.
..................................
United
States
956,549
19,618,820
a,b
Taysha
Gene
Therapies,
Inc.
.............................
United
States
372,000
9,601,320
a,b
Trillium
Therapeutics,
Inc.
...............................
Canada
717,900
6,827,229
a
Twist
Bioscience
Corp.
.................................
United
States
118,362
15,882,997
422,273,551
Building
Products
1.0%
a
Masonite
International
Corp.
.............................
United
States
344,200
43,469,018
Capital
Markets
4.3%
a,c,d,e
ArcLight
Clean
Transition
Corp.
...........................
United
States
336,400
5,328,348
Ares
Management
Corp.
................................
United
States
415,800
21,837,816
Artisan
Partners
Asset
Management,
Inc.,
A
.................
United
States
266,772
13,584,030
a,c,d,e,f
Aspirational
Consumer
Lifestyle
Corp.
......................
Singapore
2,000,000
20,000,000
Evercore
,
Inc.,
A
......................................
United
States
301,000
42,179,130
Houlihan
Lokey
,
Inc.
...................................
United
States
545,000
36,117,150
a,c,d,e
Spartan
Acquisition
Corp.
II,
A
............................
United
States
714,286
7,142,860
a,c,d,f
TPG
Pace
Governance
LLC,
A
...........................
United
States
2,500,000
25,000,000
a
TPG
Pace
Solutions
Corp.
..............................
United
States
1,230,000
12,484,500
183,673,834
Commercial
Services
&
Supplies
1.8%
a,b
ACV
Auctions,
Inc.,
A
..................................
United
States
22,000
747,780
Healthcare
Services
Group,
Inc.
..........................
United
States
822,800
24,642,860
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
38
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Commercial
Services
&
Supplies
(continued)
a,c,d
Legalzoom.com,
Inc.
...................................
United
States
1,431,280
$
22,414,698
a
US
Ecology,
Inc.
......................................
United
States
729,376
30,969,305
78,774,643
Communications
Equipment
1.8%
a
Viasat
,
Inc.
..........................................
United
States
807,612
41,826,225
a
Viavi
Solutions,
Inc.
....................................
United
States
2,253,900
36,873,804
78,700,029
Construction
&
Engineering
2.1%
Arcosa
,
Inc.
.........................................
United
States
903,800
54,490,102
Granite
Construction,
Inc.
...............................
United
States
951,550
36,254,055
90,744,157
Consumer
Finance
0.7%
a
PRA
Group,
Inc.
......................................
United
States
775,900
29,235,912
Diversified
Consumer
Services
1.2%
a
Grand
Canyon
Education,
Inc.
............................
United
States
460,600
49,878,374
Electronic
Equipment,
Instruments
&
Components
0.8%
a
Vontier
Corp.
.........................................
United
States
1,077,800
33,778,252
Equity
Real
Estate
Investment
Trusts
(REITs)
1.7%
Pebblebrook
Hotel
Trust
................................
United
States
986,200
23,550,456
Rexford
Industrial
Realty,
Inc.
............................
United
States
897,100
49,833,905
73,384,361
Food
&
Staples
Retailing
1.8%
a
Grocery
Outlet
Holding
Corp.
............................
United
States
1,125,394
45,454,664
a
Performance
Food
Group
Co.
............................
United
States
582,943
34,218,754
79,673,418
Food
Products
3.0%
a
Freshpet
,
Inc.
........................................
United
States
175,100
32,361,982
a
Hostess
Brands,
Inc.
...................................
United
States
937,300
14,331,317
a
Nomad
Foods
Ltd.
....................................
United
Kingdom
1,212,000
35,341,920
a
Simply
Good
Foods
Co.
(The)
............................
United
States
1,385,500
47,869,025
129,904,244
Health
Care
Equipment
&
Supplies
4.6%
a
CryoPort
,
Inc.
........................................
United
States
217,800
12,320,946
a
Haemonetics
Corp.
....................................
United
States
249,600
16,788,096
a
Inari
Medical,
Inc.
.....................................
United
States
182,400
20,846,496
a
Integer
Holdings
Corp.
.................................
United
States
521,400
48,949,032
a
iRhythm
Technologies,
Inc.
..............................
United
States
135,097
10,518,652
a
Neogen
Corp.
........................................
United
States
165,466
15,886,391
a
Nevro
Corp.
.........................................
United
States
204,300
35,305,083
a
Penumbra,
Inc.
.......................................
United
States
89,700
27,447,303
a
Pulmonx
Corp.
.......................................
United
States
185,400
8,715,654
196,777,653
Health
Care
Providers
&
Services
3.6%
a
1Life
Healthcare,
Inc.
..................................
United
States
1,009,512
43,923,867
a
Accolade,
Inc.
........................................
United
States
650,500
32,622,575
a
HealthEquity
,
Inc.
.....................................
United
States
473,016
35,935,025
a,b
Hims
&
Hers
Health,
Inc.
................................
United
States
1,652,200
20,454,236
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
39
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Health
Care
Providers
&
Services
(continued)
a
Signify
Health,
Inc.,
A
..................................
United
States
733,756
$
20,801,983
153,737,686
Health
Care
Technology
3.3%
a
Certara
,
Inc.
.........................................
United
States
903,200
28,730,792
a
Inspire
Medical
Systems,
Inc.
............................
United
States
278,844
66,035,836
a
Phreesia
,
Inc.
........................................
United
States
880,382
45,559,769
140,326,397
Hotels,
Restaurants
&
Leisure
3.6%
Extended
Stay
America,
Inc.
.............................
United
States
1,048,000
20,844,720
a
Red
Rock
Resorts,
Inc.,
A
...............................
United
States
1,243,300
45,542,079
a
Texas
Roadhouse,
Inc.
.................................
United
States
428,100
45,815,262
Wingstop
,
Inc.
........................................
United
States
274,229
43,440,616
155,642,677
Household
Durables
2.8%
a,b
Cricut
,
Inc.,
A
........................................
United
States
452,000
11,978,000
a
M/I
Homes,
Inc.
.......................................
United
States
976,546
68,084,787
a
Tri
Pointe
Homes,
Inc.
..................................
United
States
1,670,300
39,786,546
119,849,333
Insurance
0.7%
a
Selectquote
,
Inc.
......................................
United
States
995,800
30,999,254
Internet
&
Direct
Marketing
Retail
0.3%
a,c,d
Marqeta
,
Inc.
.........................................
United
States
1,199,415
11,554,574
IT
Services
4.0%
a
Cantaloupe,
Inc.
......................................
United
States
2,469,265
25,556,893
a
LiveRamp
Holdings,
Inc.
................................
United
States
780,400
38,223,992
a
Paya
Holdings,
Inc.,
A
..................................
United
States
2,365,200
26,395,632
a
Repay
Holdings
Corp.
..................................
United
States
1,618,400
36,980,440
a
Shift4
Payments,
Inc.,
A
................................
United
States
460,200
45,509,178
172,666,135
Life
Sciences
Tools
&
Services
1.9%
a
Akoya
Biosciences,
Inc.
................................
United
States
374,100
8,394,804
a
Berkeley
Lights,
Inc.
...................................
United
States
465,900
22,880,349
a
NeoGenomics
,
Inc.
....................................
United
States
1,017,300
49,837,527
81,112,680
Machinery
1.8%
Kennametal,
Inc.
......................................
United
States
1,256,200
50,448,992
a
RBC
Bearings,
Inc.
....................................
United
States
136,600
27,242,138
77,691,130
Personal
Products
0.8%
a
BellRing
Brands,
Inc.,
A
.................................
United
States
1,261,200
32,526,348
Pharmaceuticals
1.4%
a
EyePoint
Pharmaceuticals,
Inc.
...........................
United
States
832,000
8,894,080
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
236,574
23,988,604
a
Revance
Therapeutics,
Inc.
..............................
United
States
971,692
28,295,671
61,178,355
Professional
Services
1.6%
ManTech
International
Corp.,
A
...........................
United
States
355,610
30,351,313
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
40
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Professional
Services
(continued)
Science
Applications
International
Corp.
....................
United
States
413,000
$
36,930,460
67,281,773
Road
&
Rail
0.2%
a,c,d,e
New
Starship
Parent,
Inc.
...............................
United
States
750,000
7,500,000
Semiconductors
&
Semiconductor
Equipment
6.0%
a
Allegro
MicroSystems
,
Inc.
..............................
Japan
1,012,700
24,993,436
a
Lattice
Semiconductor
Corp.
.............................
United
States
1,203,900
60,568,209
a
Onto
Innovation,
Inc.
...................................
United
States
857,309
58,742,813
a
Semtech
Corp.
.......................................
United
States
717,500
48,603,450
a
Silicon
Laboratories,
Inc.
................................
United
States
203,100
28,626,945
a
SiTime
Corp.
.........................................
United
States
370,800
34,317,540
a
SkyWater
Technology,
Inc.
..............................
United
States
196,500
4,087,200
259,939,593
Software
7.4%
a,c,d
Alkami
Technology,
Inc.
.................................
United
States
343,750
15,494,946
a
Alkami
Technology,
Inc.
.................................
United
States
139,800
6,667,062
a
Alteryx
,
Inc.,
A
........................................
United
States
230,200
18,818,850
a
Avalara,
Inc.
.........................................
United
States
200,546
28,419,374
a
Bill.com
Holdings,
Inc.
..................................
United
States
135,708
20,984,528
a,b
BTRS
Holdings,
Inc.
...................................
United
States
2,373,100
37,494,980
a
Datto
Holding
Corp.
...................................
United
States
1,349,000
34,466,950
a
Duck
Creek
Technologies,
Inc.
...........................
United
States
450,969
18,751,291
a
Envestnet
,
Inc.
.......................................
United
States
411,822
30,404,818
a
Paylocity
Holding
Corp.
.................................
United
States
204,532
39,523,764
a
Privia
Health
Group,
Inc.
................................
United
States
467,600
16,983,232
a
Q2
Holdings,
Inc.
.....................................
United
States
274,400
28,543,088
a
Zendesk
,
Inc.
........................................
United
States
135,314
19,776,141
316,329,024
Specialty
Retail
8.1%
b
American
Eagle
Outfitters,
Inc.
...........................
United
States
2,392,900
82,722,553
a
Boot
Barn
Holdings,
Inc.
................................
United
States
625,860
44,148,165
a
Five
Below,
Inc.
.......................................
United
States
277,200
55,792,044
Lithia
Motors,
Inc.,
A
...................................
United
States
140,526
54,015,384
a,b
MYT
Netherlands
Parent
BV,
ADR
.........................
Germany
115,900
3,473,523
a,b
Petco
Health
&
Wellness
Co.,
Inc.
.........................
United
States
1,779,413
42,029,735
a
RH
................................................
United
States
43,400
29,860,068
a
Urban
Outfitters,
Inc.
...................................
United
States
963,827
34,601,389
346,642,861
Textiles,
Apparel
&
Luxury
Goods
1.0%
Steven
Madden
Ltd.
...................................
United
States
1,082,650
44,031,375
Trading
Companies
&
Distributors
2.7%
a
Beacon
Roofing
Supply,
Inc.
.............................
United
States
1,163,000
65,511,790
a
Univar
Solutions,
Inc.
..................................
United
States
2,179,032
50,880,397
116,392,187
Total
Common
Stocks
(Cost
$2,467,184,360)
....................................
3,999,331,153
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
41
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Convertible
Preferred
Stocks
0.4%
Diversified
Consumer
Services
0.4%
a,c,d
Newsela
,
Inc.,
D
......................................
United
States
709,046
$
14,854,244
a
Total
Convertible
Preferred
Stocks
(Cost
$15,000,010)
...........................
14,854,244
Preferred
Stocks
3.6%
Airlines
0.4%
a,c,d,f
Wheels
Up
Partners
LLC,
D
.............................
United
States
4,310,344
19,308,057
a
Auto
Components
0.2%
a,c,d
Tula
eTechnology
,
Inc.
..................................
United
States
361,111
a,c,d
Tula
eTechnology
,
Inc.,
E
...............................
United
States
3,611,111
8,082,642
8,082,642
Automobiles
1.1%
a,c,d
Proterra
,
Inc.,
144A,
5
..................................
United
States
1,787,047
22,971,463
a,c,d
Proterra
,
Inc.,
144A,
6
..................................
United
States
1,310,834
16,850,019
a,c,d
Proterra
,
Inc.,
7
.......................................
United
States
536,367
6,894,690
46,716,172
Commercial
Services
&
Supplies
0.3%
a,c,d,f
Optoro
,
Inc.,
E
.......................................
United
States
508,130
12,139,766
a
Food
&
Staples
Retailing
0.2%
a,c,d
Sweetgreen
,
Inc.,
H
...................................
United
States
383,435
5,740,733
a,c,d
Sweetgreen
,
Inc.,
I
....................................
United
States
41,641
709,528
a,c,d
Sweetgreen
,
Inc.,
J
....................................
United
States
113,300
1,930,537
8,380,798
Software
0.6%
a,c,d,f
ClearMotion
,
Inc.,
D
...................................
United
States
3,698,772
11,706,569
a,c,d
Smule
,
Inc.,
144A,
G
...................................
United
States
1,542,673
9,982,051
a,c,d
Smule
,
Inc.,
144A,
H
...................................
United
States
352,675
2,692,724
24,381,344
Specialty
Retail
0.5%
a,c,d
Rent
the
Runway,
Inc.,
144A,
F
...........................
United
States
596,471
12,975,592
a,c,d
Rent
the
Runway,
Inc.,
G
................................
United
States
508,787
8,950,783
21,926,375
Textiles,
Apparel
&
Luxury
Goods
0.3%
a,c,d
Allbirds
,
Inc.,
E
.......................................
United
States
1,297,305
15,570,065
a
Total
Preferred
Stocks
(Cost
$118,845,199)
.....................................
156,505,219
Warrants
Warrants
0.0%
Food
&
Staples
Retailing
0.0%
a,c,d
Sweetgreen
,
Inc.,
1/20/26
...............................
United
States
33,990
Total
Warrants
(Cost
$—)
.....................................................
Total
Long
Term
Investments
(Cost
$2,601,029,569)
.............................
4,170,690,616
a
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
42
Short
Term
Investments
6.3%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
4.8%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
205,154,775
$
205,154,775
Total
Money
Market
Funds
(Cost
$205,154,775)
.................................
205,154,775
a
a
a
a
a
i
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
1.5%
Money
Market
Funds
1.5%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
64,722,231
64,722,231
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$64,722,231)
...........................................................
64,722,231
Total
Short
Term
Investments
(Cost
$269,877,006
)
...............................
269,877,006
a
Total
Investments
(Cost
$2,870,906,575)
103.3%
................................
$4,440,567,622
Other
Assets,
less
Liabilities
(3.3)%
...........................................
(140,488,238)
Net
Assets
100.0%
...........................................................
$4,300,079,384
See
Abbreviations
on
page
86
.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2021.
See
Note
1(d).
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
11
regarding
fair
value
measurements.
d
See
Note
8
regarding
restricted
securities.
e
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1(c).
f
See
Note
9
regarding
holdings
of
5%
voting
securities.
g
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
i
See
Note
1(d)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
43
0
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$32.15
$37.17
$36.07
$34.35
$31.84
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.24)
(0.07)
(0.09)
(0.15)
(0.11)
Net
realized
and
unrealized
gains
(losses)
...........
21.89
1.24
5.33
4.97
4.73
Total
from
investment
operations
....................
21.65
1.17
5.24
4.82
4.62
Less
distributions
from:
Net
realized
gains
.............................
(4.14)
(6.19)
(4.14)
(3.10)
(2.11)
Net
asset
value,
end
of
year
.......................
$49.66
$32.15
$37.17
$36.07
$34.35
Total
return
c
...................................
68.37%
2.97%
17.43%
14.28%
15.01%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.86%
0.88%
0.88%
1.02%
0.95%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
0.85%
0.87%
0.87%
1.00%
0.94%
Net
investment
(loss)
............................
(0.54)%
(0.21)%
(0.25)%
(0.41)%
(0.34)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$4,217,167
$2,515,801
$2,684,131
$2,262,471
$2,303,113
Portfolio
turnover
rate
............................
53.69%
52.98%
54.28%
38.35%
35.46%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
44
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$19.41
$24.98
$25.84
$25.59
$24.40
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.33)
(0.22)
(0.26)
(0.31)
(0.27)
Net
realized
and
unrealized
gains
(losses)
...........
13.04
0.84
3.54
3.66
3.57
Total
from
investment
operations
....................
12.71
0.62
3.28
3.35
3.30
Less
distributions
from:
Net
realized
gains
.............................
(4.14)
(6.19)
(4.14)
(3.10)
(2.11)
Net
asset
value,
end
of
year
.......................
$27.98
$19.41
$24.98
$25.84
$25.59
Total
return
c
...................................
67.11%
2.14%
16.68%
13.39%
14.15%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.61%
1.63%
1.63%
1.77%
1.70%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
1.60%
e
1.62%
1.62%
1.75%
1.69%
Net
investment
(loss)
............................
(1.28)%
(0.96)%
(1.00)%
(1.16)%
(1.09)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$198,713
$138,940
$173,334
$334,769
$371,262
Portfolio
turnover
rate
............................
53.69%
52.98%
54.28%
38.35%
35.46%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
45
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$28.45
$33.66
$33.15
$31.87
$29.75
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.30)
(0.14)
(0.16)
(0.22)
(0.18)
Net
realized
and
unrealized
gains
(losses)
...........
19.31
1.12
4.81
4.60
4.41
Total
from
investment
operations
....................
19.01
0.98
4.65
4.38
4.23
Less
distributions
from:
Net
realized
gains
.............................
(4.14)
(6.19)
(4.14)
(3.10)
(2.11)
Net
asset
value,
end
of
year
.......................
$43.32
$28.45
$33.66
$33.15
$31.87
Total
return
....................................
67.96%
2.69%
17.17%
14.00%
14.70%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.10%
1.12%
1.12%
1.26%
1.19%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
1.09%
1.11%
1.11%
1.24%
1.18%
Net
investment
(loss)
............................
(0.78)%
(0.45)%
(0.49)%
(0.65)%
(0.58)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$60,264
$40,997
$50,721
$70,692
$81,864
Portfolio
turnover
rate
............................
53.69%
52.98%
54.28%
38.35%
35.46%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
46
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$37.12
$41.83
$39.91
$37.51
$34.43
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
....................
(0.10)
0.07
0.05
0.05
0.05
Net
realized
and
unrealized
gains
(losses)
...........
25.36
1.41
6.01
5.45
5.14
Total
from
investment
operations
....................
25.26
1.48
6.06
5.50
5.19
Less
distributions
from:
Net
realized
gains
.............................
(4.14)
(6.19)
(4.14)
(3.10)
(2.11)
Net
asset
value,
end
of
year
.......................
$58.24
$37.12
$41.83
$39.91
$37.51
Total
return
....................................
68.95%
3.40%
17.82%
14.90%
15.51%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.51%
0.52%
0.52%
0.50%
0.48%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.49%
0.48%
0.49%
0.47%
0.47%
Net
investment
income
(loss)
......................
(0.19)%
0.18%
0.13%
0.12%
0.13%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$648,078
$224,341
$259,053
$275,835
$222,577
Portfolio
turnover
rate
............................
53.69%
52.98%
54.28%
38.35%
35.46%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
47
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$36.30
$41.09
$39.33
$37.11
$34.15
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
....................
(0.14)
0.02
0.01
(0.06)
(0.03)
Net
realized
and
unrealized
gains
(losses)
...........
24.77
1.38
5.89
5.38
5.10
Total
from
investment
operations
....................
24.63
1.40
5.90
5.32
5.07
Less
distributions
from:
Net
realized
gains
.............................
(4.14)
(6.19)
(4.14)
(3.10)
(2.11)
Net
asset
value,
end
of
year
.......................
$56.79
$36.30
$41.09
$39.33
$37.11
Total
return
....................................
68.77%
3.26%
17.67%
14.57%
15.28%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.61%
0.63%
0.63%
0.77%
0.70%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.60%
0.62%
0.62%
0.75%
0.69%
Net
investment
income
(loss)
......................
(0.29
)%
0.04%
—%
d
(0.16)%
(0.09)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$552,987
$302,329
$355,141
$520,842
$584,840
Portfolio
turnover
rate
............................
53.69%
52.98%
54.28%
38.35%
35.46%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments,
April
30,
2021
Franklin
Small-Mid
Cap
Growth
Fund
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
48
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
94.5%
Aerospace
&
Defense
1.6%
a
Mercury
Systems,
Inc.
..................................
United
States
575,300
$
43,285,572
a
TransDigm
Group,
Inc.
.................................
United
States
81,700
50,142,558
93,428,130
Airlines
0.5%
a
Southwest
Airlines
Co.
.................................
United
States
470,000
29,506,600
Banks
0.5%
a
SVB
Financial
Group
...................................
United
States
51,000
29,163,330
Biotechnology
3.0%
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
440,500
20,425,985
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
623,800
25,438,564
a
Heron
Therapeutics,
Inc.
................................
United
States
1,274,000
22,269,520
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
913,565
28,722,484
a
Mirati
Therapeutics,
Inc.
................................
United
States
74,700
12,416,634
a
PTC
Therapeutics,
Inc.
.................................
United
States
433,000
17,843,930
a
Rocket
Pharmaceuticals,
Inc.
............................
United
States
234,300
10,740,312
a
Seagen
,
Inc.
.........................................
United
States
241,600
34,732,416
172,589,845
Capital
Markets
5.2%
a,b,c,d
ArcLight
Clean
Transition
Corp.
...........................
United
States
463,400
7,339,942
Ares
Management
Corp.
................................
United
States
875,000
45,955,000
a,b,c,d
Churchill
Capital
Corp.
IV
...............................
United
States
728,215
10,923,225
MarketAxess
Holdings,
Inc.
..............................
United
States
117,000
57,149,820
MSCI,
Inc.
...........................................
United
States
197,400
95,890,998
a
Soaring
Eagle
Acquisition
Corp.
..........................
United
States
1,126,700
12,179,627
a,b,c,d
Spartan
Acquisition
Corp.
II,
A
............................
United
States
963,371
9,633,710
Tradeweb
Markets,
Inc.,
A
...............................
United
States
697,600
56,700,928
295,773,250
Commercial
Services
&
Supplies
1.1%
Republic
Services,
Inc.
.................................
United
States
566,000
60,165,800
Construction
Materials
0.4%
Martin
Marietta
Materials,
Inc.
............................
United
States
60,100
21,222,512
Containers
&
Packaging
1.2%
Ball
Corp.
...........................................
United
States
733,700
68,703,668
Electronic
Equipment,
Instruments
&
Components
1.6%
Cognex
Corp.
........................................
United
States
167,900
14,459,548
a
Keysight
Technologies,
Inc.
..............................
United
States
516,500
74,556,775
89,016,323
Entertainment
2.5%
a
Roku,
Inc.
...........................................
United
States
188,978
64,813,785
a
Spotify
Technology
SA
..................................
United
States
79,000
19,917,480
a
Zynga,
Inc.,
A
........................................
United
States
5,060,000
54,749,200
139,480,465
Equity
Real
Estate
Investment
Trusts
(REITs)
2.1%
SBA
Communications
Corp.
.............................
United
States
303,400
90,935,048
Terreno
Realty
Corp.
...................................
United
States
449,800
29,021,096
119,956,144
Food
&
Staples
Retailing
0.5%
a
Grocery
Outlet
Holding
Corp.
............................
United
States
737,400
29,783,586
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
49
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Food
Products
0.7%
a,e
Beyond
Meat,
Inc.
.....................................
United
States
85,400
$
11,245,472
a
Freshpet
,
Inc.
........................................
United
States
160,100
29,589,682
40,835,154
Health
Care
Equipment
&
Supplies
7.2%
a
Align
Technology,
Inc.
..................................
United
States
75,700
45,081,621
a
DexCom
,
Inc.
........................................
United
States
71,314
27,534,335
a
IDEXX
Laboratories,
Inc.
................................
United
States
217,900
119,624,921
a
Inari
Medical,
Inc.
.....................................
United
States
271,500
31,029,735
a
Insulet
Corp.
.........................................
United
States
199,900
59,014,478
a
iRhythm
Technologies,
Inc.
..............................
United
States
106,350
8,280,411
a
Penumbra,
Inc.
.......................................
United
States
151,647
46,402,466
Teleflex,
Inc.
.........................................
United
States
170,600
72,075,088
409,043,055
Health
Care
Providers
&
Services
1.5%
a
Guardant
Health,
Inc.
..................................
United
States
399,900
63,576,102
a
HealthEquity
,
Inc.
.....................................
United
States
295,000
22,411,150
85,987,252
Health
Care
Technology
2.5%
a
American
Well
Corp.,
A
.................................
United
States
833,600
12,829,104
a
Certara
,
Inc.
.........................................
United
States
301,400
9,587,534
a
Teladoc
Health,
Inc.
...................................
United
States
193,841
33,408,496
a
Veeva
Systems,
Inc.,
A
.................................
United
States
302,000
85,299,900
141,125,034
Hotels,
Restaurants
&
Leisure
3.9%
a
Chipotle
Mexican
Grill,
Inc.
..............................
United
States
48,900
72,960,267
a
DraftKings
,
Inc.,
A
.....................................
United
States
638,455
36,174,860
a
Expedia
Group,
Inc.
...................................
United
States
160,400
28,267,292
a
Vail
Resorts,
Inc.
......................................
United
States
157,100
51,082,636
a
Wynn
Resorts
Ltd.
....................................
United
States
264,500
33,961,800
222,446,855
Household
Durables
0.7%
a
NVR,
Inc.
...........................................
United
States
8,200
41,148,420
Household
Products
1.1%
Church
&
Dwight
Co.,
Inc.
...............................
United
States
695,700
59,649,318
Interactive
Media
&
Services
2.0%
a
Bumble,
Inc.,
A
.......................................
United
States
143,100
8,620,344
a
Match
Group,
Inc.
.....................................
United
States
438,859
68,299,626
a
Pinterest,
Inc.,
A
......................................
United
States
532,300
35,328,751
112,248,721
Internet
&
Direct
Marketing
Retail
1.0%
a,e
ContextLogic
,
Inc.,
A
...................................
United
States
1,062,200
14,732,714
a,b,c
Marqeta
,
Inc.
.........................................
United
States
1,070,236
10,310,127
a,e
Wayfair,
Inc.,
A
.......................................
United
States
100,400
29,675,228
54,718,069
IT
Services
7.9%
a
BigCommerce
Holdings,
Inc.,
1
...........................
United
States
517,100
30,994,974
a
Black
Knight,
Inc.
.....................................
United
States
1,007,500
72,963,150
a
GoDaddy
,
Inc.,
A
......................................
United
States
669,300
58,108,626
a
MongoDB,
Inc.
.......................................
United
States
184,800
54,970,608
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
50
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
IT
Services
(continued)
a,f
Nuvei
Corp.,
144A,
Reg
S
...............................
Canada
199,800
$
13,942,044
a
Okta
,
Inc.
...........................................
United
States
360,500
97,226,850
a
Twilio
,
Inc.,
A
.........................................
United
States
214,000
78,709,200
a
Wix.com
Ltd.
.........................................
Israel
125,800
39,989,304
446,904,756
Life
Sciences
Tools
&
Services
4.0%
a
10X
Genomics,
Inc.,
A
..................................
United
States
260,000
51,428,000
Bio-
Techne
Corp.
.....................................
United
States
169,300
72,374,057
a
Maravai
LifeSciences
Holdings,
Inc.,
A
.....................
United
States
761,700
29,637,747
a
Mettler
-Toledo
International,
Inc.
..........................
United
States
56,100
73,677,252
227,117,056
Machinery
2.1%
Fortive
Corp.
.........................................
United
States
574,500
40,686,090
IDEX
Corp.
..........................................
United
States
220,000
49,324,000
Stanley
Black
&
Decker,
Inc.
.............................
United
States
153,300
31,697,841
121,707,931
Personal
Products
0.5%
a
BellRing
Brands,
Inc.,
A
.................................
United
States
1,177,500
30,367,725
Pharmaceuticals
1.3%
a
Horizon
Therapeutics
plc
................................
United
States
560,000
52,987,200
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
211,200
21,415,680
74,402,880
Professional
Services
5.8%
Booz
Allen
Hamilton
Holding
Corp.
........................
United
States
652,200
54,099,990
a
CoStar
Group,
Inc.
....................................
United
States
119,300
101,933,499
TransUnion
..........................................
United
States
662,900
69,332,711
Verisk
Analytics,
Inc.
...................................
United
States
543,500
102,286,700
327,652,900
Road
&
Rail
1.1%
a,b,c,d
New
Starship
Parent,
Inc.
...............................
United
States
675,200
6,752,000
Old
Dominion
Freight
Line,
Inc.
...........................
United
States
223,050
57,504,520
64,256,520
Semiconductors
&
Semiconductor
Equipment
6.1%
a
Allegro
MicroSystems
,
Inc.
..............................
Japan
983,800
24,280,184
Entegris
,
Inc.
.........................................
United
States
282,200
31,770,076
KLA
Corp.
...........................................
United
States
239,000
75,368,650
a
Lattice
Semiconductor
Corp.
.............................
United
States
1,182,214
59,477,186
Monolithic
Power
Systems,
Inc.
...........................
United
States
126,100
45,570,018
a
Semtech
Corp.
.......................................
United
States
525,463
35,594,864
a
SiTime
Corp.
.........................................
United
States
574,114
53,134,251
a
SkyWater
Technology,
Inc.
..............................
United
States
261,600
5,441,280
a
SolarEdge
Technologies,
Inc.
............................
United
States
50,200
13,229,708
343,866,217
Software
17.3%
a,b,c
Alkami
Technology,
Inc.
.................................
United
States
405,100
18,260,372
a
Alteryx
,
Inc.,
A
........................................
United
States
472,000
38,586,000
a
ANSYS,
Inc.
.........................................
United
States
255,300
93,352,998
a
AppLovin
Corp.,
A
.....................................
United
States
174,500
10,122,745
a
Avalara,
Inc.
.........................................
United
States
465,600
65,980,176
a
Bill.com
Holdings,
Inc.
..................................
United
States
271,133
41,925,296
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
51
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Software
(continued)
a
BTRS
Holdings,
Inc.
...................................
United
States
1,118,700
$
17,675,460
a
Cloudflare
,
Inc.,
A
.....................................
United
States
518,200
43,912,268
a
Coupa
Software,
Inc.
...................................
United
States
223,400
60,103,536
a
DocuSign,
Inc.
.......................................
United
States
463,200
103,265,808
a
Duck
Creek
Technologies,
Inc.
...........................
United
States
331,016
13,763,645
a
HubSpot
,
Inc.
........................................
United
States
134,800
70,965,460
a
Lightspeed
POS,
Inc.
..................................
Canada
630,700
44,029,167
a
Paylocity
Holding
Corp.
.................................
United
States
424,700
82,069,028
a
PTC,
Inc.
...........................................
United
States
255,200
33,415,888
a
Q2
Holdings,
Inc.
.....................................
United
States
352,000
36,615,040
a
Synopsys,
Inc.
.......................................
United
States
496,500
122,665,290
a
Zendesk
,
Inc.
........................................
United
States
574,000
83,890,100
980,598,277
Specialty
Retail
4.6%
a
Burlington
Stores,
Inc.
..................................
United
States
224,600
73,293,718
a
Five
Below,
Inc.
.......................................
United
States
320,700
64,547,289
a,e
Petco
Health
&
Wellness
Co.,
Inc.
.........................
United
States
1,264,100
29,858,042
Tractor
Supply
Co.
....................................
United
States
313,100
59,050,660
a
Ulta
Beauty,
Inc.
......................................
United
States
108,200
35,635,670
262,385,379
Textiles,
Apparel
&
Luxury
Goods
1.9%
Levi
Strauss
&
Co.,
A
..................................
United
States
1,004,600
28,992,756
a
Lululemon
Athletica
,
Inc.
................................
United
States
143,400
48,077,718
VF
Corp.
............................................
United
States
365,700
32,057,262
109,127,736
Trading
Companies
&
Distributors
1.1%
Fastenal
Co.
.........................................
United
States
1,176,400
61,502,192
Total
Common
Stocks
(Cost
$3,249,277,065)
....................................
5,365,881,100
Convertible
Preferred
Stocks
1.1%
Diversified
Consumer
Services
0.2%
a,b,c
Newsela
,
Inc.,
D
......................................
United
States
423,782
8,878,072
a
Internet
&
Direct
Marketing
Retail
0.4%
a,b,c
Fanatics,
Inc.,
E
......................................
United
States
775,014
20,297,196
a,b,c
Fanatics,
Inc.,
F
......................................
United
States
18,700
640,982
20,938,178
Software
0.5%
a,b,c
Databricks
,
Inc.,
G
....................................
United
States
75,943
14,072,235
a,b,c
OneTrust
LLC,
C
......................................
United
States
767,526
15,051,415
29,123,650
Total
Convertible
Preferred
Stocks
(Cost
$51,538,519)
...........................
58,939,900
Preferred
Stocks
0.9%
Automobiles
0.3%
a,b,c
Proterra
,
Inc.,
144A,
5
..................................
United
States
1,416,913
18,213,603
a
Semiconductors
&
Semiconductor
Equipment
0.2%
a,b,c,g
Phononic
Devices,
Inc.,
F
...............................
United
States
2,970,061
10,389,829
a
Software
0.2%
a,b,c,g
Blaize
,
Inc.,
D
........................................
United
States
1,294,805
13,521,001
a
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
52
See
Abbreviations
on
page
86
.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
(continued)
Textiles,
Apparel
&
Luxury
Goods
0.2%
a,b,c
Allbirds
,
Inc.,
E
.......................................
United
States
772,477
$
9,271,156
a
Total
Preferred
Stocks
(Cost
$37,088,633)
......................................
51,395,589
Warrants
Warrants
0.0%
Semiconductors
&
Semiconductor
Equipment
0.0%
a,b,c,g
Phononic
Devices,
Inc.,
12/01/29
.........................
United
States
513,050
2,022,312
Software
0.0%
a,b,c,g
Blaize
,
Inc.
Ltd.,
2/28/24
................................
United
Kingdom
64,741
Total
Warrants
(Cost
$47)
.....................................................
2,022,312
Principal
Amount
*
h,i
Senior
Floating
Rate
Interests
0.0%
Semiconductors
&
Semiconductor
Equipment
0.0%
b,c,g,j
Phononic
,
Inc.,
Advance
Term
Loan
,
B,
12%,
PIK,
7/31/26
.................................
United
States
114,327
101,784
D,
12%,
PIK,
(Prime
+
12%),
12/01/25
....................
United
States
272,977
242,282
b,c,g
Phononic
,
Inc.,
Term
Loan
,
j
A,
12%,
PIK,
1/17/24
.................................
United
States
555,913
506,783
C,
12%,
(Prime
+
12%),
8/25/24
.........................
United
States
110,744
98,759
949,608
a
a
a
a
a
a
Total
Senior
Floating
Rate
Interests
(Cost
$1,044,561)
...........................
949,608
Total
Long
Term
Investments
(Cost
$3,338,948,825)
.............................
5,479,188,509
a
Short
Term
Investments
5.3%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
3.8%
k,l
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
213,329,128
213,329,128
Total
Money
Market
Funds
(Cost
$213,329,128)
.................................
213,329,128
a
a
a
a
a
m
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
1.5%
Money
Market
Funds
1.5%
k,l
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
84,881,180
84,881,180
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$84,881,180)
...........................................................
84,881,180
Total
Short
Term
Investments
(Cost
$298,210,308
)
...............................
298,210,308
a
Total
Investments
(Cost
$3,637,159,133)
101.8%
................................
$5,777,398,817
Other
Assets,
less
Liabilities
(1.8)%
...........................................
(100,189,248)
Net
Assets
100.0%
...........................................................
$5,677,209,569
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
53
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
11
regarding
fair
value
measurements.
c
See
Note
8
regarding
restricted
securities.
d
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1(c).
e
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2021.
See
Note
1(d).
f
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
April
30,
2021,
the
aggregate
value
of
these
securities
was
$13,942,044,
representing
0.2%
of
net
assets.
g
See
Note
9
regarding
holdings
of
5%
voting
securities.
h
See
Note
1(e)
regarding
senior
floating
rate
interests.
i
The
coupon
rate
shown
represents
the
rate
at
period
end.
j
Income
may
be
received
in
additional
securities
and/or
cash.
k
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
l
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
m
See
Note
1(d)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
April
30,
2021
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
54
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
.................................
$1,982,757,839
$2,521,029,574
$3,316,883,209
Cost
-
Non-controlled
affiliates
(Note
3
f
and
9
)
..................
256,097,450
349,877,001
320,275,924
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
of
$47,650,572,
$61,245,827
and
$80,054,972
respectively)
...................
$5,561,961,180
$4,082,536,224
$5,452,305,759
Value
-
Non-controlled
affiliates
(Note
3
f
and
9
)
.................
303,794,510
358,031,398
325,093,058
Cash
..................................................
1,531,049
Receivables:
Investment
securities
sold
.................................
3,252,291
35,011,362
Capital
shares
sold
......................................
2,607,161
6,629,031
12,814,472
Dividends
and
interest
...................................
894,342
45,657
431,211
Total
assets
........................................
5,869,257,193
4,452,025,650
5,825,655,862
Liabilities:
Payables:
Investment
securities
purchased
............................
76,447,045
80,721,000
52,898,898
Capital
shares
redeemed
.................................
8,080,442
3,528,964
6,373,097
Management
fees
.......................................
2,451,787
2,070,693
2,098,480
Distribution
fees
........................................
1,090,702
353,768
1,045,662
Transfer
agent
fees
......................................
793,244
504,771
960,294
Payable
upon
return
of
securities
loaned
(Note
1
d
)
................
50,044,540
64,722,231
84,881,180
Accrued
expenses
and
other
liabilities
.........................
89,600
44,839
188,682
Total
liabilities
.......................................
138,997,360
151,946,266
148,446,293
Net
assets,
at
value
...............................
$5,730,259,833
$4,300,079,384
$5,677,209,569
Net
assets
consist
of:
Paid-in
capital
...........................................
$1,849,715,418
$2,289,397,971
$2,983,923,649
Total
distributable
earnings
(losses)
...........................
3,880,544,415
2,010,681,413
2,693,285,920
Net
assets,
at
value
...............................
$5,730,259,833
$4,300,079,384
$5,677,209,569
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
(continued)
April
30,
2021
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
55
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Class
A:
Net
assets,
at
value
.....................................
$4,203,693,071
$1,244,591,445
$4,217,166,917
Shares
outstanding
......................................
74,732,505
41,370,484
84,919,348
Net
asset
value
per
share
a
................................
$56.25
$30.08
$49.66
Maximum
offering
price
per
share
(net
asset
value
per
share
÷
94.50%)
..............................................
$59.52
$31.83
$52.55
Class
C:
Net
assets,
at
value
.....................................
$278,803,622
$86,393,833
$198,712,951
Shares
outstanding
......................................
6,354,942
3,828,343
7,101,202
Net
asset
value
and
maximum
offering
price
per
share
a
...........
$43.87
$22.57
$27.98
Class
R:
Net
assets,
at
value
.....................................
$40,396,466
$79,313,711
$60,264,172
Shares
outstanding
......................................
766,726
2,856,788
1,391,030
Net
asset
value
and
maximum
offering
price
per
share
...........
$52.69
$27.76
$43.32
Class
R6:
Net
assets,
at
value
.....................................
$563,917,891
$2,149,795,213
$648,078,415
Shares
outstanding
......................................
8,942,974
62,962,532
11,127,473
Net
asset
value
and
maximum
offering
price
per
share
...........
$63.06
$34.14
$58.24
Advisor
Class:
Net
assets,
at
value
.....................................
$643,448,783
$739,985,182
$552,987,114
Shares
outstanding
......................................
10,376,761
22,133,053
9,737,365
Net
asset
value
and
maximum
offering
price
per
share
...........
$62.01
$33.43
$56.79
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Operations
for
the
year
ended
April
30,
2021
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
56
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Investment
income:
Dividends:
(net
of
foreign
taxes
of
$–,
$–
and
$24,178,
respectively)
Unaffiliated
issuers
......................................
$19,166,268
$10,939,477
$13,627,001
Non-controlled
affiliates
(Note
3
f
and
9
)
.......................
1,170
3,523
3,699
Interest:
Unaffiliated
issuers
......................................
24,741
Non-controlled
affiliates
(Note
3
f
and
9
)
.......................
74,893
Income
from
securities
loaned:
Unaffiliated
entities
(net
of
fees
and
rebates)
...................
1,186,097
635,811
1,035,574
Non-controlled
affiliates
(Note
3
f
)
...........................
759
1,035
831
Total
investment
income
.................................
20,354,294
11,579,846
14,766,739
Expenses:
Management
fees
(Note
3
a
)
.................................
27,079,689
20,650,272
21,261,693
Distribution
fees:
(Note
3c
)
Class
A
..............................................
9,263,726
2,496,843
8,887,113
Class
C
..............................................
2,613,344
806,599
1,809,627
Class
R
..............................................
185,949
357,287
266,304
Transfer
agent
fees:
(Note
3e
)
Class
A
..............................................
4,244,128
1,600,331
4,795,194
Class
C
..............................................
300,441
130,372
245,622
Class
R
..............................................
43,515
115,058
73,553
Class
R6
.............................................
125,285
557,169
172,407
Advisor
Class
..........................................
652,839
986,479
620,707
Custodian
fees
(Note
4
)
....................................
44,108
52,022
37,118
Reports
to
shareholders
....................................
212,447
161,373
325,504
Registration
and
filing
fees
..................................
187,469
146,866
214,307
Professional
fees
.........................................
171,118
219,084
120,355
Trustees'
fees
and
expenses
................................
61,677
40,575
54,588
Other
..................................................
104,622
70,816
87,387
Total
expenses
.......................................
45,290,357
28,391,146
38,971,479
Expense
reductions
(Note
4
)
.............................
(13,782)
(5,942)
(230)
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
............
(69,067)
(276,591)
(248,107)
Net
expenses
.......................................
45,207,508
28,108,613
38,723,142
Net
investment
income
(loss)
..........................
(24,853,214)
(16,528,767)
(23,956,403)
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
Unaffiliated
issuers
....................................
562,323,992
795,665,077
979,450,918
Foreign
currency
transactions
..............................
(4,438)
(28,985)
Net
realized
gain
(loss)
................................
562,319,554
795,665,077
979,421,933
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
....................................
1,400,413,797
1,037,568,671
1,262,002,397
Non-controlled
affiliates
(Note
3
f
and
9
)
.....................
37,802,709
3,753,975
10,153,306
Net
change
in
unrealized
appreciation
(depreciation)
..........
1,438,216,506
1,041,322,646
1,272,155,703
Net
realized
and
unrealized
gain
(loss)
..........................
2,000,536,060
1,836,987,723
2,251,577,636
Net
increase
(decrease)
in
net
assets
resulting
from
operations
........
$1,975,682,846
$1,820,458,956
$2,227,621,233
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
57
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Year
Ended
April
30,
2021
Year
Ended
April
30,
2020
Year
Ended
April
30,
2021
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
.......
$(24,853,214)
$(12,850,118)
$(16,528,767)
$(7,894,136)
Net
realized
gain
(loss)
............
562,319,554
133,545,617
795,665,077
17,675,243
Net
change
in
unrealized
appreciation
(depreciation)
.................
1,438,216,506
214,046,447
1,041,322,646
(167,481,598)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.
1,975,682,846
334,741,946
1,820,458,956
(157,700,491)
Distributions
to
shareholders:
Class
A
........................
(224,148,602)
(237,578,955)
(104,691,979)
(48,340,636)
Class
C
........................
(19,547,939)
(22,239,105)
(10,525,678)
(6,520,298)
Class
R
........................
(2,400,189)
(2,892,923)
(8,100,192)
(4,473,797)
Class
R6
.......................
(26,531,757)
(28,916,895)
(155,392,084)
(64,617,144)
Advisor
Class
...................
(30,835,998)
(38,146,343)
(58,222,612)
(40,149,307)
Total
distributions
to
shareholders
.....
(303,464,485)
(329,774,221)
(336,932,545)
(164,101,182)
Capital
share
transactions:
(Note
2
)
Class
A
........................
101,012,799
62,785,864
134,170,863
68,255,158
Class
C
........................
(20,254,399)
(22,481,948)
(13,257,685)
(12,115,565)
Class
R
........................
(3,158,368)
(5,745,243)
(5,585,640)
(11,347,524)
Class
R6
.......................
17,769,683
(39,007,657)
287,293,924
198,501,453
Advisor
Class
...................
(19,471,444)
(44,198,935)
41,589,751
(237,802,378)
Total
capital
share
transactions
.......
75,898,271
(48,647,919)
444,211,213
5,491,144
Net
increase
(decrease)
in
net
assets
.....................
1,748,116,632
(43,680,194)
1,927,737,624
(316,310,529)
Net
assets:
Beginning
of
year
..................
3,982,143,201
4,025,823,395
2,372,341,760
2,688,652,289
End
of
year
......................
$5,730,259,833
$3,982,143,201
$4,300,079,384
$2,372,341,760
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
58
Franklin
Small-Mid
Cap
Growth
Fund
Year
Ended
April
30,
2021
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
............................................
$(23,956,403)
$(6,543,509)
Net
realized
gain
(loss)
.................................................
979,421,933
192,334,944
Net
change
in
unrealized
appreciation
(depreciation)
...........................
1,272,155,703
(99,401,303)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
................
2,227,621,233
86,390,132
Distributions
to
shareholders:
Class
A
.............................................................
(322,775,473)
(425,921,425)
Class
C
.............................................................
(26,786,941)
(36,725,001)
Class
R
.............................................................
(5,438,863)
(8,320,703)
Class
R6
............................................................
(33,885,852)
(36,761,924)
Advisor
Class
........................................................
(37,430,317)
(46,972,961)
Total
distributions
to
shareholders
..........................................
(426,317,446)
(554,702,014)
Capital
share
transactions:
(Note
2
)
Class
A
.............................................................
312,835,788
190,363,531
Class
C
.............................................................
(1,290,198)
(152,558)
Class
R
.............................................................
(1,603,654)
(2,601,164)
Class
R6
............................................................
275,615,792
(3,283,468)
Advisor
Class
........................................................
67,940,915
(15,986,912)
Total
capital
share
transactions
............................................
653,498,643
168,339,429
Net
increase
(decrease)
in
net
assets
...................................
2,454,802,430
(299,972,453)
Net
assets:
Beginning
of
year
.......................................................
3,222,407,139
3,522,379,592
End
of
year
...........................................................
$5,677,209,569
$3,222,407,139
Franklin
Strategic
Series
59
franklintempleton.com
Annual
Report
Notes
to
Financial
Statements
1.
Organization
and
Significant
Accounting
Policies
Franklin
Strategic
Series (Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-
end
management
investment
company,
consisting
of
ten
separate
funds, three
of
which
are
included
in
this
report
(Funds)
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP).
The
Funds
offer five classes
of
shares: Class
A,
Class
C,
Class
R,
Class
R6,
and
Advisor
Class.
Class
C
shares
automatically
convert
to
Class
A
shares
after
they
have
been
held
for
10
years. Each
class
of
shares
may
differ
by
its initial
sales
load,
contingent
deferred
sales
charges,
voting
rights
on
matters
affecting
a
single
class,
its
exchange
privilege
and
fees
due
to
differing
arrangements
for
distribution
and
transfer
agent
fees.
The
following
summarizes
the Funds'
significant
accounting
policies. 
a.
Financial
Instrument
Valuation 
The Funds'
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The Funds calculate the
net
asset
value
(NAV)
per
share
each
business
day
as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Trust's
Board
of
Trustees
(the
Board),
the
Funds' administrator
has
responsibility
for
oversight
of
valuation,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Funds
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded,
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Debt
securities
generally
trade
in
the
OTC
market rather
than
on
a
securities
exchange.
The
Funds'
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Securities
denominated
in
a
foreign
currency
are
converted
into
their
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
date
that
the
values
of
the
foreign
debt
securities
are
determined.
Investments
in open-end mutual
funds
are
valued
at
the
closing
NAV.
The
Funds
have
procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the
Funds
primarily
employ
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
book
values,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed.
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Funds'
business
day.
Events
can occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
Franklin
Strategic
Series
Notes
to
Financial
Statements
60
franklintempleton.com
Annual
Report
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Funds.
As
a
result,
differences
may
arise
between
the
value
of
the
Funds'
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time.
In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Funds'
portfolio
securities
to
the
latest
indications
of
fair
value
at
4
p.m.
Eastern
time.
At
April
30,
2021,
certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
inputs
within
the
fair
value
hierarchy
(referred
to
as
“market
level
fair
value”).
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Funds'
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Funds'
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Funds
for
financial
reporting
purposes.
b.
Foreign
Currency
Translation 
Portfolio
securities
and
other
assets
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
based
on
the
exchange
rate
of
such
currencies
against
U.S.
dollars
on
the
date
of
valuation.
The
Funds
may
enter
into
foreign
currency
exchange
contracts
to
facilitate
transactions
denominated
in
a
foreign
currency.
Purchases
and
sales
of
securities,
income
and
expense
items
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
at
the
exchange
rate
in
effect
on
the
transaction
date.
Portfolio
securities
and
assets
and
liabilities
denominated
in
foreign
currencies
contain
risks
that
those
currencies
will
decline
in
value
relative
to
the
U.S.
dollar.
Occasionally,
events
may
impact
the
availability
or
reliability
of
foreign
exchange
rates
used
to
convert
the
U.S.
dollar
equivalent
value.
If
such
an
event
occurs,
the
foreign
exchange
rate
will
be
valued
at
fair
value
using
procedures
established
and
approved
by
the
Board.
The
Funds
do
not
separately
report
the
effect
of
changes
in
foreign
exchange
rates
from
changes
in
market
prices
on
securities
held.
Such
changes
are
included
in
net
realized
and
unrealized
gain
or
loss
from
investments
in
the
Statements
of
Operations.
Realized
foreign
exchange
gains
or
losses
arise
from
sales
of
foreign
currencies,
currency
gains
or
losses
realized
between
the
trade
and
settlement
dates
on
securities
transactions
and
the
difference
between
the
recorded
amounts
of
dividends,
interest,
and
foreign
withholding
taxes
and
the
U.S.
dollar
equivalent
of
the
amounts
actually
received
or
paid.
Net
unrealized
foreign
exchange
gains
and
losses
arise
from
changes
in
foreign
exchange
rates
on
foreign
denominated
assets
and
liabilities
other
than
investments
in
securities
held
at
the
end
of
the
reporting
period.
c.
Securities
Purchased
on
a
Delayed
Delivery
Basis
Certain
or
all
Funds
purchase
securities
on
a
delayed
delivery
basis,
with
payment
and
delivery
scheduled
for
a
future
date.
These
transactions
are
subject
to
market
fluctuations
and
are
subject
to
the
risk
that
the
value
at
delivery
may
be
more
or
less
than
the
trade
date
purchase
price.
Although
the
Funds
will
generally
purchase
these
securities
with
the
intention
of
holding
the
securities,
they
may
sell
the
securities
before
the
settlement
date.
Sufficient
assets
have
been
segregated
for
these
securities
and
collateral
has
been
pledged
and/or
received
for
open
TBA
trades.
d.
Securities
Lending
Certain
or
all
Funds
participate
in
an
agency
based
securities
lending
program
to
earn
additional
income.
The
Fund
receives
collateral
in
the
form
of
cash
and/or
U.S.
Government
and
Agency
securities
against
the
loaned
securities
in
an
amount
equal
to
at
least
102%
of
the
fair
value
of
the
loaned
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
100%
of
the
fair
value
of
loaned
securities,
as
determined
at
the
close
of
Fund
business
each
day;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
Fund
on
the
next
business
day.
Any
cash
collateral
received
is
deposited
into
a
joint
cash
account
with
other
funds
and
is
used
to
invest
in
a
money
market
fund
managed
by
Franklin
Advisers,
Inc.,
an
affiliate
of
the
Funds.
The
Fund
may
receive
income
from
the
investment
of
cash
collateral,
in
addition
to
lending
fees
and
rebates
paid
by
the
borrower.
1.
Organization
and
Significant
Accounting
Policies
(continued)
a.
Financial
Instrument
Valuation 
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
61
franklintempleton.com
Annual
Report
Income
from
securities
loaned,
net
of
fees
paid
to
the
securities
lending
agent
and/or
third-party
vendor,
is
reported
separately
in
the
Statements
of
Operations.
The
Fund
bears
the
market
risk
with
respect
to any
cash collateral
investment,
securities
loaned,
and
the
risk
that
the
agent
may
default
on
its
obligations
to
the
Fund.
If
the
borrower
defaults
on
its
obligation
to
return
the
securities
loaned,
the
Fund
has
the
right
to
repurchase
the
securities
in
the
open
market
using
the
collateral
received.
The
securities
lending
agent
has
agreed
to
indemnify
the
Fund
in
the
event
of
default
by
a
third
party
borrower.
e.
Senior
Floating
Rate
Interests
Certain
or
all
Funds
invest
in
senior
secured
corporate
loans
that
pay
interest
at
rates
which
are
periodically
reset
by
reference
to
a
base
lending
rate
plus
a
spread.
These
base
lending
rates
are
generally
the
prime
rate
offered
by
a
designated
U.S.
bank
or
the
London
InterBank
Offered
Rate
(LIBOR).
Senior
secured
corporate
loans
often
require
prepayment
of
principal
from
excess
cash
flows
or
at
the
discretion
of
the
borrower.
As
a
result,
actual
maturity
may
be
substantially
less
than
the
stated
maturity.
Senior
secured
corporate
loans
in
which
the
Funds
invest
are
generally
readily
marketable,
but
may
be
subject
to
certain
restrictions
on
resale.
f.
Income
and
Deferred
Taxes
It
is each
Fund's
policy
to
qualify
as
a
regulated
investment
company
under
the
Internal
Revenue
Code. Each
Fund
intends
to
distribute
to
shareholders
substantially
all
of
its
taxable
income
and
net
realized
gains
to
relieve
it
from
federal
income
and
excise
taxes.
As
a
result,
no
provision
for
U.S.
federal
income
taxes
is
required.
The
Funds
may
be
subject
to
foreign
taxation
related
to
income
received,
capital
gains
on
the
sale
of
securities
and
certain
foreign
currency
transactions
in
the
foreign
jurisdictions
in
which
the
Funds
invest.
Foreign
taxes,
if
any,
are
recorded
based
on
the
tax
regulations
and
rates
that
exist
in
the
foreign
markets
in
which
the
Funds
invest.
When
a
capital
gain
tax
is
determined
to
apply,
certain
or
all
Funds
record
an
estimated
deferred
tax
liability
in
an
amount
that
would
be
payable
if
the
securities
were
disposed
of
on
the
valuation
date.
Each
Fund
may
recognize
an
income
tax
liability
related
to
its
uncertain
tax
positions
under
U.S.
GAAP
when
the
uncertain
tax
position
has
a
less
than
50%
probability
that
it
will
be
sustained
upon
examination
by
the
tax
authorities
based
on
its
technical
merits.
As
of
April
30,
2021, each
Fund
has
determined
that
no
tax
liability
is
required
in
its
financial
statements
related
to
uncertain
tax
positions
for
any
open
tax
years
(or
expected
to
be
taken
in
future
tax
years).
Open
tax
years
are
those
that
remain
subject
to
examination
and
are
based
on
the
statute
of
limitations
in
each
jurisdiction
in
which
the
Fund
invests. 
g.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
Security
transactions
are
accounted
for
on
trade
date.
Realized
gains
and
losses
on
security
transactions
are
determined
on
a
specific
identification
basis.
Interest
income
and
estimated
expenses
are
accrued
daily.
Dividend
income
is
recorded
on
the
ex-dividend
date
except
for
certain
dividends
from
securities
where
the
dividend
rate
is
not
available.
In
such
cases,
the
dividend
is
recorded
as
soon
as
the
information
is
received
by
the
Funds.
Distributions
to shareholders
are
recorded
on
the
ex-dividend
date.
Distributable
earnings
are
determined
according
to
income
tax
regulations
(tax
basis)
and
may
differ
from
earnings
recorded
in
accordance
with
U.S.
GAAP.
These
differences
may
be
permanent
or
temporary.
Permanent
differences
are
reclassified
among
capital
accounts
to
reflect
their
tax
character.
These
reclassifications
have
no
impact
on
net
assets
or
the
results
of
operations.
Temporary
differences
are
not
reclassified,
as
they
may
reverse
in
subsequent
periods.
Common
expenses
incurred
by
the
Trust
are
allocated
among
the
Funds
based
on
the
ratio
of
net
assets
of
each
Fund
to
the
combined
net
assets
of
the
Trust
or
based
on
the
ratio
of
number
of
shareholders
of
each
Fund
to
the
combined
number
of
shareholders
of
the
Trust.
Fund
specific
expenses
are
charged
directly
to
the
Fund
that
incurred
the
expense.
Realized
and
unrealized
gains
and
losses
and
net
investment
income,
excluding
class
specific
expenses,
are
allocated
daily
to
each
class
of
shares
based
upon
the
relative
proportion
of
net
assets
of
each
class.
Differences
in
per
share
distributions
by
class
are
generally
due
to
differences
in
class
specific
expenses.
1.
Organization
and
Significant
Accounting
Policies
(continued)
d.
Securities
Lending
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
62
franklintempleton.com
Annual
Report
h.
Accounting
Estimates
The
preparation
of
financial
statements
in
accordance
with
U.S.
GAAP
requires
management
to
make
estimates
and
assumptions
that
affect
the
reported
amounts
of
assets
and
liabilities
at
the
date
of
the
financial
statements
and
the
amounts
of
income
and
expenses
during
the
reporting
period.
Actual
results
could
differ
from
those
estimates.
i.
Guarantees
and
Indemnifications
Under
the
Trust's
organizational
documents,
its
officers
and
trustees
are
indemnified
by
the
Trust
against
certain
liabilities
arising
out
of
the
performance
of
their
duties
to
the
Trust.
Additionally,
in
the
normal
course
of
business,
the
Trust,
on
behalf
of
the
Funds,
enters
into
contracts
with
service
providers
that
contain
general
indemnification
clauses.
The
Trust's
maximum
exposure
under
these
arrangements
is
unknown
as
this
would
involve
future
claims
that
may
be
made
against
the
Trust
that
have
not
yet
occurred.
Currently,
the
Trust
expects
the
risk
of
loss
to
be
remote.
2.
Shares
of
Beneficial
Interest
At
April
30,
2021,
there
were
an
unlimited
number
of
shares
authorized
(without
par
value).
Transactions
in
the
Funds'
shares
were
as
follows:
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Shares
Amount
Shares
Amount
Class
A
Class
A
Shares:
Year
ended
April
30,
2021
Shares
sold
a
...................................
9,852,737
$499,219,179
9,833,490
$259,856,939
Shares
issued
in
reinvestment
of
distributions
..........
4,067,652
210,907,495
3,766,883
100,952,866
Shares
redeemed
...............................
(12,009,751)
(609,113,875)
(8,666,706)
(226,638,942)
Net
increase
(decrease)
..........................
1,910,638
$101,012,799
4,933,667
$134,170,863
Year
ended
April
30,
2020
Shares
sold
a
...................................
9,010,676
$350,593,688
9,570,599
$191,507,079
Shares
issued
in
reinvestment
of
distributions
..........
5,700,998
220,628,503
2,179,464
46,378,986
Shares
redeemed
...............................
(13,139,219)
(508,436,327)
(8,559,848)
(169,630,907)
Net
increase
(decrease)
..........................
1,572,455
$62,785,864
3,190,215
$68,255,158
Class
C
1.
Organization
and
Significant
Accounting
Policies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
63
franklintempleton.com
Annual
Report
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Shares
Amount
Shares
Amount
Class
C
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
1,472,577
$59,035,199
563,562
$11,698,529
Shares
issued
in
reinvestment
of
distributions
..........
479,347
19,437,795
519,218
10,467,435
Shares
redeemed
a
..............................
(2,454,585)
(98,727,393)
(1,764,756)
(35,423,649)
Net
increase
(decrease)
..........................
(502,661)
$(20,254,399)
(681,976)
$(13,257,685)
Year
ended
April
30,
2020
Shares
sold
...................................
1,293,129
$40,701,483
568,029
$8,922,309
Shares
issued
in
reinvestment
of
distributions
..........
702,780
21,772,176
377,981
6,285,830
Shares
redeemed
a
..............................
(2,670,750)
(84,955,607)
(1,712,157)
(27,323,704)
Net
increase
(decrease)
..........................
(674,841)
$(22,481,948)
(766,147)
$(12,115,565)
Class
R
Class
R
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
171,266
$8,043,810
717,438
$17,477,893
Shares
issued
in
reinvestment
of
distributions
..........
49,285
2,395,755
327,026
8,093,887
Shares
redeemed
...............................
(286,132)
(13,597,933)
(1,280,988)
(31,157,420)
Net
increase
(decrease)
..........................
(65,581)
$(3,158,368)
(236,524)
$(5,585,640)
Year
ended
April
30,
2020
Shares
sold
...................................
153,696
$5,674,779
629,374
$11,840,906
Shares
issued
in
reinvestment
of
distributions
..........
77,840
2,841,942
224,509
4,458,744
Shares
redeemed
...............................
(386,976)
(14,261,964)
(1,464,103)
(27,647,174)
Net
increase
(decrease)
..........................
(155,440)
$(5,745,243)
(610,220)
$(11,347,524)
Class
R6
Class
R6
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
1,780,597
$101,176,664
18,333,285
$556,812,453
Shares
issued
in
reinvestment
of
distributions
..........
330,490
19,184,931
4,628,874
140,578,888
Shares
redeemed
...............................
(1,883,548)
(102,591,912)
(13,948,785)
(410,097,417)
Net
increase
(decrease)
..........................
227,539
$17,769,683
9,013,374
$287,293,924
Year
ended
April
30,
2020
Shares
sold
...................................
1,145,175
$48,845,021
19,214,024
$441,200,848
Shares
issued
in
reinvestment
of
distributions
..........
497,757
21,363,741
2,403,945
57,093,695
Shares
redeemed
...............................
(2,557,431)
(109,216,419)
(13,369,234)
(299,793,090)
Net
increase
(decrease)
..........................
(914,499)
$(39,007,657)
8,248,735
$198,501,453
Advisor
Class
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
64
franklintempleton.com
Annual
Report
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Shares
Amount
Shares
Amount
Advisor
Class
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
1,388,593
$77,802,045
8,029,152
$230,742,875
Shares
issued
in
reinvestment
of
distributions
..........
529,809
30,257,387
1,670,035
49,683,553
Shares
redeemed
...............................
(2,340,525)
(127,530,876)
(8,252,648)
(238,836,677)
Net
increase
(decrease)
..........................
(422,123)
$(19,471,444)
1,446,539
$41,589,751
Year
ended
April
30,
2020
Shares
sold
...................................
1,896,594
$77,753,071
5,254,643
$114,830,032
Shares
issued
in
reinvestment
of
distributions
..........
881,490
37,286,998
1,514,761
35,354,523
Shares
redeemed
...............................
(3,804,471)
(159,239,004)
(17,129,278)
(387,986,933)
Net
increase
(decrease)
..........................
(1,026,387)
$(44,198,935)
(10,359,874)
$(237,802,378)
Franklin
Small-Mid
Cap
Growth
Fund
Shares
Amount
Class
A
Class
A
Shares:
Year
ended
April
30,
2021
Shares
sold
a
...................................
13,207,103
$591,860,878
Shares
issued
in
reinvestment
of
distributions
..........
6,654,125
306,156,283
Shares
redeemed
...............................
(13,188,883)
(585,181,373)
Net
increase
(decrease)
..........................
6,672,345
$312,835,788
Year
ended
April
30,
2020
Shares
sold
a
...................................
10,129,339
$347,408,925
Shares
issued
in
reinvestment
of
distributions
..........
12,415,749
403,511,847
Shares
redeemed
...............................
(16,517,051)
(560,557,241)
Net
increase
(decrease)
..........................
6,028,037
$190,363,531
Class
C
Class
C
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
1,554,802
$40,817,005
Shares
issued
in
reinvestment
of
distributions
..........
1,025,860
26,672,329
Shares
redeemed
a
..............................
(2,636,417)
(68,779,532)
Net
increase
(decrease)
..........................
(55,755)
$(1,290,198)
Year
ended
April
30,
2020
Shares
sold
...................................
923,627
$20,355,427
Shares
issued
in
reinvestment
of
distributions
..........
1,836,941
36,150,992
Shares
redeemed
a
..............................
(2,541,653)
(56,658,977)
Net
increase
(decrease)
..........................
218,915
$(152,558)
Class
R
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
65
franklintempleton.com
Annual
Report
Franklin
Small-Mid
Cap
Growth
Fund
Shares
Amount
Class
R
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
395,867
$15,543,080
Shares
issued
in
reinvestment
of
distributions
..........
134,671
5,411,097
Shares
redeemed
...............................
(580,286)
(22,557,831)
Net
increase
(decrease)
..........................
(49,748)
$(1,603,654)
Year
ended
April
30,
2020
Shares
sold
...................................
266,016
$8,098,504
Shares
issued
in
reinvestment
of
distributions
..........
285,909
8,231,336
Shares
redeemed
...............................
(618,220)
(18,931,004)
Net
increase
(decrease)
..........................
(66,295)
$(2,601,164)
Class
R6
Class
R6
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
6,958,014
$373,028,400
Shares
issued
in
reinvestment
of
distributions
..........
574,433
30,956,221
Shares
redeemed
...............................
(2,449,090)
(128,368,829)
Net
increase
(decrease)
..........................
5,083,357
$275,615,792
Year
ended
April
30,
2020
Shares
sold
...................................
1,909,281
$74,347,388
Shares
issued
in
reinvestment
of
distributions
..........
888,615
33,287,500
Shares
redeemed
...............................
(2,947,420)
(110,918,356)
Net
increase
(decrease)
..........................
(149,524)
$(3,283,468)
Advisor
Class
Advisor
Class
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
2,877,964
$141,845,420
Shares
issued
in
reinvestment
of
distributions
..........
683,685
35,941,325
Shares
redeemed
...............................
(2,153,257)
(109,845,830)
Net
increase
(decrease)
..........................
1,408,392
$67,940,915
Year
ended
April
30,
2020
Shares
sold
...................................
1,829,927
$68,814,106
Shares
issued
in
reinvestment
of
distributions
..........
1,212,081
44,434,905
Shares
redeemed
...............................
(3,356,267)
(129,235,923)
Net
increase
(decrease)
..........................
(314,259)
$(15,986,912)
a
May
include
a
portion
of
Class
C
shares
that
were
automatically
converted
to
Class
A.
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
66
franklintempleton.com
Annual
Report
3.
Transactions
with
Affiliates
Franklin
Resources,
Inc.
is
the
holding
company
for
various
subsidiaries
that
together
are
referred
to
as
Franklin
Templeton.
Certain
officers
and
trustees
of
the
Trust
are
also
officers
and/or
directors
of
the
following
subsidiaries:
a.
Management
Fees
Franklin
Growth
Opportunities
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Franklin
Small
Cap
Growth
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Subsidiary
Affiliation
Franklin
Advisers,
Inc.
(Advisers)
Investment
manager
Franklin
Templeton
Services,
LLC
(FT
Services)
Administrative
manager
Franklin
Templeton
Distributors,
Inc.
(Distributors)
Principal
underwriter
Franklin
Templeton
Investor
Services,
LLC
(Investor
Services)
Transfer
agent
Annualized
Fee
Rate
Net
Assets
0.700%
Up
to
and
including
$500
million
0.600%
Over
$500
million,
up
to
and
including
$1
billion
0.550%
Over
$1
billion,
up
to
and
including
$1.5
billion
0.500%
Over
$1.5
billion,
up
to
and
including
$6.5
billion
0.475%
Over
$6.5
billion,
up
to
and
including
$11.5
billion
0.450%
Over
$11.5
billion,
up
to
and
including
$16.5
billion
0.440%
Over
$16.5
billion,
up
to
and
including
$19
billion
0.430%
Over
$19
billion,
up
to
and
including
$21.5
billion
0.420%
In
excess
of
$21.5
billion
Annualized
Fee
Rate
Net
Assets
0.750%
Up
to
and
including
$500
million
0.650%
Over
$500
million,
up
to
and
including
$1
billion
0.600%
Over
$1
billion,
up
to
and
including
$1.5
billion
0.550%
Over
$1.5
billion,
up
to
and
including
$6.5
billion
0.525%
Over
$6.5
billion,
up
to
and
including
$11.5
billion
0.500%
Over
$11.5
billion,
up
to
and
including
$16.5
billion
0.490%
Over
$16.5
billion,
up
to
and
including
$19
billion
0.480%
Over
$19
billion,
up
to
and
including
$21.5
billion
0.470%
In
excess
of
$21.5
billion
Franklin
Strategic
Series
Notes
to
Financial
Statements
67
franklintempleton.com
Annual
Report
Franklin
Small-Mid
Cap
Growth
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
For
the
year
ended
April
30,
2021,
each
Fund's
gross
effective
investment
management
fee
rate
based
on
average
daily
net
assets
was
as
follows:
b.
Administrative
Fees
Under
an
agreement
with
Advisers,
FT
Services
provides
administrative
services
to
the
Funds.
The
fee
is
paid
by
Advisers
based
on
each
of
the
Fund’s
average
daily
net
assets,
and
is
not
an
additional
expense
of
the
Funds.
c.
Distribution
Fees
The
Board
has
adopted
distribution
plans
for
each
share
class,
with
the
exception
of
Class
R6
and
Advisor
Class
shares,
pursuant
to
Rule
12b-1
under
the
1940
Act.
Under
the
Funds’
Class
A
reimbursement
distribution
plans,
the
Funds
reimburse
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of each
Fund's
shares
up
to
the
maximum
annual
plan
rate.
Under
the
Class
A
reimbursement
distribution
plans,
costs
exceeding
the
maximum
for
the
current
plan
year
cannot
be
reimbursed
in
subsequent
periods.
In
addition,
under
the
Funds’
Class
C
and
R
compensation
distribution
plans,
the
Funds
pay
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
each
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
The
plan
year,
for
purposes
of
monitoring
compliance
with
the
maximum
annual
plan
rates,
is
February
1
through
January
31
for
each
Fund.
The
maximum
annual
plan
rates,
based
on
the
average
daily
net
assets,
for
each
class,
are
as
follows:
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
In
excess
of
$15
billion
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Gross
effective
investment
management
fee
rate
........
0.534%
0.599%
0.454%
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Reimbursement
Plans:
Class
A
...............................
0.35%
0.35%
0.25%
Compensation
Plans:
Class
C
...............................
1.00%
1.00%
1.00%
Class
R
...............................
0.50%
0.50%
0.50%
3.
Transactions
with
Affiliates
(continued)
a.
Management
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
68
franklintempleton.com
Annual
Report
For
Franklin
Growth
Opportunities
Fund
and
Franklin
Small
Cap
Growth
Fund,
the
Board
has
set
the
current
rate
at
0.25%
per
year
for
Class
A
shares
until
further
notice
and
approval
by
the
Board.
d.
Sales
Charges/Underwriting
Agreements
Front-end
sales
charges
and
contingent
deferred
sales
charges
(CDSC)
do
not
represent
expenses
of
the
Funds.
These
charges
are
deducted
from
the
proceeds
of
sales
of
fund
shares
prior
to
investment
or
from
redemption
proceeds
prior
to
remittance,
as
applicable.
Distributors
has
advised
the
Funds
of
the
following
commission
transactions
related
to
the
sales
and
redemptions
of
the
Funds'
shares
for
the
year:
e.
Transfer
Agent
Fees
Each
class
of
shares
pays
transfer
agent
fees
to
Investor
Services
for
its
performance
of
shareholder
servicing
obligations.
The
fees
are
based
on
an
annualized
asset
based
fee
of
0.02%
plus
a
transaction
based
fee.
In
addition,
each
class
reimburses
Investor
Services
for
out
of
pocket
expenses
incurred
and,
except
for
Class
R6,
reimburses
shareholder
servicing
fees
paid
to
third
parties.
These
fees
are
allocated
daily
based
upon
their
relative
proportion
of
such
classes'
aggregate
net
assets.
Class
R6
pays
Investor
Services
transfer
agent
fees
specific
to
that
class.
For
the
year
ended
April
30,
2021,
the
Funds
paid
transfer
agent
fees
as
noted
in
the
Statements
of
Operations
of
which
the
following
amounts
were
retained
by
Investor
Services:
f.
Investments
in
Affiliated
Management
Investment
Companies
Certain
or
all
Funds
invest
in
one
or
more
affiliated
management
investment
companies
.
As
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
fund’s
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
fund.
The
Funds
do
not
invest
for
purposes
of
exercising
a
controlling
influence
over
the
management
or
policies.
Management
fees
paid
by
the
Funds
are
waived
on
assets
invested
in
the
affiliated
management
investment
companies,
as
noted
in
the
Statements
of
Operations,
in
an
amount
not
to
exceed
the
management
and
administrative
fees
paid
directly
or
indirectly
by
each
affiliate.
During
the
year
ended
April
30,
2021,
investments
in
affiliated
management
investment
companies
were
as
follows:
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/dealers
..................
$506,747
$223,149
$545,013
CDSC
retained
...........................
$30,346
$12,819
$21,825
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Transfer
agent
fees
........................
$2,462,338
$1,653,159
$2,261,963
3.
Transactions
with
Affiliates
(continued)
c.
Distribution
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
69
franklintempleton.com
Annual
Report
g.
Waiver
and
Expense
Reimbursements
For
Franklin
Growth
Opportunities
Fund,
Franklin
Small
Cap
Growth
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund,
Investor
Services
has
contractually
agreed
in
advance
to
waive
or
limit
its
fees
so
that
the
Class
R6
transfer
agent
fees
do
not
exceed
0.03%
based
on
the
average
net
assets
of
the
class
until
August
31,
2021.
    aa
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Franklin
Growth
Opportunities
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$47,687,960
$793,857,593
$(766,873,489)
$—
$—
$74,672,064
74,672,064
$1,170
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$9,585,975
$787,498,892
$(747,040,327)
$
$
$50,044,540
50,044,540
$759
Total
Affiliated
Securities
....
$57,273,935
$1,581,356,485
$(1,513,913,816)
$—
$—
$124,716,604
$1,929
Franklin
Small
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$74,538,382
$913,328,818
$(782,712,425)
$—
$—
$205,154,775
205,154,775
$3,523
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$34,288,350
$693,196,342
$(662,762,461)
$64,722,231
64,722,231
$1,035
Total
Affiliated
Securities
....
$108,826,732
$1,606,525,160
$(1,445,474,886)
$—
$—
$269,877,006
$4,558
Franklin
Small-Mid
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$52,245,134
$1,217,058,099
$(1,055,974,105)
$—
$—
$213,329,128
213,329,128
$3,699
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$14,660,525
$589,596,009
$(519,375,354)
$84,881,180
84,881,180
$831
Total
Affiliated
Securities
....
$66,905,659
$1,806,654,108
$(1,575,349,459)
$—
$—
$298,210,308
$4,530
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
70
franklintempleton.com
Annual
Report
Prior
to
September
1,
2020,
for
Franklin
Small
Cap
Growth
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund,
Investor
Services
had
contractually
agreed
in
advance
to
waive
or
limit
its
fees
so
that
the
Class
R6
transfer
agent
fees
do
not
exceed
0.02%
based
on
the
average
net
assets
of
the
class.
4.
Expense
Offset
Arrangement
The
Funds
have entered
into
an
arrangement
with
their
custodian
whereby
credits
realized
as
a
result
of
uninvested
cash
balances
are
used
to
reduce
a
portion
of
the
Funds'
custodian
expenses. 
During
the
year ended
April
30,
2021,
the
custodian
fees
were
reduced
as
noted
in
the
Statements
of
Operations.
5.
Income
Taxes
The
tax
character
of
distributions
paid
during
the
years
ended
April
30,
2021
and
2020,
was
as
follows:
At
April
30,
2021,
the
cost
of
investments,
net
unrealized
appreciation
(depreciation),
undistributed
ordinary
income
and
undistributed
long
term
capital
gains
for
income
tax
purposes
were
as
follows:
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
2021
2020
2021
2020
Distributions
paid
from:
Ordinary
income
........................
$29,626,465
$—
$73,106,432
$22,658,947
Long
term
capital
gain
....................
273,838,020
329,774,221
263,826,113
141,442,235
$303,464,485
$329,774,221
$336,932,545
$164,101,182
Franklin
Small-Mid
Cap
Growth
Fund
2021
2020
Distributions
paid
from:
Ordinary
income
........................
$37,327,998
$23,014,333
Long
term
capital
gain
....................
388,989,448
531,687,681
$426,317,446
$554,702,014
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
a
a
a
a
Cost
of
investments
.......................
$2,248,565,398
$2,875,719,529
$3,639,030,168
Unrealized
appreciation
.....................
$3,648,977,174
$1,622,685,791
$2,215,690,131
Unrealized
depreciation
.....................
(31,786,882)
(57,837,698)
(77,321,482)
Net
unrealized
appreciation
(depreciation)
.......
$3,617,190,292
$1,564,848,093
$2,138,368,649
Distributable
earnings:
Undistributed
ordinary
income
................
$20,782,601
$97,151,885
$124,638,099
Undistributed
long
term
capital
gains
...........
242,571,532
287,696,944
422,449,037
Total
distributable
earnings
..................
$263,354,133
$384,848,829
$547,087,136
3.
Transactions
with
Affiliates
(continued)
g.
Waiver
and
Expense
Reimbursements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
71
franklintempleton.com
Annual
Report
Differences
between
income
and/or
capital
gains
as
determined
on
a
book
basis
and
a
tax
basis
are
primarily
due
to
differing
treatments
of
passive
foreign
investment
company
shares
and
wash
sales.
The
Funds
utilized
a
tax
accounting
practice
to
treat
a
portion
of
the
proceeds
from
capital
shares
redeemed
as
a
distribution
from
net
investment
income
and
realized
capital
gains.
6.
Investment
Transactions
Purchases
and
sales
of
investments
(excluding
short
term
securities)
for
the
year
ended
April
30,
2021,
were
as
follows:
At
April
30,
2021,
in
connection
with
securities
lending
transactions,
Franklin
Growth
Opportunities
Fund,
Franklin
Small
Cap
Growth
Fund,
and
Franklin
Small-Mid
Cap
Growth
Fund
loaned
equity
investments
and
received
$50,044,540,
$64,722,231
and
$84,881,180
of
cash
collateral,
respectively.
The
gross
amount
of
recognized
liability
for
such
transactions
is
included
in
payable
upon
return
of
securities
loaned
in
the
Statement
of
Assets
and
Liabilities.
The
agreements
can
be
terminated
at
any
time.
7.
Novel
Coronavirus
Pandemic 
The
global
outbreak
of
the
novel
coronavirus
disease,
known
as
COVID-19, has
caused
adverse
effects
on
many
companies,
sectors,
nations,
regions
and
the
markets
in
general, and
may
continue for
an unpredictable duration.
The
effects
of
this
pandemic
may
materially
impact
the
value
and
performance
of
the
Funds, their ability
to
buy
and
sell
fund
investments
at
appropriate
valuations
and their ability
to
achieve their investment
objectives.
8.
Restricted
Securities
Certain
or
all
Funds
invest
in
securities
that
are
restricted
under
the
Securities
Act
of
1933
(1933
Act).
Restricted
securities
are
often
purchased
in
private
placement
transactions,
and
cannot
be
sold
without
prior
registration
unless
the
sale
is
pursuant
to
an
exemption
under
the
1933
Act.
Disposal
of
these
securities
may
require
greater
effort
and
expense,
and
prompt
sale
at
an
acceptable
price
may
be
difficult.
The
Funds
may
have
registration
rights
for
restricted
securities.
The
issuer
generally
incurs
all
registration
costs.
At
April
30,
2021,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
1933
Act,
were
as
follows:
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Purchases
..............................
$878,099,948
$1,603,734,854
$2,463,539,609
Sales
..................................
$1,082,659,531
$1,565,681,885
$2,411,955,253
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
477,500
ArcLight
Clean
Transition
Corp.
.................
1/28/21
$
4,775,000
$
7,563,276
3,500,000
Aspirational
Consumer
Lifestyle
Corp.
............
2/01/21
35,000,000
35,000,000
255,039
Avidxchange
,
Inc.
............................
7/30/20
12,499,971
13,792,310
2,167,003
Churchill
Capital
Corp.
IV
......................
2/22/21
32,505,045
32,505,045
2,610,594
ClearMotion
,
Inc.,
C
..........................
11/06/17
5,499,999
7,703,411
3,698,772
ClearMotion
,
Inc.,
D
..........................
12/21/18
10,000,000
11,706,569
5.
Income
Taxes
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
72
franklintempleton.com
Annual
Report
Shares/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
(continued)
642,459
Confluent,
Inc.,
E
............................
4/13/20
$
9,616,776
$
10,233,034
112,760
Databricks
,
Inc.,
G
...........................
2/01/21
20,000,005
20,894,425
416,700
a
Dragoneer
Growth
Opportunities
Corp.
II
..........
2/02/21
4,167,000
4,167,000
920,577
Fanatics,
Inc.,
E
.............................
8/13/20
15,916,776
24,109,411
109,362
Fanatics,
Inc.,
F
.............................
3/22/21
3,813,453
3,748,614
230,802
Figs,
Inc.
..................................
10/23/20
17,756,521
20,963,721
201,294
Gitlab
,
Inc.,
E
...............................
9/11/19
3,749,987
8,909,283
415,102
HashiCorp
,
Inc.,
E
...........................
3/06/20
12,004,812
19,097,102
1,673,284
Legalzoom.com
Inc.
..........................
7/20/18
16,479,338
26,204,625
1,196,245
Marqeta
,
Inc.
...............................
8/20/20
10,353,396
11,524,036
181,494
Marqeta
,
Inc.,
A
.............................
10/09/20
2,212,159
1,748,424
19,136
Marqeta
,
Inc.,
B
.............................
10/21/20
234,416
184,347
517,056
OneTrust
LLC,
C
............................
4/01/21
10,139,623
10,139,623
509,182
Optoro
,
Inc.,
E
..............................
7/24/18
10,020,702
12,164,900
2,362,202
Proterra
,
Inc.,
144A,
5
........................
9/21/16
-
1/13/17
11,896,616
30,364,751
596,775
Proterra
,
Inc.,
144A,
6
........................
6/07/17
3,306,052
7,671,200
780,667
Proterra
,
Inc.,
7
.............................
5/21/18
-
9/18/18
5,094,960
10,035,026
289,016
Proterra
,
Inc.,
8
.............................
8/02/19
1,996,378
3,715,135
23,001
Sweetgreen
,
Inc.,
1/20/26
......................
1/21/21
928,488
Sweetgreen
,
Inc.,
H
..........................
11/09/18
12,107,484
13,901,189
100,835
Sweetgreen
,
Inc.,
I
...........................
9/16/19
1,724,278
1,718,144
76,670
Sweetgreen
,
Inc.,
J
..........................
1/21/21
1,311,057
1,306,392
1,753,060
Talkdesk
,
Inc.,
C
............................
7/15/20
11,517,955
28,638,800
805,800
Tanium,
Inc.,
G
..............................
9/14/15
4,000,233
9,206,398
504,854
Tempus
Labs,
Inc.,
F
.........................
5/29/19
12,499,983
22,633,975
126,131
Tempus
Labs,
Inc.,
G
.........................
2/06/20
4,837,426
5,814,771
5,028,735
Wheels
Up
Partners
LLC,
D
....................
5/16/19
-
8/02/19
17,499,998
22,526,068
Total
Restricted
Securities
(Value
is
7.68%
of
Net
Assets)
.............
$324,537,399
$439,891,005
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small
Cap
Growth
Fund
343,750
b
Alkami
Technology,
Inc.
.......................
9/24/20
$
5,500,000
$
15,494,946
1,297,305
Allbirds
,
Inc.,
E
..............................
9/22/20
14,999,998
15,570,065
336,400
ArcLight
Clean
Transition
Corp.
.................
1/28/21
3,364,000
5,328,348
2,000,000
Aspirational
Consumer
Lifestyle
Corp.
............
2/01/21
20,000,000
20,000,000
3,698,772
ClearMotion
,
Inc.,
D
..........................
12/21/18
10,000,000
11,706,569
1,431,280
Legalzoom.com,
Inc.
.........................
7/20/18
14,095,961
22,414,698
1,199,415
Marqeta
,
Inc.
...............................
8/20/20
10,000,003
11,554,574
750,000
New
Starship
Parent,
Inc.
......................
2/02/21
7,500,000
7,500,000
709,046
Newsela
,
Inc.,
D
.............................
1/21/21
15,000,010
14,854,244
508,130
Optoro
,
Inc.,
E
..............................
7/24/18
9,999,998
12,139,766
8.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
73
franklintempleton.com
Annual
Report
Shares/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small
Cap
Growth
Fund
(continued)
1,787,047
Proterra
,
Inc.,
144A,
5
........................
9/21/16
-
1/13/17
$
8,999,997
$
22,971,463
1,310,834
Proterra
,
Inc.,
144A,
6
........................
6/17/17
-
1/02/18
7,261,842
16,850,019
536,367
Proterra
,
Inc.,
7
.............................
5/21/18
3,500,556
6,894,690
596,471
Rent
the
Runway,
Inc.,
144A,
F
.................
3/21/19
13,333,328
12,975,592
508,787
Rent
the
Runway,
Inc.,
G
......................
4/30/20
-
4/30/21
7,500,009
8,950,783
1,542,673
Smule
,
Inc.,
144A,
G
.........................
5/31/16
11,099,995
9,982,051
352,675
Smule
,
Inc.,
144A,
H
.........................
4/27/17
2,999,995
2,692,724
714,286
Spartan
Acquisition
Corp.
II,
A
..................
1/28/21
7,142,860
7,142,860
33,990
Sweetgreen
,
Inc.,
1/20/26
......................
1/21/21
383,435
Sweetgreen
,
Inc.,
H
..........................
11/09/18
4,999,993
5,740,733
41,641
Sweetgreen
,
Inc.,
I
...........................
9/16/19
712,061
709,528
113,300
Sweetgreen
,
Inc.,
J
..........................
1/21/21
1,937,430
1,930,537
2,500,000
TPG
Pace
Governance
LLC,
A
..................
1/28/21
25,000,000
25,000,000
361,111
Tula
eTechnology
,
Inc.
........................
11/01/18
3,611,111
Tula
eTechnology
,
Inc.,
E
......................
9/08/17
6,500,000
8,082,642
4,310,344
Wheels
Up
Partners
LLC,
D
....................
5/16/19
-
8/02/19
14,999,997
19,308,057
Total
Restricted
Securities
(Value
is
6.64%
of
Net
Assets)
.............
$226,448,033
$285,794,889
Principal
Amount
*
/
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small-Mid
Cap
Growth
Fund
405,100
Alkami
Technology,
Inc.
.......................
9/24/20
$
6,481,600
$
18,260,372
772,477
Allbirds
,
Inc.
E
..............................
9/22/20
8,931,711
9,271,156
463,400
ArcLight
Clean
Transition
Corp.
.................
1/28/21
4,634,000
7,339,942
64,741
Blaize
,
Inc.
Ltd.,
2/28/24
.......................
3/01/21
1,294,805
Blaize
,
Inc.,
D
..............................
3/02/21
-
3/22/21
13,521,010
13,521,001
728,215
Churchill
Capital
Corp.
IV
......................
2/22/21
10,923,225
10,923,225
75,943
Databricks
,
Inc.,
G
...........................
2/01/21
13,469,850
14,072,235
775,014
Fanatics,
Inc.,
E
.............................
8/13/20
13,399,992
20,297,196
18,700
Fanatics,
Inc.,
F
.............................
3/22/21
652,069
640,982
1,070,236
Marqeta
,
Inc.
...............................
8/20/20
8,922,986
10,310,127
675,200
New
Starship
Parent,
Inc.
......................
2/02/21
6,752,000
6,752,000
423,782
Newsela
,
Inc.,
D
.............................
1/21/21
8,965,193
8,878,072
767,526
OneTrust
LLC,
C
............................
4/01/21
15,051,415
15,051,415
513,050
Phononic
Devices,
Inc.,
12/01/29
................
1/17/20
-
11/03/20
47
2,022,312
2,970,061
Phononic
Devices,
Inc.,
F
......................
6/06/19
7,499,998
10,389,829
114,327
Phononic
,
Inc.,
Advance
Term
Loan,
B,
12%,
PIK,
7/31/26
..................................
8/25/20
-
4/01/21
111,368
101,784
272,977
Phononic
,
Inc.,
Advance
Term
Loan,
D,
12%,
PIK,
12/01/25
.................................
1/15/21
-
4/01/21
272,303
242,282
555,913
Phononic
,
Inc.,
Term
Loan,
A,
12%,
PIK,
1/17/24
....
1/17/20
-
4/01/21
550,441
506,783
8.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
74
franklintempleton.com
Annual
Report
9.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
The
1940
Act
defines
"affiliated
companies"
to
include
investments
in
portfolio
companies
in
which
a
fund
owns
5%
or
more
of
the
outstanding
voting
securities.
Additionally,
as
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
companies’
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
company.
During
the
year
ended
April
30,
2021,
investments
in
“affiliated
companies”
were
as
follows:
Principal
Amount*/
Shares/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
110,744
Phononic
,
Inc.,
Term
Loan,
C,
12%,
8/25/24
........
12/03/20
-
4/01/21
$
110,449
$
98,759
1,416,913
Proterra
Inc.,
144A,
5
.........................
9/21/16
7,135,914
18,213,603
963,371
Spartan
Acquisition
Corp.
II,
A
..................
1/28/21
9,633,710
9,633,710
Total
Restricted
Securities
(Value
is
3.11%
of
Net
Assets)
.............
$137,019,281
$176,526,785
*
In
U.S.
dollars
unless
otherwise
indicated.
a
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$11,828,001
as
of
April
30,
2021.
b
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$6,667,062
as
of
April
30,
2021.
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
Franklin
Growth
Opportunities
Fund
Non-Controlled
Affiliates
Dividends
Aspirational
Consumer
Lifestyle
Corp.
.....
$
$
35,000,000
$
$
$
$
35,000,000
3,500,000
$
Avidxchange
,
Inc.
....
12,499,971
1,292,339
13,792,310
255,039
ClearMotion
,
Inc.,
C
...
7,675,295
28,116
7,703,411
2,610,594
ClearMotion
,
Inc.,
D
...
11,397,363
309,206
11,706,569
3,698,772
HashiCorp
,
Inc.,
E
....
12,004,812
7,092,290
19,097,102
415,102
Optoro
,
Inc.,
E
.......
13,293,475
(1,128,575)
12,164,900
509,182
Talkdesk
,
Inc.,
C
.....
11,517,955
17,120,845
28,638,800
1,753,060
Tempus
Labs,
Inc.,
F
..
15,849,773
6,784,202
22,633,975
504,854
Tempus
Labs,
Inc.,
G
..
4,843,333
971,438
5,814,771
126,131
Wheels
Up
Partners
LLC,
D
..............
17,193,220
5,332,848
22,526,068
5,028,735
Total
Affiliated
Securities
(Value
is
3.1%
of
Net
Assets)
..........
$82,257,271
$59,017,926
$—
$
$
37,802,709
$179,077,906
$—
8.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
75
franklintempleton.com
Annual
Report
10.
Credit
Facility
The
Funds,
together
with
other
U.S.
registered
and
foreign
investment
funds
(collectively,
Borrowers),
managed
by
Franklin
Templeton,
are
borrowers
in
a
joint
syndicated
senior
unsecured
credit
facility
totaling
$2.675
billion
(Global
Credit
Facility)
which
matures
on
February
4,
2022.
This
Global
Credit
Facility
provides
a
source
of
funds
to
the
Borrowers
for
temporary
and
emergency
purposes,
including
the
ability
to
meet
future
unanticipated
or
unusually
large
redemption
requests. 
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares/Principal
Amount
Held
at
End
of
Year
Investment
Income
Franklin
Small
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Aspirational
Consumer
Lifestyle
Corp.
.....
$
$
20,000,000
$
$
$
$
20,000,000
2,000,000
$
ClearMotion
,
Inc.,
D
...
11,397,363
309,206
11,706,569
3,698,772
Optoro
,
Inc.,
E
.......
13,266,009
(1,126,243)
12,139,766
508,130
TPG
Pace
Governance
LLC,
A
..........
25,000,000
25,000,000
2,500,000
Wheels
Up
Partners
LLC,
D
..............
14,737,045
4,571,012
19,308,057
4,310,344
Total
Affiliated
Securities
(Value
is
2.1%
of
Net
Assets)
..........
$39,400,417
$45,000,000
$—
$
$
3,753,975
$88,154,392
$—
Franklin
Small-Mid
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Blaize
,
Inc.
Ltd.,
2/28/24
64,741
Blaize
,
Inc.,
D
.......
11,267,510
2,253,491
13,521,001
1,294,805
Phononic
Devices,
Inc.,
12/01/29
.........
628,432
1,393,880
2,022,312
513,050
Phononic
Devices,
Inc.,
F
3,875,755
6,514,074
10,389,829
2,970,061
Interest
Phononic
,
Inc.,
Advance
Term
Loan,
B,
12%,
PIK,
7/31/26
..........
111,368
a
(9,584)
101,784
114,327
7,861
Phononic
,
Inc.,
Advance
Term
Loan,
D,
12%,
PIK,
12/01/25
......
272,303
(30,021)
242,282
272,977
7,757
Phononic
,
Inc.,
Term
Loan,
A,
12%,
PIK,
1/17/24
.
394,282
69,345
a
43,156
506,783
555,913
54,770
Phononic
,
Inc.,
Term
Loan,
C,
12%,
8/25/24
....
110,449
a
(11,690)
98,759
110,744
4,505
Total
Affiliated
Securities
(Value
is
0.5%
of
Net
Assets)
..........
$4,898,469
$11,830,975
$—
$
$
10,153,306
$26,882,750
$74,89
3
a
May
include
accretion,
amortization,
partnership
adjustments,
and/or
corporate
actions.
9.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
76
franklintempleton.com
Annual
Report
Under
the
terms
of
the
Global
Credit
Facility,
the
Funds
shall,
in
addition
to
interest
charged
on
any
borrowings
made
by
the
Funds
and
other
costs
incurred
by
the
Funds,
pay
their
share
of
fees
and
expenses
incurred
in
connection
with
the
implementation
and
maintenance
of
the
Global
Credit
Facility,
based
upon
their
relative
share
of
the
aggregate
net
assets
of
all
of
the
Borrowers,
including
an
annual
commitment
fee
of
0.15%
based
upon
the
unused
portion
of
the
Global
Credit
Facility.
These
fees
are
reflected
in
other
expenses
in
the
Statements
of
Operations.
During
the
year ended
April
30,
2021,
the
Funds
did
not
use
the
Global
Credit
Facility.
11.
Fair
Value
Measurements
The Funds
follow
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the Funds'
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the Funds' financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level
3
significant
unobservable
inputs
(including
the Funds'
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
April
30,
2021,
in
valuing
the
Funds'
assets
and
liabilities
carried
at
fair
value,
is
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Auto
Components
......................
$
27,816,815
$
$
$
27,816,815
Automobiles
..........................
56,938,235
56,938,235
Beverages
...........................
77,622,392
77,622,392
Biotechnology
.........................
131,979,032
131,979,032
Capital
Markets
........................
322,545,450
79,235,321
401,780,771
Chemicals
...........................
73,205,778
73,205,778
Commercial
Services
&
Supplies
...........
16,866,727
26,204,625
43,071,352
Electric
Utilities
........................
26,075,759
26,075,759
Entertainment
.........................
35,628,969
35,628,969
Equity
Real
Estate
Investment
Trusts
(REITs)
.
136,602,176
136,602,176
Food
Products
........................
88,460,911
88,460,911
Health
Care
Equipment
&
Supplies
.........
376,732,934
376,732,934
Health
Care
Providers
&
Services
..........
131,929,932
131,929,932
Health
Care
Technology
.................
103,642,203
103,642,203
Hotels,
Restaurants
&
Leisure
.............
121,076,413
121,076,413
Industrial
Conglomerates
................
86,622,750
86,622,750
Interactive
Media
&
Services
..............
223,774,493
223,774,493
Internet
&
Direct
Marketing
Retail
..........
509,665,561
11,524,036
521,189,597
IT
Services
...........................
791,871,555
791,871,555
Life
Sciences
Tools
&
Services
............
32,251,153
39,224,154
71,475,307
Media
...............................
40,125,125
40,125,125
Pharmaceuticals
.......................
99,212,273
99,212,273
Professional
Services
...................
223,714,768
223,714,768
Road
&
Rail
..........................
54,059,149
54,059,149
10.
Credit
Facility
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
77
franklintempleton.com
Annual
Report
Level
1
Level
2
Level
3
Total
Franklin
Growth
Opportunities
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
Common
Stocks:
Semiconductors
&
Semiconductor
Equipment
.
$
215,450,806
$
$
$
215,450,806
Software
.............................
936,539,434
13,792,310
950,331,744
Specialty
Retail
........................
16,793,268
16,793,268
Technology
Hardware,
Storage
&
Peripherals
.
212,947,321
212,947,321
Textiles,
Apparel
&
Luxury
Goods
..........
34,349,376
20,963,721
55,313,097
Wireless
Telecommunication
Services
.......
57,423,169
57,423,169
Convertible
Preferred
Stocks
...............
58,892,073
58,892,073
Preferred
Stocks
........................
229,278,919
229,278,919
Warrants
..............................
a
Short
Term
Investments
...................
124,716,604
124,716,604
Total
Investments
in
Securities
...........
$5,386,640,531
$39,224,154
b
$439,891,005
$5,865,755,690
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
...................
116,382,401
116,382,401
Airlines
..............................
79,617,336
79,617,336
Banks
...............................
117,662,588
117,662,588
Biotechnology
.........................
422,273,551
422,273,551
Building
Products
......................
43,469,018
43,469,018
Capital
Markets
........................
126,202,626
57,471,208
183,673,834
Commercial
Services
&
Supplies
...........
56,359,945
22,414,698
78,774,643
Communications
Equipment
..............
78,700,029
78,700,029
Construction
&
Engineering
...............
90,744,157
90,744,157
Consumer
Finance
.....................
29,235,912
29,235,912
Diversified
Consumer
Services
............
49,878,374
49,878,374
Electronic
Equipment,
Instruments
&
Components
........................
33,778,252
33,778,252
Equity
Real
Estate
Investment
Trusts
(REITs)
.
73,384,361
73,384,361
Food
&
Staples
Retailing
.................
79,673,418
79,673,418
Food
Products
........................
129,904,244
129,904,244
Health
Care
Equipment
&
Supplies
.........
196,777,653
196,777,653
Health
Care
Providers
&
Services
..........
153,737,686
153,737,686
Health
Care
Technology
.................
140,326,397
140,326,397
Hotels,
Restaurants
&
Leisure
.............
155,642,677
155,642,677
Household
Durables
....................
119,849,333
119,849,333
Insurance
............................
30,999,254
30,999,254
Internet
&
Direct
Marketing
Retail
..........
11,554,574
11,554,574
IT
Services
...........................
172,666,135
172,666,135
Life
Sciences
Tools
&
Services
............
81,112,680
81,112,680
Machinery
............................
77,691,130
77,691,130
Personal
Products
.....................
32,526,348
32,526,348
Pharmaceuticals
.......................
61,178,355
61,178,355
Professional
Services
...................
67,281,773
67,281,773
Road
&
Rail
..........................
7,500,000
7,500,000
Semiconductors
&
Semiconductor
Equipment
.
259,939,593
259,939,593
Software
.............................
300,834,078
15,494,946
316,329,024
Specialty
Retail
........................
346,642,861
346,642,861
Textiles,
Apparel
&
Luxury
Goods
..........
44,031,375
44,031,375
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
78
franklintempleton.com
Annual
Report
Level
1
Level
2
Level
3
Total
Franklin
Small
Cap
Growth
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
Common
Stocks:
Trading
Companies
&
Distributors
..........
$
116,392,187
$
$
$
116,392,187
Convertible
Preferred
Stocks
...............
14,854,244
14,854,244
Preferred
Stocks
........................
156,505,219
a
156,505,219
Warrants
..............................
a
Short
Term
Investments
...................
269,877,006
269,877,006
Total
Investments
in
Securities
...........
$4,154,772,733
$—
$285,794,889
$4,440,567,622
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
...................
93,428,130
93,428,130
Airlines
..............................
29,506,600
29,506,600
Banks
...............................
29,163,330
29,163,330
Biotechnology
.........................
172,589,845
172,589,845
Capital
Markets
........................
267,876,373
27,896,877
295,773,250
Commercial
Services
&
Supplies
...........
60,165,800
60,165,800
Construction
Materials
..................
21,222,512
21,222,512
Containers
&
Packaging
.................
68,703,668
68,703,668
Electronic
Equipment,
Instruments
&
Components
........................
89,016,323
89,016,323
Entertainment
.........................
139,480,465
139,480,465
Equity
Real
Estate
Investment
Trusts
(REITs)
.
119,956,144
119,956,144
Food
&
Staples
Retailing
.................
29,783,586
29,783,586
Food
Products
........................
40,835,154
40,835,154
Health
Care
Equipment
&
Supplies
.........
409,043,055
409,043,055
Health
Care
Providers
&
Services
..........
85,987,252
85,987,252
Health
Care
Technology
.................
141,125,034
141,125,034
Hotels,
Restaurants
&
Leisure
.............
222,446,855
222,446,855
Household
Durables
....................
41,148,420
41,148,420
Household
Products
....................
59,649,318
59,649,318
Interactive
Media
&
Services
..............
112,248,721
112,248,721
Internet
&
Direct
Marketing
Retail
..........
44,407,942
10,310,127
54,718,069
IT
Services
...........................
446,904,756
446,904,756
Life
Sciences
Tools
&
Services
............
227,117,056
227,117,056
Machinery
............................
121,707,931
121,707,931
Personal
Products
.....................
30,367,725
30,367,725
Pharmaceuticals
.......................
74,402,880
74,402,880
Professional
Services
...................
327,652,900
327,652,900
Road
&
Rail
..........................
57,504,520
6,752,000
64,256,520
Semiconductors
&
Semiconductor
Equipment
.
343,866,217
343,866,217
Software
.............................
962,337,905
18,260,372
980,598,277
Specialty
Retail
........................
262,385,379
262,385,379
Textiles,
Apparel
&
Luxury
Goods
..........
109,127,736
109,127,736
Trading
Companies
&
Distributors
..........
61,502,192
61,502,192
Convertible
Preferred
Stocks
...............
58,939,900
58,939,900
Preferred
Stocks
........................
51,395,589
51,395,589
Warrants
..............................
2,022,312
a
2,022,312
Senior
Floating
Rate
Interests
...............
949,608
949,608
Short
Term
Investments
...................
298,210,308
298,210,308
Total
Investments
in
Securities
...........
$5,600,872,032
$—
$176,526,785
$5,777,398,817
a
Includes
securities
determined
to
have
no
value
at
April
30,
2021.
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
79
franklintempleton.com
Annual
Report
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the year.
At
April
30,
2021,
the
reconciliation is
as follows:
b
Includes
foreign
securities
valued
at
$39,224,154,
which
were
categorized
as
Level
2
as
a
result
of
the
application
of
market
level
fair
value
procedures.
See
the
Financial
Instrument
Valuation
note
for
more
information.
Balance
at
Beginning
of
Year
Purchases
a
Sales
b
Transfer
Into
Level
3
Transfer
Out
of
Level
3
c
Net
accretion
(
amortiza
-
tion
)
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Capital
Markets
.....
$
$
76,447,045
$
$
$
$
$
$
2,788,276
$
79,235,321
$
2,788,276
Commercial
Services
&
Supplies
........
20,046,660
6,157,965
26,204,625
6,157,965
Internet
&
Direct
Marketing
Retail
...
10,353,396
1,170,640
11,524,036
1,170,640
Software
..........
43,653,245
12,499,971
(52,300,561)
9,939,655
13,792,310
1,292,339
Textiles,
Apparel
&
Luxury
Goods
....
17,756,521
3,207,200
20,963,721
3,207,200
Convertible
Preferred
Stocks
:
Internet
&
Direct
Marketing
Retail
...
19,730,229
8,127,796
27,858,025
8,127,796
Software
..........
30,139,628
894,420
31,034,048
894,420
Preferred
Stocks
:
Airlines
..........
17,193,220
5,332,848
22,526,068
5,332,848
Automobiles
.......
33,649,056
18,137,056
51,786,112
18,137,056
Commercial
Services
&
Supplies
........
13,293,475
(1,128,575)
12,164,900
(1,128,575)
Food
&
Staples
Retailing
15,056,118
1,311,057
558,550
16,925,725
558,550
Health
Care
Providers
&
Services
........
20,693,106
7,755,640
28,448,746
7,755,640
Internet
&
Direct
Marketing
Retail
...
2,446,575
(513,804)
1,932,771
(513,804)
IT
Services
........
12,004,812
7,092,290
19,097,102
7,092,290
Software
..........
38,260,725
11,517,954
26,618,816
76,397,495
26,618,816
Warrants
:
Food
&
Staples
Retailing
d
d
Total
Investments
in
Securities
.
$213,850,417
$182,202,376
$—
$—
$(52,300,561)
$—
$—
$96,138,773
$439,891,005
$87,491,457
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Capital
Markets
.....
55,506,860
1,964,348
57,471,208
1,964,348
Commercial
Services
&
Supplies
........
17,147,349
5,267,349
22,414,698
5,267,349
Hotels,
Restaurants
&
Leisure
.........
60,602,791
(74,522,452)
47,970,632
(34,050,971)
Internet
&
Direct
Marketing
Retail
...
10,000,003
1,554,571
11,554,574
1,554,571
Road
&
Rail
.......
7,500,000
7,500,000
Software
..........
5,500,000
9,994,946
15,494,946
9,994,946
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
80
franklintempleton.com
Annual
Report
Balance
at
Beginning
of
Year
Purchases
a
Sales
b
Transfer
Into
Level
3
Transfer
Out
of
Level
3
c
Net
accretion
(amortiza-
tion)
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Small
Cap
Growth
Fund
(continued)
Assets:
Investments
in
Securities:
Convertible
Preferred
Stocks
:
Diversified
Consumer
Services
........
$
$
15,000,010
$
$
$
$
$
$
(145,766)
$
14,854,244
$
(145,766)
Preferred
Stocks
:
Airlines
..........
14,737,045
4,571,012
19,308,057
4,571,012
Auto
Components
....
7,165,798
916,844
8,082,642
916,844
Automobiles
.......
30,354,762
16,361,410
46,716,172
16,361,410
Commercial
Services
&
Supplies
........
13,266,009
(1,126,243)
12,139,766
(1,126,243)
Food
&
Staples
Retailing
6,217,673
1,937,430
225,695
8,380,798
225,695
Software
..........
23,409,805
971,539
24,381,344
971,539
Specialty
Retail
.....
14,399,688
4,500,002
3,026,685
21,926,375
3,026,685
Textiles,
Apparel
&
Luxury
Goods
....
14,999,998
570,067
15,570,065
570,067
Warrants
:
Food
&
Staples
Retailing
d
d
Hotels,
Restaurants
&
Leisure
.........
637,467
(637,467)
Escrows
and
Litigation
Trusts
...........
d
d
Total
Investments
in
Securities
.
$187,938,387
$114,944,303
$(74,522,452)
$—
$—
$—
$47,970,632
$9,464,019
$285,794,889
$44,152,457
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Capital
Markets
.....
25,190,935
2,705,942
27,896,877
2,705,942
Hotels,
Restaurants
&
Leisure
.........
48,788,058
(42,128,919)
20,809,223
(27,468,362)
Internet
&
Direct
Marketing
Retail
...
8,922,986
1,387,141
10,310,127
1,387,141
Road
&
Rail
.......
6,752,000
6,752,000
Software
..........
6,481,600
11,778,772
18,260,372
11,778,771
Convertible
Preferred
Stocks
:
Diversified
Consumer
Services
........
8,965,193
(87,121)
8,878,072
(87,121)
Internet
&
Direct
Marketing
Retail
...
14,052,061
6,886,117
20,938,178
6,886,117
Software
..........
28,521,265
602,385
29,123,650
602,385
Preferred
Stocks
:
Automobiles
.......
11,834,651
6,378,952
18,213,603
6,378,952
Semiconductors
&
Semiconductor
Equipment
.......
3,875,755
6,514,074
10,389,829
6,514,074
Software
..........
23,281,742
13,521,010
(27,893,645)
4,611,894
13,521,001
(9)
Textiles,
Apparel
&
Luxury
Goods
....
8,931,711
339,445
9,271,156
339,445
Warrants
:
Hotels,
Restaurants
&
Leisure
.........
140,884
(1,034,479)
973,870
(80,275)
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
81
franklintempleton.com
Annual
Report
Significant
unobservable
valuation
inputs
for
material
Level
3 assets
and/or
liabilities and
impact
to
fair
value
as
a
result
of
changes
in
unobservable
valuation
inputs
as
of
April
30,
2021,
are
as
follows:
Balance
at
Beginning
of
Year
Purchases
a
Sales
b
Transfer
Into
Level
3
Transfer
Out
of
Level
3
c
Net
accretion
(amortiza-
tion)
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Assets:
Investments
in
Securities:
Warrants:
Semiconductors
&
Semiconductor
Equipment
.......
$
628,432
$
$
$
$
$
$
$
1,393,880
$
2,022,312
$
1,393,880
Software
..........
d
d
Senior
Floating
Rate
Interests
:
Semiconductors
&
Semiconductor
Equipment
.......
394,282
556,298
(972)
949,608
(972)
Escrows
and
Litigation
Trusts
...........
d
d
Total
Investments
in
Securities
.
$88,943,804
$121,895,059
$(43,163,398)
$—
$(27,893,645)
$—
$21,783,093
$14,961,872
$176,526,785
$37,898,605
a
Purchases
include
all
purchases
of
securities
and
securities
received
in
corporate
actions.
b
Sales
include
all
sales
of
securities,
maturities,
paydowns
and
securities
tendered
in
corporate
actions.
c
Transferred
out
of
Level
3
as
a
result
of
the
availability
of
a
quoted
price
in
an
active
market
for
identical
securities
and
other
significant
observable
valuation
inputs.
May
include
amounts
related
to
a
corporate
action.
d
Includes
securities
determined
to
have
no
value.
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Capital
Markets
..............
$75,068,321
Market
comparables
Discount
for
lack
of
marketability
1.4%
-
35.6%
(16.3%)
Decrease
c
Commercial
Services
&
Supplies
.
26,204,625
Discounted
cash
flow
Discount
for
lack
of
marketability
5.4%
Decrease
Discount
rate
11.4%
Decrease
d
Long
term
growth
rate
4.0%
Increase
d
Internet
&
Direct
Marketing
Retail
.
11,524,036
Discounted
cash
flow
Discount
for
lack
of
marketability
6.2%
Decrease
c
Discount
rate
13.6%
Decrease
d
Long
term
growth
rate
5.0%
Increase
c
Software
...................
13,792,310
Market
comparables
EV
/
EBITDA
multiple
18.7x
Increase
c
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
82
franklintempleton.com
Annual
Report
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Discount
for
lack
of
marketability
7.4%
Decrease
c
Textiles,
Apparel
&
Luxury
Goods
.
20,963,721
Market
comparables
EV
/
EBITDA
multiple
20.0x
-
28.4x
(24.2x)
Increase
c
Discount
for
lack
of
marketability
7.1%
Decrease
c
Convertible
Preferred
Stocks:
Internet
&
Direct
Marketing
Retail
24,109,411
Market
comparables
EV
/
EBITDA
multiple
35.5x
Increase
c
EV
/
revenue
multiple
4.1x
Increase
c
Discount
for
lack
of
marketability
12.9%
Decrease
c
Software
...................
20,894,425
Market
comparables
EV
/
revenue
multiple
32.7x
-
54x
(43.4x)
Increase
c
Discount
for
lack
of
marketability
11.3%
Decrease
c
Preferred
Stocks:
Airlines
.....................
22,526,068
Market
comparables
Discount
for
lack
of
marketability
2.6%
Decrease
c
Automobiles
.................
48,070,977
Discounted
cash
flow
Discount
for
lack
of
marketability
12.6%
Decrease
c
Commercial
Services
&
Supplies
.
12,164,900
Discounted
cash
flow
Discount
for
lack
of
marketability
9.8%
Decrease
c
Discount
rate
19.4%
Decrease
c
Long
term
growth
rate
5.0%
Increase
Market
comparable
EV
/
revenue
multiple
11.0x
12.0x
(11.0x)
Increase
Food
&
Staples
Retailing
.......
13,901,189
Discounted
cash
flow
Discount
for
lack
of
marketability
6.8%
Decrease
c
Discount
rate
18.1%
Decrease
Terminal
Multiple
32.5x
Increase
Market
comparables
EV
/
revenue
multiple
4.3x
Increase
c
Health
Care
Providers
&
Services
.
28,448,746
Discounted
cash
flow
Discount
for
lack
of
marketability
5.9%
Decrease
IT
Services
.................
19,097,102
Market
comparables
Discount
for
lack
of
marketability
8.7%
Decrease
c
EV
/
revenue
multiple
28.7x
Increase
c
Software
...................
76,397,496
Discounted
cash
flow
Discount
for
lack
of
marketability
12.8%
-
13.8%
(13.1%)
Decrease
c
Discount
rate
8.9%
-
10.5%
(10.0%)
Decrease
c
Long
term
growth
rate
2.0%
Increase
c
Terminal
Multiple
34.6x
Increase
c
Market
comparables
EV
/
revenue
multiple
20.1x
-
34.3x
(26.7x)
Increase
c
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
83
franklintempleton.com
Annual
Report
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Discount
for
lack
of
marketability
9.2%
-11.1%
(10.7%)
Decrease
c
All
Other
Investments…..
26,727,678
e,f 
Total
$439,891,005
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Capital
Markets
...............
$57,471,208
Market
comparables
Discount
for
lack
of
marketability
1.4%
-
4.0%
(2.7%)
Decrease
c
Commercial
Services
&
Supplies
.
22,414,698
Discounted
cash
flow
Discount
for
lack
of
marketability
5.4%
Decrease
Discount
rate
11.4%
Decrease
d
Long
term
growth
rate
4.0%
Increase
d
Internet
&
Direct
Marketing
Retail
.
11,554,574
Discounted
cash
flow
Discount
for
lack
of
marketability
6.2%
Decrease
c
Discount
rate
13.6%
Decrease
d
Long
term
growth
rate
5.0%
Increase
c
Road
&
Rail
..................
7,500,000
Market
comparables
Discount
for
lack
of
marketability
9.6%
Decrease
Software
....................
15,494,946
Market
comparables
Discount
for
lack
of
marketability
5.5%
Decrease
Convertible
Preferred
Stocks:
Diversified
Consumer
Services
..
14,854,244
Discounted
cash
flow
Discount
for
lack
of
marketability
15.2%
Decrease
c
Discount
rate
14.8%
Decrease
d
Long
term
growth
rate
5.0%
Increase
Preferred
Stocks:
Airlines
.....................
19,308,057
Market
comparables
Discount
for
lack
of
marketability
2.6%
Decrease
c
Auto
Components
............
8,082,642
Market
comparables
EV
/
EBITDA
multiple
21.4x
Increase
c
Discount
for
lack
of
marketability
10.1%
Decrease
c
Automobiles
.................
46,716,172
Discounted
cash
flow
Discount
for
lack
of
marketability
12.6%
Decrease
c
Commercial
Services
&
Supplies
.
12,139,766
Discounted
cash
flow
Discount
for
lack
of
marketability
9.8%
Decrease
c
Discount
rate
19.4%
Decrease
c
Long
term
growth
rate
5.0%
Increase
Market
comparable
EV
/
revenue
multiple
11.0x
12.0x
(11.0x)
Increase
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
84
franklintempleton.com
Annual
Report
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Food
&
Staples
Retailing
.......
5,740,733
Discounted
cash
flow
Discount
for
lack
of
marketability
6.8%
Decrease
c
Discount
rate
18.1%
Decrease
Terminal
Multiple
32.5x
Increase
Market
comparables
EV
/
revenue
multiple
4.3x
Increase
c
Software
...................
21,688,620
Discounted
cash
flow
Discount
for
lack
of
marketability
12.8%
Decrease
c
Discount
rate
10.5%
Decrease
d
Long
term
growth
rate
2.0%
Increase
Market
comparables
Discount
for
lack
of
marketability
8.1%
Decrease
c
EV
/
revenue
multiple
3.7x
Increase
c
Specialty
Retail
..............
21,926,375
Discounted
cash
flow
Discount
for
lack
of
marketability
10.2%
Decrease
c
Discount
rate
13.4%
Decrease
d
Long
term
growth
rate
4.0%
Increase
c
Textiles,
Apparel
&
Luxury
Goods
.
15,570,065
Market
comparables
Discount
for
lack
of
marketability
9.3%
Decrease
c
EV
/
revenue
multiple
5.2x
Increase
c
All
Other
Investments…..
5,332,789
e,f 
Total
$285,794,889
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Capital
Markets
...............
$27,896,877
Market
comparables
Discount
for
lack
of
marketability
2.1%
-
35.6%
(15.9%)
Decrease
c
Internet
&
Direct
Marketing
Retail
.
10,310,127
Discounted
cash
flow
Discount
for
lack
of
marketability
6.2%
Decrease
c
Discount
rate
13.6%
Decrease
d
Long
term
growth
rate
5.0%
Increase
c
Road
&
Rail
..................
6,752,000
Market
comparables
Discount
for
lack
of
marketability
9.6%
Decrease
Software
....................
18,260,372
Market
comparables
Discount
for
lack
of
marketability
5.5%
Decrease
Convertible
Preferred
Stocks:
Diversified
Consumer
Services
..
8,878,072
Discounted
cash
flow
Discount
for
lack
of
marketability
15.2%
Decrease
c
Discount
rate
14.8%
Decrease
d
Long
term
growth
rate
5.0%
Increase
Internet
&
Direct
Marketing
Retail
.
20,297,196
Market
comparables
EV
/
EBITDA
multiple
35.5x
Increase
c
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
85
franklintempleton.com
Annual
Report
12.
New
Accounting
Pronouncements
In
March
2020,
the
Financial
Accounting
Standards
Board
(FASB)
issued
Accounting
Standards
Update
(ASU)
No.
2020-
04,
Reference
Rate
Reform
(Topic
848)
Facilitation
of
the
Effects
of
Reference
Rate
Reform
on
Financial
Reporting.
The
amendments
in
the
ASU
provides
optional
temporary
financial
reporting
relief
from
the
effect
of
certain
types
of
contract
modifications
due
to
the
planned
discontinuation
of
the
London
Interbank
Offered
Rate
(LIBOR)
and
other
interbank-offered
based
reference
rates
as
of
the
end
of
2021.
The
ASU
is
effective
for
certain
reference
rate-related
contract
modifications
that
occur
during
the
period
March
12,
2020
through
December
31,
2022. Management
has
reviewed
the
requirements
and
believes
the
adoption
of
this
ASU
will
not
have
a
material
impact
on
the
financial
statements.
13.
Subsequent
Events
The
Funds
have
evaluated
subsequent
events
through
the
issuance
of
the
financial
statements
and
determined
that
no
events
have
occurred
that
require
disclosure.
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
EV
/
revenue
multiple
4.1x
Increase
c
Discount
for
lack
of
marketability
12.9%
Decrease
c
Software
...................
14,072,235
Market
comparables
EV
/
revenue
multiple
32.7x
-
54x
(43.4x)
Increase
c
Discount
for
lack
of
marketability
11.3%
Decrease
c
Preferred
Stocks:
Automobiles
.................
18,213,603
Discounted
cash
flow
Discount
for
lack
of
marketability
12.6%
Decrease
c
Semiconductors
&
Semiconductor
Equipment
..................
10,389,829
Market
comparables
Discount
for
lack
of
marketability
11.6%
Decrease
c
Textiles,
Apparel
&
Luxury
Goods
.
9,271,156
Market
comparables
Discount
for
lack
of
marketability
9.3%
Decrease
c
EV
/
revenue
multiple
5.2x
Increase
All
Other
Investments…..
32,185,318
e,f 
Total
$176,526,785
a
Weighted
based
on
the
relative
fair
value
of
the
financial
instruments.
b
Represents
the
directional
change
in
the
fair
value
that
would
result
from
a
significant
and
reasonable
increase
in
the
corresponding
input.
A
significant
and
reasonable
decrease
in
the
input
would
have
the
opposite
effect.
Significant
impacts,
if
any,
to
fair
value
and/or
net
assets
have
been
indicated.
c
Represents
a
significant
impact
to
fair
value
but
not
net
assets.
d
Represents
a
significant
impact
to
fair
value
and
net
assets.
e
Includes
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
May
also
include
values
derived
using
private
transaction
prices
or
non-public
third
party
pricing
information
which
is
unobservable.
f
Includes
securities
determined
to
have
no
value
at
April
30,
2021.
Abbreviations
List
EBITDA
-
Earnings
before
interest,
taxes,
depreciation
and
amortization
EV
-
Enterprise
value
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
86
franklintempleton.com
Annual
Report
Abbreviations
Cu
r
rency
USD
United
States
Dollar
Selected
Portfolio
ADR
American
Depositary
Receipts
LIBOR
London
Inter-Bank
Offered
Rate
PIK
Payment-In-Kind
Franklin
Strategic
Series
87
franklintempleton.com
Annual
Report
Report
of
Independent
Registered
Public
Accounting
Firm
To
the
Board
of
Trustees
of
Franklin
Strategic
Series
and
Shareholders
of
Franklin
Growth
Opportunities
Fund,
Franklin
Small
Cap
Growth
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statements
of
assets
and
liabilities,
including
the
statements
of
investments,
of
Franklin
Growth
Opportunities
Fund,
Franklin
Small
Cap
Growth
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund
(three
of
the
funds
constituting
Franklin
Strategic
Series,
hereafter
collectively
referred
to
as
the
"Funds")
as
of
April
30,
2021,
the
related
statements
of
operations
for
the
year
ended
April
30,
2021,
the
statements
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2021,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2021
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
each
of
the
Funds
as
of
April
30,
2021,
the
results
of
each
of
their
operations
for
the
year
then
ended,
the
changes
in
each
of
their
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2021
and
each
of
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2021
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinions
These
financial
statements
are
the
responsibility
of
the
Funds’
management.
Our
responsibility
is
to
express
an
opinion
on
the
Funds’
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Funds
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
April
30,
2021
by
correspondence
with
the
custodian,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinions.
PricewaterhouseCoopers
LLP
San
Francisco,
California
June
18,
2021
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
Franklin
Templeton
Group
of
Funds
since
1948.
Franklin
Strategic
Series
Tax
Information
(unaudited)
88
franklintempleton.com
Annual
Report
Under
Section
852(b)(3)(C)
of
the
Internal
Revenue
Code,
the
Funds
hereby
report
the
maximum
amount
allowable
but
no
less
than
the
following
amounts
as
long
term
capital
gain
dividends
for
the
fiscal
year
ended
April
30,
2021:
Under
Section
871(k)(2)(C)
of
the
Internal
Revenue
Code,
the
Funds
hereby
report
the
maximum
amount
allowable
but
no
less
than
the
following
amounts
as
short
term
capital
gain
dividends
for
purposes
of
the
tax
imposed
under
Section
871(a)(1)
(A)
of
the
Internal
Revenue
Code
for
the
fiscal
year
ended
April
30,
2021:
Under
Section
854(b)(1)(A)
of
the
Internal
Revenue
Code,
the
Funds
hereby
report
the
following
percentage
amounts
of
the
ordinary
income
dividends
as
income
qualifying
for
the
dividends
received
deduction
for
the
fiscal
year
ended
April
30,
2021:
Under
Section
854(b)(1)(B)
of
the
Internal
Revenue
Code,
the
Funds
hereby
report
the
maximum
amount
allowable
but
no
less
than
the
following
amounts
as
qualified
dividends
for
purposes
of
the
maximum
rate
under
Section
1(h)(11)
of
the
Internal
Revenue
Code
for
the
fiscal
year
ended
April
30,
2021:
Distributions,
including
qualified
dividend
income,
paid
during
calendar
year
2021
will
be
reported
to
shareholders
on
Form
1099-DIV
by
mid-February
2022.
Shareholders
are
advised
to
check
with
their
tax
advisors
for
information
on
the
treatment
of
these
amounts
on
their
individual
income
tax
returns.
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
$273,838,020
$275,400,753
$393,945,300
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
$34,013,725
$92,024,023
$55,324,230
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
54.43%
12.31%
33.93%
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
$17,555,614
$8,997,235
$12,783,253
Franklin
Strategic
Series
Board
Members
and
Officers
89
franklintempleton.com
Annual
Report
The
name,
year
of
birth
and
address
of
the
officers
and
board
members,
as
well
as
their
affiliations,
positions
held
with
the
Trust,
principal
occupations
during
at
least
the
past
five
years
and
number
of
U.S.
registered
portfolios
overseen
in
the
Franklin
Templeton
fund
complex,
are
shown
below.
Generally,
each
board
member
serves
until
that
person’s
successor
is
elected
and
qualified.
Independent
Board
Members
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Harris
J.
Ashton
(1932)
Trustee
Since
1991
125
Bar-S
Foods
(meat
packing
company)
(1981-2010).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Director,
RBC
Holdings,
Inc.
(bank
holding
company)
(until
2002);
and
President,
Chief
Executive
Officer
and
Chairman
of
the
Board,
General
Host
Corporation
(nursery
and
craft
centers)
(until
1998).
Terrence
J.
Checki
(1945)
Trustee
Since
2017
107
Hess
Corporation
(exploration
of
oil
and
gas)
(2014-present).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Member
of
the
Council
on
Foreign
Relations
(1996-present);
Member
of
the
National
Committee
on
U.S.-China
Relations
(1999-present);
member
of
the
board
of
trustees
of
the
Economic
Club
of
New
York
(2013-present);
member
of
the
board
of
trustees
of
the
Foreign
Policy
Association
(2005-present);
member
of
the
board
of
directors
of
Council
of
the
Americas
(2007-present)
and
the
Tallberg
Foundation
(2018–
present);
and
formerly
,
Executive
Vice
President
of
the
Federal
Reserve
Bank
of
New
York
and
Head
of
its
Emerging
Markets
and
Internal
Affairs
Group
and
Member
of
Management
Committee
(1995-2014);
and
Visiting
Fellow
at
the
Council
on
Foreign
Relations
(2014).
Mary
C.
Choksi
(1950)
Trustee
Since
2014
126
Omnicom
Group
Inc.
(advertising
and
marketing
communications
services)
(2011-present)
and
White
Mountains
Insurance
Group,
Ltd.
(holding
company)
(2017-present);
and
formerly
,
Avis
Budget
Group
Inc.
(car
rental)
(2007-2020).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Founder
and
Senior
Advisor,
Strategic
Investment
Group
(investment
management
group)
(2015-2017);
Founding
Partner
and
Senior
Managing
Director,
Strategic
Investment
Group
(1987-2015);
Founding
Partner
and
Managing
Director,
Emerging
Markets
Management
LLC
(investment
management
firm)
(1987-2011);
and
Loan
Officer/Senior
Loan
Officer/Senior
Pension
Investment
Officer,
World
Bank
Group
(international
financial
institution)
(1977-1987).
Franklin
Strategic
Series
90
franklintempleton.com
Annual
Report
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Edith
E.
Holiday
(1952)
Lead
Independent
Trustee
Trustee
since
1998
and
Lead
Independent
Trustee
since
2019
126
Hess
Corporation
(exploration
of
oil
and
gas)
(1993-present),
Santander
Consumer
USA
Holdings,
Inc.
(consumer
finance)
(2016-present);
Santander
Holdings
USA
(holding
company)
(2019-present);
and
formerly
,
Canadian
National
Railway
(railroad)
(2001-April
2021),
White
Mountains
Insurance
Group,
Ltd.
(holding
company)
(2004-May
2021),
RTI
International
Metals,
Inc.
(manufacture
and
distribution
of
titanium)
(1999-2015)
and
H.J.
Heinz
Company
(processed
foods
and
allied
products)
(1994-2013).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
or
Trustee
of
various
companies
and
trusts;
and
formerly
,
Assistant
to
the
President
of
the
United
States
and
Secretary
of
the
Cabinet
(1990-1993);
General
Counsel
to
the
United
States
Treasury
Department
(1989-1990);
and
Counselor
to
the
Secretary
and
Assistant
Secretary
for
Public
Affairs
and
Public
Liaison-United
States
Treasury
Department
(1988-1989).
J.
Michael
Luttig
(1954)
Trustee
Since
2009
126
Boeing
Capital
Corporation
(aircraft
financing)
(2006-2010).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Private
investor;
and
formerly
,
Counselor
and
Senior
Advisor
to
the
Chairman,
CEO,
and
Board
of
Directors,
of
The
Boeing
Company
(aerospace
company),
and
member
of
the
Executive
Council
(May
2019-January
1,
2020);
Executive
Vice
President,
General
Counsel
and
member
of
the
Executive
Council,
The
Boeing
Company
(2006-2019);
and
Federal
Appeals
Court
Judge,
United
States
Court
of
Appeals
for
the
Fourth
Circuit
(1991-2006).
Larry
D.
Thompson
(1945)
Trustee
Since
2007
126
Graham
Holdings
Company
(education
and
media
organization)
(2011-present);
and
formerly
,
The
Southern
Company
(energy
company)
(2014-2020;
previously
(2010-2012)
and
Cbeyond,
Inc.
(business
communications
provider)
(2010-2012).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
Counsel,
Finch
McCranie,
LLP
(law
firm)
(2015-present);
John
A.
Sibley
Professor
of
Corporate
and
Business
Law,
University
of
Georgia
School
of
Law
(2015-present;
previously
2011-2012);
and
formerly
,
Independent
Compliance
Monitor
and
Auditor,
Volkswagen
AG
(manufacturer
of
automobiles
and
commercial
vehicles)
(2017-2020);
Executive
Vice
President
-
Government
Affairs,
General
Counsel
and
Corporate
Secretary,
PepsiCo,
Inc.
(consumer
products)
(2012-2014);
Senior
Vice
President
-
Government
Affairs,
General
Counsel
and
Secretary,
PepsiCo,
Inc.
(2004-2011);
Senior
Fellow
of
The
Brookings
Institution
(2003-2004);
Visiting
Professor,
University
of
Georgia
School
of
Law
(2004);
and
Deputy
Attorney
General,
U.S.
Department
of
Justice
(2001-2003).
Independent
Board
Members
(continued)
Franklin
Strategic
Series
91
franklintempleton.com
Annual
Report
Interested
Board
Members
and
Officers
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Valerie
Williams
(1956)
Trustee
Since
May
2021
107
Omnicom
Group,
Inc.
(advertising
and
marketing
communications
services)
(2016-present),
DTE
Energy
Co.
(gas
and
electric
utility)
(2018-present),
Devon
Energy
Corporation
(exploration
and
production
of
oil
and
gas)
(January
2021-present);
and
formerly
,
WPX
Energy,
Inc.
(exploration
and
production
of
oil
and
gas)
(2018-
2021).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Regional
Assurance
Managing
Partner,
Ernst
&
Young
LLP
(public
accounting)
(2005-2016),
various
roles
of
increasing
responsibility
at
ErNst
&
Young
(1981-2005).
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
**Gregory
E.
Johnson
(1961)
Trustee
Since
2013
137
None
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Executive
Chairman,
Chairman
of
the
Board
and
Director,
Franklin
Resources,
Inc.;
officer
and/or
director
or
trustee,
as
the
case
may
be,
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
39
of
the
investment
companies
in
Franklin
Templeton;
Vice
Chairman,
Investment
Company
Institute;
and
formerly
,
Chief
Executive
Officer
(2013-2020)
and
President
(1994-2015),
Franklin
Resources,
Inc.
**Rupert
H.
Johnson,
Jr.
(1940)
Chairman
of
the
Board
and
Trustee
Chairman
of
the
Board
and
Trustee
since
2013
and
Vice
President
since
1991
126
None
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
(Vice
Chairman),
Franklin
Resources,
Inc.;
Director,
Franklin
Advisers,
Inc.;
and
officer
and/or
director
or
trustee,
as
the
case
may
be,
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
37
of
the
investment
companies
in
Franklin
Templeton.
Alison
E.
Baur
(1964)
Vice
President
Since
2012
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Deputy
General
Counsel,
Franklin
Templeton;
and
officer
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
42
of
the
investment
companies
in
Franklin
Templeton.
Breda
M.
Beckerle
(1958)
Chief
Compliance
Officer
Since
October
2020
Not
Applicable
Not
Applicable
280
Park
Avenue
New
York,
NY
10017
Principal
Occupation
During
at
Least
the
Past
5
Years:
Chief
Compliance
Officer,
Fiduciary
Investment
Management
International,
Inc.,
Franklin
Advisers,
Inc.,
Franklin
Advisory
Services,
LLC,
Franklin
Mutual
Advisers,
LLC,
Franklin
Templeton
Institutional,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Independent
Board
Members
(continued)
Franklin
Strategic
Series
92
franklintempleton.com
Annual
Report
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Sonal
Desai,
Ph.D.
(1963)
Vice
President
Since
2018
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
and
Executive
Vice
President,
Franklin
Advisers,
Inc.;
Executive
Vice
President,
Franklin
Templeton
Institutional,
LLC;
and
officer
of
17
of
the
investment
companies
in
Franklin
Templeton.
Steven
J.
Gray
(1955)
Vice
President
and
Co-Secretary
Vice
President
since
2009
and
Co-Secretary
since
2019
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Associate
General
Counsel,
Franklin
Templeton;
Vice
President,
Franklin
Templeton
Distributors,
Inc.
and
FASA,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Matthew
T.
Hinkle
(1971)
Chief
Executive
Officer
Finance
and
Administration
Since
2017
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Vice
President,
Franklin
Templeton
Services,
LLC;
officer
of
42
of
the
investment
companies
in
Franklin
Templeton;
and
formerly
,
Vice
President,
Global
Tax
(2012-April
2017)
and
Treasurer/Assistant
Treasurer,
Franklin
Templeton
(2009-2017).
Robert
G.
Kubilis
(1973)
Chief
Financial
Officer,
Chief
Accounting
Officer
and
Treasurer
Since
December
2020
Not
Applicable
Not
Applicable
300
S.E.
2nd
Street
Fort
Lauderdale,
FL
33301-
1923
Principal
Occupation
During
at
Least
the
Past
5
Years:
Treasurer,
U.S.
Fund
Administration
&
Reporting
and
officer
of
39
of
the
investment
companies
in
Franklin
Templeton.
Robert
Lim
(1948)
Vice
President
AML
Compliance
Since
2016
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Vice
President,
Franklin
Templeton
Companies,
LLC;
Chief
Compliance
Officer,
Franklin
Templeton
Distributors,
Inc.
and
Franklin
Templeton
Investor
Services,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Edward
D.
Perks
(1970)
President
and
Chief
Executive
Officer
Investment
Management
Since
2018
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
President
and
Director,
Franklin
Advisers,
Inc.;
and
officer
of
eight
of
the
investment
companies
in
Franklin
Templeton
(since
December
2018).
Navid
J.
Tofigh
(1972)
Vice
President
Since
2015
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Associate
General
Counsel
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Interested
Board
Members
and
Officers
(continued)
Franklin
Strategic
Series
93
franklintempleton.com
Annual
Report
*We
base
the
number
of
portfolios
on
each
separate
series
of
the
U.S.
registered
investment
companies
within
the
Franklin
Templeton
fund
complex.
These
portfolios
have
a
common
investment
manager
or
affiliated
investment
managers.
**Gregory
E.
Johnson
is
considered
to
be
an
interested
person
of
the
Fund
under
the
federal
securities
laws
due
to
his
position
as
an
officer
and
director
of
Franklin
Resources,
Inc.
(Resources),
which
is
the
parent
company
of
the
Fund’s
investment
manager
and
distributor.
Rupert
H.
Johnson,
Jr.
is
considered
to
be
an
interested
person
of
the
Fund
under
the
federal
securities
laws
due
to
his
position
as
an
officer
and
director
and
major
shareholder
of
Resources.
Note
1:
Rupert
H.
Johnson,
Jr.
is
the
uncle
of
Gregory
E.
Johnson.
Note
2:
Officer
information
is
current
as
of
the
date
of
this
report.
It
is
possible
that
after
this
date,
information
about
officers
may
change.
The
Sarbanes-Oxley
Act
of
2002
and
Rules
adopted
by
the
Securities
and
Exchange
Commission
require
the
Fund
to
disclose
whether
the
Fund’s
Audit
Committee
includes
at
least
one
member
who
is
an
audit
committee
financial
expert
within
the
meaning
of
such
Act
and
Rules.
The
Fund’s
Board
has
determined
that
there
is
at
least
one
such
financial
expert
on
the
Audit
Committee
and
has
designated
Mary
C.
Choksi
as
its
audit
committee
financial
expert.
The
Board
believes
that
Ms.
Choksi
qualifies
as
such
an
expert
in
view
of
her
extensive
business
background
and
experience.
She
served
as
a
director
of
Avis
Budget
Group,
Inc.
(2007-May
2020)
and
formerly,
Founder
and
Senior
Advisor,
Strategic
Investment
Group
(1987
to
2017).
Ms.
Choksi
has
been
a
Member
of
the
Fund’s
Audit
Committee
since
2014.
As
a
result
of
such
background
and
experience,
the
Board
believes
that
Ms.
Choksi
has
acquired
an
understanding
of
generally
accepted
accounting
principles
and
financial
statements,
the
general
application
of
such
principles
in
connection
with
the
accounting
estimates,
accruals
and
reserves,
and
analyzing
and
evaluating
financial
statements
that
present
a
breadth
and
level
of
complexity
of
accounting
issues
generally
comparable
to
those
of
the
Fund,
as
well
as
an
understanding
of
internal
controls
and
procedures
for
financial
reporting
and
an
understanding
of
audit
committee
functions.
Ms.
Choksi
is
an
independent
Board
member
as
that
term
is
defined
under
the
relevant
Securities
and
Exchange
Commission
Rules
and
Releases.
The
Statement
of
Additional
Information
(SAI)
includes
additional
information
about
the
board
members
and
is
available,
without
charge,
upon
request.
Shareholders
may
call
(800)
DIAL
BEN/342-5236
to
request
the
SAI.
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Craig
S.
Tyle
(1960)
Vice
President
Since
2005
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
General
Counsel
and
Executive
Vice
President,
Franklin
Resources,
Inc.;
and
officer
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
42
of
the
investment
companies
in
Franklin
Templeton.
Lori
A.
Weber
(1964)
Vice
President
and
Co-Secretary
Vice
President
since
2011
and
Co-Secretary
since
2019
Not
Applicable
Not
Applicable
300
S.E.
2nd
Street
Fort
Lauderdale,
FL
33301-
1923
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Associate
General
Counsel,
Franklin
Templeton;
Assistant
Secretary,
Franklin
Resources,
Inc.;
Vice
President
and
Secretary,
Templeton
Investment
Counsel,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Interested
Board
Members
and
Officers
(continued)
Franklin
Strategic
Series
Shareholder
Information
94
franklintempleton.com
Annual
Report
Board
Approval
of
Investment
Management
Agreements
FRANKLIN
STRATEGIC
SERIES
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
(each
a
Fund)
At
a
meeting
held
on
April
20,
2021
(Meeting),
the
Board
of
Trustees
(Board)
of
Franklin
Strategic
Series
(Trust),
including
a
majority
of
the
trustees
who
are
not
“interested
persons”
as
defined
in
the
Investment
Company
Act
of
1940
(Independent
Trustees),
reviewed
and
approved
the
continuance
of
the
investment
management
agreement
between
Franklin
Advisers,
Inc.
(Manager)
and
the
Trust,
on
behalf
of
each
Fund
(each
a
Management
Agreement)
for
an
additional
one-year
period.
The
Independent
Trustees
received
advice
from
and
met
separately
with
Independent
Trustee
counsel
in
considering
whether
to
approve
the
continuation
of
each
Management
Agreement.
Although
the
Management
Agreements
for
the
Funds
were
considered
at
the
same
Board
meeting,
the
Board
considered
the
information
provided
to
it
about
the
Funds
together
and
with
respect
to
each
Fund
separately
as
the
Board
deemed
appropriate.
In
considering
the
continuation
of
each
Management
Agreement,
the
Board
reviewed
and
considered
information
provided
by
the
Manager
at
the
Meeting
and
throughout
the
year
at
meetings
of
the
Board
and
its
committees.
The
Board
also
reviewed
and
considered
information
provided
in
response
to
a
detailed
set
of
requests
for
information
submitted
to
the
Manager
by
Independent
Trustee
counsel
on
behalf
of
the
Independent
Trustees
in
connection
with
the
annual
contract
renewal
process.
In
addition,
prior
to
the
Meeting,
the
Independent
Trustees
held
a
telephonic
contract
renewal
meeting
at
which
the
Independent
Trustees
conferred
amongst
themselves
and
Independent
Trustee
counsel
about
contract
renewal
matters
and,
in
some
cases,
requested
additional
information
from
the
Manager
relating
to
the
contract.
The
Board
reviewed
and
considered
all
of
the
factors
it
deemed
relevant
in
approving
the
continuance
of
each
Management
Agreement,
including,
but
not
limited
to:
(i)
the
nature,
extent
and
quality
of
the
services
provided
by
the
Manager;
(ii)
the
investment
performance
of
each
Fund;
(iii)
the
costs
of
the
services
provided
and
profits
realized
by
the
Manager
and
its
affiliates
from
the
relationship
with
each
Fund;
(iv)
the
extent
to
which
economies
of
scale
are
realized
as
each
Fund
grows;
and
(v)
whether
fee
levels
reflect
these
economies
of
scale
for
the
benefit
of
Fund
investors.
In
approving
the
continuance
of
each
Management
Agreement,
the
Board,
including
a
majority
of
the
Independent
Trustees,
determined
that
the
terms
of
the
Management
Agreement
are
fair
and
reasonable
and
that
the
continuance
of
such
Management
Agreement
is
in
the
best
interests
of
the
applicable
Fund
and
its
shareholders.
While
attention
was
given
to
all
information
furnished,
the
following
discusses
some
primary
factors
relevant
to
the
Board’s
determination.
Nature,
Extent
and
Quality
of
Services
The
Board
reviewed
and
considered
information
regarding
the
nature,
extent
and
quality
of
investment
management
services
provided
by
the
Manager
and
its
affiliates
to
the
Funds
and
their
shareholders.
This
information
included,
among
other
things,
the
qualifications,
background
and
experience
of
the
senior
management
and
investment
personnel
of
the
Manager,
as
well
as
information
on
succession
planning
where
appropriate;
the
structure
of
investment
personnel
compensation;
oversight
of
third-
party
service
providers;
investment
performance
reports
and
related
financial
information
for
each
Fund;
reports
on
expenses
and
shareholder
services;
legal
and
compliance
matters;
risk
controls;
pricing
and
other
services
provided
by
the
Manager
and
its
affiliates;
and
management
fees
charged
by
the
Manager
and
its
affiliates
to
US
funds
and
other
accounts,
including
management’s
explanation
of
differences
among
accounts
where
relevant.
The
Board
also
reviewed
and
considered
an
annual
report
on
payments
made
by
Franklin
Templeton
(FT)
or
the
Funds
to
financial
intermediaries,
as
well
as
a
memorandum
relating
to
third-
party
servicing
arrangements,
which
included
discussion
of
the
changing
distribution
landscape
for
the
Funds.
The
Board
noted
management’s
continuing
efforts
and
expenditures
in
establishing
effective
business
continuity
plans
and
developing
strategies
to
address
areas
of
heightened
concern
in
the
mutual
fund
industry,
such
as
cybersecurity
in
the
current
work-from-home
environment
and
liquidity
risk
management.
The
Board
also
reviewed
and
considered
the
benefits
provided
to
Fund
shareholders
of
investing
in
a
fund
that
is
part
of
the
FT
family
of
funds.
The
Board
noted
the
financial
position
of
Franklin
Resources,
Inc.
(FRI),
the
Manager’s
parent,
and
its
commitment
to
the
mutual
fund
Franklin
Strategic
Series
Shareholder
Information
95
franklintempleton.com
Annual
Report
business
as
evidenced
by
its
reassessment
of
the
fund
offerings
in
response
to
the
market
environment
and
project
initiatives
and
capital
investments
relating
to
the
services
provided
to
the
Funds
by
the
FT
organization.
The
Board
specifically
noted
FT’s
commitment
to
enhancing
services
and
controlling
costs,
as
reflected
in
its
outsourcing
of
certain
administrative
functions,
and
growth
opportunities,
as
evidenced
by
its
recent
acquisition
of
the
Legg
Mason
companies.
The
Board
also
noted
FT’s
attention
focused
on
expanding
the
distribution
opportunities
for
all
funds
in
the
FT
family
of
funds.
Following
consideration
of
such
information,
the
Board
was
satisfied
with
the
nature,
extent
and
quality
of
services
provided
by
the
Manager
and
its
affiliates
to
the
Funds
and
their
shareholders.
Fund
Performance
The
Board
reviewed
and
considered
the
performance
results
of
each
Fund
over
various
time
periods
ended
January
31,
2021.
The
Board
considered
the
performance
returns
for
each
Fund
in
comparison
to
the
performance
returns
of
mutual
funds
deemed
comparable
to
the
Fund
included
in
a
universe
(Performance
Universe)
selected
by
Broadridge
Financial
Solutions,
Inc.
(Broadridge),
an
independent
provider
of
investment
company
data.
The
Board
received
a
description
of
the
methodology
used
by
Broadridge
to
select
the
mutual
funds
included
in
a
Performance
Universe.
The
Board
also
reviewed
and
considered
Fund
performance
reports
provided
and
discussions
that
occurred
with
portfolio
managers
at
Board
meetings
throughout
the
year.
A
summary
of
each
Fund’s
performance
results
is
below.
Franklin
Growth
Opportunities
Fund
-
The
Performance
Universe
for
the
Fund
included
the
Fund
and
all
retail
and
institutional
multi-cap
growth
funds.
The
Board
noted
that
the
Fund’s
annualized
total
return
for
the
one-,
three-,
five-
and
10-year
periods
was
above
the
median
of
its
Performance
Universe.
The
Board
concluded
that
the
Fund’s
performance
was
satisfactory.
Franklin
Small
Cap
Growth
Fund
-
The
Performance
Universe
for
the
Fund
included
the
Fund
and
all
retail
and
institutional
small-cap
growth
funds.
The
Board
noted
that
the
Fund’s
annualized
total
return
for
the
one-,
three-,
five-
and
10-year
periods
was
above
the
median
of
its
Performance
Universe.
The
Board
concluded
that
the
Fund’s
performance
was
satisfactory.
Franklin
Small-Mid
Cap
Growth
Fund
-
The
Performance
Universe
for
the
Fund
included
the
Fund
and
all
retail
and
institutional
mid-cap
growth
funds.
The
Board
noted
that
the
Fund’s
annualized
total
return
for
the
one-,
three-,
five-
and
10-year
periods
was
above
the
median
of
its
Performance
Universe.
The
Board
concluded
that
the
Fund’s
performance
was
satisfactory.
Comparative
Fees
and
Expenses
The
Board
reviewed
and
considered
information
regarding
each
Fund’s
actual
total
expense
ratio
and
its
various
components,
including,
as
applicable,
management
fees;
transfer
agent
expenses;
underlying
fund
expenses;
Rule
12b-1
and
non-Rule
12b-1
service
fees;
and
other
non-
management
fees.
The
Board
also
noted
the
quarterly
and
annual
reports
it
receives
on
all
marketing
support
payments
made
by
FT
to
financial
intermediaries.
The
Board
considered
the
actual
total
expense
ratio
and,
separately,
the
contractual
management
fee
rate,
without
the
effect
of
fee
waivers,
if
any
(Management
Rate)
of
each
Fund
in
comparison
to
the
median
expense
ratio
and
median
Management
Rate,
respectively,
of
other
mutual
funds
deemed
comparable
to
and
with
a
similar
expense
structure
to
the
Fund
selected
by
Broadridge
(Expense
Group).
Broadridge
fee
and
expense
data
is
based
upon
information
taken
from
each
fund’s
most
recent
annual
report,
which
reflects
historical
asset
levels
that
may
be
quite
different
from
those
currently
existing,
particularly
in
a
period
of
market
volatility.
While
recognizing
such
inherent
limitation
and
the
fact
that
expense
ratios
and
Management
Rates
generally
increase
as
assets
decline
and
decrease
as
assets
grow,
the
Board
believed
the
independent
analysis
conducted
by
Broadridge
to
be
an
appropriate
measure
of
comparative
fees
and
expenses.
The
Broadridge
Management
Rate
includes
administrative
charges,
and
the
actual
total
expense
ratio,
for
comparative
consistency,
was
shown
for
Class
A
shares
for
each
Fund
and
for
each
of
the
other
funds
in
each
Fund’s
respective
Expense
Group.
The
Board
received
a
description
of
the
methodology
used
by
Broadridge
to
select
the
mutual
funds
included
in
an
Expense
Group.
The
Expense
Group
for
the
Franklin
Growth
Opportunities
Fund
included
the
Fund
and
15
other
multi-cap
growth
funds.
The
Expense
Group
for
the
Franklin
Small
Cap
Growth
Fund
included
the
Fund
and
11
other
small-cap
growth
funds.
The
Expense
Group
for
the
Franklin
Small-Mid
Cap
Growth
Fund
included
the
Fund
and
14
other
mid-cap
growth
funds.
The
Board
noted
that
the
Management
Rates
and
actual
total
expense
ratios
for
these
Funds
were
below
the
medians
and
in
the
first
quintile
(least
expensive)
of
their
respective
Expense
Groups.
The
Board
concluded
that
the
Management
Rates
charged
to
these
Funds
are
reasonable.
Franklin
Strategic
Series
Shareholder
Information
96
franklintempleton.com
Annual
Report
Profitability
The
Board
reviewed
and
considered
information
regarding
the
profits
realized
by
the
Manager
and
its
affiliates
in
connection
with
the
operation
of
each
Fund.
In
this
respect,
the
Board
considered
the
Fund
profitability
analysis
provided
by
the
Manager
that
addresses
the
overall
profitability
of
FT’s
US
fund
business,
as
well
as
its
profits
in
providing
investment
management
and
other
services
to
each
of
the
individual
funds
during
the
12-month
period
ended
September
30,
2020,
being
the
most
recent
fiscal
year-
end
for
FRI.
The
Board
noted
that
although
management
continually
makes
refinements
to
its
methodologies
used
in
calculating
profitability
in
response
to
organizational
and
product-related
changes,
the
overall
methodology
has
remained
consistent
with
that
used
in
the
Funds’
profitability
report
presentations
from
prior
years.
The
Board
further
noted
management’s
representation
that
the
profitability
analysis
excluded
the
impact
of
the
recent
acquisition
of
the
Legg
Mason
companies
and
that
management
expects
to
incorporate
the
legacy
Legg
Mason
companies
into
the
profitability
analysis
beginning
next
year.
The
Board
also
noted
that
PricewaterhouseCoopers
LLP,
auditor
to
FRI
and
certain
FT
funds,
has
been
engaged
by
the
Manager
to
periodically
review
and
assess
the
allocation
methodologies
to
be
used
solely
by
the
Funds’
Board
with
respect
to
the
profitability
analysis.
The
Board
noted
management’s
belief
that
costs
incurred
in
establishing
the
infrastructure
necessary
for
the
type
of
mutual
fund
operations
conducted
by
the
Manager
and
its
affiliates
may
not
be
fully
reflected
in
the
expenses
allocated
to
each
Fund
in
determining
its
profitability,
as
well
as
the
fact
that
the
level
of
profits,
to
a
certain
extent,
reflected
operational
cost
savings
and
efficiencies
initiated
by
management.
As
part
of
this
evaluation,
the
Board
considered
management’s
outsourcing
of
certain
operations,
which
effort
has
required
considerable
up
front
expenditures
by
the
Manager
but,
over
the
long
run
is
expected
to
result
in
greater
efficiencies.
The
Board
also
noted
management’s
expenditures
in
improving
shareholder
services
provided
to
the
Funds,
as
well
as
the
need
to
implement
systems
and
meet
additional
regulatory
and
compliance
requirements
resulting
from
recent
US
Securities
and
Exchange
Commission
and
other
regulatory
requirements.
The
Board
also
considered
the
extent
to
which
the
Manager
and
its
affiliates
might
derive
ancillary
benefits
from
fund
operations,
including
revenues
generated
from
transfer
agent
services,
potential
benefits
resulting
from
personnel
and
systems
enhancements
necessitated
by
fund
growth,
as
well
as
increased
leverage
with
service
providers
and
counterparties.
Based
upon
its
consideration
of
all
these
factors,
the
Board
concluded
that
the
level
of
profits
realized
by
the
Manager
and
its
affiliates
from
providing
services
to
each
Fund
was
not
excessive
in
view
of
the
nature,
extent
and
quality
of
services
provided
to
each
Fund.
Economies
of
Scale
The
Board
reviewed
and
considered
the
extent
to
which
the
Manager
may
realize
economies
of
scale,
if
any,
as
each
Fund
grows
larger
and
whether
each
Fund’s
management
fee
structure
reflects
any
economies
of
scale
for
the
benefit
of
shareholders.
With
respect
to
possible
economies
of
scale,
the
Board
noted
the
existence
of
management
fee
breakpoints,
which
operate
generally
to
share
any
economies
of
scale
with
a
Fund’s
shareholders
by
reducing
the
Fund’s
effective
management
fees
as
the
Fund
grows
in
size.
The
Board
considered
the
Manager’s
view
that
any
analyses
of
potential
economies
of
scale
in
managing
a
particular
fund
are
inherently
limited
in
light
of
the
joint
and
common
costs
and
investments
the
Manager
incurs
across
the
FT
family
of
funds
as
a
whole.
The
Board
concluded
that
to
the
extent
economies
of
scale
may
be
realized
by
the
Manager
and
its
affiliates,
each
Fund’s
management
fee
structure
provided
a
sharing
of
benefits
with
the
Fund
and
its
shareholders
as
the
Fund
grows.
Conclusion
Based
on
its
review,
consideration
and
evaluation
of
all
factors
it
believed
relevant,
including
the
above-described
factors
and
conclusions,
the
Board
unanimously
approved
the
continuation
of
each
Management
Agreement
for
an
additional
one-year
period.
Proxy
Voting
Policies
and
Procedures
The
Trust’s
investment
manager
has
established
Proxy
Voting
Policies
and
Procedures
(Policies)
that
the
Trust
uses
to
determine
how
to
vote
proxies
relating
to
portfolio
securities.
Shareholders
may
view
the
Trust’s
complete
Policies
online
at
franklintempleton.com.
Alternatively,
shareholders
may
request
copies
of
the
Policies
free
of
charge
by
calling
the
Proxy
Group
collect
at
(954)
527-
7678
or
by
sending
a
written
request
to:
Franklin
Templeton
Companies,
LLC,
300
S.E.
2nd
Street,
Fort
Lauderdale,
FL
33301,
Attention:
Proxy
Group.
Copies
of
the
Trust’s
proxy
voting
records
are
also
made
available
online
at
franklintempleton.com
and
posted
on
the
U.S.
Securities
and
Exchange
Commission’s
website
at
sec.gov
and
reflect
the
most
recent
12-month
period
ended
June
30.
Franklin
Strategic
Series
Shareholder
Information
97
franklintempleton.com
Annual
Report
Quarterly
Statement
of
Investments
The
Trust
files
a
complete
statement
of
investments
with
the
U.S.
Securities
and
Exchange
Commission
for
the
first
and
third
quarters
for
each
fiscal
year
as
an
exhibit
to
its
report
on
Form
N-PORT.
Shareholders
may
view
the
filed
Form
N-PORT
by
visiting
the
Commission’s
website
at
sec.
gov.
The
filed
form
may
also
be
viewed
and
copied
at
the
Commission’s
Public
Reference
Room
in
Washington,
DC.
Information
regarding
the
operations
of
the
Public
Reference
Room
may
be
obtained
by
calling
(800)
SEC-0330.
Householding
of
Reports
and
Prospectuses
You
will
receive,
or
receive
notice
of
the
availability
of,
each
Fund's
financial
reports
every
six
months.
In
addition,
you
will
receive
an
annual
updated
summary
prospectus
(detail
prospectus
available
upon
request).
To
reduce
Fund
expenses,
we
try
to
identify
related
shareholders
in
a
household
and
send
only
one
copy
of
the
financial
reports
(to
the
extent
received
by
mail)
and
summary
prospectus.
This
process,
called
“householding,”
will
continue
indefinitely
unless
you
instruct
us
otherwise.
If
you
prefer
not
to
have
these
documents
householded,
please
call
us
at
(800)
632-2301.
At
any
time
you
may
view
current
prospectuses/
summary
prospectuses
and
financial
reports
on
our
website.
If
you
choose,
you
may
receive
these
documents
through
electronic
delivery.
FSS1
A
06/21
©
2021
Franklin
Templeton
Investments.
All
rights
reserved.
Authorized
for
distribution
only
when
accompanied
or
preceded
by
a
summary
prospectus
and/or
prospectus.
Investors
should
carefully
consider
a
fund’s
investment
goals,
risks,
charges
and
expenses
before
investing.
A
prospectus
contains
this
and
other
information;
please
read
it
carefully
before
investing.
To
help
ensure
we
provide
you
with
quality
service,
all
calls
to
and
from
our
service
areas
are
monitored
and/or
recorded.
Annual
Report
and
Shareholder
Letter
Franklin
Strategic
Series
Investment
Manager
Distributor
Shareholder
Services
Franklin
Advisers,
Inc.
Franklin
Templeton
Distributors,
Inc.
(800)
DIAL
BEN
®
/
342-5236
franklintempleton.com
(800)
632-2301
Annual
Report
and
Shareholder
Letter
Franklin
Strategic
Series
April
30,
2021
Sign
up
for
electronic
delivery
at
franklintempleton.com/edelivery
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
franklintempleton.com
Not
part
of
the
annual
report
1
Shareholder
Letter
Dear
Shareholder:
During
the
12
months
ended
April
30,
2021,
the
novel
coronavirus
(COVID-19)
pandemic
caused
the
U.S.
economy
to
contract
in
2020’s
first
half.
For
the
remainder
of
2020,
the
economy
recovered
substantially
based
on
increased
business
and
residential
investment
and
consumer
spending.
U.S.
economic
growth
accelerated
during
2021’s
first
quarter
as
the
reopening
of
businesses,
widespread
COVID-19
vaccinations
and
federal
assistance
programs
boosted
consumer
spending.
Before
the
reporting
period,
the
U.S.
Federal
Reserve
(Fed),
in
its
efforts
to
support
U.S.
economic
activity,
lowered
the
target
range
for
the
federal
funds
rate
twice
in
March
2020
and
implemented
broad
quantitative
easing
measures
to
support
credit
markets.
During
the
reporting
period,
the
Fed
held
the
target
range
for
its
key
rate
unchanged
at
0.00%–
0.25%,
but
it
continued
quantitative
easing
and
adjusted
its
policy
in
August
2020
to
allow
more
flexibility
to
keep
interest
rates
low,
while
maintaining
a
2%
average
inflation
target.
In
this
environment,
U.S.
stocks,
as
measured
by
the
Standard
&
Poor’s
®
500
Index,
posted
a
strong
positive
total
return
for
the
12-month
period.
We
are
committed
to
our
long-term
perspective
and
disciplined
investment
approach
as
we
conduct
a
rigorous,
fundamental
analysis
of
securities
with
a
regular
emphasis
on
investment
risk
management.
We
believe
active,
professional
investment
management
serves
investors
well.
We
also
recognize
the
important
role
of
financial
professionals
in
today’s
markets
and
encourage
investors
to
continue
to
seek
their
advice.
Amid
changing
markets
and
economic
conditions,
we
are
confident
investors
with
a
well-diversified
portfolio
and
a
patient,
long-term
outlook
should
be
well-positioned
for
the
years
ahead.
In
addition,
Franklin
Strategic
Series’
annual
report
includes
more
detail
about
prevailing
conditions
and
a
discussion
about
investment
decisions
during
the
period.
All
securities
markets
fluctuate,
as
do
mutual
fund
share
prices.
We
thank
you
for
investing
with
Franklin
Templeton,
welcome
your
questions
and
comments,
and
look
forward
to
serving
your
future
investment
needs.
Sincerely,
Edward
Perks,
CFA
President
and
Chief
Executive
Officer
Investment
Management
Franklin
Strategic
Series
This
letter
reflects
our
analysis
and
opinions
as
of
April
30,
2021,
unless
otherwise
indicated.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
CFA
®
is
a
trademark
owned
by
CFA
Institute.
franklintempleton.com
Annual
Report
2
Contents
Annual
Report
Economic
and
Market
Overview
3
Franklin
Biotechnology
Discovery
Fund
4
Franklin
Natural
Resources
Fund
11
Financial
Highlights
and
Statements
of
Investments
18
Financial
Statements
34
Notes
to
Financial
Statements
38
Report
of
Independent
Registered
Public
Accounting
Firm
54
Tax
Information
55
Board
Members
and
Officers
56
Shareholder
Information
61
Visit
franklintempleton.com
for
fund
updates,
to
access
your
account,
or
to
find
helpful
financial
planning
tools.
3
franklintempleton.com
Annual
Report
ANNUAL
REPORT
Economic
and
Market
Overview
U.S.
equities,
as
measured
by
the
Standard
&
Poor’s
500
Index
(S&P
500
®
),
advanced
strongly
during
the
12
months
ended
April
30,
2021.
Equities
rose
amid
the
U.S.
recovery
from
the
initial
shock
of
the
novel
coronavirus
pandemic
and
related
restrictions.
The
phased
economic
reopening
of
many
states,
the
development
of
treatments
and
vaccines,
and
several
fiscal
stimulus
measures
that
included
direct
payments
to
many
individuals
and
programs
designed
to
help
small
businesses
keep
employees
on
the
payroll,
supported
stock
prices.
In
November
2020,
news
that
several
vaccines
showed
high
efficacy
rates
bolstered
investor
confidence.
Furthermore,
the
implementation
of
mass
vaccination
programs
in
early
2021,
a
significant
decline
in
the
U.S.
infection
rate
and
continued
economic
opening
led
U.S.
equities
to
reach
all-time
price
highs
in
April
2021.
The
U.S.
economy
was
severely
impacted
by
the
pandemic,
as
business
closures
and
restrictions
on
gatherings
disrupted
everyday
life.
As
a
result,
second-quarter
2020
gross
domestic
product
(GDP)
declined
at
a
record
annualized
rate,
and
mass
layoffs
drove
the
unemployment
rate
to
a
peak
of
14.8%
in
April.
1
However,
economic
conditions
improved
rapidly
thereafter,
with
the
GDP
rebounding
at
a
record
annualized
pace
in
2020’s
third
quarter
and
expanding
at
a
less
robust
pace
in
2020’s
fourth
quarter
and
2021’s
first
quarter.
Notably,
the
unemployment
rate
declined
to
6.1%
in
April
2021,
as
jobless
claims
fell
and
employment
openings
rose.
1
In
an
effort
to
support
the
economy,
the
U.S.
Federal
Reserve
(Fed)
kept
the
federal
funds
target
rate
at
a
record-low
range
of
0.00%–0.25%.
The
Fed
also
enacted
quantitative
easing
measures
aimed
at
ensuring
credit
flows
to
borrowers
and
supporting
credit
markets
with
open-
ended
bond
purchasing.
Furthermore,
the
Fed
signaled
that
interest
rates
would
potentially
remain
low,
even
if
inflation
moderately
exceeded
its
2%
target.
The
combination
of
stimulus
payments,
increasing
asset
prices
and
generally
rising
savings
during
lockdowns
led
to
the
strengthening
of
overall
household
balance
sheets.
The
higher
overall
household
wealth
and
pent-up
consumer
demand
led
to
stronger
consumer
spending
in
2021’s
first
quarter
that,
along
with
the
shortages
of
some
materials
and
supplies,
drove
many
investors’
inflation
expectations
to
increase
significantly
near
period-end.
The
foregoing
information
reflects
our
analysis
and
opinions
as
of
April
30,
2021.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
1.
Source:
Bureau
of
Labor
Statistics.
4
franklintempleton.com
Annual
Report
Franklin
Biotechnology
Discovery
Fund
This
annual
report
for
Franklin
Biotechnology
Discovery
Fund
covers
the
fiscal
year
ended
April
30,
2021.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
capital
appreciation.
Under
normal
market
conditions,
the
Fund
invests
at
least
80%
of
its
net
assets
in
securities
of
biotechnology
companies
and
discovery
research
firms
located
in
the
U.S.
and
other
countries.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+24.26%
cumulative
total
return
for
the
12
months
under
review.
In
comparison,
the
NASDAQ
Biotechnology
Index
®
,
which
tracks
U.S.
and
international-based
biotechnology
stocks,
posted
a
+25.45%
total
return.
1
Also
in
comparison,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
is
a
broad
measure
of
the
U.S.
stock
market,
posted
a
+45.98%
total
return.
1
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
7
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
are
research-driven,
fundamental
investors,
pursuing
a
growth
strategy.
As
bottom-up
investors
focusing
primarily
on
individual
securities,
we
choose
companies
that
have
identifiable
drivers
of
future
earnings
growth
and
that
present,
in
our
opinion,
the
best
trade-off
between
potential
earnings
growth,
business
and
financial
risk,
and
valuation.
Also,
in
seeking
sustainable
growth
characteristics,
we
look
for
companies
that
we
believe
can
produce
sustainable
earnings
growth
and
cash
flow
growth
or
the
potential
to
generate
income.
We
rely
on
a
team
of
analysts
to
help
provide
in-depth
industry
expertise
and
use
both
qualitative
and
quantitative
analysis
to
evaluate
companies
for
distinct
and
sustainable
competitive
advantages
likely
to
lead
to
growth
in
earnings
and/or
share
price.
Competitive
advantages,
such
as
a
particular
product
niche,
proven
technology,
sound
financial
position
and
strong
management,
are
all
factors
we
believe
may
contribute
to
strong
growth
potential.
Manager’s
Discussion
During
the
12
months
under
review,
the
biotechnology
industry
experienced
modest
amounts
of
volatility.
Please
keep
in
mind
that
volatility
is
not
uncommon
in
the
biotechnology
industry,
and
we
seek
to
take
advantage
of
short-term
volatility
by
initiating
positions
or
adding
to
existing
holdings
in
companies
we
believe
are
undervalued.
The
Fund
recovered
its
losses
from
pandemic-induced
lows
and
saw
significant
absolute
returns
despite
mixed
results
at
the
individual
stock
level.
Biotechnology
stocks
comprised
a
large
majority
of
the
overall
portfolio
and
provided
most
of
the
overall
gain,
followed
by
much
smaller
contributions
from
the
pharmaceuticals
and
life
sciences
tools
and
services
industries.
The
biggest
contributor
to
absolute
performance
in
biotechnology
and
the
Fund
as
a
whole
was
vaccine
developer
Novavax,
whose
equity
value
multiplied
more
than
tenfold
during
the
period.
Novavax
had
two
positive
announcements
early
in
the
period:
first,
the
initiation
of
a
Phase
1
and
2
study
for
COVID-19
vaccine
candidate
NVX-CoV2373
in
May
2020;
and
second,
the
receipt
of
hundreds
of
millions
of
dollars
in
funding
from
the
Coalition
for
Epidemic
Preparedness
Innovations
and
the
U.S.
Department
of
Defense.
The
funding
supported
clinical
trial
development
of
NVX-CoV2373
and
allowed
the
company
to
scale
up
manufacturing
of
the
vaccine
to
theoretically
reach
more
than
a
billion
doses
in
2021.
By
August
2020,
Novavax
reported
positive
first-in-human
Phase
1
data.
Consistent
with
our
view
that
NVX-CoV2373
is
a
potentially
best-in-class
COVID-19
vaccine,
the
vaccine
generated
Portfolio
Composition
4/30/21
%
of
Total
Net
Assets
Biotechnology
76.3%
Pharmaceuticals
14.7%
Life
Sciences
Tools
&
Services
4.9%
Capital
Markets
1.7%
Other
0.2%
Short-Term
Investments
&
Other
Net
Assets
2.2%
1.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
22
.
Franklin
Biotechnology
Discovery
Fund
5
franklintempleton.com
Annual
Report
a
robust
immune
response
comparable
to,
if
not
higher
than,
responses
from
patients
with
clinically
significant
COVID-19
disease.
The
company
occasionally
came
under
pressure
from
competitors
who
obtained
emergency
use
authorization
from
the
U.S.
Food
and
Drug
Adminstration
(FDA)
and
brought
their
vaccines
to
market
in
record
time,
though
the
need
to
develop
multiple
vaccines
kept
Novavax
in
the
running
as
it
continued
to
reveal
positive
clinical
trial
results.
The
stock
climbed
again
in
April
2021
after
Johnson
&
Johnson’s
(not
a
Fund
holding)
vaccine
was
temporarily
halted,
U.S.
President
Joe
Biden
mentioned
Novavax’s
vaccine
as
a
likely
new
tool
in
fighting
the
pandemic,
and
infections
around
the
world
continued
to
climb.
Other
biotechnology
holdings
that
produced
considerable
absolute
returns
included
Immunomedics,
Fate
Therapeutics,
Argenx
and
Forte
Biosciences
(purchased
during
the
period).
Cancer-focused
Immunomedics
scored
a
major
late-stage
trial
breakthrough
with
its
triple-negative
breast
cancer
(TNBC)
drug
Trodelvy
and
subsequent
FDA
approval.
TNBC
is
a
difficult-to-treat
form
of
breast
cancer
with
few
effective
treatment
options
available,
and
we
believe
Trodelvy’s
differentiated
efficacy
and
safety
profile
will
drive
its
fast
uptake
in
TNBC
patients.
The
company’s
share
price
rose
following
Gilead
Sciences’
(also
a
Fund
holding)
announcement
it
would
acquire
Immunomedics,
and
we
sold
out
of
our
position
to
realize
profits.
Argenx
reported
impressive
clinical
trial
results
for
its
lead
drug
candidate
for
treating
generalized
myasthenia
gravis
patients,
a
relatively
rare
immune
disorder
that
weakens
patients
by
impeding
the
transmission
of
signals
between
their
brains
and
muscle
fibers.
Forte
Biosciences
continued
to
make
headway
in
developing
a
live
topical
biotherapeutic,
dubbed
FB-401,
for
the
treatment
of
inflammatory
skin
diseases.
FB-401
has
completed
Phase
1
and
2a
testing
in
adult
and
pediatric
patients
with
atopic
dermatitis,
and
there
is
a
genuine
unmet
need
for
safe
and
effective
therapies
for
children
with
the
disease.
Forte
provided
an
upbeat
second-quarter
2021
update
as
it
successfully
concluded
its
reverse
merger
with
Tocagen
(not
a
Fund
holding)
and
remained
on
track
to
report
Phase
2
clinical
trial
results
of
FB-401
in
the
third
quarter.
Absolute
contributors
in
pharmaceuticals
included
GW
Pharmaceuticals
(not
held
at
period-end)
and
Horizon
Therapeutics
(purchased
during
the
period).
Shares
of
cannabis-based
pharmaceutical
developer
GW
Pharmaceuticals
vaulted
to
new
all-time
highs
after
fourth-
quarter
2020
and
full-year
2020
financial
results
showed
a
large
year-over-year
sales
increase
for
Epidiolex,
an
epileptic
seizure
treatment
and
the
company’s
only
FDA-
approved
drug.
In
addition,
Jazz
Pharmaceuticals
(also
a
Fund
holding)
announced
it
would
buy
GW
at
a
significant
premium
to
the
company’s
share
price
at
the
time
the
deal
was
announced.
Jazz,
which
focuses
primarily
on
neurological
disorders,
saw
a
good
business
fit
and
stood
to
benefit
from
GW’s
emerging
pipeline
of
other
cannabinoid-
based
treatments
for
maladies
such
as
multiple
sclerosis
and
muscle
spasticity
resulting
from
spinal
injuries.
In
life
sciences
tools
and
services,
genomic
sequencing
pioneer
Illumina
lifted
absolute
performance
after
reporting
better-than-expected
fourth-quarter
2020
and
first-quarter
2021
financial
results,
demonstrating
strength
in
the
company’s
core
business
across
all
regions
and
reflecting
growth
in
both
clinical
and
research
customers.
Perhaps
the
biggest
question
going
forward
relates
to
Illumina’s
planned
acquisition
of
GRAIL
(not
a
Fund
holding),
a
leading-edge
developer
of
blood
testing
for
early
cancer
detection,
which
was
currently
under
review
by
the
European
Commission.
Individual
detractors
from
absolute
performance
included
Gilead
Sciences,
Global
Blood
Therapeutics
and
Reata
Pharmaceuticals.
Gilead
Science’s
drug
remdesivir
was
the
first
to
be
granted
an
emergency
use
authorization
by
the
FDA
as
a
treatment
for
COVID-19,
but
the
company’s
inability
to
find
sources
of
revenue
to
offset
the
sales
declines
of
its
hepatitis
C
drugs
Top
10
Holdings
4/30/21
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Gilead
Sciences,
Inc.
6.1%
Biotechnology,
United
States
Amgen,
Inc.
5.3%
Biotechnology,
United
States
Vertex
Pharmaceuticals,
Inc.
4.6%
Biotechnology,
United
States
Regeneron
Pharmaceuticals,
Inc.
4.6%
Biotechnology,
United
States
Illumina,
Inc.
4.1%
Life
Sciences
Tools
&
Services,
United
States
Novavax
,
Inc.
4.0%
Biotechnology,
United
States
Horizon
Therapeutics
plc
3.6%
Pharmaceuticals,
United
States
Biogen,
Inc.
3.1%
Biotechnology,
United
States
Iovance
Biotherapeutics
,
Inc.
3.0%
Biotechnology,
United
States
Mirati
Therapeutics,
Inc.
2.5%
Biotechnology,
United
States
Franklin
Biotechnology
Discovery
Fund
6
franklintempleton.com
Annual
Report
eroded
investor
confidence.
Despite
numerous
attempts
to
expand
into
other
high-value
therapeutic
areas
such
as
non-alcoholic
steatohepatitis,
immunology
and
oncology,
the
company’s
efforts
have
yet
to
take
off.
Gilead’s
core
HIV
drug
franchise
has
arguably
been
its
saving
grace
during
this
turbulent
period,
though
two
of
its
HIV
drugs
lost
their
patent
protection,
putting
billions
of
dollars
of
annual
revenue
at
risk
of
generic
competition.
Gilead
could
be
nearing
an
inflection
point,
however,
thanks
to
its
acquisition
of
two
major
oncology
companies,
including
the
previously
mentioned
Immunomedics.
Global
Blood
Therapeutics
reported
disappointing
sales
for
the
recently-launched
drug
Oxbryta,
a
treatment
for
sickle
cell
anemia.
Sales
came
in
below
analysts’
consensus
estimates
as
patients
appeared
to
limit
seeking
treatment
due
to
COVID-19-related
concerns
about
entering
medical
facilities.
The
sales
miss
fueled
concerns
that
the
commercial
opportunity
in
sickle
cell
disease
may
be
smaller
than
previously
believed.
We
believe
the
weakness
in
Oxbryta
sales
was
purely
driven
by
COVID-19,
and
that
growth
in
sales
will
resume
once
the
pandemic
is
resolved.
Reata
Pharmaceuticals,
which
focuses
on
oral
antioxidative
and
anti-inflammatory
drugs
for
orphan
renal
and
neurological
diseases,
shed
more
than
one-third
of
its
equity
value
after
receiving
mixed
feedback
from
the
FDA
on
their
ability
to
file
two
drugs—
omaveloxolone
and
bardoxolone—
for
regulatory
review.
In
our
view,
omaveloxolone
still
held
the
potential
to
be
a
game-changing
drug
for
Friedreich’s
Ataxia,
an
inherited
disease
that
causes
difficulty
walking
among
other
debilitating
symptoms,
and
we
believe
it
will
eventually
receive
FDA
approval.
We
view
bardoxolone
as
the
key
value
driver
for
the
stock,
and
we
continue
to
expect
a
positive
regulatory
outcome
for
that
drug’s
first
indication
in
Alport
Syndrome,
a
rare
genetic
disorder
characterized
by
progressive
kidney
disease
and
abnormalities
of
the
inner
ear
and
the
eye.
Thank
you
for
your
continued
participation
in
Franklin
Biotechnology
Discovery
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Evan
McCulloch,
CFA
Lead
Portfolio
Manager
Wendy
Lam,
Ph.D.
Akiva
Felt
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
April
30,
2021,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Performance
Summary
as
of
April
30,
2021
Franklin
Biotechnology
Discovery
Fund
7
franklintempleton.com
Annual
Report
The
performance
table
and
graphs
do
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
4
/3
0
/2
1
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
1-Year
+24.26%
+17.42%
5-Year
+76.85%
+10.82%
10-Year
+308.18%
+14.45%
Advisor
1-Year
+24.56%
+24.56%
5-Year
+79.07%
+12.36%
10-Year
+319.02%
+15.40%
See
page
9
for
Performance
Summary
footnotes.
Franklin
Biotechnology
Discovery
Fund
Performance
Summary
8
franklintempleton.com
Annual
Report
See
page
9
for
Performance
Summary
footnotes.
Total
Return
Index
Comparison
for
a
Hypothetical
$10,000
Investment
1
Total
return
represents
the
change
in
value
of
an
investment
over
the
periods
shown.
It
includes
any
applicable
maximum
sales
charge,
Fund
expenses,
account
fees
and
reinvested
distributions.
The
unmanaged
indexes
include
reinvestment
of
any
income
or
distributions.
They
differ
from
the
Fund
in
composition
and
do
not
pay
management
fees
or
expenses.
One
cannot
invest
directly
in
an
index.
Class
A
(5/1/11–4/30/21)
Advisor
Class
(5/1/11–4/30/21)
Franklin
Biotechnology
Discovery
Fund
Performance
Summary
9
franklintempleton.com
Annual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
The
Fund
is
a
nondiversified
fund
that
concentrates
in
a
single
sector,
which
involves
risks
such
as
patent
considerations,
product
liability,
government
regulatory
requirements,
and
regulatory
approval
for
new
drugs
and
medical
products.
Biotechnol-
ogy
companies
often
are
small
and/or
relatively
new.
Smaller
companies
can
be
particularly
sensitive
to
changes
in
economic
conditions
and
have
less
certain
growth
prospects
than
larger,
more
established
companies
and
can
be
volatile,
especially
over
the
short
term.
The
Fund
may
also
invest
in
foreign
companies,
which
involve
special
risks,
including
currency
fluctuations
and
political
uncertainty.
Events
such
as
the
spread
of
deadly
diseases,
disasters,
and
financial,
political
or
social
disruptions,
may
heighten
risks
and
adversely
affect
performance.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
waiver,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
5.
Source:
Morningstar.
The
NASDAQ
Biotechnology
Index
is
a
modified
capitalization-weighted
index
designed
to
measure
performance
of
all
NASDAQ
stocks
in
the
biotechnology
sector.
The
S&P
500
is
a
market
capitalization-weighted
index
of
500
stocks
designed
to
measure
total
U.S.
equity
market
performance.
6.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Distributions
(5/1/20–4/30/21)
Share
Class
Short-Term
Capital
Gain
Long-Term
Capital
Gain
Total
A
$10.3921
$14.4512
$24.8433
C
$10.3921
$14.4512
$24.8433
R6
$10.3921
$14.4512
$24.8433
Advisor
$10.3921
$14.4512
$24.8433
Total
Annual
Operating
Expenses
6
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
1.03%
1.05%
Advisor
0.78%
0.80%
Your
Fund’s
Expenses
Franklin
Biotechnology
Discovery
Fund
10
franklintempleton.com
Annual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6
).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
181/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
11/1/20
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,104.00
$5.06
$1,019.99
$4.86
0.97%
C
$1,000
$1,099.90
$8.94
$1,016.28
$8.58
1.72%
R6
$1,000
$1,105.30
$3.36
$1,021.61
$3.22
0.64%
Advisor
$1,000
$1,105.80
$3.76
$1,021.22
$3.61
0.72%
11
franklintempleton.com
Annual
Report
Franklin
Natural
Resources
Fund
This
annual
report
for
Franklin
Natural
Resources
Fund
covers
the
fiscal
year
ended
April
30,
2021
.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
to
provide
high
total
return.
Total
return
consists
of
capital
appreciation
and
current
dividend
and
interest
income.
Under
normal
market
conditions,
the
Fund
invests
at
least
80%
of
its
net
assets
in
equity
and
debt
securities
of
companies
that
own,
produce,
refine,
process,
transport
or
market
natural
resources,
as
well
as
those
that
provide
related
services.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+50.55%
cumulative
total
return
for
the
12
months
under
review.
In
comparison,
the
Standard
&
Poor’s
(S&P
®
)
North
American
Natural
Resources
Sector
Index,
which
tracks
companies
involved
in
industries
such
as
mining,
energy,
timber
and
forestry
services,
and
the
production
of
pulp
and
paper,
posted
a
+40.59%
total
return.
1
Also
in
comparison,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
is
a
broad
measure
of
the
U.S.
stock
market,
posted
a
+45.98%
total
return.
1
Please
note
index
performance
information
is
provided
for
reference
and
we
do
not
attempt
to
track
any
index
but
rather
undertake
investments
on
the
basis
of
fundamental
research.
The
Fund’s
strategy,
which
focuses
on
companies
with
higher
long-term
growth
potential,
differs
from
the
natural
resources
index’s
large
weighting
in
income-oriented
companies
that
we
believe
typically
provide
more
limited
opportunities
for
growth.
This
difference
may
occasionally
lead
to
wide
performance
discrepancies,
especially
in
periods
when
investors
focus
on
short-term
safety
and
yield
or,
conversely,
when
investors
focus
more
heavily
on
companies
with
stronger
growth
prospects
and
greater
commodity
price
leverage.
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
14
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
are
research-driven,
fundamental
investors,
pursuing
a
growth
strategy.
As
bottom-up
investors
focusing
primarily
on
individual
securities,
we
choose
companies
that
have
identifiable
drivers
of
future
earnings
growth
and
that
present,
in
our
opinion,
the
best
trade-off
between
potential
earnings
growth,
business
and
financial
risk,
and
valuation.
Also,
in
seeking
sustainable
growth
characteristics,
we
look
for
companies
that
we
believe
can
produce
sustainable
earnings
growth
and
cash
flow
growth
or
the
potential
to
generate
income.
We
rely
on
a
team
of
analysts
to
help
provide
in-depth
industry
expertise
and
use
both
qualitative
and
quantitative
analysis
to
evaluate
companies
for
distinct
and
sustainable
competitive
advantages
likely
to
lead
to
growth
in
earnings
and/or
share
price.
Competitive
advantages,
such
as
a
particular
product
niche,
proven
technology,
sound
financial
position
and
strong
management,
are
all
factors
we
believe
may
contribute
to
strong
growth
potential.
Sector
Overview
Global
commodity
prices
rose
during
the
12
months
ended
April
30,
2021.
Energy
and
industrial
metals
prices
benefited
from
increased
economic
activity
following
the
lifting
of
the
most
restrictive
lockdowns
put
in
place
to
contain
the
novel
coronavirus
(COVID-19)
pandemic.
The
development
and
distribution
of
effective
vaccines
in
late
2020
further
cemented
these
gains.
The
sustained
economic
recovery
in
China,
the
world’s
largest
consumer
of
many
raw
materials,
and
a
resurgent
U.S.
economy
have
played
an
important
role
in
lifting
commodity
prices.
However,
new
outbreaks
of
COVID-19
in
various
countries
around
the
world
have
periodically
dampened
demand
expectations
and
prices.
Precious
metals
also
rose
in
value
as
many
investors
sought
perceived
safe-haven
assets,
though
gold
prices
Geographic
Composition
4/30/21
%
of
Total
Net
Assets
North
America
78.1%
Europe
7.3%
Latin
America
&
Caribbean
5.1%
Australia
&
New
Zealand
4.5%
Middle East & Africa
2.8%
Short-Term
Investments
&
Other
Net
Assets
2.2%
1.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
30
.
Franklin
Natural
Resources
Fund
12
franklintempleton.com
Annual
Report
in
particular
weakened
later
in
the
period
as
stock
market
gains
and
increased
economic
activity
made
investors
less
interested
in
perceived
safe
havens.
Crude
oil
prices
rose
significantly
during
the
period
after
reaching
historically
low
levels
in
early
2020.
Prices
were
supported
by
increased
demand
from
the
recovering
Chinese
and
U.S.
economies,
production
curtailments
by
the
Organization
of
the
Petroleum
Exporting
Countries
and
certain
non-member
countries,
and
a
weak
U.S.
dollar.
Attacks
on
oil
facilities
in
Saudi
Arabia
and
shipping
delays
in
the
Suez
Canal
in
2021
further
constrained
supply
and
boosted
prices.
Gains
were
held
back
periodically,
including
in
late
2020
by
weakening
adherence
to
production
cuts
and
renewed
COVID-19
lockdowns
in
Europe
and
the
U.S.,
and
in
April
2021
by
renewed
COVID-19
outbreaks
in
Asia
and
Brazil.
U.S.
natural
gas
prices
rose
significantly
during
the
period,
though
a
decline
in
the
second
half
of
the
period
meant
gains
lagged
those
of
oil.
Early
in
the
period,
prices
were
supported
by
recovering
exports
of
liquified
natural
gas,
decreased
gas
drilling
in
the
U.S.
and
a
faster-than-expected
recovery
in
demand
from
U.S.
businesses
after
the
most
restrictive
COVID-19-related
lockdowns
were
lifted.
Prices
were
held
in
check
by
relatively
cool
summer
2020
weather,
which
reduced
electricity
demand
for
air
conditioning,
and
declined
in
late
2020
due
to
relatively
warm
autumn
weather,
which
reduced
demand
for
heating.
In
2021,
rising
production
further
suppressed
pricing,
though
increased
demand
due
to
further
economic
reopenings
and
severe
snowstorms
in
Texas
somewhat
counteracted
that
effect.
The
price
of
gold
rose
modestly
during
the
period.
Demand
increased
in
the
first
half
of
the
period
as
many
investors
sought
perceived-safe
havens
out
of
fear
that
equities
would
decline
due
to
economic
lockdowns
and
inflationary
pressures
from
aggressive
monetary
and
fiscal
stimulus
measures.
COVID-19-related
mine
closures
hampered
production,
further
supporting
prices.
Gold
declined
in
the
second
half
of
the
period,
however,
as
vaccine
development
and
continued
stock
market
gains
boosted
investor
optimism
about
the
U.S.
economic
outlook
and
drew
attention
away
from
the
precious
metal.
Silver
prices
rose
significantly
during
the
period,
benefiting
from
its
reputation
as
a
hedge
against
inflation
and
its
application
in
infrastructure
and
green
energy
construction,
which
have
received
support
from
the
new
U.S.
presidential
administration.
Silver
did
decline
slightly
late
in
the
period
as
its
safe-haven
attributes
became
less
attractive
to
investors
due
to
continued
gains
in
equity
markets
and
ramped
up
U.S.
economic
activity.
Platinum
and
palladium
prices
increased
as
well.
Palladium,
a
key
component
in
pollution-control
devices
for
automobiles,
benefited
from
a
recovery
in
car
sales
in
China,
the
U.S.
and
elsewhere,
as
well
as
supply
restrictions
due
to
mine
disruptions.
Platinum
benefited
from
its
application
in
renewable
energy
technology
and
investor
optimism
about
the
future
of
that
industry.
Industrial
metal
prices
also
rose
significantly
during
the
period.
Copper
benefited
from
decreased
supply
due
to
pandemic-related
mine
closures
in
Chile
and
demand
from
China
and
U.S.
for
construction
and
infrastructure
projects.
Interest
in
the
metal
benefited
particularly
from
its
expanding
application
in
renewable
energy
and
electric
transportation
technologies.
Iron
ore
prices
also
rose
as
a
result
of
decreased
supply
due
to
mine
closures,
particularly
in
Brazil,
and
demand
from
China,
where
a
state-backed
industrial
recovery
allowed
steel
producers
to
ramp
up
output
for
the
country’s
large
construction
and
manufacturing
sectors.
Manager’s
Discussion
Natural
resources
equity
prices
increased
during
the
period.
Energy
equities,
which
make
up
a
majority
of
the
Fund’s
holdings,
started
the
period
at
relatively
low
valuations
following
the
pandemic-related
economic
shutdowns
of
March
and
April
2020.
Following
a
sharp
recovery
in
April,
the
sector
continued
to
rebound
until
June
when
virus
second
wave
concerns
and
resurgent
lockdowns
raised
the
specter
of
renewed
economic
contraction.
However,
a
significant
turning
point
for
energy
equities
came
when
oil
Portfolio
Composition
4/30/21
%
of
Total
Net
Assets
Oil
&
Gas
Exploration
&
Production
21.0%
Integrated
Oil
&
Gas
15.5%
Oil
&
Gas
Equipment
&
Services
9.7%
Gold
8.8%
Copper
7.8%
Diversified
Metals
&
Mining
6.7%
Oil
&
Gas
Refining
&
Marketing
6.4%
Oil
&
Gas
Storage
&
Transportation
6.4%
Industrial
Gases
2.6%
Investment
Banking
&
Brokerage
2.1%
Fertilizers
&
Agricultural
Chemicals
1.5%
Steel
1.4%
Environmental
&
Facilities
Services
1.2%
Construction
Materials
1.1%
Other
5.6%
Short-Term
Investments
&
Other
Net
Assets
2.2%
Franklin
Natural
Resources
Fund
13
franklintempleton.com
Annual
Report
prices
rose
in
November
with
the
announcement
of
positive
vaccine
trial
results,
which
proved
more
effective
than
expected,
and
economic
reopenings
in
2021
sustained
these
gains.
Mining
equities
performed
well
during
the
period,
benefiting
from
increased
prices—particularly
in
iron
ore
and
copper—due
to
pandemic-related
supply
curtailments
and
demand
sparked
by
current
and
expected
governments’
stimulus
spending.
In
this
environment,
overweightings
in
the
diversified
metals
and
mining
industry
and
copper
industry
contributed
to
relative
performance.
The
Fund
had
larger
positions
than
typical
in
both
industries
as
we
anticipated
a
benefit
from
government
infrastructure
spending
and
the
potential
for
supply
disruptions.
In
diversified
metals
and
mining,
off-
benchmark
positions
in
Australia-based
BHP
Group,
South
Africa-based
Anglo
American
and
Australia-based
Rio
Tinto
contributed.
In
copper,
off-benchmark
positions
in
Chile-
based
Antofagasta,
Canada-based
Lundin
Mining
(which
has
operations
in
Chile)
and
Canada-based
First
Quantum
Minerals
(which
has
operations
in
Zambia)
helped
results.
An
overweighting
and
stock
selection
in
oil
and
gas
equipment
and
services
helped
relative
results
as
well.
Although
many
companies
suffered
and
some
filed
for
bankruptcy
in
what
was
one
of
the
worst
downturns
in
the
history
of
the
industry,
the
Fund
benefited
from
focusing
on
larger,
more
established
companies
and
smaller
companies
with
strong
operational
performance
and
balance
sheets.
U.S.-based
Liberty
Oilfield
Services
(not
part
of
the
index)
was
a
significant
contributor.
Elsewhere,
an
underweighting
in
integrated
oil
and
gas
giant
Chevron,
which
initially
performed
well
into
the
depths
of
the
downturn
due
to
the
company’s
financial
strength
but
lagged
in
the
economic
recovery,
also
contributed
to
relative
performance.
An
overweighting
in
WPX
Energy,
which
was
acquired
during
the
period
and
subsequently
merged
with
Fund
holding
Devon
Energy,
also
contributed.
In
contrast,
stock
selection
in
oil
and
gas
exploration
and
production
hurt
relative
performance.
U.S.-based
natural
gas-focused
producer
Cabot
Oil
&
Gas
and
U.S.-based
Diamondback
Energy
(not
held
at
period-end)
detracted
from
relative
results.
An
underweighting
in
the
paper
packaging
industry
hurt
relative
results,
with
the
Fund
lacking
positions
in
several
companies
which
benefited
from
increased
online
ordering
and
the
subsequent
rise
in
demand
for
packaging
materials.
An
underweighting
in
construction
materials,
which
benefited
from
increased
infrastructure
and
home
construction
spending,
also
hurt
relative
performance.
Elsewhere,
U.S.-based
copper
miner
Freeport-McMoRan
boosted
absolute
performance,
but
our
underweighted
position
hurt
relative
results.
Overweightings
in
Canadian
gold
miners
SSR
Mining
and
Alamos
Gold
also
detracted
from
relative
results,
though
the
latter
did
modestly
help
absolute
returns.
Thank
you
for
your
continued
participation
in
Franklin
Natural
Resources
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Frederick
G.
Fromm,
CFA
Matthew
J.
Adams,
CFA
Stephen
M.
Land,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
April
30,
2021,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Top
10
Holdings
4/30/21
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Chevron
Corp.
4.0%
Oil,
Gas
&
Consumable
Fuels,
United
States
ConocoPhillips
3.8%
Oil,
Gas
&
Consumable
Fuels,
United
States
Exxon
Mobil
Corp.
3.5%
Oil,
Gas
&
Consumable
Fuels,
United
States
Devon
Energy
Corp.
3.5%
Oil,
Gas
&
Consumable
Fuels,
United
States
EOG
Resources,
Inc.
3.2%
Oil,
Gas
&
Consumable
Fuels,
United
States
Suncor
Energy,
Inc.
3.1%
Oil,
Gas
&
Consumable
Fuels,
Canada
Newmont
Corp.
3.0%
Metals
&
Mining,
United
States
Cabot
Oil
&
Gas
Corp.
2.5%
Oil,
Gas
&
Consumable
Fuels,
United
States
Barrick
Gold
Corp.
2.5%
Metals
&
Mining,
Canada
Freeport-McMoRan,
Inc.
2.4%
Metals
&
Mining,
United
States
Performance
Summary
as
of
April
30,
2021
Franklin
Natural
Resources
Fund
14
franklintempleton.com
Annual
Report
The
performance
table
and
graphs
do
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
4
/3
0
/2
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
1
Average
Annual
Total
Return
2
A
3
1-Year
+50.55%
+42.29%
5-Year
-12.82%
-3.80%
10-Year
-49.81%
-7.19%
Advisor
1-Year
+50.95%
+50.95%
5-Year
-11.71%
-2.46%
10-Year
-48.42%
-6.41%
See
page
16
for
Performance
Summary
footnotes.
Franklin
Natural
Resources
Fund
Performance
Summary
15
franklintempleton.com
Annual
Report
See
page
16
for
Performance
Summary
footnotes.
Total
Return
Index
Comparison
for
a
Hypothetical
$10,000
Investment
Total
return
represents
the
change
in
value
of
an
investment
over
the
periods
shown.
It
includes
any
applicable
maximum
sales
charge,
Fund
expenses,
account
fees
and
reinvested
distributions.
The
unmanaged
indexes
include
reinvestment
of
any
income
or
distributions.
They
differ
from
the
Fund
in
composition
and
do
not
pay
management
fees
or
expenses.
One
cannot
invest
directly
in
an
index.
Class
A
(5/1/11–4/30/21)
Advisor
Class
(5/1/11–4/30/21)
Franklin
Natural
Resources
Fund
Performance
Summary
16
franklintempleton.com
Annual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Investing
in
a
fund
concentrating
in
the
natural
resources
sector
involves
special
risks,
includ-
ing
increased
susceptibility
to
adverse
economic
and
regulatory
developments
affecting
the
sector.
Growth
stock
prices
may
fall
dramatically
if
the
company
fails
to
meet
projections
of
earnings
or
revenue;
their
prices
may
be
more
volatile
than
other
securities,
particularly
over
the
short
term.
Smaller
companies
can
be
particularly
sensitive
to
changes
in
economic
conditions
and
have
less
certain
growth
prospects
than
larger,
more
established
companies
and
can
be
volatile,
especially
over
the
short
term.
The
Fund
may
also
invest
in
foreign
companies,
which
involve
special
risks,
including
currency
fluctuations
and
political
uncertainty.
Events
such
as
the
spread
of
deadly
diseases,
disasters,
and
financial,
political
or
social
disruptions,
may
heighten
risks
and
adversely
affect
perfor-
mance.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
2.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
3.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
4.
Source:
Morningstar.
The
S&P
North
American
Natural
Resources
Index
is
a
modified
capitalization-weighted
index
that
includes
companies
involved
in
extractive
industries
(mining),
energy
and
forestry
services,
producers
of
pulp
and
paper,
and
owners
and
operators
of
timber
tracts
or
plantations.
The
S&P
500
is
a
market
capitaliza-
tion-weighted
index
of
500
stocks
designed
to
measure
total
U.S.
equity
market
performance.
5.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Distributions
(5/1/20–4/30/21)
Share
Class
Net
Investment
Income
A
$0.3982
C
$0.1981
R6
$0.4862
Advisor
$0.4432
Total
Annual
Operating
Expenses
5
Share
Class
A
1.17%
Advisor
0.92%
Your
Fund’s
Expenses
Franklin
Natural
Resources
Fund
17
franklintempleton.com
Annual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6
).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
181/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
11/1/20
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,578.50
$7.72
$1,018.81
$6.04
1.21%
C
$1,000
$1,572.40
$12.46
$1,015.11
$9.76
1.95%
R6
$1,000
$1,582.50
$4.51
$1,021.30
$3.53
0.70%
Advisor
$1,000
$1,581.20
$6.13
$1,020.04
$4.80
0.96%
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
18
.
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$150.48
$138.85
$146.14
$147.22
$128.19
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.99)
(0.69)
(0.99)
(0.80)
(0.79)
Net
realized
and
unrealized
gains
(losses)
...........
38.85
26.48
(1.75)
3.32
25.75
Total
from
investment
operations
....................
37.86
25.79
(2.74)
2.52
24.96
Less
distributions
from:
Net
investment
income
..........................
(1.73)
Net
realized
gains
.............................
(24.84)
(14.16)
(4.55)
(3.60)
(4.20)
Total
distributions
...............................
(24.84)
(14.16)
(4.55)
(3.60)
(5.93)
Net
asset
value,
end
of
year
.......................
$163.50
$150.48
$138.85
$146.14
$147.22
Total
return
c
...................................
24.26%
18.52%
(1.60)%
1.69%
20.02%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.98%
1.03%
1.02%
1.05%
1.04%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
0.97%
1.01%
1.00%
1.03%
1.02%
Net
investment
(loss)
............................
(0.58)%
(0.49)%
(0.67)%
(0.53)%
(0.58)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$1,160,451
$960,305
$924,611
$1,081,883
$1,176,687
Portfolio
turnover
rate
............................
47.30%
32.92%
28.62%
26.95%
34.12%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
19
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$143.00
$133.51
$141.75
$143.98
$125.99
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(2.16)
(1.70)
(2.03)
(1.90)
(1.81)
Net
realized
and
unrealized
gains
(losses)
...........
36.95
25.35
(1.66)
3.27
25.29
Total
from
investment
operations
....................
34.79
23.65
(3.69)
1.37
23.48
Less
distributions
from:
Net
investment
income
..........................
(1.29)
Net
realized
gains
.............................
(24.84)
(14.16)
(4.55)
(3.60)
(4.20)
Total
distributions
...............................
(24.84)
(14.16)
(4.55)
(3.60)
(5.49)
Net
asset
value,
end
of
year
.......................
$152.95
$143.00
$133.51
$141.75
$143.98
Total
return
c
...................................
23.33%
17.62%
(2.33)%
0.93%
19.14%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.73%
1.78%
1.77%
1.80%
1.79%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
1.72%
1.76%
1.75%
1.78%
1.77%
Net
investment
(loss)
............................
(1.32)%
(1.24)%
(1.42)%
(1.28)%
(1.33)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$64,801
$48,363
$46,508
$58,433
$53,935
Portfolio
turnover
rate
............................
47.30%
32.92%
28.62%
26.95%
34.12%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
20
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$156.99
$143.83
$150.65
$151.03
$131.37
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.45)
(0.18)
(0.46)
(0.17)
(0.25)
Net
realized
and
unrealized
gains
(losses)
...........
40.51
27.50
(1.81)
3.39
26.41
Total
from
investment
operations
....................
40.06
27.32
(2.27)
3.22
26.16
Less
distributions
from:
Net
investment
income
..........................
(2.30)
Net
realized
gains
.............................
(24.84)
(14.16)
(4.55)
(3.60)
(4.20)
Total
distributions
...............................
(24.84)
(14.16)
(4.55)
(3.60)
(6.50)
Net
asset
value,
end
of
year
.......................
$172.21
$156.99
$143.83
$150.65
$151.03
Total
return
....................................
24.67%
18.95%
(1.24)%
2.11%
20.50%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.71%
0.74%
0.70%
0.65%
0.63%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.64%
0.64%
0.63%
0.61%
0.61%
Net
investment
(loss)
............................
(0.25)%
(0.12)%
(0.30)%
(0.11)%
(0.17)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$16,721
$9,484
$6,164
$8,307
$8,891
Portfolio
turnover
rate
............................
47.30%
32.92%
28.62%
26.95%
34.12%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
21
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$155.30
$142.56
$149.54
$150.20
$130.67
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.59)
(0.34)
(0.63)
(0.45)
(0.46)
Net
realized
and
unrealized
gains
(losses)
...........
40.08
27.24
(1.80)
3.39
26.27
Total
from
investment
operations
....................
39.49
26.90
(2.43)
2.94
25.81
Less
distributions
from:
Net
investment
income
..........................
(2.08)
Net
realized
gains
.............................
(24.84)
(14.16)
(4.55)
(3.60)
(4.20)
Total
distributions
...............................
(24.84)
(14.16)
(4.55)
(3.60)
(6.28)
Net
asset
value,
end
of
year
.......................
$169.95
$155.30
$142.56
$149.54
$150.20
Total
return
....................................
24.56%
18.82%
(1.36)%
1.94%
20.32%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.73%
0.78%
0.77%
0.80%
0.79%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.72%
0.76%
0.75%
0.78%
0.77%
Net
investment
(loss)
............................
(0.33)%
(0.24)%
(0.42)%
(0.28)%
(0.33)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$206,375
$159,348
$153,874
$180,219
$159,894
Portfolio
turnover
rate
............................
47.30
%
32.92%
28.62%
26.95%
34.12%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments,
April
30,
2021
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Annual
Report
22
2
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
96.7%
Biotechnology
75.9%
a
89bio,
Inc.
...........................................
United
States
284,400
$
7,476,876
a
ACADIA
Pharmaceuticals,
Inc.
...........................
United
States
294,600
6,056,976
a
Acceleron
Pharma,
Inc.
.................................
United
States
158,700
19,832,739
a
Akouos
,
Inc.
.........................................
United
States
157,600
2,241,072
a
Albireo
Pharma,
Inc.
...................................
United
States
102,400
3,287,040
a
Alector
,
Inc.
..........................................
United
States
846,046
16,497,897
a
ALX
Oncology
Holdings,
Inc.
.............................
United
States
86,100
5,395,026
Amgen,
Inc.
.........................................
United
States
318,700
76,373,268
a,b
Applied
Molecular
Transport,
Inc.
.........................
United
States
138,000
7,933,620
a
Applied
Therapeutics,
Inc.
...............................
United
States
311,757
5,773,740
a
Arcus
Biosciences,
Inc.
.................................
United
States
330,800
11,164,500
a
Arcutis
Biotherapeutics
,
Inc.
.............................
United
States
125,200
4,194,200
a
Argenx
SE,
ADR
......................................
Netherlands
51,298
14,707,650
a
Ascendis
Pharma
A/S,
ADR
.............................
Denmark
222,800
32,299,316
a
Biogen,
Inc.
.........................................
United
States
169,775
45,385,951
a
BioMarin
Pharmaceutical,
Inc.
............................
United
States
142,456
11,100,171
a
Biomea
Fusion,
Inc.
...................................
United
States
77,200
1,308,540
a
Black
Diamond
Therapeutics,
Inc.
.........................
United
States
127,800
3,404,592
a
Blueprint
Medicines
Corp.
...............................
United
States
117,200
11,288,705
a,b
Bolt
Biotherapeutics
,
Inc.
................................
United
States
62,500
1,397,500
a
Bridgebio
Pharma,
Inc.
.................................
United
States
118,800
6,643,296
a
Cardiff
Oncology,
Inc.
..................................
United
States
256,400
2,546,052
a
Codiak
Biosciences,
Inc.
................................
United
States
252,600
5,001,480
a
CRISPR
Therapeutics
AG
...............................
Switzerland
130,614
17,145,700
a
Cullinan
Oncology,
Inc.
.................................
United
States
94,700
3,073,962
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
678,554
31,464,549
a
Dyne
Therapeutics,
Inc.
................................
United
States
215,539
4,241,807
a,b
Equillium
,
Inc.
........................................
United
States
294,800
1,910,304
a
Fate
Therapeutics,
Inc.
.................................
United
States
314,710
27,502,507
a
Forte
Biosciences,
Inc.
.................................
United
States
343,464
12,429,962
a,b
Gemini
Therapeutics,
Inc.
...............................
United
States
211,300
2,470,097
Gilead
Sciences,
Inc.
..................................
United
States
1,388,300
88,115,401
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
391,500
15,965,370
a
Harpoon
Therapeutics,
Inc.
..............................
United
States
220,200
4,985,328
a
Heron
Therapeutics,
Inc.
................................
United
States
1,739,677
30,409,554
a
Insmed
,
Inc.
.........................................
United
States
839,400
28,312,962
a,c,d
Intarcia
Therapeutics,
Inc.,
DD
...........................
United
States
80,195
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
1,395,901
43,887,127
a
KalVista
Pharmaceuticals,
Inc.
...........................
United
States
366,100
9,141,517
a
Karuna
Therapeutics,
Inc.
...............................
United
States
42,300
4,695,723
a
Keros
Therapeutics,
Inc.
................................
United
States
109,951
6,465,119
a
Kezar
Life
Sciences,
Inc.
................................
United
States
853,550
4,976,196
a
Kinnate
Biopharma,
Inc.
................................
United
States
72,600
1,947,132
a
Kodiak
Sciences,
Inc.
..................................
United
States
77,300
9,340,932
a
Kronos
Bio,
Inc.
......................................
United
States
82,400
2,230,568
a
Krystal
Biotech,
Inc.
...................................
United
States
52,100
4,138,824
a
Kura
Oncology,
Inc.
....................................
United
States
132,400
3,565,532
a
Legend
Biotech
Corp.,
ADR
.............................
United
States
207,725
6,252,522
a,b
LogicBio
Therapeutics,
Inc.
..............................
United
States
661,200
3,649,824
a
Merus
NV
...........................................
Netherlands
73,200
1,532,808
a
Metacrine
,
Inc.
.......................................
United
States
512,819
1,989,738
a
Mirati
Therapeutics,
Inc.
................................
United
States
221,119
36,754,400
a
Moderna
,
Inc.
........................................
United
States
95,500
17,077,310
a
Neurocrine
Biosciences,
Inc.
.............................
United
States
215,800
20,390,942
a
Nkarta
,
Inc.
..........................................
United
States
238,955
7,610,717
a
Novavax
,
Inc.
........................................
United
States
241,600
57,242,288
a,b
Olema
Pharmaceuticals,
Inc.
.............................
United
States
154,500
4,333,725
a
PMV
Pharmaceuticals,
Inc.
..............................
United
States
83,100
2,802,963
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Annual
Report
23
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Biotechnology
(continued)
a
Praxis
Precision
Medicines,
Inc.
..........................
United
States
103,600
$
3,176,376
a
Prometheus
Biosciences,
Inc.
............................
United
States
207,500
5,098,275
a
Protara
Therapeutics,
Inc.
...............................
United
States
145,500
1,628,145
a
PTC
Therapeutics,
Inc.
.................................
United
States
799,400
32,943,274
a
Regeneron
Pharmaceuticals,
Inc.
.........................
United
States
138,309
66,568,122
a
Reneo
Pharmaceuticals,
Inc.
.............................
United
States
194,700
2,803,680
a
Repare
Therapeutics,
Inc.
...............................
Canada
38,100
1,245,870
a
Rocket
Pharmaceuticals,
Inc.
............................
United
States
375,771
17,225,343
a
Sage
Therapeutics,
Inc.
................................
United
States
101,070
7,960,273
a
Scholar
Rock
Holding
Corp.
.............................
United
States
41,500
1,342,525
a,b
Silverback
Therapeutics,
Inc.
.............................
United
States
83,300
2,669,765
a
Sutro
Biopharma,
Inc.
..................................
United
States
669,974
13,741,167
a
Taysha
Gene
Therapies,
Inc.
.............................
United
States
304,256
7,852,853
a,b
Trillium
Therapeutics,
Inc.
...............................
Canada
1,091,800
10,383,018
a
Ultragenyx
Pharmaceutical,
Inc.
..........................
United
States
83,996
9,377,313
a
Vertex
Pharmaceuticals,
Inc.
.............................
United
States
308,200
67,249,240
a,b
VistaGen
Therapeutics,
Inc.
.............................
United
States
4,542,953
11,493,671
a,b
Yumanity
Therapeutics,
Inc.
.............................
United
States
90,804
1,520,059
a
Zymeworks
,
Inc.
......................................
Canada
471,320
15,327,326
1,098,969,912
Capital
Markets
1.7%
a,c,d,e
ARYA
Sciences
Acquisition
Corp.
.........................
United
States
415,600
4,421,039
a
ARYA
Sciences
Acquisition
Corp.
III
.......................
United
States
212,500
2,371,500
a
ARYA
Sciences
Acquisition
Corp.
IV,
A
......................
United
States
162,200
1,789,066
a,c,d
FS
Development
Corp.,
A
...............................
United
States
103,589
1,210,955
a
FS
Development
Corp.
II,
A
..............................
United
States
164,600
1,670,690
a
Health
Sciences
Acquisitions
Corp.
2
.......................
United
States
171,600
1,877,304
a
Jiya
Acquisition
Corp.,
A
................................
United
States
208,800
2,090,088
a
Omega
Alpha
SPAC,
A
.................................
United
States
294,400
2,923,392
a
Panacea
Acquisition
Corp.
II,
A
...........................
United
States
195,100
1,958,804
a,b
Therapeutics
Acquisition
Corp.,
A
.........................
United
States
429,800
4,306,596
24,619,434
Life
Sciences
Tools
&
Services
4.9%
a
Illumina,
Inc.
.........................................
United
States
150,900
59,279,556
Thermo
Fisher
Scientific,
Inc.
............................
United
States
26,400
12,414,072
71,693,628
Pharmaceuticals
14.2%
a,b
Angion
Biomedica
Corp.
................................
United
States
256,000
3,617,280
a,b
Athira
Pharma,
Inc.
....................................
United
States
779,576
15,342,056
a
EyePoint
Pharmaceuticals,
Inc.
...........................
United
States
836,730
8,944,644
a
Horizon
Therapeutics
plc
................................
United
States
545,749
51,638,770
a
Intra-Cellular
Therapies,
Inc.
.............................
United
States
456,700
15,724,181
a
Jazz
Pharmaceuticals
plc
...............................
United
States
216,200
35,543,280
a
Marinus
Pharmaceuticals,
Inc.
............................
United
States
149,200
2,194,732
a,b
Nuvation
Bio,
Inc.
.....................................
United
States
345,800
3,869,502
a
Pliant
Therapeutics,
Inc.
................................
United
States
149,100
4,994,850
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
199,009
20,179,513
a
Relmada
Therapeutics,
Inc.
..............................
United
States
91,266
3,519,217
a
Revance
Therapeutics,
Inc.
..............................
United
States
275,500
8,022,560
Royalty
Pharma
plc,
A
..................................
United
States
150,300
6,613,200
a,b
VYNE
Therapeutics,
Inc.
................................
United
States
720,650
3,560,011
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Annual
Report
24
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Pharmaceuticals
(continued)
a,b
Zogenix
,
Inc.
.........................................
United
States
1,144,759
$
21,624,497
205,388,293
Total
Common
Stocks
(Cost
$850,177,635)
.....................................
1,400,671,267
Convertible
Preferred
Stocks
0.3%
Pharmaceuticals
0.3%
a,c,d
Day
One
Therapeutics
Holding
Company
LLC,
B
..............
United
States
159,440
5,000,000
a
Total
Convertible
Preferred
Stocks
(Cost
$4,999,991)
............................
5,000,000
Preferred
Stocks
0.7%
Biotechnology
0.4%
a,c,d
Amunix
Pharmaceuticals,
Inc.,
B
..........................
United
States
2,333,755
3,846,546
a,c,d
Pipeline
Therapeutics,
Inc.,
C
............................
United
States
779,505
1,727,957
5,574,503
Health
Care
Providers
&
Services
0.1%
a,c,d,f
Artiva
Biotherapeutics
,
Inc.,
B
............................
United
States
189,499
2,084,489
a
Pharmaceuticals
0.2%
a,c,d
United
BioPharma
,
Inc.,
A
...............................
United
States
379,473
2,087,102
a
Total
Preferred
Stocks
(Cost
$10,385,965)
......................................
9,746,094
Warrants
Warrants
0.0%
Pharmaceuticals
0.0%
a
Nuvation
Bio,
Inc.,
7/07/27
..............................
United
States
115,266
351,561
Total
Warrants
(Cost
$—)
.....................................................
351,561
Shares
Escrows
and
Litigation
Trusts
0.1%
a,c
True
North
Therapeutics,
Inc.,
Escrow
Account
...............
United
States
759,880
851,316
Total
Escrows
and
Litigation
Trusts
(Cost
$1,939,532)
...........................
851,316
Total
Long
Term
Investments
(Cost
$867,503,123)
...............................
1,416,620,238
a
Short
Term
Investments
6.3%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
4.3%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
62,712,992
62,712,992
Total
Money
Market
Funds
(Cost
$62,712,992)
..................................
62,712,992
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Annual
Report
25
Short
Term
Investments
(continued)
a
a
Country
Shares
a
Value
a
a
a
a
a
a
i
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
2.0%
Money
Market
Funds
2.0%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
28,782,225
$
28,782,225
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$28,782,225)
...........................................................
28,782,225
Total
Short
Term
Investments
(Cost
$91,495,217
)
................................
91,495,217
a
Total
Investments
(Cost
$958,998,340)
104.1%
..................................
$1,508,115,455
Other
Assets,
less
Liabilities
(4.1)%
...........................................
(59,767,742)
Net
Assets
100.0%
...........................................................
$1,448,347,713
See
Abbreviations
on
page
53
.
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2021.
See
Note
1(d).
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
12
regarding
fair
value
measurements.
d
See
Note
9
regarding
restricted
securities.
e
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1(c).
f
See
Note
10
regarding
holdings
of
5%
voting
securities.
g
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
i
See
Note
1(d)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
26
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$13.60
$23.58
$27.96
$25.11
$25.02
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.28
0.34
0.31
0.39
c
0.20
Net
realized
and
unrealized
gains
(losses)
...........
6.54
(9.96)
(4.20)
2.77
0.17
Total
from
investment
operations
....................
6.82
(9.62)
(3.89)
3.16
0.37
Less
distributions
from:
Net
investment
income
..........................
(0.40)
(0.36)
(0.49)
(0.31)
(0.28)
Net
asset
value,
end
of
year
.......................
$20.02
$13.60
$23.58
$27.96
$25.11
Total
return
d
...................................
50.55%
(41.30)%
(13.69)%
12.74%
1.37%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.24%
1.17%
1.03%
1.13%
1.06%
Expenses
net
of
waiver
and
payments
by
affiliates
e
......
1.24%
f
1.17%
f
1.03%
f
1.13%
f
1.05%
Net
investment
income
...........................
1.71%
1.75%
1.21%
1.56%
c
0.79%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$176,127
$123,467
$247,362
$344,695
$398,703
Portfolio
turnover
rate
............................
49.23%
25.60%
29.83%
29.98%
29.74%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
0.91%.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
27
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$13.25
$22.82
$27.17
$24.28
$24.25
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.15
0.19
0.11
0.20
c
0.01
Net
realized
and
unrealized
gains
(losses)
...........
6.38
(9.70)
(4.07)
2.69
0.15
Total
from
investment
operations
....................
6.53
(9.51)
(3.96)
2.89
0.16
Less
distributions
from:
Net
investment
income
..........................
(0.20)
(0.06)
(0.39)
(0.13)
Net
asset
value,
end
of
year
.......................
$19.58
$13.25
$22.82
$27.17
$24.28
Total
return
d
...................................
49.42%
(41.71)%
(14.37)%
11.90%
0.63%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.99%
1.92%
1.78%
1.88%
1.81%
Expenses
net
of
waiver
and
payments
by
affiliates
e
......
1.99%
f
1.92%
f
1.78%
f
1.88%
f
1.80%
Net
investment
income
...........................
0.93%
1.00%
0.46%
0.81%
c
0.04%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$27,753
$23,391
$49,620
$83,814
$96,835
Portfolio
turnover
rate
............................
49.23%
25.60%
29.83%
29.98%
29.74%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
0.16%.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
28
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$14.63
$25.22
$29.79
$26.87
$26.73
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.39
0.54
0.45
0.57
c
0.47
Net
realized
and
unrealized
gains
(losses)
...........
7.05
(10.76)
(4.49)
2.95
0.04
Total
from
investment
operations
....................
7.44
(10.22)
(4.04)
3.52
0.51
Less
distributions
from:
Net
investment
income
..........................
(0.49)
(0.37)
(0.53)
(0.60)
(0.37)
Net
asset
value,
end
of
year
.......................
$21.58
$14.63
$25.22
$29.79
$26.87
Total
return
....................................
51.43%
(41.02)%
(13.31)%
13.37%
1.89%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.89%
0.72%
0.62%
0.64%
0.83%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
0.72%
0.66%
0.59%
0.57%
0.54%
Net
investment
income
...........................
2.22%
2.26%
1.65%
2.12%
c
1.30%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$1,722
$839
$15,627
$15,866
$218
Portfolio
turnover
rate
............................
49.23%
25.60%
29.83%
29.98%
29.74%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
1.47%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
29
In
a
Year
Ended
April
30,
2021
2020
2019
2018
2017
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$14.54
$25.20
$29.80
$26.81
$26.71
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.33
0.41
0.40
0.49
c
0.29
Net
realized
and
unrealized
gains
(losses)
...........
7.01
(10.64)
(4.49)
2.95
0.17
Total
from
investment
operations
....................
7.34
(10.23)
(4.09)
3.44
0.46
Less
distributions
from:
Net
investment
income
..........................
(0.44)
(0.43)
(0.51)
(0.45)
(0.36)
Net
asset
value,
end
of
year
.......................
$21.44
$14.54
$25.20
$29.80
$26.81
Total
return
....................................
50.95%
(41.15)%
(13.50)%
13.04%
1.64%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.00%
0.92%
0.78%
0.88%
0.81%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
1.00%
e
0.92%
e
0.78%
e
0.88%
e
0.80%
Net
investment
income
...........................
1.93
%
2.00%
1.46%
1.81%
c
1.04%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$39,562
$28,334
$62,639
$78,443
$94,070
Portfolio
turnover
rate
............................
49.23%
25.60%
29.83%
29.98%
29.74%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
1.16%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments,
April
30,
2021
Franklin
Natural
Resources
Fund
franklintempleton.com
Annual
Report
30
a
a
Country
Shares
a
Value
a
Common
Stocks
97.2%
Agricultural
Products
1.0%
Bunge
Ltd.
..........................................
United
States
15,700
$
1,325,394
a
Darling
Ingredients,
Inc.
................................
United
States
15,000
1,041,750
2,367,144
Construction
Materials
1.1%
Martin
Marietta
Materials,
Inc.
............................
United
States
7,400
2,613,088
Copper
7.8%
Antofagasta
plc
.......................................
Chile
208,500
5,371,183
a
ERO
Copper
Corp.
....................................
Canada
62,700
1,237,933
First
Quantum
Minerals
Ltd.
.............................
Zambia
111,800
2,576,607
Freeport-McMoRan,
Inc.
................................
United
States
157,600
5,943,096
a
Imperial
Metals
Corp.
..................................
Canada
111,600
450,304
Lundin
Mining
Corp.
...................................
Chile
310,800
3,754,631
19,333,754
Diversified
Chemicals
0.8%
Huntsman
Corp.
......................................
United
States
66,500
1,906,555
Diversified
Metals
&
Mining
6.7%
Anglo
American
plc
....................................
South
Africa
102,600
4,350,444
BHP
Group
plc,
ADR
...................................
Australia
94,400
5,711,200
a
Glencore
plc
.........................................
Australia
569,200
2,318,677
Rio
Tinto
plc,
ADR
.....................................
Australia
31,500
2,679,390
Teck
Resources
Ltd.,
B
.................................
Canada
69,100
1,462,847
16,522,558
Electrical
Components
&
Equipment
0.4%
a
Shoals
Technologies
Group,
Inc.,
A
........................
United
States
28,200
904,374
a
Environmental
&
Facilities
Services
1.2%
a,b,c,d
Li-Cycle
Holdings
Corp.
.................................
Canada
173,800
1,738,000
a
US
Ecology,
Inc.
......................................
United
States
29,300
1,244,078
2,982,078
Fertilizers
&
Agricultural
Chemicals
1.5%
Corteva
,
Inc.
.........................................
United
States
39,600
1,930,896
Nutrien
Ltd.
..........................................
Canada
30,500
1,683,295
3,614,191
Food
Distributors
0.6%
a
Performance
Food
Group
Co.
............................
United
States
22,900
1,344,230
a
Gold
8.8%
Agnico
Eagle
Mines
Ltd.
................................
Canada
35,200
2,199,767
Alamos
Gold,
Inc.,
A
...................................
Canada
270,000
2,163,514
B2Gold
Corp.
........................................
Canada
309,500
1,490,535
Barrick
Gold
Corp.
....................................
Canada
282,891
6,011,434
Newcrest
Mining
Ltd.
...................................
Australia
26,800
547,811
Newmont
Corp.
.......................................
United
States
117,615
7,340,352
SSR
Mining,
Inc.
......................................
Canada
103,900
1,647,854
21,401,267
Heavy
Electrical
Equipment
0.5%
a
TPI
Composites,
Inc.
...................................
United
States
22,900
1,217,135
a
Industrial
Gases
2.6%
Air
Products
and
Chemicals,
Inc.
..........................
United
States
11,400
3,288,672
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Natural
Resources
Fund
franklintempleton.com
Annual
Report
31
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Industrial
Gases
(continued)
Linde
plc
............................................
United
Kingdom
11,600
$
3,315,744
6,604,416
Integrated
Oil
&
Gas
15.4%
Chevron
Corp.
.......................................
United
States
95,200
9,812,264
Exxon
Mobil
Corp.
.....................................
United
States
150,800
8,631,792
Occidental
Petroleum
Corp.
.............................
United
States
121,200
3,073,632
Royal
Dutch
Shell
plc,
ADR,
A
............................
Netherlands
114,021
4,332,798
Suncor
Energy,
Inc.
....................................
Canada
359,500
7,688,635
TOTAL
SE,
ADR
......................................
France
91,210
4,038,779
37,577,900
Investment
Banking
&
Brokerage
2.1%
a,b,c
Alussa
Energy
Acquisition
Corp.
..........................
United
States
138,200
1,382,000
a,b,c,d
ArcLight
Clean
Transition
Corp.
...........................
United
States
18,500
293,028
a
ArcLight
Clean
Transition
Corp.,
A
.........................
United
States
44,500
720,010
a,b,c,d
Churchill
Capital
Corp.
IV
...............................
United
States
141,414
2,121,210
a,b,c,d
Spartan
Acquisition
Corp.
II,
A
............................
United
States
74,343
743,430
5,259,678
Oil
&
Gas
Drilling
0.8%
Helmerich
&
Payne,
Inc.
................................
United
States
36,000
922,680
Patterson-UTI
Energy,
Inc.
..............................
United
States
152,600
1,031,576
1,954,256
Oil
&
Gas
Equipment
&
Services
9.2%
Baker
Hughes
Co.
.....................................
United
States
160,000
3,212,800
Cactus,
Inc.,
A
........................................
United
States
29,100
867,471
a
ChampionX
Corp.
.....................................
United
States
89,600
1,882,496
Halliburton
Co.
.......................................
United
States
132,335
2,588,472
a
Liberty
Oilfield
Services,
Inc.,
A
...........................
United
States
118,900
1,391,130
a
NexTier
Oilfield
Solutions,
Inc.
............................
United
States
289,122
1,037,948
a
Nine
Energy
Service,
Inc.
...............................
United
States
316,583
623,668
a
Oceaneering
International,
Inc.
...........................
United
States
77,900
837,425
a
Oil
States
International,
Inc.
.............................
United
States
135,166
758,281
a
Ranger
Energy
Services,
Inc.
............................
United
States
169,957
973,854
Schlumberger
NV
.....................................
United
States
155,547
4,207,546
a
Schoeller-Bleckmann
Oilfield
Equipment
AG
.................
Austria
27,200
1,162,334
a
Select
Energy
Services,
Inc.,
A
...........................
United
States
193,119
932,765
a,e
Technip
Energies
NV
...................................
France
40,899
582,453
a
TechnipFMC
plc
......................................
United
Kingdom
216,100
1,599,140
22,657,783
Oil
&
Gas
Exploration
&
Production
21.0%
Aker
BP
ASA
.........................................
Norway
52,300
1,489,483
Cabot
Oil
&
Gas
Corp.
.................................
United
States
373,316
6,223,177
Cairn
Energy
plc
......................................
United
Kingdom
592,328
1,389,101
Canadian
Natural
Resources
Ltd.
.........................
Canada
172,600
5,238,727
ConocoPhillips
.......................................
United
States
181,591
9,286,564
Devon
Energy
Corp.
...................................
United
States
368,282
8,610,433
EOG
Resources,
Inc.
..................................
United
States
107,300
7,901,572
a
EQT
Corp.
..........................................
United
States
108,500
2,072,350
Hess
Corp.
..........................................
United
States
53,300
3,971,383
Pioneer
Natural
Resources
Co.
...........................
United
States
37,301
5,738,013
51,920,803
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Natural
Resources
Fund
franklintempleton.com
Annual
Report
32
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Oil
&
Gas
Refining
&
Marketing
6.4%
Marathon
Petroleum
Corp.
..............................
United
States
93,800
$
5,219,970
New
Fortress
Energy,
Inc.
...............................
United
States
18,100
769,612
Phillips
66
...........................................
United
States
62,900
5,089,239
Valero
Energy
Corp.
...................................
United
States
61,900
4,578,124
15,656,945
Oil
&
Gas
Storage
&
Transportation
6.4%
Enbridge,
Inc.
........................................
Canada
64,847
2,501,149
Kinder
Morgan,
Inc.
....................................
United
States
98,100
1,672,605
Targa
Resources
Corp.
.................................
United
States
69,500
2,410,955
TC
Energy
Corp.
......................................
Canada
77,900
3,853,713
Williams
Cos.,
Inc.
(The)
................................
United
States
207,500
5,054,700
15,493,122
Paper
Packaging
0.4%
Packaging
Corp.
of
America
.............................
United
States
7,200
1,063,080
Semiconductor
Equipment
0.3%
a
SolarEdge
Technologies,
Inc.
............................
United
States
2,400
632,496
a
Steel
1.4%
Vale
SA,
ADR
........................................
Brazil
168,500
3,390,220
Trading
Companies
&
Distributors
0.8%
a
Univar
Solutions,
Inc.
..................................
United
States
85,700
2,001,095
a
Total
Common
Stocks
(Cost
$172,125,323)
.....................................
238,418,168
Warrants
a
a
a
a
a
Warrants
0.1%
Integrated
Oil
&
Gas
0.1%
a
Occidental
Petroleum
Corp.
,
8/03/27
.......................
United
States
17,900
192,962
Total
Warrants
(Cost
$88,605)
.................................................
192,962
Principal
Amount
*
Convertible
Bonds
0.5%
Oil
&
Gas
Equipment
&
Services
0.5%
f
Oil
States
International,
Inc.,
Senior
Note,
144A,
4.75%,
4/01/26
..
United
States
1,200,000
1,097,415
Total
Convertible
Bonds
(Cost
$1,200,000)
.....................................
1,097,415
Total
Long
Term
Investments
(Cost
$173,413,928)
...............................
239,708,545
a
Short
Term
Investments
4.9%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
4.7%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
11,479,563
11,479,563
Total
Money
Market
Funds
(Cost
$11,479,563)
..................................
11,479,563
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Natural
Resources
Fund
franklintempleton.com
Annual
Report
33
Short
Term
Investments
(continued)
a
a
Country
Shares
a
Value
a
a
a
a
a
a
i
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.2%
Money
Market
Funds
0.2%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
450,105
$
450,105
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$450,105)
...................................................................
450,105
Total
Short
Term
Investments
(Cost
$11,929,668
)
................................
11,929,668
a
Total
Investments
(Cost
$185,343,596)
102.7%
..................................
$251,638,213
Other
Assets,
less
Liabilities
(2.7)%
...........................................
(6,474,451)
Net
Assets
100.0%
...........................................................
$245,163,762
See
Abbreviations
on
page
53
.
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
12
regarding
fair
value
measurements.
c
See
Note
9
regarding
restricted
securities.
d
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1(c).
e
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2021.
See
Note
1(d).
f
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
April
30,
2021,
the
value
of
this
security
was
$1,097,415,
representing
0.4%
of
net
assets.
g
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
i
See
Note
1(d)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
April
30,
2021
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
34
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
..................................................
$865,418,634
$173,413,928
Cost
-
Non-controlled
affiliates
(Note
3
f
and
10
)
..................................
93,579,706
11,929,668
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
of
$27,983,200
and
$427,870
respectively)
............................................................
$1,414,535,749
$239,708,545
Value
-
Non-controlled
affiliates
(Note
3
f
and
10
)
.................................
93,579,706
11,929,668
Cash
...................................................................
46,303
Foreign
currency,
at
value
(cost
$–
and
$45,660
respectively)
.........................
45,660
Receivables:
Capital
shares
sold
.......................................................
700,268
658,794
Dividends
and
interest
....................................................
15,251
367,596
Due
from
custodian
.......................................................
109,200
Total
assets
.........................................................
1,508,986,477
252,710,263
Liabilities:
Payables:
Investment
securities
purchased
.............................................
28,613,978
6,169,640
Capital
shares
redeemed
..................................................
1,943,686
552,078
Management
fees
........................................................
719,250
110,843
Distribution
fees
.........................................................
290,659
58,499
Transfer
agent
fees
.......................................................
50,203
90,200
Payable
upon
return
of
securities
loaned
(Note
1
d
)
.................................
28,891,425
450,105
Accrued
expenses
and
other
liabilities
..........................................
129,563
115,136
Total
liabilities
........................................................
60,638,764
7,546,501
Net
assets,
at
value
................................................
$1,448,347,713
$245,163,762
Net
assets
consist
of:
Paid-in
capital
............................................................
$797,674,015
$412,341,299
Total
distributable
earnings
(losses)
............................................
650,673,698
(167,177,537)
Net
assets,
at
value
................................................
$1,448,347,713
$245,163,762
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
(continued)
April
30,
2021
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
35
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Class
A:
Net
assets,
at
value
......................................................
$1,160,450,757
$176,126,505
Shares
outstanding
.......................................................
7,097,556
8,797,686
Net
asset
value
per
share
a
.................................................
$163.50
$20.02
Maximum
offering
price
per
share
(net
asset
val
ue
per
share
÷
94.50%
)
...............
$173.02
$21.19
Class
C:
Net
assets,
at
value
......................................................
$64,800,641
$27,753,387
Shares
outstanding
.......................................................
423,675
1,417,208
Net
asset
value
and
maximum
offering
price
per
share
a
............................
$152.95
$19.58
Class
R6:
Net
assets,
at
value
......................................................
$16,720,919
$1,722,029
Shares
outstanding
.......................................................
97,094
79,797
Net
asset
value
and
maximum
offering
price
per
share
............................
$172.21
$21.58
Advisor
Class:
Net
assets,
at
value
......................................................
$206,375,396
$39,561,841
Shares
outstanding
.......................................................
1,214,358
1,845,277
Net
asset
value
and
maximum
offering
price
per
share
............................
$169.95
$21.44
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Operations
for
the
year
ended
April
30,
2021
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
36
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Investment
income:
Dividends:
(net
of
foreign
taxes
of
$–
and
$254,796,
respectively)
Unaffiliated
issuers
.......................................................
$5,262,868
$5,829,800
Non-controlled
affiliates
(Note
3
f
and
10
)
.......................................
691
263
Interest:
Unaffiliated
issuers
.......................................................
6,650
Income
from
securities
loaned:
Unaffiliated
entities
(net
of
fees
and
rebates)
....................................
426,046
2,781
Non-controlled
affiliates
(Note
3
f
)
............................................
545
12
Total
investment
income
..................................................
5,690,150
5,839,506
Expenses:
Management
fees
(Note
3
a
)
..................................................
8,377,138
1,115,067
Distribution
fees:
(Note
3c
)
Class
A
...............................................................
2,882,922
352,590
Class
C
...............................................................
623,283
243,156
Transfer
agent
fees:
(Note
3e
)
Class
A
...............................................................
1,310,751
431,627
Class
C
...............................................................
70,663
74,502
Class
R6
..............................................................
12,338
2,263
Advisor
Class
...........................................................
236,797
96,039
Custodian
fees
(Note
4
)
.....................................................
64,000
3,312
Reports
to
shareholders
.....................................................
179,348
98,689
Registration
and
filing
fees
...................................................
118,446
69,642
Professional
fees
..........................................................
70,144
62,761
Trustees'
fees
and
expenses
.................................................
18,378
3,686
Other
...................................................................
37,374
15,985
Total
expenses
........................................................
14,001,582
2,569,319
Expense
reductions
(Note
4
)
..............................................
(2,412)
(252)
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
.............................
(118,777)
(6,776)
Net
expenses
........................................................
13,880,393
2,562,291
Net
investment
income
(loss)
...........................................
(8,190,243)
3,277,215
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
Unaffiliated
issuers
.....................................................
260,875,031
(40,440,342)
Foreign
currency
transactions
...............................................
(94,269)
Net
realized
gain
(loss)
.................................................
260,875,031
(40,534,611)
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
.....................................................
37,007,017
116,289,348
Translation
of
other
assets
and
liabilities
denominated
in
foreign
currencies
.............
2,173,104
Net
change
in
unrealized
appreciation
(depreciation)
...........................
37,007,017
118,462,452
Net
realized
and
unrealized
gain
(loss)
...........................................
297,882,048
77,927,841
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.........................
$289,691,805
$81,205,056
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
37
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Year
Ended
April
30,
2021
Year
Ended
April
30,
2020
Year
Ended
April
30,
2021
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
.......
$(8,190,243)
$(5,334,586)
$3,277,215
$4,504,278
Net
realized
gain
(loss)
............
260,875,031
96,628,087
(40,534,611)
(39,172,430)
Net
change
in
unrealized
appreciation
(depreciation)
.................
37,007,017
98,772,198
118,462,452
(90,505,249)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.
289,691,805
190,065,699
81,205,056
(125,173,401)
Distributions
to
shareholders:
Class
A
........................
(158,473,630)
(85,259,141)
(3,383,596)
(3,164,483)
Class
C
........................
(9,137,943)
(4,306,918)
(282,821)
(111,347)
Class
R6
.......................
(1,586,782)
(645,173)
(30,669)
(13,751)
Advisor
Class
...................
(27,324,424)
(13,979,384)
(789,349)
(833,185)
Total
distributions
to
shareholders
.....
(196,522,779)
(104,190,616)
(4,486,435)
(4,122,766)
Capital
share
transactions:
(Note
2
)
Class
A
........................
124,171,813
(34,210,659)
(2,174,380)
(34,646,355)
Class
C
........................
14,137,153
(1,170,193)
(5,035,749)
(9,393,999)
Class
R6
.......................
6,785,898
2,793,619
437,681
(12,686,535)
Advisor
Class
...................
32,584,271
(6,945,668)
(812,850)
(13,195,013)
Total
capital
share
transactions
.......
177,679,135
(39,532,901)
(7,585,298)
(69,921,902)
Net
increase
(decrease)
in
net
assets
.....................
270,848,161
46,342,182
69,133,323
(199,218,069)
Net
assets:
Beginning
of
year
..................
1,177,499,552
1,131,157,370
176,030,439
375,248,508
End
of
year
......................
$1,448,347,713
$1,177,499,552
$245,163,762
$176,030,439
Franklin
Strategic
Series
Notes
to
Financial
Statements
38
franklintempleton.com
Annual
Report
1.
Organization
and
Significant
Accounting
Policies
Franklin
Strategic
Series (Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-
end
management
investment
company,
consisting
of
ten
separate
funds, two
of
which
are
included
in
this
report
(Funds)
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP).
The
Funds
offer four classes
of
shares: Class A,
Class
C,
Class R6
and
Advisor
Class.
Class
C
shares
automatically
convert
to
Class
A
shares
after
they
have
been
held
for
10
years. Each
class
of
shares
may
differ
by
its initial
sales
load,
contingent
deferred
sales
charges,
voting
rights
on
matters
affecting
a
single
class,
its
exchange
privilege
and
fees
due
to
differing
arrangements
for
distribution
and
transfer
agent
fees.
The
following
summarizes
the Funds'
significant
accounting
policies. 
a.
Financial
Instrument
Valuation 
The Funds'
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The Funds calculate the
net
asset
value
(NAV)
per
share
each
business
day
as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Trust's
Board
of
Trustees
(the
Board),
the
Funds' administrator
has
responsibility
for
oversight
of
valuation,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Funds
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded,
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Debt
securities
generally
trade
in
the
OTC
market rather
than
on
a
securities
exchange.
The
Funds'
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Investments
in open-end mutual
funds
are
valued
at
the
closing
NAV.
The
Funds
have
procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the
Funds
primarily
employ
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
book
values,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed.
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Funds'
business
day.
Occasionally,
events
occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Fund.
As
a
result,
differences
may
arise
between
the
value
of
the
Funds'
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
Franklin
Strategic
Series
Notes
to
Financial
Statements
39
franklintempleton.com
Annual
Report
at
4
p.m.
Eastern
time.
In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Funds'
securities
to
the
latest
indications
of
fair
value
at
4
p.m.
Eastern
time.
At
April
30,
2021,
certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
inputs
within
the
fair
value
hierarchy
(referred
to
as
“market
level
fair”).
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Funds'
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Funds'
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Funds
for
financial
reporting
purposes.
b.
Foreign
Currency
Translation 
Portfolio
securities
and
other
assets
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
based
on
the
exchange
rate
of
such
currencies
against
U.S.
dollars
on
the
date
of
valuation.
The
Funds
may
enter
into
foreign
currency
exchange
contracts
to
facilitate
transactions
denominated
in
a
foreign
currency.
Purchases
and
sales
of
securities,
income
and
expense
items
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
at
the
exchange
rate
in
effect
on
the
transaction
date.
Portfolio
securities
and
assets
and
liabilities
denominated
in
foreign
currencies
contain
risks
that
those
currencies
will
decline
in
value
relative
to
the
U.S.
dollar.
Occasionally,
events
may
impact
the
availability
or
reliability
of
foreign
exchange
rates
used
to
convert
the
U.S.
dollar
equivalent
value.
If
such
an
event
occurs,
the
foreign
exchange
rate
will
be
valued
at
fair
value
using
procedures
established
and
approved
by
the
Board.
The
Funds
do
not
separately
report
the
effect
of
changes
in
foreign
exchange
rates
from
changes
in
market
prices
on
securities
held.
Such
changes
are
included
in
net
realized
and
unrealized
gain
or
loss
from
investments
in
the
Statements
of
Operations.
Realized
foreign
exchange
gains
or
losses
arise
from
sales
of
foreign
currencies,
currency
gains
or
losses
realized
between
the
trade
and
settlement
dates
on
securities
transactions
and
the
difference
between
the
recorded
amounts
of
dividends,
interest,
and
foreign
withholding
taxes
and
the
U.S.
dollar
equivalent
of
the
amounts
actually
received
or
paid.
Net
unrealized
foreign
exchange
gains
and
losses
arise
from
changes
in
foreign
exchange
rates
on
foreign
denominated
assets
and
liabilities
other
than
investments
in
securities
held
at
the
end
of
the
reporting
period.
c.
Securities
Purchased
on
a
Delayed
Delivery
Basis
Certain
or
all
Funds
purchase
securities
on
a
delayed
delivery
basis,
with
payment
and
delivery
scheduled
for
a
future
date.
These
transactions
are
subject
to
market
fluctuations
and
are
subject
to
the
risk
that
the
value
at
delivery
may
be
more
or
less
than
the
trade
date
purchase
price.
Although
the
Funds
will
generally
purchase
these
securities
with
the
intention
of
holding
the
securities,
they
may
sell
the
securities
before
the
settlement
date.
Sufficient
assets
have
been
segregated
for
these
securities.
d.
Securities
Lending
Certain
or
all
Funds
participate
in
an
agency
based
securities
lending
program
to
earn
additional
income.
The
Fund
receives
collateral
in
the
form
of
cash
and/or
U.S.
Government
and
Agency
securities
against
the
loaned
securities
in
an
amount
equal
to
at
least
102%
of
the
fair
value
of
the
loaned
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
100%
of
the
fair
value
of
loaned
securities,
as
determined
at
the
close
of
Fund
business
each
day;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
Fund
on
the
next
business
day.
Any
cash
collateral
received
is
deposited
into
a
joint
cash
account
with
other
funds
and
is
used
to
invest
in
a
money
market
fund
managed
by
Franklin
Advisers,
Inc.,
an
affiliate
of
the
Funds,
and/or
uninvested
cash
as
included
in
due
from
custodian
in
the
Statements
of
Assets
and
Liabilities.
The
Fund
may
receive
income
from
the
investment
of
cash
collateral,
in
addition
to
lending
fees
and
rebates
paid
by
the
borrower.
Income
from
securities
loaned,
net
of
fees
paid
to
the
securities
lending
agent
and/or
third-party
vendor,
is
reported
separately
in
the
Statements
of
Operations.
The
Fund
bears
the
market
risk
with
respect
to any
cash collateral
investment,
securities
loaned,
and
the
risk
that
the
agent
may
default
on
its
obligations
to
the
Fund.
If
the
borrower
defaults
on
its
1.
Organization
and
Significant
Accounting
Policies
(continued)
a.
Financial
Instrument
Valuation 
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
40
franklintempleton.com
Annual
Report
obligation
to
return
the
securities
loaned,
the
Fund
has
the
right
to
repurchase
the
securities
in
the
open
market
using
the
collateral
received.
The
securities
lending
agent
has
agreed
to
indemnify
the
Fund
in
the
event
of
default
by
a
third
party
borrower.
e.
Income
and
Deferred
Taxes
It
is each
Fund's
policy
to
qualify
as
a
regulated
investment
company
under
the
Internal
Revenue
Code. Each
Fund
intends
to
distribute
to
shareholders
substantially
all
of
its
taxable
income
and
net
realized
gains
to
relieve
it
from
federal
income
and
excise
taxes.
As
a
result,
no
provision
for
U.S.
federal
income
taxes
is
required.
The
Funds
may
be
subject
to
foreign
taxation
related
to
income
received,
capital
gains
on
the
sale
of
securities
and
certain
foreign
currency
transactions
in
the
foreign
jurisdictions
in
which
the
Funds
invest.
Foreign
taxes,
if
any,
are
recorded
based
on
the
tax
regulations
and
rates
that
exist
in
the
foreign
markets
in
which
the
Funds
invest.
When
a
capital
gain
tax
is
determined
to
apply,
certain
or
all
Funds
record
an
estimated
deferred
tax
liability
in
an
amount
that
would
be
payable
if
the
securities
were
disposed
of
on
the
valuation
date.
Each
Fund
may
recognize
an
income
tax
liability
related
to
its
uncertain
tax
positions
under
U.S.
GAAP
when
the
uncertain
tax
position
has
a
less
than
50%
probability
that
it
will
be
sustained
upon
examination
by
the
tax
authorities
based
on
its
technical
merits.
As
of
April
30,
2021, each
Fund
has
determined
that
no
tax
liability
is
required
in
its
financial
statements
related
to
uncertain
tax
positions
for
any
open
tax
years
(or
expected
to
be
taken
in
future
tax
years).
Open
tax
years
are
those
that
remain
subject
to
examination
and
are
based
on
the
statute
of
limitations
in
each
jurisdiction
in
which
the
Fund
invests. 
f.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
Security
transactions
are
accounted
for
on
trade
date.
Realized
gains
and
losses
on
security
transactions
are
determined
on
a
specific
identification
basis.
Interest
income
and
estimated
expenses
are
accrued
daily.
Amortization
of
premium
and
accretion
of
discount
on
debt
securities
are
included
in
interest
income.
Facility
fees
are
recognized
as
income
over
the
expected
term
of
the
loan.
Dividend
income
is
recorded
on
the
ex-dividend
date
except
for
certain
dividends
from
securities
where
the
dividend
rate
is
not
available.
In
such
cases,
the
dividend
is
recorded
as
soon
as
the
information
is
received
by
the
Funds.
Distributions
to shareholders
are
recorded
on
the
ex-dividend
date.
Distributable
earnings
are
determined
according
to
income
tax
regulations
(tax
basis)
and
may
differ
from
earnings
recorded
in
accordance
with
U.S.
GAAP.
These
differences
may
be
permanent
or
temporary.
Permanent
differences
are
reclassified
among
capital
accounts
to
reflect
their
tax
character.
These
reclassifications
have
no
impact
on
net
assets
or
the
results
of
operations.
Temporary
differences
are
not
reclassified,
as
they
may
reverse
in
subsequent
periods.
Common
expenses
incurred
by
the
Trust
are
allocated
among
the
Funds
based
on
the
ratio
of
net
assets
of
each
Fund
to
the
combined
net
assets
of
the
Trust
or
based
on
the
ratio
of
number
of
shareholders
of
each
Fund
to
the
combined
number
of
shareholders
of
the
Trust.
Fund
specific
expenses
are
charged
directly
to
the
Fund
that
incurred
the
expense.
Realized
and
unrealized
gains
and
losses
and
net
investment
income,
excluding
class
specific
expenses,
are
allocated
daily
to
each
class
of
shares
based
upon
the
relative
proportion
of
net
assets
of
each
class.
Differences
in
per
share
distributions
by
class
are
generally
due
to
differences
in
class
specific
expenses.
g.
Accounting
Estimates
The
preparation
of
financial
statements
in
accordance
with
U.S.
GAAP
requires
management
to
make
estimates
and
assumptions
that
affect
the
reported
amounts
of
assets
and
liabilities
at
the
date
of
the
financial
statements
and
the
amounts
of
income
and
expenses
during
the
reporting
period.
Actual
results
could
differ
from
those
estimates.
h.
Guarantees
and
Indemnifications
Under
the
Trust's
organizational
documents,
its
officers
and
trustees
are
indemnified
by
the
Trust
against
certain
liabilities
arising
out
of
the
performance
of
their
duties
to
the
Trust.
Additionally,
in
the
normal
course
of
business,
the
Trust,
on
behalf
of
the
Funds,
enters
into
contracts
with
service
providers
that
contain
general
indemnification
clauses.
The
Trust's
maximum
exposure
under
these
arrangements
is
1.
Organization
and
Significant
Accounting
Policies
(continued)
d.
Securities
Lending
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
41
franklintempleton.com
Annual
Report
unknown
as
this
would
involve
future
claims
that
may
be
made
against
the
Trust
that
have
not
yet
occurred.
Currently,
the
Trust
expects
the
risk
of
loss
to
be
remote.
2.
Shares
of
Beneficial
Interest
At
April
30,
2021,
there
were
an
unlimited
number
of
shares
authorized
(without
par
value).
Transactions
in
the
Funds'
shares
were
as
follows:
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Shares
Amount
Shares
Amount
Class
A
Class
A
Shares:
Year
ended
April
30,
2021
Shares
sold
a
...................................
1,106,111
$190,970,597
2,266,637
$38,321,213
Shares
issued
in
reinvestment
of
distributions
..........
873,696
151,123,087
195,163
3,313,861
Shares
redeemed
...............................
(1,263,851)
(217,921,871)
(2,741,345)
(43,809,454)
Net
increase
(decrease)
..........................
715,956
$124,171,813
(279,545)
$(2,174,380)
Year
ended
April
30,
2020
Shares
sold
a
...................................
790,060
$113,642,349
2,038,606
$29,732,882
Shares
issued
in
reinvestment
of
distributions
..........
537,057
81,305,070
148,428
3,105,113
Shares
redeemed
...............................
(1,604,682)
(229,158,078)
(3,601,621)
(67,484,350)
Net
increase
(decrease)
..........................
(277,565)
$(34,210,659)
(1,414,587)
$(34,646,355)
Class
C
Class
C
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
139,814
$22,954,794
375,909
$6,161,042
Shares
issued
in
reinvestment
of
distributions
..........
56,116
9,105,394
16,868
281,023
Shares
redeemed
a
..............................
(110,459)
(17,923,035)
(740,499)
(11,477,814)
Net
increase
(decrease)
..........................
85,471
$14,137,153
(347,722)
$(5,035,749)
Year
ended
April
30,
2020
Shares
sold
...................................
66,779
$9,196,211
417,343
$5,926,617
Shares
issued
in
reinvestment
of
distributions
..........
29,739
4,290,371
5,386
110,099
Shares
redeemed
a
..............................
(106,671)
(14,656,775)
(831,954)
(15,430,715)
Net
increase
(decrease)
..........................
(10,153)
$(1,170,193)
(409,225)
$(9,393,999)
Class
R6
Class
R6
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
59,665
$10,868,376
49,526
$940,798
Shares
issued
in
reinvestment
of
distributions
..........
8,532
1,552,442
1,679
30,669
Shares
redeemed
...............................
(31,511)
(5,634,920)
(28,743)
(533,786)
Net
increase
(decrease)
..........................
36,686
$6,785,898
22,462
$437,681
Year
ended
April
30,
2020
Shares
sold
...................................
35,149
$5,389,737
96,853
$2,098,343
Shares
issued
in
reinvestment
of
distributions
..........
4,090
645,154
613
13,751
Shares
redeemed
...............................
(21,691)
(3,241,272)
(659,867)
(14,798,629)
Net
increase
(decrease)
..........................
17,548
$2,793,619
(562,401)
$(12,686,535)
Advisor
Class
1.
Organization
and
Significant
Accounting
Policies
(continued)
h.
Guarantees
and
Indemnifications
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
42
franklintempleton.com
Annual
Report
3.
Transactions
with
Affiliates
Franklin
Resources,
Inc.
is
the
holding
company
for
various
subsidiaries
that
together
are
referred
to
as
Franklin
Templeton.
Certain
officers
and
trustees
of
the
Trust
are
also
officers
and/or
directors
of
the
following
subsidiaries:
a.
Management
Fees
Franklin
Biotechnology
Discovery
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Shares
Amount
Shares
Amount
Advisor
Class
Shares:
Year
ended
April
30,
2021
Shares
sold
...................................
482,142
$85,624,728
940,812
$16,811,124
Shares
issued
in
reinvestment
of
distributions
..........
137,265
24,655,507
43,029
781,847
Shares
redeemed
...............................
(431,123)
(77,695,964)
(1,086,738)
(18,405,821)
Net
increase
(decrease)
..........................
188,284
$32,584,271
(102,897)
$(812,850)
Year
ended
April
30,
2020
Shares
sold
...................................
256,733
$38,219,541
849,335
$14,059,870
Shares
issued
in
reinvestment
of
distributions
..........
80,467
12,560,088
36,902
824,379
Shares
redeemed
...............................
(390,486)
(57,725,297)
(1,423,757)
(28,079,262)
Net
increase
(decrease)
..........................
(53,286)
$(6,945,668)
(537,520)
$(13,195,013)
a
May
include
a
portion
of
Class
C
shares
that
were
automatically
converted
to
Class
A.
Subsidiary
Affiliation
Franklin
Advisers,
Inc.
(Advisers)
Investment
manager
Franklin
Templeton
Services,
LLC
(FT
Services)
Administrative
manager
Franklin
Templeton
Distributors,
Inc.
(Distributors)
Principal
underwriter
Franklin
Templeton
Investor
Services,
LLC
(Investor
Services)
Transfer
agent
Annualized
Fee
Rate
Net
Assets
0.775%
Up
to
and
including
$100
million
0.650%
Over
$100
million,
up
to
and
including
$200
million
0.635%
Over
$200
million,
up
to
and
including
$250
million
0.585%
Over
$250
million,
up
to
and
including
$700
million
0.550%
Over
$700
billion,
up
to
and
including
$1.2
billion
0.525%
Over
$1.2
billion,
up
to
and
including
$7.5
billion
0.515%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.505%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.495%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.475%
In
excess
of
$15
billion
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
43
franklintempleton.com
Annual
Report
Franklin
Natural
Resources
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
For
the
year
ended
April
30,
2021,
each
Fund's
annualized
gross
effective
investment
management
fee
rate
based
on
average
daily
net
assets
was
as
follows:
b.
Administrative
Fees
Under
an
agreement
with
Advisers,
FT
Services
provides
administrative
services
to
the
Funds.
The
fee
is
paid
by
Advisers
based
on
the
Funds’
average
daily
net
assets,
and
is
not
an
additional
expense
of
the
Funds.
c.
Distribution
Fees
The
Board
has
adopted
distribution
plans
for
each
share
class,
with
the
exception
of
Class
R6
and
Advisor
Class
shares,
pursuant
to
Rule
12b-1
under
the
1940
Act.
Under
the
Funds’
Class
A
reimbursement
distribution
plans,
the
Funds
reimburse
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of each
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
Under
the
Class
A
reimbursement
distribution
plans,
costs
exceeding
the
maximum
for
the
current
plan
year
cannot
be
reimbursed
in
subsequent
periods.
In
addition,
under
the
Funds’
Class
C
compensation
distribution
plans,
the
Funds
pay
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
each
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
The
plan
year,
for
purposes
of
monitoring
compliance
with
the
maximum
annual
plan
rates,
is
February
1
through
January
31
for
each
Fund.
The
maximum
annual
plan
rates,
based
on
the
average
daily
net
assets,
for
each
class,
are
as
follows:
The
Board
has
set
the
current
rate
at
0.25%
per
year
for
Class
A
shares
until
further
notice
and
approval
by
the
Board.
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
In
excess
of
$15
billion
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Gross
effective
investment
management
fee
rate
........
0.582%
0.562%
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Reimbursement
Plans:
Class
A
...............................
0.35%
0.35%
Class
C
...............................
1.00%
1.00%
3.
Transactions
with
Affiliates
(continued)
a.
Management
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
44
franklintempleton.com
Annual
Report
d.
Sales
Charges/Underwriting
Agreements
Front-end
sales
charges
and
contingent
deferred
sales
charges
(CDSC)
do
not
represent
expenses
of
the
Funds.
These
charges
are
deducted
from
the
proceeds
of
sales
of
fund
shares
prior
to
investment
or
from
redemption
proceeds
prior
to
remittance,
as
applicable.
Distributors
has
advised
the
Funds
of
the
following
commission
transactions
related
to
the
sales
and
redemptions
of
the
Funds'
shares
for
the
period:
e.
Transfer
Agent
Fees
Each
class
of
shares
pays
transfer
agent
fees
to
Investor
Services
for
its
performance
of
shareholder
servicing
obligations.
The
fees
are
based
on
an
annualized
asset
based
fee
of
0.02%
plus
a
transaction
based
fee.
In
addition,
each
class
reimburses
Investor
Services
for
out
of
pocket
expenses
incurred
and,
except
for
Class
R6,
reimburses
shareholder
servicing
fees
paid
to
third
parties.
These
fees
are
allocated
daily
based
upon
their
relative
proportion
of
such
classes'
aggregate
net
assets.
Class
R6
pays
Investor
Services
transfer
agent
fees
specific
to
that
class.
For
the
year
ended
April
30,
2021,
the
Funds
paid
transfer
agent
fees
as
noted
in
the
Statements
of
Operations
of
which
the
following
amounts
were
retained
by
Investor
Services:
f.
Investments
in
Affiliated
Management
Investment
Companies
Certain
or
all
Funds
invest
in
one
or
more
affiliated
management
investment
companies.
As
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
fund’s
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
fund.
The
Funds
do
not
invest
for
purposes
of
exercising
a
controlling
influence
over
the
management
or
policies.
Management
fees
paid
by
the
Funds
are
waived
on
assets
invested
in
the
affiliated
management
investment
companies,
as
noted
in
the
Statements
of
Operations,
in
an
amount
not
to
exceed
the
management
and
administrative
fees
paid
directly
or
indirectly
by
each
affiliate.
During
the
year
ended
April
30,
2021,
investments
in
affiliated
management
investment
companies
were
as
follows:
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/dealers
..................
$259,119
$33,071
CDSC
retained
...........................
$14,347
$4,689
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Transfer
agent
fees
........................
$769,044
$258,546
    aa
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Franklin
Biotechnology
Discovery
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$102,836,782
$536,539,635
$(576,663,425)
$—
$—
$62,712,992
62,712,992
$691
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
45
franklintempleton.com
Annual
Report
g.
Waiver
and
Expense
Reimbursements
Investor
Services
has
contractually
agreed
in
advance
to
waive
or
limit
its
fees
so
that
the
Class
R6
transfer
agent
fees
do
not
exceed
0.03%
based
on
the
average
net
assets
of
the
class
until
August
31,
2021.
4.
Expense
Offset
Arrangement
The
Funds
have entered
into
an
arrangement
with
their
custodian
whereby
credits
realized
as
a
result
of
uninvested
cash
balances
are
used
to
reduce
a
portion
of
the
Funds'
custodian
expenses. During
the year
ended
April
30,
2021 the
custodian
fees
were
reduced
as
noted
in
the
Statements
of
Operations.
    aa
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Franklin
Biotechnology
Discovery
Fund
(continued)
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$39,742,135
$467,628,454
$(478,588,364)
$
$
$28,782,225
28,782,225
$545
Total
Affiliated
Securities
....
$142,578,917
$1,004,168,089
$(1,055,251,789)
$—
$—
$91,495,217
$1,236
Franklin
Natural
Resources
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$6,778,486
$62,382,253
$(57,681,176)
$—
$—
$11,479,563
11,479,563
$263
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$—
$21,725,795
$(21,275,690)
$450,105
450,105
$12
Total
Affiliated
Securities
....
$6,778,486
$84,108,048
$(78,956,866)
$—
$—
$11,929,668
$275
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
46
franklintempleton.com
Annual
Report
5.
Income
Taxes
For
tax
purposes,
capital
losses
may
be
carried
over
to
offset
future
capital
gains. 
At
April
30,
2021,
the
capital
loss
carryforwards
were
as
follows:
The
tax
character
of
distributions
paid
during
the
years
ended
April
30,
2021
and
2020,
was
as
follows:
At
April
30,
2021,
the
cost
of
investments
and
net
unrealized
appreciation
(depreciation)
for
income
tax
purposes
were
as
follows:
Differences
between
income
and/or
capital
gains
as
determined
on
a
book
basis
and
a
tax
basis
are
primarily
due
to
differing
treatment
of
wash
sales,
passive
foreign
investment
company
shares,
foreign
currency
transactions
and
installment
sale
income.
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
1
1
1
Capital
loss
carryforwards
not
subject
to
expiration:
Short
term
.............................
$
$
14,240,875
Long
term
.............................
216,157,741
Total
capital
loss
carryforwards
............
$—
$230,398,616
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
2021
2020
2021
2020
Distributions
paid
from:
Ordinary
income
........................
$82,206,647
$—
$4,486,435
$4,122,766
Long
term
capital
gain
....................
114,316,132
104,190,616
$196,522,779
$104,190,616
$4,486,435
$4,122,766
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
a
a
a
Cost
of
investments
.......................
$965,387,902
$193,817,544
Unrealized
appreciation
.....................
$583,810,642
$74,723,001
Unrealized
depreciation
.....................
(41,083,089)
(16,902,331)
Net
unrealized
appreciation
(depreciation)
.......
$542,727,553
$57,820,670
Distributable
earnings:
Undistributed
ordinary
income
................
$9,512,962
$3,226,235
Undistributed
long
term
capital
gains
...........
98,433,187
Total
distributable
earnings
..................
$107,946,149
$3,226,235
Franklin
Strategic
Series
Notes
to
Financial
Statements
47
franklintempleton.com
Annual
Report
6.
Investment
Transactions
Purchases
and
sales
of
investments
(excluding
short
term
securities)
for
the
year
ended
April
30,
2021,
were
as
follows:
At
April
30,
2021,
in
connection
with
securities
lending
transactions,
the
Franklin
Biotechnology
Discovery
Fund
and
Franklin
Natural
Resources
Fund
loaned
equity
investments
and
received
$28,782,225
and
$450,105
of
cash
collateral,
respectively.
The
gross
amount
of
recognized
liability
for
such
transactions
is
included
in
payable
upon
return
of
securities
loaned
in
the
Statement
of
Assets
and
Liabilities.
The
agreements
can
be
terminated
at
any
time.
7.
Concentration
of
Risk
Investing
in
foreign
securities
may
include
certain
risks
and
considerations
not
typically
associated
with
investing
in
U.S.
securities,
such
as
fluctuating
currency
values
and
changing
local,
regional
and
global
economic,
political
and
social
conditions,
which
may
result
in
greater
market
volatility.
Current
political
and
financial
uncertainty
surrounding
the
European
Union
may
increase
market
volatility
and
the
economic
risk
of
investing
in
securities
in
Europe.
In
addition,
certain
foreign
securities
may
not
be
as
liquid
as
U.S.
securities.
8.
Novel
Coronavirus
Pandemic 
The
global
outbreak
of
the
novel
coronavirus
disease,
known
as
COVID-19, has
caused
adverse
effects
on
many
companies,
sectors,
nations,
regions
and
the
markets
in
general, and
may
continue for
an unpredictable duration.
The
effects
of
this
pandemic
may
materially
impact
the
value
and
performance
of
the
Funds, their ability
to
buy
and
sell
fund
investments
at
appropriate
valuations
and their ability
to
achieve their investment
objectives.
9.
Restricted
Securities
Certain
or
all
Funds
invest
in
securities
that
are
restricted
under
the
Securities
Act
of
1933
(1933
Act).
Restricted
securities
are
often
purchased
in
private
placement
transactions,
and
cannot
be
sold
without
prior
registration
unless
the
sale
is
pursuant
to
an
exemption
under
the
1933
Act.
Disposal
of
these
securities
may
require
greater
effort
and
expense,
and
prompt
sale
at
an
acceptable
price
may
be
difficult.
The
Funds
may
have
registration
rights
for
restricted
securities.
The
issuer
generally
incurs
all
registration
costs.
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Purchases
..............................
$684,162,030
$93,740,417
Sales
..................................
$642,055,569
$99,454,697
Franklin
Strategic
Series
Notes
to
Financial
Statements
48
franklintempleton.com
Annual
Report
At
April
30,
2021,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
1933
Act,
were
as
follows:
10.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
The
1940
Act
defines
"affiliated
companies"
to
include
investments
in
portfolio
companies
in
which
a
fund
owns
5%
or
more
of
the
outstanding
voting
securities.
Additionally,
as
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
companies’
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
company.
During
the
year
ended
April
30,
2021,
investments
in
“affiliated
companies”
were
as
follows:
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Biotechnology
Discovery
Fund
2,333,755
Amunix
Pharmaceuticals,
Inc.
..................
2/26/21
$
4,125,379
$
3,846,546
189,499
Artiva
Biotherapeutics
,
Inc.
.....................
2/22/21
2,084,489
2,084,489
415,600
a
ARYA
Sciences
Acquisition
Corp.
................
2/08/21
4,156,000
4,421,039
159,440
Day
One
Therapeutics
Holding
Company
LLC
......
2/01/21
4,999,991
5,000,000
103,589
b
FS
Development
Corp.
........................
1/28/21
1,035,890
1,210,955
80,195
Intarcia
Therapeutics,
Inc.
.....................
3/26/14
2,597,516
779,505
Pipeline
Therapeutics,
Inc.
.....................
2/09/21
2,088,995
1,727,957
379,473
United
BioPharma
,
Inc.
.......................
1/28/21
2,087,102
2,087,102
Total
Restricted
Securities
(Value
is
1.41%
of
Net
Assets)
.............
$23,175,362
$20,378,088
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Natural
Resources
Fund
138,200
Alussa
Energy
Acquisition
Corp.
.................
1/29/21
$
1,382,000
$
1,382,000
18,500
c
ArcLight
Clean
Transition
Corp.
.................
1/28/21
185,000
293,028
141,414
Churchill
Capital
Corp.
IV
......................
2/22/21
2,121,210
2,121,210
173,800
Li-Cycle
Holdings
Corp.
.......................
2/16/21
1,738,000
1,738,000
74,343
Spartan
Acquisition
Corp.
II
....................
1/28/21
743,430
743,430
Total
Restricted
Securities
(Value
is
2.56%
of
Net
Assets)
.............
$6,169,640
$6,277,668
a
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$720,010
as
of
April
30,
2021.
b
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$4,160,566
as
of
April
30,
2021.
c
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$1,670,690
as
of
April
30,
2021.
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
Franklin
Biotechnology
Discovery
Fund
Non-Controlled
Affiliates
Dividends
Artiva
Biotherapeutics
,
Inc.
$
$
2,084,489
a
$
$
$
$
2,084,489
189,499
$
9.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
49
franklintempleton.com
Annual
Report
11.
Credit
Facility
The
Funds,
together
with
other
U.S.
registered
and
foreign
investment
funds
(collectively,
Borrowers),
managed
by
Franklin
Templeton,
are
borrowers
in
a
joint
syndicated
senior
unsecured
credit
facility
totaling
$2.675
billion
(Global
Credit
Facility)
which
matures
on
February
4,
2022.
This
Global
Credit
Facility
provides
a
source
of
funds
to
the
Borrowers
for
temporary
and
emergency
purposes,
including
the
ability
to
meet
future
unanticipated
or
unusually
large
redemption
requests.
Under
the
terms
of
the
Global
Credit
Facility,
the
Funds
shall,
in
addition
to
interest
charged
on
any
borrowings
made
by
the
Funds
and
other
costs
incurred
by
the
Funds,
pay
their
share
of
fees
and
expenses
incurred
in
connection
with
the
implementation
and
maintenance
of
the
Global
Credit
Facility,
based
upon
their
relative
share
of
the
aggregate
net
assets
of
all
of
the
Borrowers,
including
an
annual
commitment
fee
of
0.15%
based
upon
the
unused
portion
of
the
Global
Credit
Facility.
These
fees
are
reflected
in
other
expenses
in
the
Statements
of
Operations.
During
the
year
ended
April
30,
2021,
the
Funds
did
not
use
the
Global
Credit
Facility.
12.
Fair
Value
Measurements
The Funds
follow
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the Funds'
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the Funds' financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level
3
significant
unobservable
inputs
(including
the Funds'
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
Franklin
Biotechnology
Discovery
Fund
(continued)
Non-Controlled
Affiliates
Total
Affiliated
Securities
(Value
is
0.1%
of
Net
Assets)
..........
$—
$2,084,489
$—
$
$
$2,084,489
$—
10.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
50
franklintempleton.com
Annual
Report
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
April
30,
2021,
in
valuing
the
Fund's
assets
and
liabilities
carried
at
fair
value,
is
as
follows:
55
Level
1
Level
2
Level
3
Total
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Biotechnology
.........................
$
1,098,969,912
$
$
b
$
1,098,969,912
Capital
Markets
........................
18,987,440
5,631,994
24,619,434
Life
Sciences
Tools
&
Services
............
71,693,628
71,693,628
Pharmaceuticals
.......................
205,388,293
205,388,293
Convertible
Preferred
Stocks
...............
5,000,000
5,000,000
Preferred
Stocks
........................
9,746,094
9,746,094
Warrants
..............................
351,561
351,561
Escrows
and
Litigation
Trusts
...............
851,316
851,316
Short
Term
Investments
...................
91
,
495
,
217
91,495,217
Total
Investments
in
Securities
...........
$1,486,886,051
$—
$21,229,404
$1,508,115,455
Level
1
Level
2
Level
3
Total
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Agricultural
Products
....................
$
2,367,144
$
$
$
2,367,144
Construction
Materials
..................
2,613,088
2,613,088
Copper
..............................
13,962,571
5,371,183
19,333,754
Diversified
Chemicals
...................
1,906,555
1,906,555
Diversified
Metals
&
Mining
...............
9,853,437
6,669,121
16,522,558
Electrical
Components
&
Equipment
........
904,374
904,374
Environmental
&
Facilities
Services
.........
1,244,078
1,738,000
2,982,078
Fertilizers
&
Agricultural
Chemicals
.........
3,614,191
3,614,191
Food
Distributors
......................
1,344,230
1,344,230
Gold
................................
20,853,456
547,811
21,401,267
Heavy
Electrical
Equipment
..............
1,217,135
1,217,135
Industrial
Gases
.......................
6,604,416
6,604,416
Integrated
Oil
&
Gas
....................
37,577,900
37,577,900
Investment
Banking
&
Brokerage
..........
720,010
4,539,668
5,259,678
Oil
&
Gas
Drilling
......................
1,954,256
1,954,256
Oil
&
Gas
Equipment
&
Services
...........
21,495,449
1,162,334
22,657,783
Oil
&
Gas
Exploration
&
Production
.........
49,042,219
2,878,584
51,920,803
Oil
&
Gas
Refining
&
Marketing
............
15,656,945
15,656,945
Oil
&
Gas
Storage
&
Transportation
.........
15,493,122
15,493,122
Paper
Packaging
......................
1,063,080
1,063,080
Semiconductor
Equipment
...............
632,496
632,496
Steel
................................
3,390,220
3,390,220
Trading
Companies
&
Distributors
..........
2,001,095
2,001,095
Warrants
..............................
192,962
192,962
Convertible
Bonds
.......................
1,097,415
1,097,415
Short
Term
Investments
...................
11,
929
,
668
11,
929
,
668
Total
Investments
in
Securities
...........
$227,634,097
$17,726,448
c
$6,277,668
$251,638,213
a
For
detailed
categories,
see
the
accompanying
Statement
of
Investments.
b
Includes
securities
determined
to
have
no
value
at
April
30,
2021.
12.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
51
franklintempleton.com
Annual
Report
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the period.
At
April
30,
2021,
the
reconciliation is
as follows:
Significant
unobservable
valuation
inputs
for
material
Level
3 assets
and/or
liabilities and
impact
to
fair
value
as
a
result
of
changes
in
unobservable
valuation
inputs
as
of
April
30,
2021,
are
as
follows:
c
Includes
foreign
securities
valued
at
$16,629,033,
which
were
categorized
as
Level
2
as
a
result
of
the
application
of
market
level
fair
value
procedures.
See
the
Financial
Instrument
Valuation
note
for
more
information.
Balance
at
Beginning
of
Year
Purchases
Sales
Transfer
Into
Level
3
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
a
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Biotechnology
......
$
$
$
$
$
$
$
$
$
$
Capital
Markets
.....
5,191,890
440,104
5,631,994
440,104
Convertible
Preferred
Stocks
:
Pharmaceuticals
....
4,999,991
9
5,000,000
Preferred
Stocks
:
Biotechnology
......
2,747,737
6,214,374
(2,821,056)
(566,552)
5,574,503
(639,871)
Health
Care
Providers
&
Services
........
2,084,489
2,084,489
Pharmaceuticals
....
2,087,102
2,087,102
Escrows
and
Litigation
Trusts
...........
958,814
(151,078)
43,580
851,316
43,580
Total
Investments
in
Securities
.
$3,706,551
$20,577,846
$—
$—
$—
$(2,972,134)
$—
$(82,859)
$21,229,404
$(156,187)
Balance
at
Beginning
of
Year
Purchases
Sales
Transfer
Into
Level
3
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
Common
Stocks
Environmental
&
Facilities
Services
..
$
$
1,738,000
$
$
$
$
$
$
$
1,738,000
$
Investment
Banking
&
Brokerage
.......
4,431,641
108,027
4,539,668
108,027
Total
Investments
in
Securities
.
$—
$6,169,641
$—
$—
$—
108,027
$6,277,668
108,027
a
May
include
accretion,
amortization,
partnership
adjustments,
and/or
other
cost
basis
adjustments.
12.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
52
franklintempleton.com
Annual
Report
a
Weighted
based
on
the
relative
fair
value
of
the
financial
instruments.
b
Represents
the
directional
change
in
the
fair
value
that
would
result
from
a
significant
and
reasonable
increase
in
the
corresponding
input.
A
significant
and
reasonable
decrease
in
the
input
would
have
the
opposite
effect.
Significant
impacts,
if
any,
to
fair
value
and/or
net
assets
have
been
indicated.
c
Represents
a
significant
impact
to
fair
value
but
not
net
assets.
d
Includes
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
May
also
include
values
derived
using
private
transaction
prices
or
non-public
third
party
pricing
information
which
is
unobservable.
e
Includes
securities
determined
to
have
no
value
at
April
30,
2021.
13.
New
Accounting
Pronouncements
In
March
2020,
the
Financial
Accounting
Standards
Board
issued
Accounting
Standards
Update
(ASU)
No.
2020-04,
Reference
Rate
Reform
(Topic
848)
Facilitation
of
the
Effects
of
Reference
Rate
Reform
on
Financial
Reporting.
The
amendments
in
the
ASU
provides
optional
temporary
financial
reporting
relief
from
the
effect
of
certain
types
of
contract
modifications
due
to
the
planned
discontinuation
of
the
London
Interbank
Offered
Rate
and
other
interbank-offered
based
reference
rates
as
of
the
end
of
2021.
The
ASU
is
effective
for
certain
reference
rate-related
contract
modifications
that
occur
during
the
period
March
12,
2020
through
December
31,
2022. Management
has
reviewed
the
requirements
and
believes
the
adoption
of
this
ASU
will
not
have
a
material
impact
on
the
financial
statements.
Description
Fair
Value
at
End
of
Year
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
Common
Stocks:
Capital
Markets
...........
$4,421,039
Market
comparables
Discount
for
lack
of
marketability
4.7%
Decrease
c
All
other
Investments
..........
16,808,365
d.e
Total
.......................
$21,229,404
Description
Fair
Value
at
End
of
Year
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
Common
Stocks:
Environmental
&
Facilities
Services
...................
$1,738,000
Market
comparables
Discount
for
lack
of
marketability
12.8%
Decrease
Investment
Banking
&
Brokerage
4,539,668
Market
comparables 
Discount
for
lack
of
marketability
0.4%
-
35.6%
(17.5%) 
Decrease 
c
Total
.......................
$6,277,668
12.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
53
franklintempleton.com
Annual
Report
14.
Subsequent
Events
The
Funds
have
evaluated
subsequent
events
through
the
issuance
of
the
financial
statements
and
determined
that
no
events
have
occurred
that
require
disclosure.
Abbreviations
Selected
Portfolio
ADR
American
Depositary
Receipt
Franklin
Strategic
Series
Report
of
Independent
Registered
Public
Accounting
Firm
54
franklintempleton.com
Annual
Report
To
the
Board
of
Trustees
of
Franklin
Strategic
Series
and
Shareholders
of
Franklin
Biotechnology
Discovery
Fund
and
Franklin
Natural
Resources
Fund
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statements
of
assets
and
liabilities,
including
the
statements
of
investments,
of
Franklin
Biotechnology
Discovery
Fund
and
Franklin
Natural
Resources
Fund
(two
of
the
funds
constituting
Franklin
Strategic
Series,
hereafter
collectively
referred
to
as
the
"Funds")
as
of
April
30,
2021,
the
related
statements
of
operations
for
the
year
ended
April
30,
2021,
the
statements
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2021,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2021
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
each
of
the
Funds
as
of
April
30,
2021,
the
results
of
each
of
their
operations
for
the
year
then
ended,
the
changes
in
each
of
their
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2021
and
each
of
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2021
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinions
These
financial
statements
are
the
responsibility
of
the
Funds’
management.
Our
responsibility
is
to
express
an
opinion
on
the
Funds’
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Funds
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
April
30,
2021
by
correspondence
with
the
custodian,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinions.
PricewaterhouseCoopers
LLP
San
Francisco,
California
June
18,
2021
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
Franklin
Templeton
Group
of
Funds
since
1948.
Franklin
Strategic
Series
Tax
Information
(unaudited)
55
franklintempleton.com
Annual
Report
Under
Section
852(b)(3)(C)
of
the
Internal
Revenue
Code,
Franklin
Biotechnology
Discovery
Fund
hereby
reports
the
maximum
amount
allowable
but
no
less
than
$114,316,132
as
long
term
capital
gain
dividends
for
the
fiscal
year
ended
April
30,
2021.
Under
Section
871(k)(2)(C)
of
the
Internal
Revenue
Code,
Franklin
Biotechnology
Discovery
Fund
hereby
reports
the
maximum
amount
allowable
but
no
less
than
$82,206,647
as
a
short
term
capital
gain
dividend
for
purposes
of
the
tax
imposed
under
Section
871(a)(1)(A)
of
the
Internal
Revenue
Code
for
the
fiscal
year
ended
April
30,
2021.
Under
Section
854(b)(1)(A)
of
the
Internal
Revenue
Code,
the
Funds
hereby
report
the
following
percentage
amounts
of
the
ordinary
income
dividends
as
income
qualifying
for
the
dividends
received
deduction
for
the
fiscal
year
ended
April
30,
2021.
Under
Section
854(b)
(1)(B)
of
the
Internal
Revenue
Code,
the
Funds
hereby
report
the
maximum
amount
allowable
but
no
less
than
the
following
amounts
as
qualified
dividends
for
purposes
of
the
maximum
rate
under
Section
1(h)(11)
of
the
Internal
Revenue
Code
for
the
fiscal
year
ended
April
30,
2021:
Distributions,
including
qualified
dividend
income,
paid
during
calendar
year
2021
will
be
reported
to
shareholders
on
Form
1099-DIV
by
mid-February
2022.
Shareholders
are
advised
to
check
with
their
tax
advisors
for
information
on
the
treatment
of
these
amounts
on
their
individual
income
tax
returns.
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
6.32%
66.44%
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
$5,196,809
$6,404,211
Franklin
Strategic
Series
Board
Members
and
Officers
56
franklintempleton.com
Annual
Report
The
name,
year
of
birth
and
address
of
the
officers
and
board
members,
as
well
as
their
affiliations,
positions
held
with
the
Trust,
principal
occupations
during
at
least
the
past
five
years
and
number
of
U.S.
registered
portfolios
overseen
in
the
Franklin
Templeton
fund
complex,
are
shown
below.
Generally,
each
board
member
serves
until
that
person’s
successor
is
elected
and
qualified.
Independent
Board
Members
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Harris
J.
Ashton
(1932)
Trustee
Since
1991
125
Bar-S
Foods
(meat
packing
company)
(1981-2010).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Director,
RBC
Holdings,
Inc.
(bank
holding
company)
(until
2002);
and
President,
Chief
Executive
Officer
and
Chairman
of
the
Board,
General
Host
Corporation
(nursery
and
craft
centers)
(until
1998).
Terrence
J.
Checki
(1945)
Trustee
Since
2017
107
Hess
Corporation
(exploration
of
oil
and
gas)
(2014-present).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Member
of
the
Council
on
Foreign
Relations
(1996-present);
Member
of
the
National
Committee
on
U.S.-China
Relations
(1999-present);
member
of
the
board
of
trustees
of
the
Economic
Club
of
New
York
(2013-present);
member
of
the
board
of
trustees
of
the
Foreign
Policy
Association
(2005-present);
member
of
the
board
of
directors
of
Council
of
the
Americas
(2007-present)
and
the
Tallberg
Foundation
(2018
-
present);
and
formerly
,
Executive
Vice
President
of
the
Federal
Reserve
Bank
of
New
York
and
Head
of
its
Emerging
Markets
and
Internal
Affairs
Group
and
Member
of
Management
Committee
(1995-2014);
and
Visiting
Fellow
at
the
Council
on
Foreign
Relations
(2014).
Mary
C.
Choksi
(1950)
Trustee
Since
2014
126
Omnicom
Group
Inc.
(advertising
and
marketing
communications
services)
(2011-present)
and
White
Mountains
Insurance
Group,
Ltd.
(holding
company)
(2017-present);
and
formerly
,
Avis
Budget
Group
Inc.
(car
rental)
(2007-2020).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Founder
and
Senior
Advisor,
Strategic
Investment
Group
(investment
management
group)
(2015-2017);
Founding
Partner
and
Senior
Managing
Director,
Strategic
Investment
Group
(1987-2015);
Founding
Partner
and
Managing
Director,
Emerging
Markets
Management
LLC
(investment
management
firm)
(1987-2011);
and
Loan
Officer/Senior
Loan
Officer/Senior
Pension
Investment
Officer,
World
Bank
Group
(international
financial
institution)
(1977-1987).
Franklin
Strategic
Series
57
franklintempleton.com
Annual
Report
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Edith
E.
Holiday
(1952)
Lead
Independent
Trustee
Trustee
since
1998
and
Lead
Independent
Trustee
since
2019
126
Hess
Corporation
(exploration
of
oil
and
gas)
(1993-present),
Santander
Consumer
USA
Holdings,
Inc.
(consumer
finance)
(2016-present);
Santander
Holdings
USA
(holding
company)
(2019-present);
and
formerly
,
Canadian
National
Railway
(railroad)
(2001-April
2021),
White
Mountains
Insurance
Group,
Ltd.
(holding
company)
(2004-May
2021),
RTI
International
Metals,
Inc.
(manufacture
and
distribution
of
titanium)
(1999-2015)
and
H.J.
Heinz
Company
(processed
foods
and
allied
products)
(1994-2013).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
or
Trustee
of
various
companies
and
trusts;
and
formerly
,
Assistant
to
the
President
of
the
United
States
and
Secretary
of
the
Cabinet
(1990-1993);
General
Counsel
to
the
United
States
Treasury
Department
(1989-1990);
and
Counselor
to
the
Secretary
and
Assistant
Secretary
for
Public
Affairs
and
Public
Liaison-United
States
Treasury
Department
(1988-1989).
J.
Michael
Luttig
(1954)
Trustee
Since
2009
126
Boeing
Capital
Corporation
(aircraft
financing)
(2006-2010).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Private
investor;
and
formerly
,
Counselor
and
Senior
Advisor
to
the
Chairman,
CEO,
and
Board
of
Directors,
of
The
Boeing
Company
(aerospace
company),
and
member
of
the
Executive
Council
(May
2019-January
1,
2020);
Executive
Vice
President,
General
Counsel
and
member
of
the
Executive
Council,
The
Boeing
Company
(2006-2019);
and
Federal
Appeals
Court
Judge,
United
States
Court
of
Appeals
for
the
Fourth
Circuit
(1991-2006).
Larry
D.
Thompson
(1945)
Trustee
Since
2007
126
Graham
Holdings
Company
(education
and
media
organization)
(2011-present);
and
formerly
,
The
Southern
Company
(energy
company)
(2014-2020);
previously
(2010-2012)
and
Cbeyond,
Inc.
(business
communications
provider)
(2010-2012).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
Counsel,
Finch
McCranie,
LLP
(law
firm)
(2015-present);
John
A.
Sibley
Professor
of
Corporate
and
Business
Law,
University
of
Georgia
School
of
Law
(2015-present;
previously
2011-2012);
and
formerly
,
Independent
Compliance
Monitor
and
Auditor,
Volkswagen
AG
(manufacturer
of
automobiles
and
commercial
vehicles)
(2017-2020);
Executive
Vice
President
-
Government
Affairs,
General
Counsel
and
Corporate
Secretary,
PepsiCo,
Inc.
(consumer
products)
(2012-2014);
Senior
Vice
President
-
Government
Affairs,
General
Counsel
and
Secretary,
PepsiCo,
Inc.
(2004-2011);
Senior
Fellow
of
The
Brookings
Institution
(2003-2004);
Visiting
Professor,
University
of
Georgia
School
of
Law
(2004);
and
Deputy
Attorney
General,
U.S.
Department
of
Justice
(2001-2003).
Independent
Board
Members
(continued)
Franklin
Strategic
Series
58
franklintempleton.com
Annual
Report
Interested
Board
Members
and
Officers
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Valerie
Williams
(1956)
Trustee
Since
May
2021
107
Omnicom
Group,
Inc.
(advertising
and
marketing
communications
services)
(2016-present),
DTE
Energy
Co.
(gas
and
electric
utility)
(2018-present),
Devon
Energy
Corporation
(exploration
and
production
of
oil
and
gas)
(January
2021-present);
and
formerly
,
WPX
Energy,
Inc.
(exploration
and
production
of
oil
and
gas)
(2018-
2021).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Regional
Assurance
Managing
Partner,
Ernst
&
Young
LLP
(public
accounting)
(2005-2016),
various
roles
of
increasing
responsibility
at
ErNst
&
Young
(1981-2005).
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
**Gregory
E.
Johnson
(1961)
Trustee
Since
2013
137
None
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Executive
Chairman,
Chairman
of
the
Board
and
Director,
Franklin
Resources,
Inc.;
officer
and/or
director
or
trustee,
as
the
case
may
be,
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
39
of
the
investment
companies
in
Franklin
Templeton;
Vice
Chairman,
Investment
Company
Institute;
and
formerly
,
Chief
Executive
Officer
(2013-2020)
and
President
(1994-2015),
Franklin
Resources,
Inc.
**Rupert
H.
Johnson,
Jr.
(1940)
Chairman
of
the
Board
and
Trustee
Chairman
of
the
Board
and
Trustee
since
2013
and
Vice
President
since
1991
126
None
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
(Vice
Chairman),
Franklin
Resources,
Inc.;
Director,
Franklin
Advisers,
Inc.;
and
officer
and/or
director
or
trustee,
as
the
case
may
be,
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
37
of
the
investment
companies
in
Franklin
Templeton.
Alison
E.
Baur
(1964)
Vice
President
Since
2012
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Deputy
General
Counsel,
Franklin
Templeton;
and
officer
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
42
of
the
investment
companies
in
Franklin
Templeton.
Breda
M.
Beckerle
(1958)
Chief
Compliance
Officer
Since
October
2020
Not
Applicable
Not
Applicable
280
Park
Avenue
New
York,
NY
10017
Principal
Occupation
During
at
Least
the
Past
5
Years:
Chief
Compliance
Officer,
Fiduciary
Investment
Management
International,
Inc.,
Franklin
Advisers,
Inc.,
Franklin
Advisory
Services,
LLC,
Franklin
Mutual
Advisers,
LLC,
Franklin
Templeton
Institutional,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Independent
Board
Members
(continued)
Franklin
Strategic
Series
59
franklintempleton.com
Annual
Report
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Sonal
Desai,
Ph.D.
(1963)
Vice
President
Since
2018
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
and
Executive
Vice
President,
Franklin
Advisers,
Inc.;
Executive
Vice
President,
Franklin
Templeton
Institutional,
LLC;
and
officer
of
17
of
the
investment
companies
in
Franklin
Templeton.
Steven
J.
Gray
(1955)
Vice
President
and
Co-Secretary
Vice
President
since
2009
and
Co-Secretary
since
2019
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Associate
General
Counsel,
Franklin
Templeton;
Vice
President,
Franklin
Templeton
Distributors,
Inc.
and
FASA,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Matthew
T.
Hinkle
(1971)
Chief
Executive
Officer
Finance
and
Administration
Since
2017
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Vice
President,
Franklin
Templeton
Services,
LLC;
officer
of
42
of
the
investment
companies
in
Franklin
Templeton;
and
formerly
,
Vice
President,
Global
Tax
(2012-April
2017)
and
Treasurer/Assistant
Treasurer,
Franklin
Templeton
(2009-2017).
Robert
G.
Kubilis
(1973)
Chief
Financial
Officer,
Chief
Accounting
Officer
and
Treasurer
Since
December
2020
Not
Applicable
Not
Applicable
300
S.E.
2nd
Street
Fort
Lauderdale,
FL
33301-
1923
Principal
Occupation
During
at
Least
the
Past
5
Years:
Treasurer,
U.S.
Fund
Administration
&
Reporting
and
officer
of
39
of
the
investment
companies
in
Franklin
Templeton.
Robert
Lim
(1948)
Vice
President
AML
Compliance
Since
2016
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Vice
President,
Franklin
Templeton
Companies,
LLC;
Chief
Compliance
Officer,
Franklin
Templeton
Distributors,
Inc.
and
Franklin
Templeton
Investor
Services,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Edward
D.
Perks
(1970)
President
and
Chief
Executive
Officer
Investment
Management
Since
2018
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
President
and
Director,
Franklin
Advisers,
Inc.;
and
officer
of
eight
of
the
investment
companies
in
Franklin
Templeton
(since
December
2018).
Navid
J.
Tofigh
(1972)
Vice
President
Since
2015
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Associate
General
Counsel
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Interested
Board
Members
and
Officers
(continued)
Franklin
Strategic
Series
60
franklintempleton.com
Annual
Report
*We
base
the
number
of
portfolios
on
each
separate
series
of
the
U.S.
registered
investment
companies
within
the
Franklin
Templeton
fund
complex.
These
portfolios
have
a
common
investment
manager
or
affiliated
investment
managers.
**Gregory
E.
Johnson
is
considered
to
be
an
interested
person
of
the
Fund
under
the
federal
securities
laws
due
to
his
position
as
an
officer
and
director
of
Franklin
Resources,
Inc.
(Resources),
which
is
the
parent
company
of
the
Fund’s
investment
manager
and
distributor.
Rupert
H.
Johnson,
Jr.
is
considered
to
be
an
interested
person
of
the
Fund
under
the
federal
securities
laws
due
to
his
position
as
an
officer
and
director
and
major
shareholder
of
Resources.
Note
1:
Rupert
H.
Johnson,
Jr.
is
the
uncle
of
Gregory
E.
Johnson.
Note
2:
Officer
information
is
current
as
of
the
date
of
this
report.
It
is
possible
that
after
this
date,
information
about
officers
may
change.
The
Sarbanes-Oxley
Act
of
2002
and
Rules
adopted
by
the
Securities
and
Exchange
Commission
require
the
Fund
to
disclose
whether
the
Fund’s
Audit
Committee
includes
at
least
one
member
who
is
an
audit
committee
financial
expert
within
the
meaning
of
such
Act
and
Rules.
The
Fund’s
Board
has
determined
that
there
is
at
least
one
such
financial
expert
on
the
Audit
Committee
and
has
designated
Mary
C.
Choksi
as
its
audit
committee
financial
expert.
The
Board
believes
that
Ms.
Choksi
qualifies
as
such
an
expert
in
view
of
her
extensive
business
background
and
experience.
She
served
as
a
director
of
Avis
Budget
Group,
Inc.
(2007-May
2020)
and
formerly,
Founder
and
Senior
Advisor,
Strategic
Investment
Group
(1987
to
2017).
Ms.
Choksi
has
been
a
Member
of
the
Fund’s
Audit
Committee
since
2014.
As
a
result
of
such
background
and
experience,
the
Board
believes
that
Ms.
Choksi
has
acquired
an
understanding
of
generally
accepted
accounting
principles
and
financial
statements,
the
general
application
of
such
principles
in
connection
with
the
accounting
estimates,
accruals
and
reserves,
and
analyzing
and
evaluating
financial
statements
that
present
a
breadth
and
level
of
complexity
of
accounting
issues
generally
comparable
to
those
of
the
Fund,
as
well
as
an
understanding
of
internal
controls
and
procedures
for
financial
reporting
and
an
understanding
of
audit
committee
functions.
Ms.
Choksi
is
an
independent
Board
member
as
that
term
is
defined
under
the
relevant
Securities
and
Exchange
Commission
Rules
and
Releases.
The
Statement
of
Additional
Information
(SAI)
includes
additional
information
about
the
board
members
and
is
available,
without
charge,
upon
request.
Shareholders
may
call
(800)
DIAL
BEN/342-5236
to
request
the
SAI.
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Craig
S.
Tyle
(1960)
Vice
President
Since
2005
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
General
Counsel
and
Executive
Vice
President,
Franklin
Resources,
Inc.;
and
officer
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
42
of
the
investment
companies
in
Franklin
Templeton.
Lori
A.
Weber
(1964)
Vice
President
and
Co-Secretary
Vice
President
since
2011
and
Co-Secretary
since
2019
Not
Applicable
Not
Applicable
300
S.E.
2nd
Street
Fort
Lauderdale,
FL
33301-
1923
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Associate
General
Counsel,
Franklin
Templeton;
Assistant
Secretary,
Franklin
Resources,
Inc.;
Vice
President
and
Secretary,
Templeton
Investment
Counsel,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Interested
Board
Members
and
Officers
(continued)
Franklin
Strategic
Series
Shareholder
Information
61
franklintempleton.com
Annual
Report
Board
Approval
of
Investment
Management
Agreements
FRANKLIN
STRATEGIC
SERIES
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
(each
a
Fund)
At
a
meeting
held
on
April
20,
2021
(Meeting),
the
Board
of
Trustees
(Board)
of
Franklin
Strategic
Series
(Trust),
including
a
majority
of
the
trustees
who
are
not
“interested
persons”
as
defined
in
the
Investment
Company
Act
of
1940
(Independent
Trustees),
reviewed
and
approved
the
continuance
of
the
investment
management
agreement
between
Franklin
Advisers,
Inc.
(Manager)
and
the
Trust,
on
behalf
of
each
Fund
(each
a
Management
Agreement)
for
an
additional
one-year
period.
The
Independent
Trustees
received
advice
from
and
met
separately
with
Independent
Trustee
counsel
in
considering
whether
to
approve
the
continuation
of
each
Management
Agreement.
Although
the
Management
Agreements
for
the
Funds
were
considered
at
the
same
Board
meeting,
the
Board
considered
the
information
provided
to
it
about
the
Funds
together
and
with
respect
to
each
Fund
separately
as
the
Board
deemed
appropriate.
In
considering
the
continuation
of
each
Management
Agreement,
the
Board
reviewed
and
considered
information
provided
by
the
Manager
at
the
Meeting
and
throughout
the
year
at
meetings
of
the
Board
and
its
committees.
The
Board
also
reviewed
and
considered
information
provided
in
response
to
a
detailed
set
of
requests
for
information
submitted
to
the
Manager
by
Independent
Trustee
counsel
on
behalf
of
the
Independent
Trustees
in
connection
with
the
annual
contract
renewal
process.
In
addition,
prior
to
the
Meeting,
the
Independent
Trustees
held
a
telephonic
contract
renewal
meeting
at
which
the
Independent
Trustees
conferred
amongst
themselves
and
Independent
Trustee
counsel
about
contract
renewal
matters
and,
in
some
cases,
requested
additional
information
from
the
Manager
relating
to
the
contract.
The
Board
reviewed
and
considered
all
of
the
factors
it
deemed
relevant
in
approving
the
continuance
of
each
Management
Agreement,
including,
but
not
limited
to:
(i)
the
nature,
extent
and
quality
of
the
services
provided
by
the
Manager;
(ii)
the
investment
performance
of
each
Fund;
(iii)
the
costs
of
the
services
provided
and
profits
realized
by
the
Manager
and
its
affiliates
from
the
relationship
with
each
Fund;
(iv)
the
extent
to
which
economies
of
scale
are
realized
as
each
Fund
grows;
and
(v)
whether
fee
levels
reflect
these
economies
of
scale
for
the
benefit
of
Fund
investors.
In
approving
the
continuance
of
each
Management
Agreement,
the
Board,
including
a
majority
of
the
Independent
Trustees,
determined
that
the
terms
of
the
Management
Agreement
are
fair
and
reasonable
and
that
the
continuance
of
such
Management
Agreement
is
in
the
best
interests
of
the
applicable
Fund
and
its
shareholders.
While
attention
was
given
to
all
information
furnished,
the
following
discusses
some
primary
factors
relevant
to
the
Board’s
determination.
Nature,
Extent
and
Quality
of
Services
The
Board
reviewed
and
considered
information
regarding
the
nature,
extent
and
quality
of
investment
management
services
provided
by
the
Manager
and
its
affiliates
to
the
Funds
and
their
shareholders.
This
information
included,
among
other
things,
the
qualifications,
background
and
experience
of
the
senior
management
and
investment
personnel
of
the
Manager,
as
well
as
information
on
succession
planning
where
appropriate;
the
structure
of
investment
personnel
compensation;
oversight
of
third-
party
service
providers;
investment
performance
reports
and
related
financial
information
for
each
Fund;
reports
on
expenses
and
shareholder
services;
legal
and
compliance
matters;
risk
controls;
pricing
and
other
services
provided
by
the
Manager
and
its
affiliates;
and
management
fees
charged
by
the
Manager
and
its
affiliates
to
US
funds
and
other
accounts,
including
management’s
explanation
of
differences
among
accounts
where
relevant.
The
Board
also
reviewed
and
considered
an
annual
report
on
payments
made
by
Franklin
Templeton
(FT)
or
the
Funds
to
financial
intermediaries,
as
well
as
a
memorandum
relating
to
third-
party
servicing
arrangements,
which
included
discussion
of
the
changing
distribution
landscape
for
the
Funds.
The
Board
noted
management’s
continuing
efforts
and
expenditures
in
establishing
effective
business
continuity
plans
and
developing
strategies
to
address
areas
of
heightened
concern
in
the
mutual
fund
industry,
such
as
cybersecurity
in
the
current
work-from-home
environment
and
liquidity
risk
management.
The
Board
also
reviewed
and
considered
the
benefits
provided
to
Fund
shareholders
of
investing
in
a
fund
that
is
part
of
the
FT
family
of
funds.
The
Board
noted
the
financial
position
of
Franklin
Resources,
Inc.
(FRI),
the
Manager’s
parent,
and
its
commitment
to
the
mutual
fund
Franklin
Strategic
Series
Shareholder
Information
62
franklintempleton.com
Annual
Report
business
as
evidenced
by
its
reassessment
of
the
fund
offerings
in
response
to
the
market
environment
and
project
initiatives
and
capital
investments
relating
to
the
services
provided
to
the
Funds
by
the
FT
organization.
The
Board
specifically
noted
FT’s
commitment
to
enhancing
services
and
controlling
costs,
as
reflected
in
its
outsourcing
of
certain
administrative
functions,
and
growth
opportunities,
as
evidenced
by
its
recent
acquisition
of
the
Legg
Mason
companies.
The
Board
also
noted
FT’s
attention
focused
on
expanding
the
distribution
opportunities
for
all
funds
in
the
FT
family
of
funds.
Following
consideration
of
such
information,
the
Board
was
satisfied
with
the
nature,
extent
and
quality
of
services
provided
by
the
Manager
and
its
affiliates
to
the
Funds
and
their
shareholders.
Fund
Performance
The
Board
reviewed
and
considered
the
performance
results
of
each
Fund
over
various
time
periods
ended
January
31,
2021.
The
Board
considered
the
performance
returns
for
each
Fund
in
comparison
to
the
performance
returns
of
mutual
funds
deemed
comparable
to
the
Fund
included
in
a
universe
(Performance
Universe)
selected
by
Broadridge
Financial
Solutions,
Inc.
(Broadridge),
an
independent
provider
of
investment
company
data.
The
Board
received
a
description
of
the
methodology
used
by
Broadridge
to
select
the
mutual
funds
included
in
a
Performance
Universe.
The
Board
also
reviewed
and
considered
Fund
performance
reports
provided
and
discussions
that
occurred
with
portfolio
managers
at
Board
meetings
throughout
the
year.
A
summary
of
each
Fund’s
performance
results
is
below.
Franklin
Biotechnology
Discovery
Fund
-
The
Performance
Universe
for
the
Fund
included
the
Fund
and
all
retail
and
institutional
health/biotechnology
funds.
The
Board
noted
that
the
Fund’s
annualized
total
return
for
the
three-
and
five-year
periods
was
below
the
median
of
its
Performance
Universe,
but
for
the
one-
and
10-year
periods
was
above
the
median
of
its
Performance
Universe.
The
Board
discussed
this
performance
with
management
and
management
explained
that
the
Fund
concentrates
its
investments
within
the
biotechnology
industries,
while
the
Performance
Universe
is
comprised
mostly
of
general
healthcare
funds.
Management
further
explained
that,
while
the
Fund’s
one-year
performance
was
above
the
median
of
its
Performance
Universe,
the
Fund
underperformed
other
biotechnology
funds,
noting
that
such
underperformance
was
due
to
the
Fund’s
underperformance
in
January
2021.
Management
also
explained
that
this
underperformance
was
driven
by
stock
selection
and
material
declines
in
many
of
the
Fund’s
larger
small
cap
positions,
which
drove
the
Fund’s
underperformance
over
longer-time
periods.
In
addition,
management
reviewed
with
the
Board
the
enhancements
to
the
Fund’s
investment
processes
in
an
effort
to
improve
performance.
The
Board
concluded
that
the
Fund’s
Management
Agreement
should
be
continued
for
an
additional
one-year
period,
and
management’s
efforts
should
continue
to
be
closely
monitored.
Franklin
Natural
Resources
Fund
-
The
Performance
Universe
for
the
Fund
included
the
Fund
and
all
retail
and
institutional
global
natural
resources
funds.
The
Board
noted
that
the
Fund’s
annualized
total
return
for
the
one-
,
three,
five-
and
10-year
periods
was
below
the
median
of
its
Performance
Universe.
The
Board
discussed
this
performance
with
management
and
management
explained
that
the
investments
of
the
Fund’s
peer
group
have
changed
over
the
past
two
years
as
peers
have
shifted
away
from
energy
investments
and
several
energy
focused
funds
have
closed.
Management
further
explained
that
the
Fund’s
benchmark
is
weighted
70-80%
in
energy
investments
and
that,
prior
to
the
pandemic,
the
Fund’s
portfolio
was
also
weighted
approximately
70%
in
energy
investments.
Management
also
explained
that
the
Fund
was
materially
overweight
energy
investments
versus
its
peers
and
that
this
overweight
position
adversely
impacted
the
Fund’s
relative
performance.
Management
then
discussed
with
the
Board
the
actions
that
have
been
taken
in
an
effort
to
address
the
sources
of
the
Fund’s
underperformance,
including
the
reduction
in
the
weighting
of
the
Fund’s
energy
investments
from
approximately
70%
to
60%.
The
Board
concluded
that
the
Fund’s
Management
Agreement
should
be
continued
for
an
additional
one-year
period,
and
management’s
efforts
should
continue
to
be
closely
monitored.
Comparative
Fees
and
Expenses
The
Board
reviewed
and
considered
information
regarding
each
Fund’s
actual
total
expense
ratio
and
its
various
components,
including,
as
applicable,
management
fees;
transfer
agent
expenses;
underlying
fund
expenses;
Rule
12b-1
and
non-Rule
12b-1
service
fees;
and
other
non-
management
fees.
The
Board
also
noted
the
quarterly
and
annual
reports
it
receives
on
all
marketing
support
payments
made
by
FT
to
financial
intermediaries.
The
Board
considered
the
actual
total
expense
ratio
and,
separately,
the
contractual
management
fee
rate,
without
the
effect
of
fee
waivers,
if
any
(Management
Rate)
of
each
Fund
in
comparison
to
the
median
expense
ratio
and
median
Management
Rate,
respectively,
of
other
mutual
funds
deemed
comparable
to
and
with
a
similar
expense
structure
to
the
Fund
selected
by
Broadridge
(Expense
Group).
Broadridge
fee
and
expense
data
is
based
upon
information
taken
from
each
fund’s
most
recent
annual
report,
which
reflects
historical
asset
levels
that
may
be
quite
different
from
Franklin
Strategic
Series
Shareholder
Information
63
franklintempleton.com
Annual
Report
those
currently
existing,
particularly
in
a
period
of
market
volatility.
While
recognizing
such
inherent
limitation
and
the
fact
that
expense
ratios
and
Management
Rates
generally
increase
as
assets
decline
and
decrease
as
assets
grow,
the
Board
believed
the
independent
analysis
conducted
by
Broadridge
to
be
an
appropriate
measure
of
comparative
fees
and
expenses.
The
Broadridge
Management
Rate
includes
administrative
charges,
and
the
actual
total
expense
ratio,
for
comparative
consistency,
was
shown
for
Class
A
shares
for
each
Fund
and
for
each
of
the
funds
in
each
Fund’s
respective
Expense
Group.
The
Board
received
a
description
of
the
methodology
used
by
Broadridge
to
select
the
mutual
funds
included
in
an
Expense
Group.
The
Expense
Group
for
the
Franklin
Biotechnology
Discovery
Fund
included
the
Fund
and
nine
other
health/
biotechnology
funds.
The
Expense
Group
for
the
Franklin
Natural
Resources
Fund
included
the
Fund,
five
other
global
natural
resources
funds
and
four
natural
resources
funds.
The
Board
noted
that
the
Management
Rates
and
actual
total
expense
ratios
for
the
Funds
were
below
the
medians
and
in
the
first
quintile
(least
expensive)
of
their
respective
Expense
Groups.
The
Board
concluded
that
the
Management
Rates
charged
to
the
Funds
are
reasonable.
Profitability
The
Board
reviewed
and
considered
information
regarding
the
profits
realized
by
the
Manager
and
its
affiliates
in
connection
with
the
operation
of
each
Fund.
In
this
respect,
the
Board
considered
the
Fund
profitability
analysis
provided
by
the
Manager
that
addresses
the
overall
profitability
of
FT’s
US
fund
business,
as
well
as
its
profits
in
providing
investment
management
and
other
services
to
each
of
the
individual
funds
during
the
12-month
period
ended
September
30,
2020,
being
the
most
recent
fiscal
year-
end
for
FRI.
The
Board
noted
that
although
management
continually
makes
refinements
to
its
methodologies
used
in
calculating
profitability
in
response
to
organizational
and
product-related
changes,
the
overall
methodology
has
remained
consistent
with
that
used
in
the
Funds’
profitability
report
presentations
from
prior
years.
The
Board
further
noted
management’s
representation
that
the
profitability
analysis
excluded
the
impact
of
the
recent
acquisition
of
the
Legg
Mason
companies
and
that
management
expects
to
incorporate
the
legacy
Legg
Mason
companies
into
the
profitability
analysis
beginning
next
year.
The
Board
also
noted
that
PricewaterhouseCoopers
LLP,
auditor
to
FRI
and
certain
FT
funds,
has
been
engaged
by
the
Manager
to
periodically
review
and
assess
the
allocation
methodologies
to
be
used
solely
by
the
Funds’
Board
with
respect
to
the
profitability
analysis.
The
Board
noted
management’s
belief
that
costs
incurred
in
establishing
the
infrastructure
necessary
for
the
type
of
mutual
fund
operations
conducted
by
the
Manager
and
its
affiliates
may
not
be
fully
reflected
in
the
expenses
allocated
to
each
Fund
in
determining
its
profitability,
as
well
as
the
fact
that
the
level
of
profits,
to
a
certain
extent,
reflected
operational
cost
savings
and
efficiencies
initiated
by
management.
As
part
of
this
evaluation,
the
Board
considered
management’s
outsourcing
of
certain
operations,
which
effort
has
required
considerable
up-front
expenditures
by
the
Manager
but,
over
the
long
run
is
expected
to
result
in
greater
efficiencies.
The
Board
also
noted
management’s
expenditures
in
improving
shareholder
services
provided
to
the
Funds,
as
well
as
the
need
to
implement
systems
and
meet
additional
regulatory
and
compliance
requirements
resulting
from
recent
US
Securities
and
Exchange
Commission
and
other
regulatory
requirements.
The
Board
also
considered
the
extent
to
which
the
Manager
and
its
affiliates
might
derive
ancillary
benefits
from
fund
operations,
including
revenues
generated
from
transfer
agent
services,
potential
benefits
resulting
from
personnel
and
systems
enhancements
necessitated
by
fund
growth,
as
well
as
increased
leverage
with
service
providers
and
counterparties.
Based
upon
its
consideration
of
all
these
factors,
the
Board
concluded
that
the
level
of
profits
realized
by
the
Manager
and
its
affiliates
from
providing
services
to
each
Fund
was
not
excessive
in
view
of
the
nature,
extent
and
quality
of
services
provided
to
each
Fund.
Economies
of
Scale
The
Board
reviewed
and
considered
the
extent
to
which
the
Manager
may
realize
economies
of
scale,
if
any,
as
each
Fund
grows
larger
and
whether
each
Fund’s
management
fee
structure
reflects
any
economies
of
scale
for
the
benefit
of
shareholders.
With
respect
to
possible
economies
of
scale,
the
Board
noted
the
existence
of
management
fee
breakpoints,
which
operate
generally
to
share
any
economies
of
scale
with
a
Fund’s
shareholders
by
reducing
the
Fund’s
effective
management
fees
as
the
Fund
grows
in
size.
The
Board
considered
the
Manager’s
view
that
any
analyses
of
potential
economies
of
scale
in
managing
a
particular
fund
are
inherently
limited
in
light
of
the
joint
and
common
costs
and
investments
the
Manager
incurs
across
the
FT
family
of
funds
as
a
whole.
The
Board
noted
that
the
Franklin
Natural
Resources
Fund
had
experienced
a
decrease
in
assets
and
would
not
be
expected
to
demonstrate
additional
economies
of
scale
in
the
near
term,
but
concluded
that
to
the
extent
economies
of
scale
may
be
realized
by
the
Manager
and
its
affiliates,
each
Fund’s
management
fee
structure
provided
a
sharing
of
benefits
with
the
Fund
and
its
shareholders
as
the
Fund
grows.
Franklin
Strategic
Series
Shareholder
Information
64
franklintempleton.com
Annual
Report
Conclusion
Based
on
its
review,
consideration
and
evaluation
of
all
factors
it
believed
relevant,
including
the
above-described
factors
and
conclusions,
the
Board
unanimously
approved
the
continuation
of
each
Management
Agreement
for
an
additional
one-year
period.
Proxy
Voting
Policies
and
Procedures
The
Trust’s
investment
manager
has
established
Proxy
Voting
Policies
and
Procedures
(Policies)
that
the
Trust
uses
to
determine
how
to
vote
proxies
relating
to
portfolio
securities.
Shareholders
may
view
the
Trust’s
complete
Policies
online
at
franklintempleton.com.
Alternatively,
shareholders
may
request
copies
of
the
Policies
free
of
charge
by
calling
the
Proxy
Group
collect
at
(954)
527-
7678
or
by
sending
a
written
request
to:
Franklin
Templeton
Companies,
LLC,
300
S.E.
2nd
Street,
Fort
Lauderdale,
FL
33301,
Attention:
Proxy
Group.
Copies
of
the
Trust’s
proxy
voting
records
are
also
made
available
online
at
franklintempleton.com
and
posted
on
the
U.S.
Securities
and
Exchange
Commission’s
website
at
sec.gov
and
reflect
the
most
recent
12-month
period
ended
June
30.
Quarterly
Statement
of
Investments
The
Trust
files
a
complete
statement
of
investments
with
the
U.S.
Securities
and
Exchange
Commission
for
the
first
and
third
quarters
for
each
fiscal
year
as
an
exhibit
to
its
report
on
Form
N-PORT.
Shareholders
may
view
the
filed
Form
N-PORT
by
visiting
the
Commission’s
website
at
sec.
gov.
The
filed
form
may
also
be
viewed
and
copied
at
the
Commission’s
Public
Reference
Room
in
Washington,
DC.
Information
regarding
the
operations
of
the
Public
Reference
Room
may
be
obtained
by
calling
(800)
SEC-0330.
Householding
of
Reports
and
Prospectuses
You
will
receive,
or
receive
notice
of
the
availability
of,
each
Fund’s
financial
reports
every
six
months.
In
addition,
you
will
receive
an
annual
updated
summary
prospectus
(detail
prospectus
available
upon
request).
To
reduce
Fund
expenses,
we
try
to
identify
related
shareholders
in
a
household
and
send
only
one
copy
of
the
financial
reports
(to
the
extent
received
by
mail)
and
summary
prospectus.
This
process,
called
“householding,”
will
continue
indefinitely
unless
you
instruct
us
otherwise.
If
you
prefer
not
to
have
these
documents
householded,
please
call
us
at
(800)
632-2301.
At
any
time
you
may
view
current
prospectuses/
summary
prospectuses
and
financial
reports
on
our
website.
If
you
choose,
you
may
receive
these
documents
through
electronic
delivery.
FSS2
A
06/21
©
2021
Franklin
Templeton
Investments.
All
rights
reserved.
Authorized
for
distribution
only
when
accompanied
or
preceded
by
a
summary
prospectus
and/or
prospectus.
Investors
should
carefully
consider
a
fund’s
investment
goals,
risks,
charges
and
expenses
before
investing.
A
prospectus
contains
this
and
other
information;
please
read
it
carefully
before
investing.
To
help
ensure
we
provide
you
with
quality
service,
all
calls
to
and
from
our
service
areas
are
monitored
and/or
recorded.
Annual
Report
and
Shareholder
Letter
Franklin
Strategic
Series
Investment
Manager
Distributor
Shareholder
Services
Franklin
Advisers,
Inc.
Franklin
Templeton
Distributors,
Inc.
(800)
DIAL
BEN
®
/
342-5236
franklintempleton.com
(800)
632-2301
Annual
Report
and
Shareholder
Letter
Franklin
Strategic
Income
Fund
A
Series
of
Franklin
Strategic
Series
April
30,
2021
Sign
up
for
electronic
delivery
at
franklintempleton.com/edelivery
Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
franklintempleton.com
Not
part
of
the
annual
report
1
Shareholder
Letter
Dear
Shareholder:
During
the
12
months
ended
April
30,
2021,
the
novel
coronavirus
(COVID-19)
pandemic
caused
the
U.S.
economy
to
contract
in
2020’s
first
half.
For
the
remainder
of
2020,
the
economy
recovered
substantially
based
on
increased
business
and
residential
investment
and
consumer
spending.
U.S.
economic
growth
accelerated
during
2021’s
first
quarter
as
the
reopening
of
businesses,
widespread
COVID-19
vaccinations
and
federal
assistance
programs
boosted
consumer
spending.
Before
the
reporting
period,
the
U.S.
Federal
Reserve
(Fed),
in
its
efforts
to
support
U.S.
economic
activity,
lowered
the
target
range
for
the
federal
funds
rate
twice
in
March
2020
and
implemented
broad
quantitative
easing
measures
to
support
credit
markets.
During
the
reporting
period,
the
Fed
held
the
target
range
for
its
key
rate
unchanged
at
0.00%–
0.25%,
but
it
continued
quantitative
easing
and
adjusted
its
policy
in
August
2020
to
allow
more
flexibility
to
keep
interest
rates
low,
while
maintaining
a
2%
average
inflation
target.
In
this
environment,
investment-grade
bonds,
as
measured
by
the
Bloomberg
Barclays
U.S.
Aggregate
Bond
Index,
posted
a
marginally
negative
total
return
for
the
12-month
period.
We
are
committed
to
our
long-term
perspective
and
disciplined
investment
approach
as
we
conduct
a
rigorous,
fundamental
analysis
of
securities
with
a
regular
emphasis
on
investment
risk
management.
We
believe
active,
professional
investment
management
serves
investors
well.
We
also
recognize
the
important
role
of
financial
professionals
in
today’s
markets
and
encourage
investors
to
continue
to
seek
their
advice.
Amid
changing
markets
and
economic
conditions,
we
are
confident
investors
with
a
well-diversified
portfolio
and
a
patient,
long-term
outlook
should
be
well-positioned
for
the
years
ahead.
In
addition,
Franklin
Strategic
Income
Fund’s
annual
report
includes
more
detail
about
prevailing
conditions
and
a
discussion
about
investment
decisions
during
the
period.
All
securities
markets
fluctuate,
as
do
mutual
fund
share
prices.
We
thank
you
for
investing
with
Franklin
Templeton,
welcome
your
questions
and
comments,
and
look
forward
to
serving
your
future
investment
needs.
Sincerely,
Edward
Perks,
CFA
President
and
Chief
Executive
Officer
Investment
Management
Franklin
Strategic
Series
This
letter
reflects
our
analysis
and
opinions
as
of
April
30,
2021,
unless
otherwise
indicated.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
CFA
®
is
a
trademark
owned
by
CFA
Institute.
franklintempleton.com
Annual
Report
2
Contents
Annual
Report
Franklin
Strategic
Income
Fund
3
Performance
Summary
6
Your
Fund’s
Expenses
9
Consolidated
Financial
Highlights
and
Statement
of
Investments
10
Consolidated
Financial
Statements
40
Notes
to
Consolidated
Financial
Statements
45
Report
of
Independent
Registered
Public
Accounting
Firm
68
Board
Members
and
Officers
69
Shareholder
Information
74
Visit
franklintempleton.com
for
fund
updates,
to
access
your
account,
or
to
find
helpful
financial
planning
tools.
3
franklintempleton.com
Annual
Report
ANNUAL
REPORT
Franklin
Strategic
Income
Fund
This
annual
report
for
Franklin
Strategic
Income
Fund
covers
the
fiscal
year
ended
April
30,
2021.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
to
earn
a
high
level
of
current
income.
A
secondary
goal
is
capital
appreciation
over
the
long
term.
The
Fund
uses
an
active
asset
allocation
process
and
under
normal
market
conditions
invests
at
least
65%
of
its
assets
in
U.S.
and
foreign
debt
securities,
including
those
in
emerging
markets.
The
Fund
may
invest
in
all
varieties
of
fixed,
variable
and
floating
rate
income
securities,
including
bonds,
U.S.
and
foreign
government
and
agency
securities,
corporate
loans
(and
loan
participations),
mortgage-backed
securities
and
other
asset-backed
securities.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+13.05%
cumulative
total
return
for
the
12
months
under
review.
In
comparison,
the
Bloomberg
Barclays
U.S.
Aggregate
Bond
Index,
which
represents
the
U.S.
investment-grade
fixed
rate
taxable
bond
market,
posted
a
-0.27%
total
return.
1
The
Lipper
Multi-Sector
Income
Funds
Classification
Average,
which
consists
of
funds
chosen
by
Lipper
that
seek
current
income
by
allocating
assets
among
different
fixed
income
securities
sectors,
with
a
significant
portion
rated
below
investment
grade,
posted
a
+12.48%
total
return.
2
You
can
find
more
of
the
Fund’s
performance
data
in
the
Performance
Summary
beginning
on
page
6
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236.
Economic
and
Market
Overview
The
U.S.
bond
market,
as
measured
by
the
Bloomberg
Barclays
U.S.
Aggregate
Bond
Index,
posted
marginally
negative
total
returns
during
the
12
months
ended
April
30,
2021.
The
period
began
during
the
early
stage
of
the
economic
and
social
disruption
that
came
in
the
wake
of
the
novel
coronavirus
(COVID-19)
pandemic,
which
significantly
impacted
U.S.
bond
markets.
Throughout
the
12-month
period,
as
the
U.S.
economy
adapted
to
the
pandemic,
investor
appetite
for
risk
increased.
Consequently,
lower-rated
bonds
posted
significantly
greater
returns
than
higher-rated
bonds.
In
early
2021,
the
implementation
of
mass
vaccination
programs
alongside
improving
economic
indicators
prompted
investors
to
anticipate
that
increased
inflation
would
lead
to
higher
interest
rates.
The
U.S.
Federal
Reserve
(Fed)
maintained
the
federal
funds
target
rate
at
a
range
of
0.00%–0.25%
and
continued
its
program
of
open-ended
purchasing
of
government-
backed
and
corporate
bonds
as
necessary
to
provide
liquidity
to
bond
markets.
Furthermore,
the
Fed
signaled
that
interest
rates
would
potentially
remain
low,
even
if
inflation
moderately
exceeded
the
Fed’s
2%
target
for
some
time.
U.S.
Treasury
bonds,
as
measured
by
the
Bloomberg
Barclays
U.S.
Treasury
Index,
posted
negative
total
returns
during
the
period.
The
10-year
U.S.
Treasury
yield
(which
moves
inversely
to
price)
was
at
or
near
all-time
lows
for
much
of
the
reporting
period’s
first
half.
However,
yields
rose
thereafter,
as
renewed
economic
strength
prompted
many
investors
to
increase
their
inflation
expectations.
Mortgage-
backed
securities
(MBS),
as
measured
by
the
Bloomberg
Barclays
MBS
Index,
posted
marginally
negative
total
returns
for
the
period
despite
Fed
support,
as
low
interest
rates
accelerated
prepayments
from
mortgage
refinancing,
which
weighed
on
MBS
returns.
Fed
action
was
a
catalyst
for
the
recovery
in
the
corporate
bond
market,
which
advanced
overall
but
varied
significantly
based
on
credit
rating.
The
strengthening
economy
and
prospect
of
a
return
to
normal
conditions
tempered
concerns
about
credit
quality,
which
benefited
lower-rated
bonds.
Consequently,
high-yield
corporate
bonds,
as
represented
by
the
Bloomberg
Barclays
U.S.
Corporate
High
Yield
Bond
Index,
posted
strong
total
returns,
outpacing
investment-
1.
Source:
Morningstar.
2.
Source:
Lipper,
a
Thomson
Reuters
Company.
For
the
12-month
period
ended
4/30/21,
this
category
consisted
of
348
funds.
Lipper
calculations
do
not
include
sales
charges
or
expense
subsidization
by
a
fund’s
manager.
Fund
performance
relative
to
the
average
may
have
differed
if
these
or
other
factors
had
been
considered.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
15
.
Franklin
Strategic
Income
Fund
4
franklintempleton.com
Annual
Report
grade
corporate
bonds,
as
represented
by
the
Bloomberg
Barclays
U.S.
Corporate
Bond
Index,
which
nevertheless
posted
positive
total
returns.
Investment
Strategy
We
use
an
active
asset
allocation
strategy
to
try
to
achieve
the
Fund’s
investment
goals.
We
employ
a
top-down
analysis
of
macroeconomic
trends
combined
with
a
bottom-
up
fundamental
analysis
of
market
sectors,
industries
and
issuers
to
try
to
take
advantage
of
varying
sector
reactions
to
economic
events.
We
regularly
enter
into
various
currency-
related
transactions
involving
derivative
instruments,
including
currency
and
cross
currency
forwards,
currency
swaps,
currency
and
currency
index
futures
contracts
and
currency
options.
We
may
also
enter
into
interest-rate
and
credit-related
transactions
involving
derivative
instruments,
including
interest-rate,
fixed
income
total
return
and
credit
default
swaps
and
interest
rate
and/or
bond
futures
contracts.
Manager’s
Discussion
Financial
markets
experienced
a
significant
turnaround
over
the
12-month
reporting
period.
While
the
market
rebound
persisted
throughout
the
period,
the
pace
of
the
recovery
was
impacted
at
times
due
to
various
influences,
from
a
resurgence
of
COVID-19
cases
in
the
U.S.
to
fiscal
uncertainty
over
the
size
and
scope
of
stimulus
measures.
The
Fed
serving
as
a
sizable
and
consistent
backstop
for
credit
markets,
and
as
a
source
of
significant
monetary
and
fiscal
stimulus,
generally
bolstered
investor
confidence.
Against
this
backdrop,
fixed
income
total
return
performance
was
mixed.
However,
all
fixed
income
markets
posted
positive
excess
returns
over
the
period
and
outperformed
U.S.
Treasuries
(USTs).
High-yield
corporate
credit
(HY),
non-agency
residential
mortgage-backed
securities
(RMBS)
and
emerging
market
bonds
were
the
top
performers
on
an
excess
return
basis.
Additionally,
fixed
income
spreads
tightened
across
asset
classes
over
the
period.
While
portfolio
positioning
was
diversified
from
a
risk
perspective,
the
Fund’s
largest
allocation
was
in
corporate
credit—inclusive
of
HY
and
investment-grade
corporate
credit
(IG),
senior
secured
floating-rate
bank
loans
and
collateralized
loan
obligations
(CLOs)—with
a
majority
of
credit
exposure
in
HY
corporate
securities.
We
remain
constructive
on
the
HY
asset
class
and
added
to
the
sector
over
the
reporting
period.
While
we
remained
generally
comfortable
with
IG
fundamentals
and
market
technical
conditions,
given
tighter
valuations,
the
portfolio
decreased
allocation
over
the
period
and
held
an
underweighted
allocation
to
the
sector
relative
to
the
benchmark.
We
also
pared
our
allocations
to
senior
secured
floating-rate
bank
loans
and
CLOs
and
increased
our
exposures
to
USTs
and
sovereign
developed
securities.
During
the
period,
our
allocation
to
corporate
credit,
inclusive
of
HY,
IG,
CLOs
and
senior
secured
floating-rate
bank
loans,
was
the
most
significant
contributor
to
performance,
primarily
from
HY
allocation.
Sovereign
emerging
markets
securities
and
RMBS
allocations
also
contributed
to
Fund
performance.
In
contrast,
foreign
currency
exposure
detracted
from
performance,
as
gains
mainly
from
our
long
South
African
rand
and
Mexican
peso
positions
were
offset
by
negative
returns
mainly
from
our
Australian
dollar,
euro
and
short
Canadian
dollar
positions.
Over
the
period,
we
moved
from
short
to
long
positions
on
the
Australian
dollar
and
the
euro
and
exited
the
South
African
rand
exposure.
Thank
you
for
your
participation
in
Franklin
Strategic
Income
Fund.
We
look
forward
to
continuing
to
serve
your
investment
needs.
Sonal
Desai,
Ph.D.
Patricia
O’Connor,
CFA
William
Chong,
CFA,
FRM
David
Yuen,
CFA,
FRM
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
April
30,
2021,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
Portfolio
Composition
4/30/21
%
of
Total
Net
Assets
Corporate
Bonds
48.9%
Foreign
Government
and
Agency
Securities
15.3%
Residential
Mortgage-Backed
Securities
8.7%
Asset-Backed
Securities
8.3%
Management
Investment
Companies
7.8%
Mortgage-Backed
Securities
3.1%
U.S.
Government
and
Agency
Securities
2.9%
Municipal
Bonds
2.1%
Senior
Floating
Rate
Interests
1.2%
Other
0.9%
Short-Term
Investments
&
Other
Net
Assets
0.8%
Franklin
Strategic
Income
Fund
5
franklintempleton.com
Annual
Report
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Performance
Summary
as
of
April
30,
2021
Franklin
Strategic
Income
Fund
6
franklintempleton.com
Annual
Report
The
performance
tables
and
graphs
do
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
4/30/21
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
3.75%
and
the
minimum
is
0%.
Class
A:
3.75%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
1-Year
+13.05%
+8.79%
5-Year
+20.53%
+3.02%
10-Year
+38.09%
+2.88%
Advisor
1-Year
+13.32%
+13.32%
5-Year
+22.02%
+4.06%
10-Year
+41.53%
+3.53%
30-Day
Standardized
Yield
6
Share
Class
Distribution
Rate
5
(with
fee
waiver)
(without
fee
waiver)
A
3.58%
2.53%
2.49%
Advisor
3.96%
2.87%
2.83%
See
page
8
for
Performance
Summary
footnotes.
Franklin
Strategic
Income
Fund
Performance
Summary
7
franklintempleton.com
Annual
Report
See
Page
8
for
Performance
Summary
footnotes.
Total
Return
Index
Comparison
for
a
Hypothetical
$10,000
Investment
1
Total
return
represents
the
change
in
value
of
an
investment
over
the
periods
shown.
It
includes
any
applicable
maximum
sales
charge,
Fund
expenses,
account
fees
and
reinvested
distributions.
The
unmanaged
indexes
include
reinvestment
of
any
income
or
distributions.
They
differ
from
the
Fund
in
composition
and
do
not
pay
management
fees
or
expenses.
One
cannot
invest
directly
in
an
index.
Class
A
(5/1/11–4/30/21)
Advisor
Class
(5/1/11–4/30/21)
Franklin
Strategic
Income
Fund
Performance
Summary
8
franklintempleton.com
Annual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Bond
prices
generally
move
in
the
opposite
direction
of
interest
rates.
Thus,
as
prices
of
bonds
in
the
Fund
adjust
to
a
rise
in
interest
rates,
the
Fund’s
share
price
may
decline.
Changes
in
the
financial
strength
of
a
bond
issuer
or
in
a
bond’s
credit
rating
may
affect
its
value.
High
yields
reflect
the
higher
credit
risks
associated
with
certain
lower-rated
securities
held
in
the
portfolio.
Floating-rate
loans
and
high-yield
corporate
bonds
are
rated
below
investment
grade
and
are
subject
to
greater
risk
of
default,
which
could
result
in
loss
of
principal—a
risk
that
may
be
heightened
in
a
slowing
economy.
The
risks
of
foreign
securities
include
currency
fluctuations
and
political
uncertainty.
Investments
in
developing
markets
involve
heightened
risks
related
to
the
same
factors,
in
addition
to
those
associated
with
their
relatively
small
size
and
lesser
liquidity.
Investing
in
derivative
securities
and
the
use
of
foreign
currency
techniques
involve
special
risks
as
such
may
not
achieve
the
anticipated
benefits
and/or
may
result
in
losses
to
the
Fund.
Events
such
as
the
spread
of
deadly
diseases,
disasters,
and
financial,
political
or
social
disruptions,
may
heighten
risks
and
adversely
affect
perfor-
mance.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
waiver,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
3/1/19,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
4.25%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
3.75%.
5.
Distribution
rate
is
based
on
the
sum
of
the
respective
class’s
dividend
distributions
over
the
past
12
months
and
the
maximum
offering
price
(NAV
for
Advisor
Class)
per
share
on
4/30/21.
6.
The
Fund’s
30-day
standardized
yield
is
calculated
over
a
trailing
30-day
period
using
the
yield
to
maturity
on
bonds
and/or
the
dividends
accrued
on
stocks.
It
may
not
equal
the
Fund’s
actual
income
distribution
rate,
which
reflects
the
Fund’s
past
dividends
paid
to
shareholders.
7.
Source:
Morningstar.
The
Bloomberg
Barclays
U.S.
Aggregate
Bond
Index
measures
the
investment-grade,
U.S.
dollar-denominated,
fixed-rate
taxable
bond
market.
The
index
includes
Treasuries,
government-related
and
corporate
securities,
mortgage-backed
securities
(agency
fixed-rate
and
hybrid
adjustable-rate
mortgage
pass-throughs),
asset-backed
securities
and
commercial
mortgage-backed
securities
(agency
and
nonagency).
8.
Source:
Lipper,
a
Thomson
Reuters
Company.
The
Lipper
Multi-Sector
Income
Funds
Classification
Average
is
calculated
by
averaging
the
total
returns
of
all
funds
within
the
Lipper
Multi-Sector
Income
Funds
classification
in
the
Lipper
Open-End
underlying
funds
universe.
Lipper
Multi-Sector
Income
Funds
are
defined
as
funds
that
seek
current
income
by
allocating
assets
among
different
fixed
income
securities
sectors
(not
primarily
in
one
sector
except
for
defensive
purposes),
including
U.S.
and
foreign
governments,
with
a
significant
portion
rated
below
investment
grade.
For
the
12-month
period
ended
4/30/21,
there
were
348
funds
in
this
category.
Lipper
calculations
do
not
include
sales
charges,
but
include
reinvestment
of
any
income
or
distributions.
Fund
performance
relative
to
the
average
may
have
differed
if
these
and
other
factors
had
been
considered.
9.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Consolidated
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Distributions
(5/1/20–4/30/21)
Share
Class
Net
Investment
Income
A
$0.3509
C
$0.3115
R
$0.3273
R6
$0.3849
Advisor
$0.3740
Total
Annual
Operating
Expenses
9
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
0.88%
0.90%
Advisor
0.63%
0.65%
Your
Fund’s
Expenses
Franklin
Strategic
Income
Fund
9
franklintempleton.com
Annual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6
).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
181/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
11/1/20
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,
2
Ending
Account
Value
4/30/21
Expenses
Paid
During
Period
11/1/20–4/30/21
1,
2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,043.10
$4.37
$1,020.52
$4.32
0.86%
C
$1,000
$1,040.96
$6.41
$1,018.51
$6.34
1.27%
R
$1,000
$1,041.98
$5.63
$1,019.28
$5.57
1.11%
R6
$1,000
$1,044.86
$2.46
$1,022.39
$2.43
0.48%
Advisor
$1,000
$1,044.32
$3.12
$1,021.74
$3.08
0.62%
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
10
2
a
Year
Ended
April
30,
2021*
2020
2019
2018
2017
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.67
$9.61
$9.61
$9.84
$9.32
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.37
0.38
0.42
0.39
0.39
Net
realized
and
unrealized
gains
(losses)
...........
0.75
(0.90)
c
(0.32)
0.30
Total
from
investment
operations
....................
1.12
(0.52)
0.42
0.07
0.69
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
..
(0.35)
(0.42)
(0.42)
(0.30)
(0.17)
Net
asset
value,
end
of
year
.......................
$9.44
$8.67
$9.61
$9.61
$9.84
Total
return
d
...................................
13.05%
(5.72)%
4.52%
0.64%
7.50%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.88%
0.88%
0.89%
0.90%
0.88%
Expenses
net
of
waiver
and
payments
by
affiliates
e
......
0.86%
0.86%
0.84%
0.85%
0.82%
Net
investment
income
...........................
3.93%
4.01%
4.39%
3.93%
4.08%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$2,862,068
$2,686,523
$3,131,799
$3,291,002
$3,833,786
Portfolio
turnover
rate
............................
111.72%
f
118.64%
116.21%
f
115.94%
140.83%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
g
....
54.21%
f
86.69%
39.01%
f
47.40%
87.33%
*
Includes
the
consolidated
operations
of
FT
Holdings
Corporation
II
from
May
1,
2020
through
April
27,
2021.
See
Note
1(h).
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Consolidated
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Amount
rounds
to
less
than
$0.01
per
share.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
12.
g
See
Note
1
(
j
)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
Annual
Report
11
a
Year
Ended
April
30,
2021*
2020
2019
2018
2017
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.67
$9.61
$9.60
$9.84
$9.31
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.33
0.34
0.38
0.35
0.35
Net
realized
and
unrealized
gains
(losses)
...........
0.75
(0.90)
0.01
(0.33)
0.31
Total
from
investment
operations
....................
1.08
(0.56)
0.39
0.02
0.66
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
..
(0.31)
(0.38)
(0.38)
(0.26)
(0.13)
Net
asset
value,
end
of
year
.......................
$9.44
$8.67
$9.61
$9.60
$9.84
Total
return
c
...................................
12.58%
(6.11)%
4.19%
0.14%
7.19%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.28%
1.28%
1.29%
1.30%
1.28%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
1.26%
1.26%
1.24%
1.25%
1.22%
Net
investment
income
...........................
3.51%
3.61%
3.99%
3.53%
3.68%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$387,589
$518,795
$716,327
$1,078,890
$1,385,981
Portfolio
turnover
rate
............................
111.72%
e
118.64%
116.21%
e
115.94%
140.83%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
f
....
54.21%
e
86.69%
39.01%
e
47.40%
87.33%
*
Includes
the
consolidated
operations
of
FT
Holdings
Corporation
II
from
May
1,
2020
through
April
27,
2021.
See
Note
1(h).
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Consolidated
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
12.
f
See
Note
1
(
j
)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
12
a
Year
Ended
April
30,
2021*
2020
2019
2018
2017
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.63
$9.57
$9.57
$9.81
$9.28
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.34
0.36
0.39
0.36
0.37
Net
realized
and
unrealized
gains
(losses)
...........
0.76
(0.91)
0.01
(0.33)
0.31
Total
from
investment
operations
....................
1.10
(0.55)
0.40
0.03
0.68
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
..
(0.33)
(0.39)
(0.40)
(0.27)
(0.15)
Net
asset
value,
end
of
year
.......................
$9.40
$8.63
$9.57
$9.57
$9.81
Total
return
....................................
12.83%
(5.98)%
4.28%
0.29%
7.38%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.13%
1.13%
1.14%
1.15%
1.13%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
1.11%
1.11%
1.09%
1.10%
1.07%
Net
investment
income
...........................
3.68%
3.76%
4.14%
3.68%
3.83%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$59,366
$62,063
$85,458
$105,692
$146,552
Portfolio
turnover
rate
............................
111.72%
d
118.64%
116.21%
d
115.94%
140.83%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
e
....
54.21%
d
86.69%
39.01%
d
47.40%
87.33%
*
Includes
the
consolidated
operations
of
FT
Holdings
Corporation
II
from
May
1,
2020
through
April
27,
2021.
See
Note
1(h).
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Consolidated
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
12.
e
See
Note
1
(
j
)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
Annual
Report
13
a
Year
Ended
April
30,
2021*
2020
2019
2018
2017
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.68
$9.63
$9.62
$9.86
$9.33
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.40
0.43
0.45
0.43
0.43
Net
realized
and
unrealized
gains
(losses)
...........
0.75
(0.93)
0.02
(0.34)
0.31
Total
from
investment
operations
....................
1.15
(0.50)
0.47
0.09
0.74
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
..
(0.38)
(0.45)
(0.46)
(0.33)
(0.21)
Net
asset
value,
end
of
year
.......................
$9.45
$8.68
$9.63
$9.62
$9.86
Total
return
....................................
13.45%
(5.46)%
5.03%
0.95%
8.03%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.54%
0.52%
0.51%
0.50%
0.48%
Expenses
net
of
waiver
and
payments
by
affiliates
c
......
0.50%
0.49%
0.45%
0.45%
0.42%
Net
investment
income
...........................
4.30%
4.38%
4.78%
4.33%
4.48%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$132,736
$133,575
$307,287
$433,068
$369,106
Portfolio
turnover
rate
............................
111.72%
d
118.64%
116.21%
d
115.94%
140.83%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
e
....
54.21%
d
86.69%
39.01%
d
47.40%
87.33%
*
Includes
the
consolidated
operations
of
FT
Holdings
Corporation
II
from
May
1,
2020
through
April
27,
2021.
See
Note
1(h).
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Consolidated
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
12.
e
See
Note
1
(
j
)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
14
a
Year
Ended
April
30,
2021*
2020
2019
2018
2017
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.68
$9.62
$9.62
$9.85
$9.33
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.39
0.40
0.44
0.41
0.42
Net
realized
and
unrealized
gains
(losses)
...........
0.75
(0.90)
c
(0.32)
0.30
Total
from
investment
operations
....................
1.14
(0.50)
0.44
0.09
0.72
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
..
(0.37)
(0.44)
(0.44)
(0.32)
(0.20)
Net
asset
value,
end
of
year
.......................
$9.45
$8.68
$9.62
$9.62
$9.85
Total
return
....................................
13.32%
(5.47)%
4.88%
0.79%
7.76%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.63%
0.63%
0.64%
0.65%
0.63%
Expenses
net
of
waiver
and
payments
by
affiliates
d
......
0.61%
0.61%
0.59%
0.60%
0.57%
Net
investment
income
...........................
4.18%
4.26%
4.64%
4.18%
4.33%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$462,624
$517,522
$608,317
$933,747
$1,070,103
Portfolio
turnover
rate
............................
111.72%
e
118.64%
116.21%
e
115.94%
140.83%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
f
....
54.21%
e
86.69%
39.01%
e
47.40%
87.33%
*
Includes
the
consolidated
operations
of
FT
Holdings
Corporation
II
from
May
1,
2020
through
April
27,
2021.
See
Note
1(h).
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Consolidated
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Amount
rounds
to
less
than
$0.01
per
share.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
12.
f
See
Note
1
(
j
)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Statement
of
Investments,
April
30,
2021
Franklin
Strategic
Income
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
15
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
0.3%
Energy
Equipment
&
Services
0.1%
a
Weatherford
International
plc
.............................
United
States
151,545
$
1,606,377
Machinery
0.1%
a
Birch
Permian
Holdings,
Inc.
.............................
United
States
406,124
5,234,619
Media
0.1%
a
Clear
Channel
Outdoor
Holdings,
Inc.
......................
United
States
285,564
716,766
a
iHeartMedia,
Inc.,
A
....................................
United
States
115,085
2,202,727
a,b
iHeartMedia,
Inc.,
B
...................................
United
States
1,941
34,550
2,954,043
Multiline
Retail
0.0%
a,b,c
K2016470219
South
Africa
Ltd.,
A
.........................
South
Africa
125,940,079
a,b,c
K2016470219
South
Africa
Ltd.,
B
.........................
South
Africa
12,532,821
Oil,
Gas
&
Consumable
Fuels
0.0%
a
Amplify
Energy
Corp.
..................................
United
States
5,288
14,119
a,b
Riviera
Resources,
Inc.
.................................
United
States
84,462
21,816
35,935
Paper
&
Forest
Products
0.0%
Verso
Corp.,
A
........................................
United
States
38,905
600,693
Specialty
Retail
0.0%
a
Party
City
Holdco,
Inc.
..................................
United
States
117,385
821,695
Total
Common
Stocks
(Cost
$24,518,034)
......................................
11,253,362
Management
Investment
Companies
7.8%
Capital
Markets
7.8%
d
Franklin
Floating
Rate
Income
Fund
.......................
United
States
34,705,988
269,318,469
Invesco
Senior
Loan
ETF
...............................
United
States
1,562,500
34,609,375
303,927,844
Total
Management
Investment
Companies
(Cost
$376,927,715)
...................
303,927,844
Warrants
Warrants
0.0%
Oil,
Gas
&
Consumable
Fuels
0.0%
a,b
Battalion
Oil
Corp.,
A,
10/08/22
...........................
United
States
10,639
1,017
a,b
Battalion
Oil
Corp.,
B,
10/08/22
...........................
United
States
13,300
603
a,b
Battalion
Oil
Corp.,
C,
10/08/22
...........................
United
States
17,100
282
a,b
Chaparral
Energy,
Inc.,
10/01/24
..........................
United
States
18
1,902
Paper
&
Forest
Products
0.0%
a
Verso
Corp.,
7/25/23
...................................
United
States
4,095
9,623
Software
0.0%
a,b
WorkCapital
BSD
SARL,
2/13/26
..........................
Brazil
6,000,000
Total
Warrants
(Cost
$750,000)
................................................
11,525
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
16
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Convertible
Bonds
0.0%
Wireless
Telecommunication
Services
0.0%
e,f,g
Digicel
Group
Holdings
Ltd.
,
Sub.
Bond
,
144A,
PIK,
7
%
,
Perpetual
Bermuda
620,300
$
456,954
Total
Convertible
Bonds
(Cost
$130,626)
.......................................
456,954
Corporate
Bonds
48.9%
Aerospace
&
Defense
0.7%
Boeing
Co.
(The)
,
Senior
Note
,
2.196
%
,
2/04/26
..............
United
States
9,500,000
9,518,935
g
TransDigm,
Inc.
,
Senior
Secured
Note
,
144A,
6.25
%
,
3/15/26
....
United
States
15,000,000
15,900,000
25,418,935
Air
Freight
&
Logistics
0.5%
g
DAE
Funding
LLC
,
Senior
Note,
144A,
4.5%,
8/01/22
.......................
United
Arab
Emirates
2,000,000
2,009,710
Senior
Note,
144A,
5%,
8/01/24
........................
United
Arab
Emirates
14,000,000
14,393,750
FedEx
Corp.
,
Senior
Bond
,
4.05
%
,
2/15/48
..................
United
States
1,200,000
1,307,643
17,711,103
Airlines
1.0%
g
American
Airlines
Inc/AAdvantage
Loyalty
IP
Ltd.
,
Senior
Secured
Note
,
144A,
5.75
%
,
4/20/29
............................
United
States
5,900,000
6,329,225
Delta
Air
Lines,
Inc.
,
Senior
Note
,
2.9
%
,
10/28/24
.............
United
States
8,100,000
8,175,550
g
Delta
Air
Lines,
Inc.
/
SkyMiles
IP
Ltd.
,
Senior
Secured
Note
,
144A,
4.5
%
,
10/20/25
.....................................
United
States
10,400,000
11,160,244
g
Hawaiian
Brand
Intellectual
Property
Ltd.
/
HawaiianMiles
Loyalty
Ltd.
,
Senior
Secured
Note
,
144A,
5.75
%
,
1/20/26
............
United
States
8,300,000
8,777,250
United
Airlines
Holdings,
Inc.
,
Senior
Note
,
5
%
,
2/01/24
.........
United
States
4,200,000
4,326,000
g
United
Airlines,
Inc.
,
Senior
Secured
Note
,
144A,
4.375
%
,
4/15/26
.
United
States
1,700,000
1,766,249
40,534,518
Auto
Components
1.0%
g
Allison
Transmission,
Inc.
,
Senior
Bond,
144A,
5.875%,
6/01/29
.....................
United
States
7,000,000
7,577,500
Senior
Bond,
144A,
3.75%,
1/30/31
......................
United
States
6,700,000
6,473,875
Dana,
Inc.
,
Senior
Note
,
5.625
%
,
6/15/28
...................
United
States
12,400,000
13,376,500
Goodyear
Tire
&
Rubber
Co.
(The)
,
Senior
Bond
,
4.875
%
,
3/15/27
United
States
13,000,000
13,603,200
41,031,075
Banks
1.7%
g
Akbank
TAS
,
Senior
Bond,
144A,
5.125%,
3/31/25
.....................
Turkey
12,400,000
12,375,113
Senior
Note,
144A,
6.8%,
2/06/26
.......................
Turkey
3,200,000
3,322,125
Banco
Santander
SA
,
Sub.
Bond
,
2.749
%
,
12/03/30
...........
Spain
3,000,000
2,916,960
Bank
of
America
Corp.
,
Senior
Bond
,
3.248
%
,
10/21/27
.........
United
States
5,000,000
5,429,330
g
China
Construction
Bank
Corp.
,
Sub.
Bond
,
Reg
S,
4.25%
to
2/27/24,
FRN
thereafter
,
2/27/29
........................
China
8,000,000
8,587,023
f
Comerica,
Inc.
,
Junior
Sub.
Bond
,
5.625%
to
10/01/25,
FRN
thereafter
,
Perpetual
.................................
United
States
3,000,000
3,341,250
HSBC
Holdings
plc
,
Senior
Bond
,
2.848%
to
6/04/30,
FRN
thereafter
,
6/04/31
...........................................
United
Kingdom
8,300,000
8,392,450
Industrial
&
Commercial
Bank
of
China
Ltd.
,
Senior
Bond
,
3.538
%
,
11/08/27
..........................................
China
8,500,000
9,393,180
JPMorgan
Chase
&
Co.
,
Senior
Bond
,
2.522%
to
4/22/30,
FRN
thereafter
,
4/22/31
...................................
United
States
9,400,000
9,504,572
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
17
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Banks
(continued)
g
Akbank
TAS,
(continued)
Lloyds
Banking
Group
plc
,
Senior
Note
,
3.87%
to
7/09/24,
FRN
thereafter
,
7/09/25
...................................
United
Kingdom
1,600,000
$
1,741,050
SVB
Financial
Group
,
Senior
Bond
,
3.125
%
,
6/05/30
...........
United
States
2,700,000
2,835,032
67,838,085
Beverages
0.5%
Anheuser-Busch
InBev
Worldwide,
Inc.
,
Senior
Bond
,
3.5
%
,
6/01/30
Belgium
10,000,000
10,926,406
g
Primo
Water
Holdings,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
4/30/29
..
Canada
6,700,000
6,693,702
17,620,108
Biotechnology
0.2%
AbbVie,
Inc.
,
Senior
Note
,
3.2
%
,
11/21/29
...................
United
States
6,000,000
6,419,106
Building
Products
0.5%
Carrier
Global
Corp.
,
Senior
Note
,
2.722
%
,
2/15/30
............
United
States
16,000,000
16,305,161
Owens
Corning
,
Senior
Bond
,
4.3
%
,
7/15/47
.................
United
States
2,000,000
2,245,940
18,551,101
Capital
Markets
0.8%
Goldman
Sachs
Group,
Inc.
(The)
,
Senior
Bond
,
3.75
%
,
2/25/26
..
United
States
8,500,000
9,449,067
Morgan
Stanley
,
Senior
Bond,
3.875%,
1/27/26
..........................
United
States
10,000,000
11,157,322
Senior
Bond,
3.591%
to
7/22/27,
FRN
thereafter,
7/22/28
.....
United
States
10,000,000
11,013,686
31,620,075
Chemicals
2.9%
g
Alpek
SAB
de
CV
,
Senior
Bond
,
144A,
4.25
%
,
9/18/29
.........
Mexico
8,000,000
8,487,600
g
Axalta
Coating
Systems
LLC
,
Senior
Note
,
144A,
3.375
%
,
2/15/29
United
States
10,150,000
9,876,102
g
Braskem
Netherlands
Finance
BV
,
Senior
Bond
,
144A,
4.5
%
,
1/31/30
...........................................
Brazil
15,600,000
15,872,220
g
CNAC
HK
Finbridge
Co.
Ltd.
,
Senior
Note
,
Reg
S,
4.875
%
,
3/14/25
China
7,800,000
8,328,049
g
Element
Solutions,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
9/01/28
.....
United
States
10,000,000
9,987,550
g
Gates
Global
LLC
/
Gates
Corp.
,
Senior
Note
,
144A,
6.25
%
,
1/15/26
United
States
12,500,000
13,107,875
g
GPD
Cos.,
Inc.
,
Senior
Secured
Note
,
144A,
10.125
%
,
4/01/26
...
United
States
5,000,000
5,468,750
HB
Fuller
Co.
,
Senior
Note
,
4.25
%
,
10/15/28
.................
United
States
5,000,000
5,097,925
g
Ingevity
Corp.
,
Senior
Note
,
144A,
3.875
%
,
11/01/28
...........
United
States
3,900,000
3,889,919
Methanex
Corp.
,
Senior
Note
,
5.125
%
,
10/15/27
..............
Canada
5,000,000
5,286,400
g
SABIC
Capital
II
BV
,
Senior
Bond
,
144A,
4.5
%
,
10/10/28
........
Saudi
Arabia
5,500,000
6,301,845
g
SCIH
Salt
Holdings,
Inc.
,
Senior
Note,
144A,
6.625%,
5/01/29
.....................
United
States
4,200,000
4,137,000
Senior
Secured
Note,
144A,
4.875%,
5/01/28
..............
United
States
3,100,000
3,096,125
g
Syngenta
Finance
NV
,
Senior
Note
,
144A,
4.892
%
,
4/24/25
......
Switzerland
8,000,000
8,676,604
Westlake
Chemical
Corp.
,
Senior
Bond
,
3.375
%
,
6/15/30
.......
United
States
2,500,000
2,626,102
g
Yara
International
ASA
,
Senior
Bond
,
144A,
3.148
%
,
6/04/30
.....
Brazil
1,400,000
1,465,502
111,705,568
Commercial
Services
&
Supplies
0.3%
g
Prime
Security
Services
Borrower
LLC
/
Prime
Finance,
Inc.
,
Senior
Secured
Note
,
144A,
3.375
%
,
8/31/27
....................
United
States
13,000,000
12,577,500
Communications
Equipment
0.3%
g
CommScope
Technologies
LLC
,
Senior
Bond
,
144A,
6
%
,
6/15/25
.
United
States
12,652,000
12,889,225
Construction
&
Engineering
0.1%
g
Arcosa,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
4/15/29
.............
United
States
2,600,000
2,662,296
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
18
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Construction
&
Engineering
(continued)
g
Rutas
2
and
7
Finance
Ltd.
,
Senior
Secured
Bond
,
144A,
Zero
Cpn.,
9/30/36
...........................................
United
States
1,200,000
$
856,500
3,518,796
Consumer
Finance
0.7%
g
FirstCash,
Inc.
,
Senior
Note
,
144A,
4.625
%
,
9/01/28
...........
United
States
12,700,000
13,066,458
OneMain
Finance
Corp.
,
Senior
Bond,
5.375%,
11/15/29
.........................
United
States
3,300,000
3,565,667
Senior
Note,
6.625%,
1/15/28
..........................
United
States
5,700,000
6,496,176
Senior
Note,
4%,
9/15/30
.............................
United
States
5,000,000
4,843,750
27,972,051
Containers
&
Packaging
1.7%
g
Ardagh
Metal
Packaging
Finance
USA
LLC
/
Ardagh
Metal
Packaging
Finance
plc
,
Senior
Note
,
144A,
4
%
,
9/01/29
.......
United
States
5,800,000
5,781,962
g
Ardagh
Packaging
Finance
plc
/
Ardagh
Holdings
USA,
Inc.
,
Senior
Note,
144A,
6%,
2/15/25
........................
United
States
3,167,000
3,270,782
Senior
Note,
144A,
5.25%,
8/15/27
......................
United
States
3,700,000
3,786,343
Crown
Americas
LLC
/
Crown
Americas
Capital
Corp.
VI
,
Senior
Note
,
4.75
%
,
2/01/26
.................................
United
States
7,100,000
7,378,675
g
Mauser
Packaging
Solutions
Holding
Co.
,
Senior
Note
,
144A,
7.25
%
,
4/15/25
...........................................
United
States
15,000,000
14,606,250
g
Owens-Brockway
Glass
Container,
Inc.
,
Senior
Note
,
144A,
5.875
%
,
8/15/23
...........................................
United
States
10,000,000
10,837,500
g
Reynolds
Group
Issuer,
Inc.
/
Reynolds
Group
Issuer
LLC
/
Reynolds
Group
Issuer
Luxembourg
SA
,
Senior
Secured
Note
,
144A,
4
%
,
10/15/27
..........................................
United
States
4,600,000
4,554,138
g
Sealed
Air
Corp.
,
Senior
Bond
,
144A,
5.125
%
,
12/01/24
........
United
States
11,300,000
12,338,188
WRKCo,
Inc.
,
Senior
Bond
,
3
%
,
6/15/33
....................
United
States
3,600,000
3,722,318
66,276,156
Diversified
Financial
Services
0.4%
Cia
Securitizadora
de
Creditos
Financeiros
Vert-Fintech
,
12
,
Senior
Secured
Note
,
0
%
,
(
BZDIOVRA
+
5.75
%
),
2/14/24
...........
Brazil
11,513,000
BRL
2,480,598
g
MPH
Acquisition
Holdings
LLC
,
Senior
Note
,
144A,
5.75
%
,
11/01/28
United
States
13,000,000
12,836,460
15,317,058
Diversified
Telecommunication
Services
1.1%
g
Altice
France
Holding
SA
,
Senior
Note
,
144A,
6
%
,
2/15/28
......
Luxembourg
9,100,000
9,043,125
g
Altice
France
SA
,
Senior
Secured
Note
,
144A,
5.5
%
,
1/15/28
....
France
2,500,000
2,578,725
g
AT&T,
Inc.
,
Senior
Bond
,
144A,
3.65
%
,
9/15/59
...............
United
States
4,000,000
3,695,822
Bell
Canada,
Inc.
,
Senior
Bond
,
4.464
%
,
4/01/48
..............
Canada
1,400,000
1,650,859
g
CCO
Holdings
LLC
/
CCO
Holdings
Capital
Corp.
,
Senior
Bond,
144A,
4.5%,
8/15/30
.......................
United
States
2,000,000
2,037,280
Senior
Bond,
144A,
4.5%,
5/01/32
.......................
United
States
13,000,000
13,146,250
TELUS
Corp.
,
Senior
Bond
,
4.6
%
,
11/16/48
..................
Canada
1,000,000
1,191,395
g
Virgin
Media
Secured
Finance
plc
,
Senior
Secured
Bond
,
144A,
4.5
%
,
8/15/30
......................................
United
Kingdom
10,600,000
10,670,528
44,013,984
Electric
Utilities
1.7%
g
CGNPC
International
Ltd.
,
Senior
Bond
,
Reg
S,
3.75
%
,
12/11/27
..
China
3,289,000
3,519,618
Duke
Energy
Corp.
,
Senior
Bond,
2.45%,
6/01/30
...........................
United
States
3,800,000
3,789,990
Senior
Bond,
3.75%,
9/01/46
...........................
United
States
1,600,000
1,655,879
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
19
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Electric
Utilities
(continued)
Exelon
Corp.
,
Senior
Bond,
4.05%,
4/15/30
...........................
United
States
13,400,000
$
15,079,708
Senior
Bond,
4.45%,
4/15/46
...........................
United
States
1,400,000
1,644,333
Southern
Co.
(The)
,
Senior
Bond
,
3.25
%
,
7/01/26
.............
United
States
9,200,000
9,939,633
g
State
Grid
Overseas
Investment
2016
Ltd.
,
Senior
Bond
,
144A,
3.5
%
,
5/04/27
......................................
China
15,800,000
17,418,950
g
Three
Gorges
Finance
I
Cayman
Islands
Ltd.
,
Senior
Bond
,
144A,
3.15
%
,
6/02/26
.....................................
China
12,800,000
13,585,154
Virginia
Electric
and
Power
Co.
,
Senior
Bond
,
6.35
%
,
11/30/37
...
United
States
820,000
1,169,581
67,802,846
Electrical
Equipment
0.2%
g
Sensata
Technologies
BV
,
Senior
Note
,
144A,
4
%
,
4/15/29
......
United
States
9,600,000
9,671,520
Electronic
Equipment,
Instruments
&
Components
0.4%
CDW
LLC
/
CDW
Finance
Corp.
,
Senior
Note
,
3.25
%
,
2/15/29
....
United
States
5,000,000
4,962,500
Flex
Ltd.
,
Senior
Bond
,
4.875
%
,
5/12/30
....................
United
States
7,100,000
8,188,342
FLIR
Systems,
Inc.
,
Senior
Note
,
2.5
%
,
8/01/30
...............
United
States
2,100,000
2,092,098
15,242,940
Energy
Equipment
&
Services
0.4%
g
Nabors
Industries
Ltd.
,
Senior
Note
,
144A,
7.25
%
,
1/15/26
......
United
States
6,000,000
5,291,250
g
Schlumberger
Holdings
Corp.
,
Senior
Note
,
144A,
3.9
%
,
5/17/28
..
United
States
3,800,000
4,173,839
g
Weatherford
International
Ltd.
,
Senior
Note
,
144A,
11
%
,
12/01/24
.
United
States
4,591,000
4,544,378
14,009,467
Entertainment
0.5%
g
Live
Nation
Entertainment,
Inc.
,
Senior
Secured
Note
,
144A,
3.75
%
,
1/15/28
...........................................
United
States
5,800,000
5,786,138
Netflix,
Inc.
,
Senior
Bond,
4.375%,
11/15/26
.........................
United
States
11,800,000
13,327,510
g
Senior
Bond,
144A,
4.875%,
6/15/30
.....................
United
States
2,000,000
2,322,810
21,436,458
Equity
Real
Estate
Investment
Trusts
(REITs)
1.5%
g
Global
Net
Lease,
Inc.
/
Global
Net
Lease
Operating
Partnership
LP
,
Senior
Note
,
144A,
3.75
%
,
12/15/27
......................
United
States
7,700,000
7,629,911
g
MGM
Growth
Properties
Operating
Partnership
LP
/
MGP
Finance
Co-Issuer,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
2/15/29
..........
United
States
3,300,000
3,345,260
MPT
Operating
Partnership
LP
/
MPT
Finance
Corp.
,
Senior
Bond,
5.25%,
8/01/26
...........................
United
States
4,200,000
4,342,422
Senior
Bond,
5%,
10/15/27
............................
United
States
5,700,000
6,006,375
Senior
Bond,
3.5%,
3/15/31
............................
United
States
4,000,000
3,996,560
g
Park
Intermediate
Holdings
LLC
/
PK
Domestic
Property
LLC
/
PK
Finance
Co-Issuer
,
Senior
Secured
Note
,
144A,
5.875
%
,
10/01/28
United
States
10,200,000
10,838,265
SBA
Communications
Corp.
,
Senior
Note
,
3.875
%
,
2/15/27
......
United
States
9,000,000
9,219,375
Simon
Property
Group
LP
,
Senior
Bond
,
4.25
%
,
11/30/46
.......
United
States
3,000,000
3,377,674
g
VICI
Properties
LP
/
VICI
Note
Co.,
Inc.
,
Senior
Bond,
144A,
4.125%,
8/15/30
.....................
United
States
1,300,000
1,321,944
Senior
Note,
144A,
3.75%,
2/15/27
......................
United
States
7,500,000
7,569,600
57,647,386
Food
&
Staples
Retailing
0.2%
g
Cencosud
SA
,
Senior
Bond
,
144A,
4.375
%
,
7/17/27
...........
Chile
6,900,000
7,673,904
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
20
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Food
Products
1.4%
B&G
Foods,
Inc.
,
Senior
Note
,
5.25
%
,
9/15/27
...............
United
States
9,000,000
$
9,325,170
g
Chobani
LLC
/
Chobani
Finance
Corp.,
Inc.
,
Senior
Secured
Note
,
144A,
4.625
%
,
11/15/28
...............................
United
States
7,000,000
7,227,500
Kraft
Heinz
Foods
Co.
,
Senior
Bond,
4.25%,
3/01/31
...........................
United
States
2,000,000
2,207,758
Senior
Note,
3.875%,
5/15/27
..........................
United
States
11,500,000
12,533,559
g
MHP
Lux
SA
,
Senior
Note
,
144A,
6.95
%
,
4/03/26
.............
Ukraine
10,500,000
10,782,555
g
Post
Holdings,
Inc.
,
Senior
Bond
,
144A,
4.5
%
,
9/15/31
.........
United
States
13,000,000
12,922,650
54,999,192
Gas
Utilities
0.1%
Piedmont
Natural
Gas
Co.,
Inc.
,
Senior
Bond
,
3.35
%
,
6/01/50
....
United
States
2,800,000
2,780,911
Health
Care
Providers
&
Services
1.4%
Anthem,
Inc.
,
Senior
Bond
,
3.7
%
,
9/15/49
...................
United
States
1,400,000
1,485,080
Centene
Corp.
,
g
Senior
Note,
144A,
5.375%,
6/01/26
.....................
United
States
7,600,000
7,927,180
Senior
Note,
4.25%,
12/15/27
..........................
United
States
3,000,000
3,148,125
Senior
Note,
4.625%,
12/15/29
.........................
United
States
2,300,000
2,492,843
Senior
Note,
3.375%,
2/15/30
..........................
United
States
1,400,000
1,407,007
g
CHS/Community
Health
Systems,
Inc.
,
Secured
Note,
144A,
6.875%,
4/15/29
....................
United
States
8,000,000
8,371,640
Senior
Secured
Note,
144A,
5.625%,
3/15/27
..............
United
States
3,700,000
3,928,605
Senior
Secured
Note,
144A,
6%,
1/15/29
..................
United
States
3,600,000
3,794,400
CVS
Health
Corp.
,
Senior
Bond
,
4.3
%
,
3/25/28
...............
United
States
3,272,000
3,725,667
g
DaVita,
Inc.
,
Senior
Note
,
144A,
4.625
%
,
6/01/30
.............
United
States
7,300,000
7,400,375
g
Molina
Healthcare,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
11/15/30
....
United
States
2,800,000
2,887,500
Orlando
Health
Obligated
Group
,
3.777
%
,
10/01/28
............
United
States
3,870,000
4,277,994
Quest
Diagnostics,
Inc.
,
Senior
Bond
,
2.8
%
,
6/30/31
...........
United
States
2,100,000
2,152,988
52,999,404
Hotels,
Restaurants
&
Leisure
3.4%
g
1011778
BC
ULC
/
New
Red
Finance,
Inc.
,
Secured
Bond
,
144A,
4
%
,
10/15/30
.......................................
Canada
14,000,000
13,668,270
g
Caesars
Entertainment,
Inc.
,
Senior
Secured
Note
,
144A,
6.25
%
,
7/01/25
...........................................
United
States
3,700,000
3,938,465
g
Caesars
Resort
Collection
LLC
/
CRC
Finco,
Inc.
,
Senior
Secured
Note
,
144A,
5.75
%
,
7/01/25
............................
United
States
8,800,000
9,279,688
g
Carnival
Corp.
,
Senior
Note
,
144A,
5.75
%
,
3/01/27
............
United
States
4,100,000
4,328,083
g
Genting
New
York
LLC
/
GENNY
Capital,
Inc.
,
Senior
Note
,
144A,
3.3
%
,
2/15/26
......................................
United
States
2,200,000
2,198,216
g
Golden
Nugget,
Inc.
,
Senior
Note
,
144A,
6.75
%
,
10/15/24
.......
United
States
13,200,000
13,381,500
g
International
Game
Technology
plc
,
Senior
Secured
Note
,
144A,
5.25
%
,
1/15/29
.....................................
United
States
13,000,000
13,801,144
Las
Vegas
Sands
Corp.
,
Senior
Bond
,
3.9
%
,
8/08/29
...........
United
States
8,300,000
8,665,732
MGM
Resorts
International
,
Senior
Note
,
4.75
%
,
10/15/28
.......
United
States
10,000,000
10,561,900
g
NCL
Corp.
Ltd.
,
Senior
Note
,
144A,
5.875
%
,
3/15/26
...........
United
States
17,700,000
18,522,873
g
Studio
City
Finance
Ltd.
,
Senior
Note
,
144A,
5
%
,
1/15/29
.......
Macau
11,700,000
11,977,875
g
Wynn
Macau
Ltd.
,
Senior
Note
,
144A,
5.625
%
,
8/26/28
.........
Macau
5,800,000
6,111,837
Yum!
Brands,
Inc.
,
Senior
Bond
,
4.625
%
,
1/31/32
.............
United
States
14,300,000
14,964,235
131,399,818
Household
Durables
0.6%
Mohawk
Industries,
Inc.
,
Senior
Bond
,
3.625
%
,
5/15/30
.........
United
States
14,300,000
15,533,631
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
21
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Household
Durables
(continued)
g
Williams
Scotsman
International,
Inc.
,
Senior
Secured
Note
,
144A,
4.625
%
,
8/15/28
.....................................
United
States
7,500,000
$
7,669,388
23,203,019
Household
Products
0.9%
g
Central
Garden
&
Pet
Co.
,
Senior
Bond
,
144A,
4.125
%
,
4/30/31
..
United
States
11,000,000
10,958,750
g
Energizer
Holdings,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
3/31/29
....
United
States
13,500,000
13,416,435
g
Kimberly-Clark
de
Mexico
SAB
de
CV
,
Senior
Bond
,
144A,
2.431
%
,
7/01/31
...........................................
Mexico
2,200,000
2,165,823
g
Spectrum
Brands,
Inc.
,
Senior
Bond,
144A,
5.5%,
7/15/30
.......................
United
States
2,300,000
2,485,437
Senior
Bond,
144A,
3.875%,
3/15/31
.....................
United
States
4,800,000
4,710,000
33,736,445
Independent
Power
and
Renewable
Electricity
Producers
1.5%
g
Calpine
Corp.
,
Senior
Bond,
144A,
5%,
2/01/31
........................
United
States
4,300,000
4,241,112
Senior
Note,
144A,
5.125%,
3/15/28
.....................
United
States
4,000,000
4,070,420
Senior
Note,
144A,
4.625%,
2/01/29
.....................
United
States
6,500,000
6,417,320
g
Clearway
Energy
Operating
LLC
,
Senior
Note
,
144A,
3.75
%
,
2/15/31
United
States
7,800,000
7,698,132
g
Colbun
SA
,
Senior
Bond,
144A,
3.95%,
10/11/27
.....................
Chile
7,500,000
8,207,059
Senior
Bond,
144A,
3.15%,
3/06/30
......................
Chile
2,900,000
2,971,091
g
InterGen
NV
,
Senior
Secured
Bond
,
144A,
7
%
,
6/30/23
.........
Netherlands
11,900,000
11,528,125
g
Talen
Energy
Supply
LLC
,
Senior
Note,
144A,
10.5%,
1/15/26
......................
United
States
3,000,000
2,762,925
Senior
Secured
Note,
144A,
7.25%,
5/15/27
...............
United
States
10,800,000
11,124,108
59,020,292
Insurance
0.3%
Arch
Capital
Group
Ltd.
,
Senior
Bond
,
3.635
%
,
6/30/50
.........
United
States
10,000,000
10,292,421
Interactive
Media
&
Services
0.4%
g
Tencent
Holdings
Ltd.
,
Senior
Bond
,
144A,
2.39
%
,
6/03/30
......
China
17,100,000
16,771,403
Internet
&
Direct
Marketing
Retail
0.3%
JD.com,
Inc.
,
Senior
Bond
,
3.375
%
,
1/14/30
.................
China
12,200,000
12,756,349
IT
Services
0.9%
g
Cablevision
Lightpath
LLC
,
Senior
Secured
Note
,
144A,
3.875
%
,
9/15/27
...........................................
United
States
9,200,000
9,085,000
g
Gartner,
Inc.
,
Senior
Note
,
144A,
4.5
%
,
7/01/28
...............
United
States
7,000,000
7,367,640
g
Presidio
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
4.875
%
,
2/01/27
United
States
12,000,000
12,375,840
g
Tempo
Acquisition
LLC
/
Tempo
Acquisition
Finance
Corp.
,
Senior
Note
,
144A,
6.75
%
,
6/01/25
............................
United
States
6,000,000
6,118,260
34,946,740
Life
Sciences
Tools
&
Services
0.1%
g
Charles
River
Laboratories
International,
Inc.
,
Senior
Note,
144A,
3.75%,
3/15/29
......................
United
States
2,100,000
2,139,375
Senior
Note,
144A,
4%,
3/15/31
........................
United
States
2,200,000
2,271,170
4,410,545
Machinery
0.4%
g
Manitowoc
Co.,
Inc.
(The)
,
Secured
Note
,
144A,
9
%
,
4/01/26
....
United
States
7,000,000
7,590,625
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
22
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Machinery
(continued)
g
Vertical
US
Newco,
Inc.
,
Senior
Secured
Note
,
144A,
5.25
%
,
7/15/27
Germany
9,000,000
$
9,433,170
17,023,795
Marine
0.3%
g
ICTSI
Treasury
BV
,
Senior
Bond
,
Reg
S,
4.625
%
,
1/16/23
.......
Philippines
12,000,000
12,726,000
Media
2.9%
Charter
Communications
Operating
LLC
/
Charter
Communications
Operating
Capital
,
Senior
Secured
Bond
,
2.8
%
,
4/01/31
.......
United
States
15,900,000
15,771,905
g
Clear
Channel
International
BV
,
Senior
Secured
Note
,
144A,
6.625
%
,
8/01/25
.....................................
United
States
1,300,000
1,363,375
g
Clear
Channel
Outdoor
Holdings,
Inc.
,
Senior
Note
,
144A,
7.75
%
,
4/15/28
...........................................
United
States
5,200,000
5,361,356
Clear
Channel
Worldwide
Holdings,
Inc.
,
Senior
Note,
9.25%,
2/15/24
...........................
United
States
5,242,000
5,481,743
g
Senior
Secured
Note,
144A,
5.125%,
8/15/27
..............
United
States
3,200,000
3,252,800
g
CSC
Holdings
LLC
,
Senior
Note
,
144A,
5.5
%
,
5/15/26
..........
United
States
16,000,000
16,474,400
g
Diamond
Sports
Group
LLC
/
Diamond
Sports
Finance
Co.
,
Senior
Note,
144A,
6.625%,
8/15/27
.....................
United
States
4,500,000
2,437,110
Senior
Secured
Note,
144A,
5.375%,
8/15/26
..............
United
States
4,300,000
3,144,375
Fox
Corp.
,
Senior
Bond
,
3.5
%
,
4/08/30
.....................
United
States
1,400,000
1,503,631
g
Gray
Television,
Inc.
,
Senior
Note
,
144A,
4.75
%
,
10/15/30
.......
United
States
10,300,000
10,312,875
g
News
Corp.
,
Senior
Note
,
144A,
3.875
%
,
5/15/29
.............
United
States
2,000,000
2,041,920
g
Nexstar
Broadcasting,
Inc.
,
Senior
Note
,
144A,
4.75
%
,
11/01/28
..
United
States
8,000,000
8,160,000
g
Outfront
Media
Capital
LLC
/
Outfront
Media
Capital
Corp.
,
Senior
Note
,
144A,
4.25
%
,
1/15/29
............................
United
States
11,000,000
10,942,800
g
Sinclair
Television
Group,
Inc.
,
Senior
Bond,
144A,
5.5%,
3/01/30
.......................
United
States
3,900,000
3,885,102
Senior
Secured
Note,
144A,
4.125%,
12/01/30
.............
United
States
7,600,000
7,419,576
g
Univision
Communications,
Inc.
,
Senior
Secured
Note
,
144A,
5.125
%
,
2/15/25
.....................................
United
States
16,000,000
16,291,280
113,844,248
Metals
&
Mining
1.2%
g
Constellium
SE
,
Senior
Note
,
144A,
3.75
%
,
4/15/29
...........
United
States
10,200,000
9,996,255
g
CSN
Inova
Ventures
,
Senior
Note
,
144A,
6.75
%
,
1/28/28
........
Brazil
8,000,000
8,704,920
g
FMG
Resources
August
2006
Pty.
Ltd.
,
Senior
Bond
,
144A,
4.375
%
,
4/01/31
...........................................
Australia
13,300,000
13,833,463
g
Novelis
Corp.
,
Senior
Bond
,
144A,
5.875
%
,
9/30/26
...........
United
States
14,000,000
14,622,160
47,156,798
Multiline
Retail
0.0%
b,e,g
K2016470219
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
PIK,
3
%
,
12/31/22
.......................................
South
Africa
10,437,480
b,e,g
K2016470260
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
PIK,
25
%
,
12/31/22
......................................
South
Africa
3,376,654
Multi-Utilities
0.2%
Dominion
Energy,
Inc.
,
C
,
Senior
Note
,
3.375
%
,
4/01/30
........
United
States
7,800,000
8,411,510
Oil,
Gas
&
Consumable
Fuels
5.3%
g
Aker
BP
ASA
,
Senior
Bond,
144A,
4%,
1/15/31
........................
Norway
4,400,000
4,666,888
Senior
Note,
144A,
4.75%,
6/15/24
......................
Norway
5,900,000
6,053,964
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
23
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Oil,
Gas
&
Consumable
Fuels
(continued)
g
Antero
Resources
Corp.
,
Senior
Note,
144A,
8.375%,
7/15/26
.....................
United
States
1,700,000
$
1,911,021
Senior
Note,
144A,
7.625%,
2/01/29
.....................
United
States
2,600,000
2,822,820
Apache
Corp.
,
Senior
Note,
4.625%,
11/15/25
.........................
United
States
5,600,000
5,922,000
Senior
Note,
4.875%,
11/15/27
.........................
United
States
5,000,000
5,283,750
Canadian
Natural
Resources
Ltd.
,
Senior
Bond
,
2.95
%
,
7/15/30
..
Canada
3,700,000
3,745,564
Cheniere
Corpus
Christi
Holdings
LLC
,
Senior
Secured
Note
,
5.875
%
,
3/31/25
.....................................
United
States
6,400,000
7,330,896
g
Cheniere
Energy
Partners
LP
,
Senior
Note
,
144A,
4
%
,
3/01/31
...
United
States
12,000,000
12,225,000
g
Continental
Resources,
Inc.
,
Senior
Bond
,
144A,
5.75
%
,
1/15/31
..
United
States
6,000,000
6,967,710
g
Crestwood
Midstream
Partners
LP
/
Crestwood
Midstream
Finance
Corp.
,
Senior
Note
,
144A,
6
%
,
2/01/29
....................
United
States
15,200,000
15,733,824
g
CrownRock
LP
/
CrownRock
Finance,
Inc.
,
Senior
Note
,
144A,
5
%
,
5/01/29
...........................................
United
States
3,100,000
3,178,384
g
CVR
Energy,
Inc.
,
Senior
Note
,
144A,
5.25
%
,
2/15/25
..........
United
States
5,000,000
5,031,250
Energy
Transfer
LP
,
Senior
Bond
,
4.05
%
,
3/15/25
.............
United
States
1,300,000
1,408,618
EnLink
Midstream
LLC
,
Senior
Bond,
5.375%,
6/01/29
..........................
United
States
10,900,000
10,913,625
g
Senior
Note,
144A,
5.625%,
1/15/28
.....................
United
States
1,700,000
1,759,500
e,g
EnQuest
plc
,
Senior
Note
,
144A,
Reg
S,
PIK,
7
%
,
10/15/23
......
United
Kingdom
11,037,421
9,402,656
Enterprise
Products
Operating
LLC
,
Senior
Bond
,
4.8
%
,
2/01/49
..
United
States
1,200,000
1,403,317
g
Hilcorp
Energy
I
LP
/
Hilcorp
Finance
Co.
,
Senior
Bond,
144A,
6%,
2/01/31
........................
United
States
6,500,000
6,711,445
Senior
Note,
144A,
5.75%,
2/01/29
......................
United
States
2,000,000
2,039,710
g
Martin
Midstream
Partners
LP
/
Martin
Midstream
Finance
Corp.
,
Secured
Note,
144A,
10%,
2/29/24
......................
United
States
3,608,495
3,775,388
Secured
Note,
144A,
11.5%,
2/28/25
.....................
United
States
16,387,122
16,960,671
MPLX
LP
,
Senior
Note
,
2.65
%
,
8/15/30
.....................
United
States
15,000,000
14,824,878
g
Oasis
Midstream
Partners
LP
/
OMP
Finance
Corp.
,
Senior
Note
,
144A,
8
%
,
4/01/29
...................................
United
States
5,200,000
5,328,492
Occidental
Petroleum
Corp.
,
Senior
Bond,
8.875%,
7/15/30
..........................
United
States
6,800,000
8,746,500
Senior
Bond,
6.125%,
1/01/31
..........................
United
States
5,900,000
6,571,125
Senior
Bond,
6.45%,
9/15/36
...........................
United
States
5,000,000
5,687,600
g
Rattler
Midstream
LP
,
Senior
Note
,
144A,
5.625
%
,
7/15/25
......
United
States
8,200,000
8,657,765
Sabine
Pass
Liquefaction
LLC
,
Senior
Secured
Note
,
4.5
%
,
5/15/30
United
States
10,000,000
11,273,348
g
Sunoco
LP
/
Sunoco
Finance
Corp.
,
Senior
Note
,
144A,
4.5
%
,
5/15/29
...........................................
United
States
12,000,000
12,135,000
208,472,709
Paper
&
Forest
Products
0.2%
Suzano
Austria
GmbH
,
Senior
Bond
,
3.75
%
,
1/15/31
...........
Brazil
7,100,000
7,278,281
Personal
Products
0.2%
g,h
Oriflame
Investment
Holding
plc
,
Senior
Secured
Note
,
144A,
5.125
%
,
5/04/26
.....................................
Switzerland
3,100,000
3,113,485
g
Prestige
Brands,
Inc.
,
Senior
Bond
,
144A,
3.75
%
,
4/01/31
.......
United
States
2,900,000
2,787,523
5,901,008
Pharmaceuticals
1.5%
g
Bausch
Health
Cos.,
Inc.
,
Senior
Bond,
144A,
5.25%,
2/15/31
......................
United
States
4,000,000
4,012,000
Senior
Note,
144A,
5%,
2/15/29
........................
United
States
4,000,000
4,011,160
g
Bayer
US
Finance
II
LLC
,
Senior
Bond
,
144A,
4.375
%
,
12/15/28
..
Germany
11,700,000
13,248,152
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
24
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Pharmaceuticals
(continued)
g
Endo
Dac
/
Endo
Finance
LLC
/
Endo
Finco,
Inc.
,
Secured
Note,
144A,
9.5%,
7/31/27
......................
United
States
6,580,000
$
6,983,025
Senior
Note,
144A,
6%,
6/30/28
........................
United
States
6,537,000
4,976,978
g
Organon
Finance
1
LLC
,
Senior
Bond,
144A,
5.125%,
4/30/31
.....................
United
States
7,300,000
7,583,605
Senior
Secured
Note,
144A,
4.125%,
4/30/28
..............
United
States
10,100,000
10,359,974
g
Par
Pharmaceutical,
Inc.
,
Senior
Secured
Note
,
144A,
7.5
%
,
4/01/27
United
States
1,716,000
1,808,235
g
Royalty
Pharma
plc
,
Senior
Bond
,
144A,
3.3
%
,
9/02/40
.........
United
States
5,300,000
5,136,754
58,119,883
Real
Estate
Management
&
Development
0.8%
g
China
Overseas
Finance
Cayman
VI
Ltd.
,
Senior
Bond
,
Reg
S,
5.95
%
,
5/08/24
.....................................
China
7,500,000
8,478,291
g
Five
Point
Operating
Co.
LP
/
Five
Point
Capital
Corp.
,
Senior
Note
,
144A,
7.875
%
,
11/15/25
...............................
United
States
8,000,000
8,475,000
g
Forestar
Group,
Inc.
,
Senior
Note
,
144A,
3.85
%
,
5/15/26
........
United
States
5,300,000
5,367,098
g
Howard
Hughes
Corp.
(The)
,
Senior
Note
,
144A,
5.375
%
,
8/01/28
.
United
States
10,000,000
10,592,500
32,912,889
Road
&
Rail
0.6%
CSX
Corp.
,
Senior
Bond
,
4.1
%
,
3/15/44
....................
United
States
1,600,000
1,802,643
g
Kazakhstan
Temir
Zholy
Finance
BV
,
Senior
Bond
,
144A,
6.95
%
,
7/10/42
...........................................
Kazakhstan
14,900,000
20,040,500
21,843,143
Semiconductors
&
Semiconductor
Equipment
0.2%
g
ON
Semiconductor
Corp.
,
Senior
Note
,
144A,
3.875
%
,
9/01/28
...
United
States
7,300,000
7,523,957
Software
0.5%
i
Anagram,
Inc.
,
FRN
,
10
%
,
8/15/26
........................
United
States
640,432
627,090
g
Blackboard,
Inc.
,
Secured
Note
,
144A,
10.375
%
,
11/15/24
.......
United
States
4,200,000
4,438,875
g
NortonLifeLock,
Inc.
,
Senior
Note
,
144A,
5
%
,
4/15/25
..........
United
States
7,500,000
7,611,750
g
Rocket
Software,
Inc.
,
Senior
Note
,
144A,
6.5
%
,
2/15/29
........
United
States
8,600,000
8,716,100
21,393,815
Specialty
Retail
0.7%
AutoNation,
Inc.
,
Senior
Bond
,
4.75
%
,
6/01/30
...............
United
States
1,900,000
2,217,733
L
Brands,
Inc.
,
Senior
Bond,
5.25%,
2/01/28
...........................
United
States
5,500,000
6,036,250
g
Senior
Bond,
144A,
6.625%,
10/01/30
....................
United
States
1,600,000
1,845,968
g
Lithia
Motors,
Inc.
,
Senior
Bond
,
144A,
4.375
%
,
1/15/31
........
United
States
5,000,000
5,272,975
g
Magic
Mergeco,
Inc.
,
Senior
Note,
144A,
7.875%,
5/01/29
.....................
United
States
6,100,000
6,275,375
Senior
Secured
Note,
144A,
5.25%,
5/01/28
...............
United
States
2,700,000
2,737,125
g,i
Party
City
Holdings,
Inc.
,
144A,
FRN,
5.75
%
,
(
6-month
USD
LIBOR
+
5%
),
7/15/25
......................................
United
States
1,153,545
1,055,494
25,440,920
Thrifts
&
Mortgage
Finance
0.7%
MGIC
Investment
Corp.
,
Senior
Note
,
5.25
%
,
8/15/28
..........
United
States
7,000,000
7,393,750
g
PennyMac
Financial
Services,
Inc.
,
Senior
Note
,
144A,
5.375
%
,
10/15/25
..........................................
United
States
9,000,000
9,495,000
g
United
Wholesale
Mortgage
LLC
,
Senior
Note
,
144A,
5.5
%
,
11/15/25
United
States
11,400,000
11,863,809
28,752,559
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
25
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Tobacco
0.4%
Altria
Group,
Inc.
,
Senior
Bond
,
3.4
%
,
5/06/30
................
United
States
12,400,000
$
12,932,415
BAT
Capital
Corp.
,
Senior
Bond
,
4.54
%
,
8/15/47
..............
United
Kingdom
600,000
591,903
g
Imperial
Brands
Finance
plc
,
Senior
Bond
,
144A,
3.875
%
,
7/26/29
.
United
Kingdom
2,200,000
2,349,499
15,873,817
Trading
Companies
&
Distributors
1.0%
g
Beacon
Roofing
Supply,
Inc.
,
Senior
Note
,
144A,
4.875
%
,
11/01/25
United
States
9,000,000
9,219,285
g
H&E
Equipment
Services,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
12/15/28
United
States
13,600,000
13,294,000
g
Herc
Holdings,
Inc.
,
Senior
Note
,
144A,
5.5
%
,
7/15/27
..........
United
States
5,300,000
5,613,919
g
WESCO
Distribution,
Inc.
,
Senior
Note,
144A,
7.125%,
6/15/25
.....................
United
States
4,700,000
5,081,875
Senior
Note,
144A,
7.25%,
6/15/28
......................
United
States
5,500,000
6,111,875
39,320,954
Wireless
Telecommunication
Services
1.2%
e,g
Digicel
Group
Holdings
Ltd.
,
Senior
Note
,
144A,
PIK,
8
%
,
4/01/25
.
Bermuda
1,151,888
964,361
Hughes
Satellite
Systems
Corp.
,
Senior
Note
,
6.625
%
,
8/01/26
...
United
States
8,000,000
8,866,800
Sprint
Communications,
Inc.
,
Senior
Note
,
6
%
,
11/15/22
........
United
States
10,000,000
10,688,950
T-Mobile
USA,
Inc.
,
Senior
Note,
5.125%,
4/15/25
..........................
United
States
6,000,000
6,121,890
g
Senior
Secured
Bond,
144A,
3.875%,
4/15/30
..............
United
States
13,400,000
14,613,370
g
Senior
Secured
Bond,
144A,
3.3%,
2/15/51
................
United
States
4,800,000
4,483,032
45,738,403
Total
Corporate
Bonds
(Cost
$1,885,126,250)
...................................
1,909,550,193
a
h,j
Senior
Floating
Rate
Interests
1.2%
Aerospace
&
Defense
0.2%
Dynasty
Acquisition
Co.,
Inc.,
2020
Term
Loan
,
B1,
3.703%,
(3-month
USD
LIBOR
+
3.5%),
4/06/26
..........
United
States
5,151,206
5,020,751
B2,
3.703%,
(3-month
USD
LIBOR
+
3.5%),
4/06/26
..........
United
States
2,769,465
2,699,329
7,720,080
a
a
a
a
a
a
Diversified
Consumer
Services
0.2%
KUEHG
Corp.,
Term
Loan
,
B3
,
4.75
%
,
(
3-month
USD
LIBOR
+
3.75
%
),
2/21/25
.....................................
United
States
7,118,368
7,041,454
Entertainment
0.2%
Diamond
Sports
Group
LLC,
Term
Loan
,
3.37
%
,
(
1-month
USD
LIBOR
+
3.25
%
),
8/24/26
..............................
United
States
2,955,000
2,123,109
William
Morris
Endeavor
Entertainment
LLC
(IMG
Worldwide
Holdings
LLC),
First
Lien,
Term
Loan
,
B1
,
2.903
%
,
(
1-month
USD
LIBOR
+
2.75%;
3-month
USD
LIBOR
+
2.75%
),
5/18/25
......
United
States
7,243,210
7,089,328
9,212,437
a
a
a
a
a
a
Leisure
Products
0.2%
i
Hercules
Achievement,
Inc.
(Varsity
Brands
Holding
Co.,
Inc.),
First
Lien,
Initial
Term
Loan
,
4.5
%
,
(
1-month
USD
LIBOR
+
3.5
%
),
12/16/24
..........................................
United
States
7,973,475
7,687,785
Media
0.2%
Cengage
Learning,
Inc.,
2016
Refinancing
Term
Loan
,
5.25
%
,
(
2-month
USD
LIBOR
+
4.25%;
3-month
USD
LIBOR
+
4.25%
),
6/07/23
...........................................
United
States
6,982,556
6,961,817
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
26
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
h,j
Senior
Floating
Rate
Interests
(continued)
Personal
Products
0.2%
Coty,
Inc.,
USD
Term
Loan
,
B
,
2.36
%
,
(
1-month
USD
LIBOR
+
2.25
%
),
4/07/25
.....................................
United
States
8,076,723
$
7,767,546
Software
0.0%
b,k
WorkCapital
BSD
SARL,
Term
Loan
,
6.5
%
,
11/02/22
...........
United
States
20,000,000
Total
Senior
Floating
Rate
Interests
(Cost
$65,993,905)
..........................
46,391,119
l
Marketplace
Loans
0.2%
Diversified
Financial
Services
0.2%
b
Lending
Club
-
LCX
PM,
6.74%
-
23.99%,
9/04/23
-
2/01/26
.....
United
States
3,983,499
3,803,578
b
Lending
Club
-
LCX,
5%
-
25.65%,
5/31/22
-
3/17/25
...........
United
States
3,188,552
2,905,410
b
Prosper,
11.99%
-
23.2%,
11/12/23
-
10/12/26
................
United
States
219,884
213,105
b
Upgrade,
14.19%
-
30.51%,
11/05/22
-
2/11/25
...............
United
States
1,373,510
1,261,454
8,183,547
a
a
a
a
a
a
Total
Marketplace
Loans
(Cost
$8,579,271)
.....................................
8,183,547
m
Loan
Participations
and
Assignments
0.4%
g
Russian
Railways
Via
RZD
Capital
plc,
Senior
Bond,
Reg
S,
5.7%,
4/05/22
...........................................
Russia
14,600,000
15,220,062
Total
Loan
Participations
and
Assignments
(Cost
$14,899,741)
...................
15,220,062
Foreign
Government
and
Agency
Securities
15.3%
g
African
Export-Import
Bank
(The),
Senior
Bond,
144A,
3.994%,
9/21/29
...........................................
Supranational
n
19,100,000
20,040,102
g
Angola
Government
Bond,
Senior
Bond,
144A,
8.25%,
5/09/28
...
Angola
26,800,000
27,604,000
g
Banque
Centrale
de
Tunisie,
Senior
Note,
Reg
S,
5.625%,
2/17/24
Tunisia
24,800,000
EUR
28,413,790
g
Banque
Ouest
Africaine
de
Developpement,
Senior
Bond,
144A,
5%,
7/27/27
...........................................
Supranational
n
11,500,000
12,736,940
g
Belarus
Government
Bond
,
Senior
Bond,
144A,
7.625%,
6/29/27
.....................
Belarus
11,400,000
11,858,223
Senior
Bond,
144A,
6.2%,
2/28/30
.......................
Belarus
12,300,000
11,758,493
Brazil
Notas
do
Tesouro
Nacional
,
10%,
1/01/23
.......................................
Brazil
34,402,000
BRL
6,695,078
o
Index
Linked,
6%,
5/15/23
.............................
Brazil
68,632,142
BRL
13,703,550
Colombia
Government
Bond
,
Senior
Bond,
3.875%,
4/25/27
..........................
Colombia
14,000,000
15,002,400
Senior
Bond,
9.85%,
6/28/27
...........................
Colombia
55,750,000,000
COP
18,427,495
Senior
Bond,
4.5%,
3/15/29
............................
Colombia
2,800,000
3,058,468
Senior
Bond,
5%,
6/15/45
.............................
Colombia
20,700,000
22,106,151
g
Dominican
Republic
Government
Bond,
Senior
Note,
144A,
8.9%,
2/15/23
...........................................
Dominican
Republic
838,300,000
DOP
15,408,190
Ecopetrol
SA,
Senior
Bond,
4.125%,
1/16/25
.................
Colombia
8,200,000
8,751,778
f,g
Electricite
de
France
SA
,
Junior
Sub.
Bond,
144A,
5.25%
to
1/29/23,
FRN
thereafter,
Perpetual
..........................................
France
25,000,000
26,196,750
Junior
Sub.
Bond,
144A,
5.625%
to
1/22/24,
FRN
thereafter,
Perpetual
..........................................
France
5,000,000
5,387,500
Equinor
ASA,
Senior
Bond,
2.375%,
5/22/30
.................
Norway
7,000,000
7,085,175
g
Export-Import
Bank
of
India,
Senior
Bond,
144A,
3.875%,
2/01/28
.
India
16,000,000
17,086,959
g
Gabon
Government
Bond
,
144A,
6.375%,
12/12/24
...............................
Gabon
8,243,918
8,725,775
Senior
Bond,
144A,
6.625%,
2/06/31
.....................
Gabon
17,150,000
17,301,160
g
Indonesia
Asahan
Aluminium
Persero
PT,
Senior
Bond,
144A,
5.45%,
5/15/30
.....................................
Indonesia
13,800,000
15,905,121
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
27
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Foreign
Government
and
Agency
Securities
(continued)
Indonesia
Government
Bond
,
FR34,
12.8%,
6/15/21
................................
Indonesia
64,210,000,000
IDR
$
4,497,367
FR39,
11.75%,
8/15/23
...............................
Indonesia
29,150,000,000
IDR
2,310,488
FR44,
10%,
9/15/24
..................................
Indonesia
8,340,000,000
IDR
655,838
FR56,
8.375%,
9/15/26
...............................
Indonesia
215,988,000,000
IDR
16,696,493
g
Senior
Bond,
144A,
4.35%,
1/08/27
......................
Indonesia
8,100,000
9,152,028
g
Senior
Bond,
144A,
3.85%,
7/18/27
......................
Indonesia
22,000,000
24,334,718
g
Senior
Bond,
144A,
4.625%,
4/15/43
.....................
Indonesia
7,000,000
7,899,885
g
Iraq
Government
Bond,
Senior
Bond,
144A,
5.8%,
1/15/28
......
Iraq
23,975,000
23,197,011
g
Israel
Electric
Corp.
Ltd.,
Senior
Secured
Bond,
144A,
Reg
S,
4.25%,
8/14/28
...........................................
Israel
9,200,000
10,240,980
g
Kazakhstan
Government
Bond,
Senior
Bond,
144A,
4.875%,
10/14/44
..........................................
Kazakhstan
17,700,000
21,706,926
Mexico
Government
Bond
,
Senior
Bond,
4.15%,
3/28/27
...........................
Mexico
28,700,000
32,197,812
Senior
Bond,
3.75%,
1/11/28
...........................
Mexico
4,000,000
4,340,300
Senior
Bond,
4.75%,
4/27/32
...........................
Mexico
6,400,000
7,206,400
Peru
Government
Bond,
Senior
Bond,
6.55%,
3/14/37
..........
Peru
8,600,000
11,569,623
Petroleos
Mexicanos,
Senior
Bond,
6.625%,
6/15/35
...........
Mexico
6,500,000
6,291,187
g
Russia
Government
Bond
,
Senior
Bond,
Reg
S,
4.75%,
5/27/26
.....................
Russia
12,000,000
13,564,056
Senior
Bond,
144A,
5.625%,
4/04/42
.....................
Russia
5,800,000
7,324,124
South
Africa
Government
Bond
,
p
Senior
Bond,
5.875%,
6/22/30
..........................
South
Africa
6,500,000
7,186,725
Senior
Bond,
7%,
2/28/31
.............................
South
Africa
185,000,000
ZAR
10,597,709
Turkey
Government
Bond,
Senior
Bond,
4.875%,
10/09/26
......
Turkey
8,000,000
7,670,000
g
Turkiye
Vakiflar
Bankasi
TAO,
Covered
Note,
Reg
S,
2.375%,
5/04/21
...........................................
Turkey
3,900,000
EUR
4,688,970
g
Ukraine
Government
Bond
,
Senior
Note,
144A,
7.75%,
9/01/23
.......................
Ukraine
4,355,000
4,642,840
Senior
Note,
144A,
7.75%,
9/01/24
.......................
Ukraine
4,355,000
4,684,425
Senior
Bond,
144A,
7.375%,
9/25/32
.....................
Ukraine
6,000,000
6,078,150
q
VRI,
GDP
Linked
Securi
ty,
Senior
Bond,
144A,
5/31/40
.......
Ukraine
9,990,000
10,573,466
o
Uruguay
Government
Bond,
Index
Linked,
Senior
Bond,
3.7%,
6/26/37
...........................................
Uruguay
953,182,061
UYU
24,445,282
Total
Foreign
Government
and
Agency
Securities
(Cost
$605,000,578)
............
597,005,901
U.S.
Government
and
Agency
Securities
2.9%
U.S.
Treasury
Bonds
,
7.125%,
2/15/23
.....................................
United
States
3,000,000
3,375,117
6.25%,
8/15/23
.....................................
United
States
4,000,000
4,552,500
6.875%,
8/15/25
.....................................
United
States
1,000,000
1,262,773
U.S.
Treasury
Notes
,
1.5%,
11/30/21
......................................
United
States
30,000,000
30,254,870
o
0.125%,
7/15/24
.....................................
United
States
10,340,000
12,451,562
0.25%,
6/30/25
.....................................
United
States
41,000,000
40,336,152
o
0.375%,
7/15/25
.....................................
United
States
17,700,000
21,786,447
Total
U.S.
Government
and
Agency
Securities
(Cost
$110,227,779)
................
114,019,421
Asset-Backed
Securities
8.3%
Airlines
0.1%
United
Airlines
Pass-Through
Trust
,
2020-1
,
B
,
4.875
%
,
7/15/27
..
United
States
1,164,600
1,218,378
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
28
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Consumer
Finance
0.5%
r
Citibank
Credit
Card
Issuance
Trust
,
2017-A7
,
A7
,
FRN
,
0.48
%
,
(
1-month
USD
LIBOR
+
0.37
%
),
8/08/24
..................
United
States
20,069,000
$
20,171,757
Diversified
Financial
Services
7.7%
g,r
AMMC
CLO
XI
Ltd.
,
2012-11A
,
CR2
,
144A,
FRN
,
2.086
%
,
(
3-month
USD
LIBOR
+
1.9
%
),
4/30/31
...........................
United
States
1,000,000
976,333
g,r
Antares
CLO
Ltd.
,
2018-1A
,
B
,
144A,
FRN
,
1.838
%
,
(
3-month
USD
LIBOR
+
1.65
%
),
4/20/31
..............................
United
States
17,500,000
17,280,897
g,r
BCC
Middle
Market
CLO
LLC
,
2018-1A
,
A2
,
144A,
FRN
,
2.338
%
,
(
3-month
USD
LIBOR
+
2.15
%
),
10/20/30
.................
United
States
6,300,000
6,166,974
g,r
BlueMountain
CLO
Ltd.
,
2012-2A,
BR2,
144A,
FRN,
1.632%,
(3-month
USD
LIBOR
+
1.45%),
11/20/28
....................................
United
States
6,710,000
6,717,864
2012-2A,
CR2,
144A,
FRN,
2.182%,
(3-month
USD
LIBOR
+
2%),
11/20/28
..........................................
United
States
2,730,000
2,703,005
2014-2A,
CR2,
144A,
FRN,
2.388%,
(3-month
USD
LIBOR
+
2.2%),
10/20/30
.....................................
United
States
3,800,000
3,810,292
2016-3A,
CR,
144A,
FRN,
2.394%,
(3-month
USD
LIBOR
+
2.2%),
11/15/30
..........................................
United
States
300,000
300,759
2018-1A,
D,
144A,
FRN,
3.236%,
(3-month
USD
LIBOR
+
3.05%),
7/30/30
...........................................
United
States
5,000,000
4,785,575
g,r
BlueMountain
Fuji
EUR
CLO
V
DAC
,
5A
,
B
,
144A,
FRN
,
1.55
%
,
(
3-month
EURIBOR
+
1.55
%
),
1/15/33
....................
Ireland
6,200,000
EUR
7,487,012
g,r
BlueMountain
Fuji
US
CLO
III
Ltd.
,
2017-3A
,
C
,
144A,
FRN
,
1.884
%
,
(
3-month
USD
LIBOR
+
1.7
%
),
1/15/30
...................
United
States
1,250,000
1,226,963
g,r
Burnham
Park
CLO
Ltd.
,
2016-1A
,
BR
,
144A,
FRN
,
1.688
%
,
(
3-month
USD
LIBOR
+
1.5
%
),
10/20/29
..................
United
States
3,500,000
3,491,305
g,r
Buttermilk
Park
CLO
Ltd.
,
2018-1A
,
C
,
144A,
FRN
,
2.284
%
,
(
3-month
USD
LIBOR
+
2.1
%
),
10/15/31
..................
United
States
9,730,950
9,745,000
g,r
Carlyle
Global
Market
Strategies
CLO
Ltd.
,
2013-3A,
BR,
144A,
FRN,
1.884%,
(3-month
USD
LIBOR
+
1.7%),
10/15/30
..........................................
United
States
300,000
294,002
2014-2RA,
B,
144A,
FRN,
2.019%,
(3-month
USD
LIBOR
+
1.825%),
5/15/31
....................................
United
States
580,000
572,631
2014-4RA,
C,
144A,
FRN,
3.084%,
(3-month
USD
LIBOR
+
2.9%),
7/15/30
...........................................
United
States
3,000,000
2,833,590
g,r
Carlyle
GMS
Finance
MM
CLO
LLC
,
2015-1A
,
A2R
,
144A,
FRN
,
2.384
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
10/15/31
............
United
States
12,000,000
11,787,212
g
CF
Hippolyta
LLC
,
2020-1
,
A1
,
144A,
1.69
%
,
7/15/60
..........
United
States
4,094,285
4,155,785
g,s
Consumer
Loan
Underlying
Bond
Certificate
Issuer
Trust
I
,
2018-14,
PT,
144A,
FRN,
9.597%,
9/16/41
.................
United
States
586,803
573,653
b
2018-29,
PT,
144A,
FRN,
31.791%,
12/15/43
...............
United
States
931,915
923,337
2019-26,
PT,
144A,
FRN,
23.345%,
8/15/44
................
United
States
3,660,756
3,622,710
2019-31,
PT,
144A,
FRN,
23.325%,
9/15/44
................
United
States
3,358,053
3,291,749
2019-37,
PT,
144A,
FRN,
26.381%,
10/17/44
...............
United
States
3,409,616
3,321,342
2019-42,
PT,
144A,
FRN,
22.361%,
11/15/44
...............
United
States
3,786,737
3,741,605
2019-51,
PT,
144A,
FRN,
18.534%,
1/15/45
................
United
States
4,217,620
4,169,664
2019-52,
PT,
144A,
FRN,
17.047%,
1/15/45
................
United
States
4,155,060
4,136,355
2019-S1,
PT,
144A,
FRN,
19.425%,
4/15/44
................
United
States
2,219,462
2,158,848
2019-S2,
PT,
144A,
FRN,
16.111%,
5/16/44
................
United
States
1,796,944
1,778,230
2019-S3,
PT,
144A,
FRN,
16.022%,
6/15/44
................
United
States
2,425,930
2,391,570
2019-S4,
PT,
144A,
FRN,
14.705%,
8/15/44
................
United
States
2,835,940
2,799,660
2019-S5,
PT,
144A,
FRN,
15.275%,
9/15/44
................
United
States
2,803,811
2,767,901
2019-S6,
PT,
144A,
FRN,
13.945%,
10/17/44
...............
United
States
2,778,002
2,696,128
2019-S7,
PT,
144A,
FRN,
12.842%,
12/15/44
...............
United
States
2,337,753
2,279,098
2019-S8,
PT,
144A,
FRN,
12.006%,
1/15/45
................
United
States
3,023,973
2,935,215
2020-2,
PT,
144A,
FRN,
17.867%,
3/15/45
.................
United
States
4,001,920
3,969,843
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
29
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Diversified
Financial
Services
(continued)
g,s
Consumer
Loan
Underlying
Bond
Certificate
Issuer
Trust
I,
(continued)
2020-7,
PT,
144A,
FRN,
18.379%,
4/17/45
.................
United
States
2,510,132
$
2,458,165
s
CWABS
Asset-Backed
Certificates
Trust
,
2005-11
,
AF4
,
FRN
,
5.21
%
,
3/25/34
...........................................
United
States
99,946
99,883
g,r
Dryden
38
Senior
Loan
Fund
,
2015-38A
,
CR
,
144A,
FRN
,
2.184
%
,
(
3-month
USD
LIBOR
+
2
%
),
7/15/30
.....................
United
States
7,186,000
7,198,683
g,r
Dryden
42
Senior
Loan
Fund
,
2016-42A
,
DR
,
144A,
FRN
,
3.114
%
,
(
3-month
USD
LIBOR
+
2.93
%
),
7/15/30
..................
United
States
8,400,000
8,380,018
g,r
Dryden
55
CLO
Ltd.
,
2018-55A
,
D
,
144A,
FRN
,
3.034
%
,
(
3-month
USD
LIBOR
+
2.85
%
),
4/15/31
..........................
United
States
3,000,000
2,930,442
g,r
Galaxy
XVIII
CLO
Ltd.
,
2018-28A
,
C
,
144A,
FRN
,
2.134
%
,
(
3-month
USD
LIBOR
+
1.95
%
),
7/15/31
..........................
United
States
3,070,000
3,063,860
g,r
Galaxy
XXVII
CLO
Ltd.
,
2018-27A
,
C
,
144A,
FRN
,
1.994
%
,
(
3-month
USD
LIBOR
+
1.8
%
),
5/16/31
...........................
United
States
3,600,000
3,599,915
g,r
HPS
Loan
Management
Ltd.
,
13A-18
,
C
,
144A,
FRN
,
2.334
%
,
(
3-month
USD
LIBOR
+
2.15
%
),
10/15/30
.................
United
States
4,950,000
4,954,178
g,r
LCM
XVII
LP
,
17A,
BRR,
144A,
FRN,
1.784%,
(3-month
USD
LIBOR
+
1.6%),
10/15/31
..........................................
United
States
4,590,000
4,558,437
17A,
CRR,
144A,
FRN,
2.284%,
(3-month
USD
LIBOR
+
2.1%),
10/15/31
..........................................
United
States
4,240,000
4,229,423
g,r
LCM
XVIII
LP
,
18A
,
DR
,
144A,
FRN
,
2.988
%
,
(
3-month
USD
LIBOR
+
2.8
%
),
4/20/31
....................................
United
States
6,860,000
6,527,878
g,r
Madison
Park
Euro
Funding
VIII
DAC
,
8A
,
BRN
,
144A,
FRN
,
1.7
%
,
(
3-month
EURIBOR
+
1.7
%
),
4/15/32
.....................
Ireland
4,100,000
EUR
4,948,639
g,s
Mill
City
Mortgage
Loan
Trust
,
2018-4
,
A1B
,
144A,
FRN
,
3.5
%
,
4/25/66
...........................................
United
States
13,252,556
13,879,095
g,r
Neuberger
Berman
CLO
XVIII
Ltd.
,
2014-18A
,
CR2
,
144A,
FRN
,
3.186
%
,
(
3-month
USD
LIBOR
+
3
%
),
10/21/30
.............
United
States
500,000
490,190
g,r
Neuberger
Berman
CLO
XXII
Ltd.
,
2016-22A
,
CR
,
144A,
FRN
,
2.39
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
10/17/30
.............
United
States
2,129,630
2,132,337
g,r
NZCG
Funding
Ltd.
,
2015-1A
,
A2R
,
144A,
FRN
,
1.74
%
,
(
3-month
USD
LIBOR
+
1.55
%
),
2/26/31
..........................
United
States
15,500,000
15,498,735
g,r
Octagon
Investment
Partners
28
Ltd.
,
2016-1A,
A2R,
144A,
FRN,
1.626%,
(3-month
USD
LIBOR
+
1.45%),
10/24/30
....................................
United
States
5,000,000
5,004,892
2016-1A,
BR,
144A,
FRN,
1.976%,
(3-month
USD
LIBOR
+
1.8%),
10/24/30
..........................................
United
States
3,914,730
3,924,722
g,r
Octagon
Investment
Partners
36
Ltd.
,
2018-1A
,
A1
,
144A,
FRN
,
1.154
%
,
(
3-month
USD
LIBOR
+
0.97
%
),
4/15/31
............
United
States
7,475,000
7,464,720
g,r
Octagon
Investment
Partners
37
Ltd.
,
2018-2A
,
C
,
144A,
FRN
,
3.026
%
,
(
3-month
USD
LIBOR
+
2.85
%
),
7/25/30
............
United
States
4,000,000
3,962,623
g,r
Octagon
Investment
Partners
38
Ltd.
,
2018-1A
,
C
,
144A,
FRN
,
3.138
%
,
(
3-month
USD
LIBOR
+
2.95
%
),
7/20/30
............
United
States
5,000,000
4,873,238
g,r
Octagon
Investment
Partners
XVI
Ltd.
,
2013-1A
,
DR
,
144A,
FRN
,
3.19
%
,
(
3-month
USD
LIBOR
+
3
%
),
7/17/30
...............
United
States
6,000,000
6,011,446
g,r
Octagon
Investment
Partners
XXIII
Ltd.
,
2015-1A
,
BR
,
144A,
FRN
,
1.384
%
,
(
3-month
USD
LIBOR
+
1.2
%
),
7/15/27
.............
United
States
4,590,000
4,593,335
g,s
Prosper
Pass-Thru
Trust
III
,
2020-PT1,
A,
144A,
FRN,
8.796%,
3/15/26
.................
United
States
2,543,326
2,517,390
2020-PT2,
A,
144A,
FRN,
9.444%,
4/15/26
.................
United
States
2,884,030
2,834,586
2020-PT3,
A,
144A,
FRN,
7.183%,
5/15/26
.................
United
States
804,524
811,780
g,r
Strata
CLO
I
Ltd.
,
2018-1A
,
B
,
144A,
FRN
,
2.384
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
1/15/31
...............................
United
States
14,100,000
13,962,379
g,s
Upgrade
Master
Pass-Thru
Trust
,
2019-PT1,
A,
144A,
FRN,
11.995%,
6/15/25
................
United
States
1,369,729
1,232,230
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
30
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Diversified
Financial
Services
(continued)
g,s
Upgrade
Master
Pass-Thru
Trust,
(continued)
2019-PT2,
A,
144A,
FRN,
15.25%,
2/15/26
.................
United
States
2,209,787
$
2,210,783
g,r
Voya
CLO
Ltd.
,
2013-2A,
A2AR,
144A,
FRN,
1.576%,
(3-month
USD
LIBOR
+
1.4%),
4/25/31
......................................
United
States
2,200,000
2,193,468
2013-2A,
BR,
144A,
FRN,
2.026%,
(3-month
USD
LIBOR
+
1.85%),
4/25/31
.....................................
United
States
5,770,000
5,691,512
2014-1A,
CR2,
144A,
FRN,
2.99%,
(3-month
USD
LIBOR
+
2.8%),
4/18/31
...........................................
United
States
8,000,000
7,733,270
2015-2A,
BR,
144A,
FRN,
1.673%,
(3-month
USD
LIBOR
+
1.5%),
7/23/27
...........................................
United
States
9,290,000
9,292,323
2016-1A,
BR,
144A,
FRN,
1.988%,
(3-month
USD
LIBOR
+
1.8%),
1/20/31
...........................................
United
States
590,000
580,726
301,737,408
a
a
a
a
a
a
Total
Asset-Backed
Securities
(Cost
$321,835,364)
..............................
323,127,543
Commercial
Mortgage-Backed
Securities
0.0%
Diversified
Financial
Services
0.0%
s
Commercial
Mortgage
Trust
,
2006-GG7
,
AJ
,
FRN
,
6.214
%
,
7/10/38
United
States
2,336,688
2,103,603
Total
Commercial
Mortgage-Backed
Securities
(Cost
$2,251,544)
.................
2,103,603
Mortgage-Backed
Securities
3.1%
t
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Adjustable
Rate
0.0%
FHLMC,
2.348%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
1/01/33
..
United
States
10,287
10,247
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Fixed
Rate
0.1%
FHLMC
Gold
Pools,
15
Year,
5%,
7/01/22
...................
United
States
9,707
10,194
FHLMC
Gold
Pools,
20
Year,
5%,
5/01/27
-
5/01/30
............
United
States
208,324
232,021
FHLMC
Gold
Pools,
20
Year,
6.5%,
10/01/21
.................
United
States
326
366
FHLMC
Gold
Pools,
20
Year,
7%,
9/01/21
...................
United
States
198
199
FHLMC
Gold
Pools,
30
Year,
4.5%,
10/01/40
.................
United
States
89,345
100,971
FHLMC
Gold
Pools,
30
Year,
5%,
3/01/34
-
2/01/38
............
United
States
461,323
527,125
FHLMC
Gold
Pools,
30
Year,
5.5%,
6/01/33
-
6/01/36
..........
United
States
570,673
654,065
FHLMC
Gold
Pools,
30
Year,
6%,
6/01/33
-
6/01/37
............
United
States
206,056
235,695
FHLMC
Gold
Pools,
30
Year,
6.5%,
12/01/25
-
6/01/36
.........
United
States
63,814
73,777
FHLMC
Gold
Pools,
30
Year,
7%,
4/01/28
-
8/01/32
............
United
States
12,242
12,912
FHLMC
Gold
Pools,
30
Year,
7.5%,
1/01/26
-
1/01/31
..........
United
States
3,364
3,993
FHLMC
Gold
Pools,
30
Year,
8%,
11/01/25
-
1/01/26
...........
United
States
51
52
FHLMC
Gold
Pools,
30
Year,
9%,
12/01/24
..................
United
States
36
39
1,851,409
t
Federal
National
Mortgage
Association
(FNMA)
Adjustable
Rate
0.0%
FNMA,
2.331%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
12/01/34
..
United
States
79,490
81,182
Federal
National
Mortgage
Association
(FNMA)
Fixed
Rate
2.6%
FNMA,
15
Year,
2.5%,
7/01/27
...........................
United
States
145,272
152,369
FNMA,
15
Year,
5.5%,
4/01/22
...........................
United
States
1,107
1,114
FNMA,
20
Year,
4.5%,
3/01/28
...........................
United
States
40,137
43,726
FNMA,
20
Year,
5%,
9/01/23
-
6/01/31
......................
United
States
262,693
292,511
FNMA,
30
Year,
3%,
9/01/48
-
4/01/51
......................
United
States
25,176,409
26,588,405
FNMA,
30
Year,
4.5%,
2/01/41
...........................
United
States
224,718
252,557
FNMA,
30
Year,
5%,
10/01/35
............................
United
States
482,934
558,477
FNMA,
30
Year,
5.5%,
9/01/33
-
12/01/35
...................
United
States
714,889
822,701
FNMA,
30
Year,
6%,
6/01/34
-
5/01/38
......................
United
States
1,622,031
1,881,075
FNMA,
30
Year,
6.5%,
3/01/28
-
10/01/37
...................
United
States
216,323
249,962
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
31
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Mortgage-Backed
Securities
(continued)
Federal
National
Mortgage
Association
(FNMA)
Fixed
Rate
(continued)
FNMA,
30
Year,
7.5%,
10/01/29
...........................
United
States
3,666
$
4,301
FNMA,
30
Year,
8%,
1/01/25
-
5/01/26
......................
United
States
1,548
1,712
u
FNMA,
Single-family,
15
Year,
2%,
5/25/36
..................
United
States
14,514,000
14,993,076
u
FNMA,
Single-family,
30
Year,
2%,
5/25/51
..................
United
States
19,610,000
19,806,100
u
FNMA,
Single-family,
30
Year,
2.5%,
5/25/51
.................
United
States
34,852,000
36,158,949
101,807,035
Government
National
Mortgage
Association
(GNMA)
Fixed
Rate
0.4%
GNMA
I,
30
Year,
8%,
2/15/25
............................
United
States
21
22
GNMA
I,
Single-family,
30
Year,
5%,
6/15/34
-
7/15/34
..........
United
States
76,331
87,225
GNMA
I,
Single-family,
30
Year,
5.5%,
2/15/33
-
6/15/36
........
United
States
259,371
294,921
GNMA
I,
Single-family,
30
Year,
6%,
8/15/36
.................
United
States
15,726
18,610
GNMA
I,
Single-family,
30
Year,
6.5%,
2/15/29
-
3/15/32
........
United
States
4,306
4,818
GNMA
I,
Single-family,
30
Year,
7%,
11/15/27
-
5/15/28
.........
United
States
4,852
4,875
GNMA
I,
Single-family,
30
Year,
7.5%,
9/15/23
-
5/15/27
........
United
States
465
479
GNMA
I,
Single-family,
30
Year,
8%,
7/15/26
-
9/15/27
..........
United
States
2,404
2,499
GNMA
I,
Single-family,
30
Year,
8.5%,
8/15/24
................
United
States
32
33
GNMA
I,
Single-family,
30
Year,
9%,
1/15/25
.................
United
States
116
116
GNMA
I,
Single-family,
30
Year,
9.5%,
6/15/25
................
United
States
283
284
u
GNMA
II,
Single-family,
30
Year,
2%,
5/15/51
.................
United
States
7,714,000
7,871,896
u
GNMA
II,
Single-family,
30
Year,
-,
2.5%,
5/15/51
..............
United
States
7,651,000
7,953,454
GNMA
II,
Single-family,
30
Year,
5%,
9/20/33
-
11/20/33
.........
United
States
128,009
146,526
GNMA
II,
Single-family,
30
Year,
5.5%,
6/20/34
...............
United
States
66,904
78,595
GNMA
II,
Single-family,
30
Year,
6%,
11/20/34
................
United
States
69,737
81,920
GNMA
II,
Single-family,
30
Year,
6.5%,
7/20/28
-
12/20/31
.......
United
States
38,573
44,717
GNMA
II,
Single-family,
30
Year,
7.5%,
4/20/32
...............
United
States
13,779
15,749
16,606,739
Total
Mortgage-Backed
Securities
(Cost
$118,213,962)
...........................
120,356,612
Municipal
Bonds
2.1%
California
0.3%
City
of
San
Francisco,
Public
Utilities
Commission
Water,
Revenue,
2019
A,
Refunding,
3.473%,
11/01/43
.....................
United
States
2,310,000
2,447,749
San
Bernardino
Community
College
District,
GO,
2019
A-1,
3.271%,
8/01/39
...........................................
United
States
2,160,000
2,260,825
San
Diego
County
Regional
Transportation
Commission,
Revenue,
2019
A,
Refunding,
3.248%,
4/01/48
.....................
United
States
2,360,000
2,437,079
San
Jose
Redevelopment
Agency
Successor
Agency,
Tax
Allocation,
Senior
Lien,
2017A-T,
Refunding,
3.25%,
8/01/29
............
United
States
5,675,000
6,163,673
13,309,326
Colorado
0.1%
Metro
Wastewater
Reclamation
District,
Revenue,
2019
B,
Refunding,
3.158%,
4/01/41
............................
United
States
4,880,000
5,107,902
Hawaii
0.0%
City
&
County
Honolulu,
Wastewater
System,
Revenue,
2019
B,
Refunding,
2.585%,
7/01/28
............................
United
States
1,180,000
1,235,586
Illinois
0.2%
State
of
Illinois,
GO,
2003,
5.1%,
6/01/33
...................
United
States
6,960,000
7,944,473
Massachusetts
0.1%
Massachusetts
School
Building
Authority,
Revenue,
2019
B,
Refunding,
3.395%,
10/15/40
...........................
United
States
2,905,000
3,058,982
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
32
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Municipal
Bonds
(continued)
New
Jersey
0.3%
New
Jersey
Transportation
Trust
Fund
Authority,
Revenue,
2019
B,
Refunding,
4.131%,
6/15/42
............................
United
States
3,535,000
$
3,764,524
State
of
New
Jersey,
GO,
2020
A,
3%,
6/01/32
...............
United
States
6,730,000
7,639,635
11,404,159
New
York
0.2%
Metropolitan
Transportation
Authority,
Revenue,
2020
E,
Refunding,
4%,
11/15/45
.......................................
United
States
5,340,000
6,101,879
New
York
State
Dormitory
Authority,
State
University
of
New
York,
Revenue,
2019B,
Refunding,
3.142%,
7/01/43
..............
United
States
3,145,000
3,182,987
9,284,866
Ohio
0.1%
State
of
Ohio,
Cleveland
Clinic
Health
System
Obligated
Group,
Revenue,
2019G,
Refunding,
3.276%,
1/01/42
..............
United
States
1,975,000
2,096,963
Oregon
0.1%
State
of
Oregon,
Department
of
Transportation,
Revenue,
Senior
Lien,
2019
B,
Refunding,
3.168%,
11/15/38
................
United
States
3,930,000
4,177,645
Pennsylvania
0.2%
University
of
Pittsburgh-of
the
Commonwealth
System
of
Higher
Education,
Revenue,
2017
C,
Refunding,
3.005%,
9/15/41
.....
United
States
5,500,000
5,629,136
Texas
0.3%
State
of
Texas,
GO,
2019,
Refunding,
3.211%,
4/01/44
.........
United
States
5,895,000
6,211,322
Texas
State
University
System
,
Revenue,
2019
B,
Refunding,
2.938%,
3/15/33
..............
United
States
2,315,000
2,418,841
Revenue,
2019
B,
Refunding,
3.289%,
3/15/40
..............
United
States
1,965,000
2,017,017
10,647,180
Utah
0.2%
Salt
Lake
City
Corp.,
Revenue,
2019B,
Refunding,
3.102%,
4/01/38
United
States
2,750,000
2,891,624
Utah
Transit
Authority,
Revenue,
Senior
Lien,
2019
B,
Refunding,
3.443%,
12/15/42
....................................
United
States
3,930,000
4,132,565
7,024,189
Total
Municipal
Bonds
(Cost
$75,787,867)
......................................
80,920,407
Residential
Mortgage-Backed
Securities
8.7%
Capital
Markets
0.0%
r
Merrill
Lynch
Mortgage
Investors
Trust
,
2005-A6
,
2A3
,
FRN
,
0.866
%
,
(
1-month
USD
LIBOR
+
0.76
%
),
8/25/35
..................
United
States
128,119
128,549
Diversified
Financial
Services
0.7%
g
BRAVO
Residential
Funding
Trust
,
2019-1,
A1C,
144A,
3.5%,
3/25/58
.......................
United
States
5,260,660
5,414,993
s
2019-2,
A3,
144A,
FRN,
3.5%,
10/25/44
...................
United
States
6,825,076
7,142,395
g,s
CIM
Trust
,
2019-INV1,
A1,
144A,
FRN,
4%,
2/25/49
..................
United
States
4,099,083
4,169,996
2019-INV2,
A3,
144A,
FRN,
4%,
5/25/49
..................
United
States
5,710,413
5,848,262
g,s
Provident
Funding
Mortgage
Trust
,
2019-1,
A2,
144A,
FRN,
3%,
12/25/49
....................
United
States
3,098,982
3,141,196
2020-1,
A3,
144A,
FRN,
3%,
2/25/50
.....................
United
States
1,534,969
1,540,728
27,257,570
a
a
a
a
a
a
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
33
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Residential
Mortgage-Backed
Securities
(continued)
Thrifts
&
Mortgage
Finance
8.0%
r
FHLMC
Structured
Agency
Credit
Risk
Debt
Notes
,
2013-DN2,
M2,
FRN,
4.356%,
(1-month
USD
LIBOR
+
4.25%),
11/25/23
..........................................
United
States
7,975,712
$
8,133,183
2014-DN2,
M3,
FRN,
3.706%,
(1-month
USD
LIBOR
+
3.6%),
4/25/24
...........................................
United
States
14,643,335
14,626,096
2014-DN3,
M3,
FRN,
4.106%,
(1-month
USD
LIBOR
+
4%),
8/25/24
...........................................
United
States
493,156
503,988
2014-DN4,
M3,
FRN,
4.656%,
(1-month
USD
LIBOR
+
4.55%),
10/25/24
..........................................
United
States
5,611,609
5,755,987
2014-HQ1,
M3,
FRN,
4.206%,
(1-month
USD
LIBOR
+
4.1%),
8/25/24
...........................................
United
States
845,212
854,426
2014-HQ3,
M3,
FRN,
4.856%,
(1-month
USD
LIBOR
+
4.75%),
10/25/24
..........................................
United
States
1,433,413
1,448,988
2015-DNA1,
M3,
FRN,
3.406%,
(1-month
USD
LIBOR
+
3.3%),
10/25/27
..........................................
United
States
1,781,603
1,812,601
2015-DNA3,
M3,
FRN,
4.806%,
(1-month
USD
LIBOR
+
4.7%),
4/25/28
...........................................
United
States
16,929,082
17,559,045
2015-HQA1,
M3,
FRN,
4.806%,
(1-month
USD
LIBOR
+
4.7%),
3/25/28
...........................................
United
States
13,566,006
14,054,370
2016-DNA2,
M3,
FRN,
4.756%,
(1-month
USD
LIBOR
+
4.65%),
10/25/28
..........................................
United
States
12,253,752
12,827,716
2017-DNA1,
M2,
FRN,
3.356%,
(1-month
USD
LIBOR
+
3.25%),
7/25/29
...........................................
United
States
6,923,014
7,194,742
2017-DNA2,
M2,
FRN,
3.556%,
(1-month
USD
LIBOR
+
3.45%),
10/25/29
..........................................
United
States
5,868,312
6,101,003
2017-DNA3,
M2,
FRN,
2.606%,
(1-month
USD
LIBOR
+
2.5%),
3/25/30
...........................................
United
States
26,312,269
26,939,401
2017-HQA1,
M2,
FRN,
3.656%,
(1-month
USD
LIBOR
+
3.55%),
8/25/29
...........................................
United
States
23,755,258
24,572,757
2017-HQA2,
M2,
FRN,
2.756%,
(1-month
USD
LIBOR
+
2.65%),
12/25/29
..........................................
United
States
2,644,604
2,707,313
r
FNMA
Connecticut
Avenue
Securities
,
2013-C01,
M2,
FRN,
5.356%,
(1-month
USD
LIBOR
+
5.25%),
10/25/23
..........................................
United
States
8,011,879
8,356,901
2014-C01,
M2,
FRN,
4.506%,
(1-month
USD
LIBOR
+
4.4%),
1/25/24
...........................................
United
States
9,810,659
10,018,488
2014-C02,
1M2,
FRN,
2.706%,
(1-month
USD
LIBOR
+
2.6%),
5/25/24
...........................................
United
States
8,264,465
8,272,141
2014-C03,
1M2,
FRN,
3.106%,
(1-month
USD
LIBOR
+
3%),
7/25/24
...........................................
United
States
18,716,553
18,863,940
2014-C03,
2M2,
FRN,
3.006%,
(1-month
USD
LIBOR
+
2.9%),
7/25/24
...........................................
United
States
1,947,690
1,966,677
2015-C01,
1M2,
FRN,
4.406%,
(1-month
USD
LIBOR
+
4.3%),
2/25/25
...........................................
United
States
3,990,079
4,089,955
2015-C01,
2M2,
FRN,
4.656%,
(1-month
USD
LIBOR
+
4.55%),
2/25/25
...........................................
United
States
1,597,823
1,611,488
2015-C02,
1M2,
FRN,
4.106%,
(1-month
USD
LIBOR
+
4%),
5/25/25
...........................................
United
States
11,972,446
12,153,732
2015-C02,
2M2,
FRN,
4.106%,
(1-month
USD
LIBOR
+
4%),
5/25/25
...........................................
United
States
3,255,501
3,302,797
2015-C03,
1M2,
FRN,
5.106%,
(1-month
USD
LIBOR
+
5%),
7/25/25
...........................................
United
States
14,162,986
14,518,074
2015-C03,
2M2,
FRN,
5.106%,
(1-month
USD
LIBOR
+
5%),
7/25/25
...........................................
United
States
4,111,365
4,185,933
2016-C02,
1M2,
FRN,
6.106%,
(1-month
USD
LIBOR
+
6%),
9/25/28
...........................................
United
States
5,247,812
5,544,066
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
34
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Residential
Mortgage-Backed
Securities
(continued)
Thrifts
&
Mortgage
Finance
(continued)
r
FNMA
Connecticut
Avenue
Securities,
(continued)
2016-C04,
1M2,
FRN,
4.356%,
(1-month
USD
LIBOR
+
4.25%),
1/25/29
...........................................
United
States
6,417,009
$
6,733,359
2016-C05,
2M2,
FRN,
4.556%,
(1-month
USD
LIBOR
+
4.45%),
1/25/29
...........................................
United
States
3,569,649
3,725,492
2016-C06,
1M2,
FRN,
4.356%,
(1-month
USD
LIBOR
+
4.25%),
4/25/29
...........................................
United
States
1,629,966
1,701,415
2016-C07,
2M2,
FRN,
4.456%,
(1-month
USD
LIBOR
+
4.35%),
5/25/29
...........................................
United
States
2,500,900
2,609,310
2017-C01,
1M2,
FRN,
3.656%,
(1-month
USD
LIBOR
+
3.55%),
7/25/29
...........................................
United
States
15,809,837
16,362,887
2017-C03,
1M2,
FRN,
3.106%,
(1-month
USD
LIBOR
+
3%),
10/25/29
..........................................
United
States
22,378,758
23,020,831
2017-C04,
2M2,
FRN,
2.956%,
(1-month
USD
LIBOR
+
2.85%),
11/25/29
..........................................
United
States
6,037,829
6,186,303
2017-C05,
1M2,
FRN,
2.306%,
(1-month
USD
LIBOR
+
2.2%),
1/25/30
...........................................
United
States
15,160,864
15,372,661
313,688,066
a
a
a
a
a
a
Total
Residential
Mortgage-Backed
Securities
(Cost
$359,760,039)
................
341,074,185
Shares
Escrows
and
Litigation
Trusts
0.0%
a,b
Millennium
Corporate
Claim
Trust,
Escrow
Account
............
United
States
8,736,450
a,b
Millennium
Lender
Claim
Trust,
Escrow
Account
..............
United
States
8,736,450
Sanchez
Energy
Corp.,
Escrow
Account
....................
United
States
6,000,000
37,500
b
Vistra
Energy
Corp.,
Escrow
Account
......................
United
States
30,000,000
45,000
Total
Escrows
and
Litigation
Trusts
(Cost
$6,576,621)
...........................
82,500
Total
Long
Term
Investments
(Cost
$3,976,579,296)
.............................
3,873,684,778
a
Number
of
Contracts
Notional
Amount
#
a
a
aa
Options
Purchased
0.0%
Calls
-
Over-the-Counter
Interest
Rate
Swaptions
0.0%
Receive
Fixed
0.9%,
Pay
Floating
3
month
USD
LIBOR,
Counterparty
CITI,
Expires
9/16/21
.......................
1
209,200,000
709,665
Total
Options
Purchased
(Cost
$1,103,530)
.....................................
709,665
Short
Term
Investments
2.4%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
1.3%
d,v
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
50,800,930
50,800,930
Total
Money
Market
Funds
(Cost
$50,800,930)
..................................
50,800,930
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
35
0
Short
Term
Investments
(continued)
a
a
Principal
Amount
*
a
Value
a
a
a
a
a
a
Repurchase
Agreements
1.0%
w
Joint
Repurchase
Agreement,
0.005%,
5/03/21
(Maturity
Value
$38,267,668)
BNP
Paribas
Securities
Corp.
(Maturity
Value
$27,651,451)
Deutsche
Bank
Securities,
Inc.
(Maturity
Value
$3,384,393)
HSBC
Securities
(USA),
Inc.
(Maturity
Value
$7,231,824)
Collateralized
by
U.S.
Government
Agency
Securities,
3%
-
4.5%,
5/20/46
-
11/20/50;
and
U.S.
Treasury
Notes,
1.38%
-
2.88%,
5/31/21
-
3/31/26
(valued
at
$39,032,080)
.................
38,267,653
$
38,267,653
Total
Repurchase
Agreements
(Cost
$38,267,653)
...............................
38,267,653
x
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.1%
Country
Shares
Money
Market
Funds
0.1%
d,v
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
3,737,000
3,737,000
Principal
Amount
*
Repurchase
Agreements
0.0%
w
Joint
Repurchase
Agreement,
BofA
Securities,
Inc.,
0%,
5/03/21
(Maturity
Value
$934,302)
Collateralized
by
U.S.
Treasury
Note,
1.5%,
11/30/24
(valued
at
$952,989)
.........................................
934,302
934,302
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$4,671,302)
............................................................
4,671,302
Total
Short
Term
Investments
(Cost
$93,739,885
)
................................
93,739,885
a
Total
Investments
(Cost
$4,071,422,711)
101.6%
.................................
$3,968,134,328
Options
Written
(0.0)%
......................................................
(717,180)
Other
Assets,
less
Liabilities
(1.6)%
...........................................
(63,033,936)
Net
Assets
100.0%
...........................................................
$3,904,383,212
Number
of
Contracts
Notional
Amount
#
y
Options
Written
(0.0)%
Puts
-
Over-the-Counter
Interest
Rate
Swaptions
(0.0)%
Receive
Floating
3-month
USD
LIBOR,
Pay
Fixed
1.39%,
Counterparty
CITI,
Expires
9/16/21
.......................
1
(209,200,000)
(717,180)
(717,180)
Total
Options
Written
(Premiums
received
$1,082,610)
...........................
$
(717,180)
#
Notional
amount
is
the
number
of
units
specified
in
the
contract,
and
can
include
currency
units,
bushels,
shares,
pounds,
barrels
or
other
units.
Currency
units
are
stated
in
U.S.
dollars
unless
otherwise
indicated.
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
14
regarding
fair
value
measurements.
c
See
Note
9
regarding
restricted
securities.
d
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
36
e
Income
may
be
received
in
additional
securities
and/or
cash.
f
Perpetual
security
with
no
stated
maturity
date.
g
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
April
30,
2021,
the
aggregate
value
of
these
securities
was
$2,021,404,016,
representing
51.8%
of
net
assets.
h
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1(d).
i
The
coupon
rate
shown
represents
the
rate
at
period
end.
j
See
Note
1(k)
regarding
senior
floating
rate
interests.
k
See
Note
7
regarding
credit
risk
and
defaulted
securities.
l
See
Note
1(i)
regarding
Marketplace
Lending.
m
See
Note
1(g)
regarding
loan
participations
and
assignments.
n
A
supranational
organization
is
an
entity
formed
by
two
or
more
central
governments
through
international
treaties.
o
Principal
amount
of
security
is
adjusted
for
inflation.
See
Note
1(m).
p
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2021.
See
Note
1(e).
q
The
principal
represents
the
notional
amount.
See
Note
1(f)
regarding
value
recovery
instruments.
r
The
coupon
rate
shown
represents
the
rate
inclusive
of
any
caps
or
floors,
if
applicable,
in
effect
at
period
end.
s
Adjustable
rate
security
with
an
interest
rate
that
is
not
based
on
a
published
reference
index
and
spread.  The
rate
is
based
on
the
structure
of
the
agreement
and
current
market
conditions.
The
coupon
rate
shown
represents
the
rate
at
period
end.
t
Adjustable
Rate
Mortgage-Backed
Security
(ARM);
the
rate
shown
is
the
effective
rate
at
period
end.
ARM
rates
are
not
based
on
a
published
reference
rate
and
spread,
but
instead
pass-through
weighted
average
interest
income
inclusive
of
any
caps
or
floors,
if
applicable,
from
the
underlying
mortgage
loans
in
which
the
majority
of
mortgages
pay
interest
based
on
the
index
shown
at
their
designated
reset
dates
plus
a
spread,
less
the
applicable
servicing
and
guaranty
fee
(MBS
margin).
u
Security
purchased
on
a
to-be-announced
(TBA)
basis.
See
Note
1(d).
v
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
w
See
Note
1(c)
regarding
joint
repurchase
agreement.
x
See
Note
1(e)
regarding
securities
on
loan.
y
See
Note
1(f)
regarding
written
options.
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
37
At
April
30,
2021,
the
Fund
had
the
following futures
contracts
outstanding.
See
Note
1(f). 
At
April
30,
2021,
the
Fund
had
the
following
forward
exchange
contracts
outstanding.
See
Note
1
(
f
). 
Futures
Contracts
Description
Type
Number
of
Contracts
Notional
Amount
*
Expiration
Date
Value/
Unrealized
Appreciation
(Depreciation)
Interest
rate
contracts
U.S.
Treasury
10
Year
Ultra
Notes
................
Short
524
$
76,266,562
6/21/21
$
1,598,129
U.S.
Treasury
2
Year
Notes
.....................
Long
912
201,331,125
6/30/21
(150,739)
U.S.
Treasury
5
Year
Notes
.....................
Long
3,090
382,966,875
6/30/21
(2,606,243)
U.S.
Treasury
Long
Bonds
.....................
Short
594
93,406,500
6/21/21
(30,062)
Total
Futures
Contracts
......................................................................
$(1,188,915)
*
As
of
period
end.
Forward
Exchange
Contracts
Currency
Counter-
party
a
Type
Quantity
Contract
Amount
*
Settlement
Date
Unrealized
Appreciation
Unrealized
Depreciation
a
a
a
a
a
a
a
a
OTC
Forward
Exchange
Contracts
Brazilian
Real
......
JPHQ
Sell
3,778,007
690,085
5/10/21
$
$
(5,045)
Indonesian
Rupiah
..
JPHQ
Buy
69,000,000,000
4,705,080
5/10/21
66,753
Indonesian
Rupiah
..
JPHQ
Sell
135,000,000,000
9,449,150
5/10/21
112,955
Canadian
Dollar
....
JPHQ
Sell
4,500,000
3,597,603
5/11/21
(63,211)
Euro
.............
JPHQ
Buy
2,900,000
3,458,236
5/14/21
29,135
Euro
.............
JPHQ
Sell
28,262,000
33,539,928
5/14/21
(446,303)
South
African
Rand
..
JPHQ
Sell
155,000,000
10,676,769
5/17/21
7,784
Canadian
Dollar
....
JPHQ
Sell
11,500,000
9,075,413
5/26/21
(280,248)
Brazilian
Real
......
JPHQ
Sell
119,495,000
21,701,505
6/01/21
(243,076)
Mexican
Peso
......
JPHQ
Buy
357,700,000
17,287,877
6/21/21
271,711
Japanese
Yen
......
JPHQ
Buy
1,800,000,000
16,661,036
6/25/21
(183,006)
Australian
Dollar
....
JPHQ
Buy
11,000,000
8,470,660
6/28/21
5,949
South
Korean
Won
..
JPHQ
Buy
10,300,000,000
9,314,945
6/28/21
(101,420)
Euro
.............
JPHQ
Sell
9,200,000
10,973,990
7/19/21
(105,030)
Chinese
Yuan
......
JPHQ
Buy
64,000,000
9,736,950
8/17/21
73,842
Turkish
Lira
........
JPHQ
Buy
61,000,000
6,827,084
9/07/21
62,695
Total
Forward
Exchange
Contracts
...................................................
$630,824
$(1,427,339)
Net
unrealized
appreciation
(depreciation)
............................................
$(796,515)
*
In
U.S.
dollars
unless
otherwise
indicated.
a
May
be
comprised
of
multiple
contracts
with
the
same
counterparty,
currency
and
settlement
date.
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
38
At
April
30,
2021,
the
Fund
had
the
following credit
default
swap
contracts outstanding.
See
Note
1
(
f
). 
Credit
Default
Swap
Contracts
Description
Periodic
Payment
Rate
Received
(Paid)
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
(a)
Value
Unamortized
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Rating
(b)
OTC
Swap
Contracts
Contracts
to
Sell
Protection
(c)(d)
Single
Name
Air
France-KLM
.
5.00%
Quarterly
BOFA
6/20/26
970,000
EUR
$
12,636
$
20,038
$
(7,402)
NR
Air
France-KLM
.
5.00%
Quarterly
JPHQ
6/20/26
2,310,000
EUR
30,092
41,690
(11,598)
NR
Air
France-KLM
.
5.00%
Quarterly
MSCO
12/20/25
6,680,000
EUR
99,094
7,394
91,700
NR
American
Airlines
Group,
Inc.
..
5.00%
Quarterly
CITI
12/20/21
8,100,000
177,089
(346,748)
523,837
CCC
American
Airlines
Group,
Inc.
..
5.00%
Quarterly
GSCO
6/20/22
2,000,000
(2,146)
(21,367)
19,221
CCC
Carnival
Corp.
..
1.00%
Quarterly
CITI
12/20/25
8,100,000
(739,784)
(1,175,160)
435,376
B-
Macy's
Retail
Holdings
LLC
.
1.00%
Quarterly
JPHQ
12/20/25
8,100,000
(938,621)
(1,399,762)
461,141
B
Royal
Caribbean
Cruises
Ltd.
..
5.00%
Quarterly
BZWS
12/20/25
8,100,000
546,502
(223,840)
770,342
B
United
Airlines
Holdings,
Inc.
.
5.00%
Quarterly
FBCO
12/20/25
5,918,000
342,710
(26,357)
369,067
B
Traded
Index
(e)
Citibank
Bespoke
Franklin,
Equity
Tranche
0-5%
—%
Quarterly
CITI
12/20/22
9,500,000
(2,358,462)
(2,151,330)
(207,132)
Non-
Investment
Grade
(e)
Citibank
Bespoke
Palma
Index,
Mezzanine
Tranche
5-7%
2.30%
Quarterly
CITI
6/20/21
6,700,000
32,439
32,439
Non-
Investment
Grade
(e)
Citibank
Bespoke
Phoenix
Index,
Mezzanine
Tranche
5-7%
2.90%
Quarterly
CITI
12/20/21
8,500,000
128,626
128,626
Non-
Investment
Grade
MCDX.
NA.MAIN.31
.
1.00%
Quarterly
CITI
12/20/23
23,060,000
263,839
123,173
140,666
Investment
Grade
(e)
Morgan
Stanley
Bespoke
Pecan
Index,
Mezzanine
Tranche
5-10%
4.10%
Quarterly
MSCO
12/20/21
9,000,000
(21,720)
(21,720)
Non-
Investment
Grade
(e)
Morgan
Stanley
Bespoke
Pecan
Index,
Mezzanine
Tranche
5-10%
3.98%
Quarterly
MSCO
12/20/21
9,000,000
(29,827)
(29,827)
Non-
Investment
Grade
Total
OTC
Swap
Contracts
..............................................
$(2,457,533)
$(5,152,269)
$2,694,736
Total
Credit
Default
Swap
Contracts
....................................
$(2,457,533)
$
(5,152,269)
$2,694,736
(a)
In
U.S.
dollars
unless
otherwise
indicated.
For
contracts
to
sell
protection,
the
notional
amount
is
equal
to
the
maximum
potential
amount
of
the
future
payments
and
no
recourse
provisions
have
been
entered
into
in
association
with
the
contracts.
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
39
At
April
30,
2021,
the
Fund
had
the
following cross-currency
swap
contracts outstanding.
See
Note
1
(
f
). 
At
April
30,
2021,
the
Fund
had
the
following inflation index
swap
contracts outstanding.
See
Note
1
(
f
). 
(b)
Based
on
Standard
and
Poor's
(S&P)
Rating
for
single
name
swaps
and
internal
ratings
for
index
swaps.
Internal
ratings
based
on
mapping
into
equivalent
ratings
from
external
vendors.
(c)
Performance
triggers
for
settlement
of
contract
include
default,
bankruptcy
or
restructuring
for
single
name
swaps,
and
failure
to
pay
or
bankruptcy
of
the
underlying
securities
for
traded
index
swaps.
(d)
The
fund
enters
contracts
to
sell
protection
to
create
a
long
credit
position.
(e)
Represents
a
custom
index
comprised
of
a
basket
of
underlying
instruments.
Cross-Currency
Swap
Contracts
Description
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
Value/
Unrealized
Appreciation
(Depreciation)
aA
aaa
aaa
aaa
OTC
Swap
Contracts
Receive
Floating
3-month
USD
LIBOR
+
2.87%
.....
Quarterly
3,834,600
USD
Pay
Fixed
2.5%
.............................
Annual
CITI
5/04/21
3,300,000
EUR
$
(203,321)
Total
Cross
Currency
Swap
Contracts
...........................................................
$(203,321)
Inflation
Index
Swap
Contracts
Description
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
Value
Unamortized
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Centrally
Cleared
Swap
Contracts
Receive
variable
change
  in
USA
CPI-U
........
At
Maturity
Pay
Fixed
1.913%
.....
At
Maturity
1/14/29
$
34,600,000
$
1,913,556
$
$
1,913,556
Receive
variable
change
  in
USA
CPI-U
........
At
Maturity
Pay
Fixed
1.943%
.....
At
Maturity
1/15/29
4,900,000
257,160
257,160
Total
Inflation
Index
Swap
Contracts
..................................
$2,170,716
$—
$2,170,716
See
Note 10
regarding
other
derivative
information.
See
Abbreviations
on
page
67.
Franklin
Strategic
Series
Consolidated
Financial
Statements
Statement
of
Assets
and
Liabilities
April
30,
2021
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
40
Franklin
Strategic
Income
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
...................................................................
$3,635,734,260
Cost
-
Controlled
affiliates
(Note
3
f
and
11
)
......................................................
341,948,566
Cost
-
Non-controlled
affiliates
(Note
3
f
and
11
)
...................................................
54,537,930
Cost
-
Unaffiliated
repurchase
agreements
......................................................
39,201,955
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
of
$4,491,150)
.................................
$3,605,075,974
Value
-
Controlled
affiliates
(Note
3
f
and
11
)
.....................................................
269,318,469
Value
-
Non-controlled
affiliates
(Note
3
f
and
11
)
..................................................
54,537,930
Value
-
Unaffiliated
repurchase
agreements
......................................................
39,201,955
Cash
....................................................................................
2,959,689
Receivables:
Investment
securities
sold
...................................................................
2,671,736
Capital
shares
sold
........................................................................
2,281,408
Dividends
and
interest
.....................................................................
35,807,263
Deposits
with
brokers
for:
OTC
derivative
contracts
..................................................................
7,100,716
Futures
contracts
........................................................................
1,951,185
Centrally
cleared
swap
contracts
............................................................
1,682,280
Variation
margin
on
futures
contracts
...........................................................
18,071
OTC
swap
contracts
(upfront
payments
$203,408)
..................................................
192,295
Unrealized
appreciation
on
OTC
forward
exchange
contracts
..........................................
630,824
Unrealized
appreciation
on
OTC
swap
contracts
....................................................
2,972,415
D
eferred
tax
benefit
(Note
1
h
)
.................................................................
981,055
Total
assets
..........................................................................
4,027,383,265
Liabilities:
Payables:
Investment
securities
purchased
..............................................................
98,573,548
Capital
shares
redeemed
...................................................................
5,814,030
Management
fees
.........................................................................
1,334,040
Distribution
fees
..........................................................................
822,117
Transfer
agent
fees
........................................................................
802,736
Distributions
to
shareholders
.................................................................
612,732
Variation
margin
on
centrally
cleared
swap
contracts
...............................................
1,997,337
OTC
swap
contracts
(upfront
receipts
$5,355,677)
..................................................
5,344,564
Unrealized
depreciation
on
OTC
swap
contracts
....................................................
481,000
Options
written,
at
value
(premiums
received
$1,082,610)
............................................
717,180
Unrealized
depreciation
on
OTC
forward
exchange
contracts
..........................................
1,427,339
Payable
upon
return
of
securities
loaned
(Note
1
e
)
..................................................
4,671,302
Deferred
tax
...............................................................................
108,592
Accrued
expenses
and
other
liabilities
...........................................................
293,534
Total
liabilities
.........................................................................
123,000,051
Net
assets,
at
value
.................................................................
$3,904,383,214
Net
assets
consist
of:
Paid-in
capital
.............................................................................
$4,576,041,948
Total
distributable
earnings
(losses)
.............................................................
(671,658,734)
Net
assets,
at
value
.................................................................
$3,904,383,214
Franklin
Strategic
Series
Consolidated
Financial
Statements
Statement
of
Assets
and
Liabilities
(continued)
April
30,
2021
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
Annual
Report
41
Franklin
Strategic
Income
Fund
Class
A:
Net
assets,
at
value
.......................................................................
$2,862,068,434
Shares
outstanding
........................................................................
303,209,813
Net
asset
value
per
share
a
..................................................................
$9.44
Maximum
offering
price
per
share
(net
asset
value
per
share
÷
96.25%)
................................
$9.81
Class
C:
Net
assets,
at
value
.......................................................................
$387,588,801
Shares
outstanding
........................................................................
41,050,621
Net
asset
value
and
maximum
offering
price
per
share
a
.............................................
$9.44
Class
R:
Net
assets,
at
value
.......................................................................
$59,365,619
Shares
outstanding
........................................................................
6,316,096
Net
asset
value
and
maximum
offering
price
per
share
.............................................
$9.40
Class
R6:
Net
assets,
at
value
.......................................................................
$132,735,960
Shares
outstanding
........................................................................
14,039,441
Net
asset
value
and
maximum
offering
price
per
share
.............................................
$9.45
Advisor
Class:
Net
assets,
at
value
.......................................................................
$462,624,400
Shares
outstanding
........................................................................
48,933,812
Net
asset
value
and
maximum
offering
price
per
share
.............................................
$9.45
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
Franklin
Strategic
Series
Consolidated
Financial
Statements
Consolidated
Statement
of
Operations*
for
the
year
ended
April
30,
2021
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
42
Franklin
Strategic
Income
Fund
Investment
income:
Dividends:
Unaffiliated
issuers
........................................................................
$793,241
Controlled
affiliates
(Note
3
f
and
11
)
...........................................................
5,534,929
Non-controlled
affiliates
(Note
3
f
and
11
)
........................................................
843
Interest:
(net
of
foreign
taxes
of
$460,511)
Unaffiliated
issuers:
Paydown
gain
(loss)
.....................................................................
(18,751,835)
Paid
in
cash
a
...........................................................................
205,258,347
Income
from
securities
loaned:
Unaffiliated
entities
(net
of
fees
and
rebates)
.....................................................
3,625
Non-controlled
affiliates
(Note
3
f
)
.............................................................
19
Total
investment
income
...................................................................
192,839,169
Expenses:
Management
fees
(Note
3
a
)
...................................................................
18,371,509
Distribution
fees:
(Note
3c
)
    Class
A
................................................................................
7,140,183
    Class
C
................................................................................
2,976,728
    Class
R
................................................................................
312,522
Transfer
agent
fees:
(Note
3e
)
    Class
A
................................................................................
4,079,911
    Class
C
................................................................................
655,394
    Class
R
................................................................................
89,706
    Class
R6
...............................................................................
65,050
    Advisor
Class
............................................................................
737,525
Custodian
fees
(Note
4
)
......................................................................
51,923
Reports
to
shareholders
......................................................................
328,826
Registration
and
filing
fees
....................................................................
168,335
Professional
fees
...........................................................................
159,458
Trustees'
fees
and
expenses
..................................................................
54,628
Marketplace
lending
fees
(Note
1i)
..............................................................
288,836
Other
....................................................................................
262,642
Total
expenses
.........................................................................
35,743,176
Expense
reductions
(Note
4
)
...............................................................
(148,830)
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
..............................................
(816,632)
Net
expenses
.........................................................................
34,777,714
Net
investment
income
................................................................
158,061,455
Franklin
Strategic
Series
Consolidated
Financial
Statements
Consolidated
Statement
of
Operations*
(continued)
for
the
year
ended
April
30,
2021
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
Annual
Report
43
Franklin
Strategic
Income
Fund
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
(net
of
foreign
taxes
of
$4,583)
Unaffiliated
issuers
......................................................................
(23,713,457)
Foreign
currency
transactions
................................................................
176,190
Forward
exchange
contracts
.................................................................
(28,787,850)
Futures
contracts
.........................................................................
4,059,344
TBA
sale
commitments
.....................................................................
529,382
Swap
contracts
...........................................................................
(15,350,780)
Net
realized
gain
(loss)
..................................................................
(63,087,171)
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
......................................................................
332,299,297
Controlled
affiliates
(Note
3
f
)
...............................................................
11,575,632
Non-controlled
affiliates
(Note
3
f
and
11
)
......................................................
1,024,890
Translation
of
other
assets
and
liabilities
denominated
in
foreign
currencies
..............................
(1,681,134)
Written
options
...........................................................................
365,430
Forward
exchange
contracts
.................................................................
2,629,854
Futures
contracts
.........................................................................
(4,405,766)
Swap
contracts
...........................................................................
56,410,539
Change
in
deferred
tax
benefit
(Note
1
h
)
........................................................
578,179
Change
in
deferred
taxes
on
unrealized
appreciation
...............................................
(78,938)
Net
change
in
unrealized
appreciation
(depreciation)
............................................
398,717,983
Net
realized
and
unrealized
gain
(loss)
............................................................
335,630,812
Net
increase
(decrease)
in
net
assets
resulting
from
operations
..........................................
$493,692,267
*
Includes
the
consolidated
operations
of
FT
Holdings
Corporation
II
from
May
1,
2020
through
April
27,
2021.
See
Note
1(h).
a
Includes
amortization
of
premium
and
accretion
of
discount.
Franklin
Strategic
Series
Consolidated
Financial
Statements
Consolidated
Statement
of
Changes
in
Net
Assets
franklintempleton.com
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
44
Franklin
Strategic
Income
Fund
Year
Ended
April
30,
2021*
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
.................................................
$158,061,455
$182,627,278
Net
realized
gain
(loss)
.................................................
(63,087,171)
(42,550,243)
Net
change
in
unrealized
appreciation
(depreciation)
...........................
398,717,983
(382,746,373)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
................
493,692,267
(242,669,338)
Distributions
to
shareholders:
Class
A
.............................................................
(107,559,827)
(133,707,047)
Class
C
.............................................................
(15,093,095)
(25,071,873)
Class
R
.............................................................
(2,213,268)
(3,171,248)
Class
R6
............................................................
(5,315,212)
(9,963,217)
Advisor
Class
........................................................
(20,592,895)
(26,896,542)
Total
distributions
to
shareholders
..........................................
(150,774,297)
(198,809,927)
Capital
share
transactions:
(Note
2
)
Class
A
.............................................................
(62,316,513)
(141,906,067)
Class
C
.............................................................
(174,939,408)
(138,604,206)
Class
R
.............................................................
(8,115,630)
(16,035,134)
Class
R6
............................................................
(11,480,330)
(159,106,633)
Advisor
Class
........................................................
(100,161,067)
(33,579,296)
Total
capital
share
transactions
............................................
(357,012,948)
(489,231,336)
Net
increase
(decrease)
in
net
assets
...................................
(14,094,978)
(930,710,601)
Net
assets:
Beginning
of
year
.......................................................
3,918,478,192
4,849,188,793
End
of
year
...........................................................
$3,904,383,214
$3,918,478,192
*
Includes
the
consolidated
operations
of
FT
Holdings
Corporation
II
fro
m
May
1,
2020
through
April
27,
2021.
See
Note
1(h)
.
Franklin
Strategic
Series
45
franklintempleton.com
Annual
Report
Notes
to
Consolidated
Financial
Statements
Franklin
Strategic
Income
Fund
1.
Organization
and
Significant
Accounting
Policies
Franklin
Strategic
Series (Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-
end
management
investment
company,
consisting
of 
ten
separate
funds
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP).
Franklin
Strategic
Income
Fund
(Fund)
is
included
in
this
report.
The
Fund
offers five
classes
of
shares:
Class
A,
Class
C,
Class
R,
Class
R6
and
Advisor
Class. Class
C
shares
automatically
convert
to
Class
A
shares
after
they
have
been
held
for
10
years.
Each
class
of
shares
may
differ
by
its
initial
sales
load,
contingent
deferred
sales
charges,
voting
rights
on
matters
affecting
a
single
class,
its
exchange
privilege
and
fees
due
to
differing
arrangements
for
distribution
and
transfer
agent
fees. 
The
following
summarizes
the Fund's
significant
accounting
policies.
a.
Financial
Instrument
Valuation 
The
Fund's
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The
Fund
calculates
the
net
asset
value
(NAV)
per
share
each business
day as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Trust's
Board
of
Trustees
(the
Board),
the Fund's
administrator
has
responsibility
for
oversight
of
valuation,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Fund
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities
and
derivative
financial
instruments
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded,
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Debt
securities
generally
trade
in
the OTC
market
rather
than
on
a
securities
exchange.
The
Fund's
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Securities
denominated
in
a
foreign
currency
are
converted
into
their
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
date
that
the
values
of
the
foreign
debt
securities
are
determined.
Investments
in 
open-end mutual
funds
are
valued
at
the
closing
NAV.
Investments
in
repurchase
agreements
are
valued
at
cost,
which
approximates
fair
value.
Certain
derivative
financial
instruments
are
centrally
cleared
or
trade
in
the
OTC
market.
The
Fund's
pricing
services
use
various
techniques
including
industry
standard
option
pricing
models
and
proprietary
discounted
cash
flow
models
to
determine
the
fair
value
of
those
instruments.
The
Fund's
net
benefit
or
obligation
under
the
derivative
contract,
as
measured
by
the
fair
value
of
the
contract,
is
included
in
net
assets.
The
Fund
has
procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the Fund
primarily
employs
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
book
values,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
46
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed.
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Fund's
business
day. Events
can occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Fund.
As
a
result,
differences
may
arise
between
the
value
of
the
Fund's
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time. In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Fund's
securities
to
the
latest
indications
of
fair
value
at
4
p.m.
Eastern
time.
At
April
30,
2021,
certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
inputs
within
the
fair
value
hierarchy
(referred
to
as
“market
level
fair
value”).
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Fund's
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Fund's
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Fund
for
financial
reporting
purposes.
b.
Foreign
Currency
Translation 
Portfolio
securities
and
other
assets
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
based
on
the
exchange
rate
of
such
currencies
against
U.S.
dollars
on
the
date
of
valuation.
The
Fund
may
enter
into
foreign
currency
exchange
contracts
to
facilitate
transactions
denominated
in
a
foreign
currency.
Purchases
and
sales
of
securities,
income
and
expense
items
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
at
the
exchange
rate
in
effect
on
the
transaction
date.
Portfolio
securities
and
assets
and
liabilities
denominated
in
foreign
currencies
contain
risks
that
those
currencies
will
decline
in
value
relative
to
the
U.S.
dollar.
Occasionally,
events
may
impact
the
availability
or
reliability
of
foreign
exchange
rates
used
to
convert
the
U.S.
dollar
equivalent
value.
If
such
an
event
occurs,
the
foreign
exchange
rate
will
be
valued
at
fair
value
using
procedures
established
and
approved
by
the
Board.
The
Fund
does
not
separately
report
the
effect
of
changes
in
foreign
exchange
rates
from
changes
in
market
prices
on
securities
held.
Such
changes
are
included
in
net
realized
and
unrealized
gain
or
loss
from
investments
in
the
Consolidated
Statement of
Operations.
Realized
foreign
exchange
gains
or
losses
arise
from
sales
of
foreign
currencies,
currency
gains
or
losses
realized
between
the
trade
and
settlement
dates
on
securities
transactions
and
the
difference
between
the
recorded
amounts
of
dividends,
interest,
and
foreign
withholding
taxes
and
the
U.S.
dollar
equivalent
of
the
amounts
actually
received
or
paid.
Net
unrealized
foreign
exchange
gains
and
losses
arise
from
changes
in
foreign
exchange
rates
on
foreign
denominated
assets
and
liabilities
other
than
investments
in
securities
held
at
the
end
of
the
reporting
period.
c.
Joint
Repurchase
Agreement
The
Fund
enters
into
a
joint
repurchase
agreement
whereby
its
uninvested
cash
balance
is
deposited
into
a
joint
cash
account
with
other
funds
managed
by
the
investment
manager
or
an
affiliate
of
the
investment
manager
and
is
used
to
invest
in
one
or
more
repurchase
agreements.
The
value
and
face
amount
of
the
joint
repurchase
agreement
are
allocated
to
the
funds
based
on
their
pro-rata
interest.
A
repurchase
agreement
is
accounted
for
as
a
loan
by
the
Fund
to
the
seller,
collateralized
by
securities
which
are
delivered
to
the
Fund's
custodian.
The
fair
value,
including
accrued
interest,
of
the
initial
collateralization
is
required
to
be
at
least
102%
of
the
dollar
amount
invested
by
the
funds,
with
the
value
of
the
underlying
securities
marked
to
market
daily
to
maintain
coverage
of
at
least
100%.
Repurchase
agreements
are
subject
to
the
terms
of
Master
Repurchase
Agreements
(MRAs)
with
approved
counterparties
(sellers).
The
MRAs
contain
various
provisions,
including
but
not
limited
to
events
of
default
and
maintenance
of
collateral
for
repurchase
agreements.
In
the
event
of
default
by
either
the
seller
or
the
Fund,
certain
MRAs
may
permit
the
non-
defaulting
party
to
net
and
close-out
all
transactions,
if
any,
traded
under
such
agreements.
The
Fund
may
sell
securities
1.
Organization
and
Significant
Accounting
Policies
(continued)
a.
Financial
Instrument
Valuation 
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
47
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
it
holds
as
collateral
and
apply
the
proceeds
towards
the
repurchase
price
and
any
other
amounts
owed
by
the
seller
to
the
Fund
in
the
event
of
default
by
the
seller.
This
could
involve
costs
or
delays
in
addition
to
a
loss
on
the
securities
if
their
value
falls
below
the
repurchase
price
owed
by
the
seller.
The
joint
repurchase
agreement
held
by
the Fund
at
year
end,
as
indicated
in
the
Statement
of
Investments,
had
been
entered
into
on
April
30,
2021.
d.
Securities
Purchased
on
Delayed
Delivery
and
TBA
Basis
The
Fund
purchases
securities
on
a
when-issued
or
delayed
delivery
and
to-be-announced
(TBA)
basis,
with
payment
and
delivery
scheduled
for
a
future
date.
These
transactions
are
subject
to
market
fluctuations
and
are
subject
to
the
risk
that
the
value
at
delivery
may
be
more
or
less
than
the
trade
date
purchase
price.
Although
the
Fund
will
generally
purchase
these
securities
with
the
intention
of
holding
the
securities,
it
may
sell
the
securities
before
the
settlement
date.
Sufficient
assets
have
been
segregated
for
these
securities
and
collateral
has
been
pledged
and/or
received
for
open
TBA
trades.
e.
Securities
Lending
The
Fund
participates
in
an
agency
based
securities
lending
program
to
earn
additional
income.
The
Fund
receives
collateral
in
the
form
of
cash
and/or
U.S.
Government
and
Agency
securities
against
the
loaned
securities
in
an
amount
equal
to
at
least
102%
of
the
fair
value
of
the
loaned
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
100%
of
the
fair
value
of
loaned
securities,
as
determined
at
the
close
of
Fund
business
each
day;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
Fund
on
the
next
business
day.
Any
cash
collateral
received
is
deposited
into
a
joint
cash
account
with
other
funds
and
is
used
to
invest
in
a
money
market
fund
managed
by
Franklin
Advisers,
Inc.,
an
affiliate
of
the Fund,
and/or
a
joint
repurchase
agreement
in
the
Statement
of
Assets
and
Liabilities.
These
securities
received
as
collateral
are
held
in
segregated
accounts
with
the
Fund’s
custodian.
The
Fund
cannot
repledge
or
resell
these
securities
received
as
collateral.
As
such,
the
non-
cash
collateral
is
excluded
from
the
Statement
of
Assets
and
Liabilities.
The
Fund
may
receive
income
from
the
investment
of
cash
collateral,
in
addition
to
lending
fees
and
rebates
paid
by
the
borrower.
Income
from
securities
loaned,
net
of
fees
paid
to
the
securities
lending
agent
and/or
third-party
vendor,
is
reported
separately
in
the
Consolidated
Statement
of
Operations.
The
Fund
bears
the
market
risk
with
respect
to any
cash collateral
investment,
securities
loaned,
and
the
risk
that
the
agent
may
default
on
its
obligations
to
the
Fund.
If
the
borrower
defaults
on
its
obligation
to
return
the
securities
loaned,
the
Fund
has
the
right
to
repurchase
the
securities
in
the
open
market
using
the
collateral
received.
f.
Derivative
Financial
Instruments
The
Fund
invested
in
derivative
financial
instruments
in
order
to
manage
risk
or
gain
exposure
to
various
other
investments
or
markets.
Derivatives
are
financial
contracts
based
on
an
underlying
or
notional
amount,
require
no
initial
investment
or
an
initial
net
investment
that
is
smaller
than
would
normally
be
required
to
have
a
similar
response
to
changes
in
market
factors,
and
require
or
permit
net
settlement.
Derivatives
contain
various
risks
including
the
potential
inability
of
the
counterparty
to
fulfill
their
obligations
under
the
terms
of
the
contract,
the
potential
for
an
illiquid
secondary
market,
and/or
the
potential
for
market
movements
which
expose
the
Fund
to
gains
or
losses
in
excess
of
the
amounts
shown
in
the
Statement
of
Assets
and
Liabilities.
Realized
gain
and
loss
and
unrealized
appreciation
and
depreciation
on
these
contracts
for
the
period
are
included
in
the Consolidated
Statement
of
Operations. 
Derivative
counterparty
credit
risk
is
managed
through
a
formal
evaluation
of
the
creditworthiness
of
all
potential
counterparties.
The
Fund
attempts
to
reduce
its
exposure
to
counterparty
credit
risk
on
OTC
derivatives,
whenever
possible,
by
entering
into
International
Swaps
and
Derivatives
Association
(ISDA)
master
agreements
with
certain
counterparties.
These
agreements
contain
various
provisions,
including
but
not
limited
to
collateral
requirements,
events
of
default,
or
early
termination.
Termination
events
applicable
to
the
counterparty
include
certain
deteriorations
in
the
credit
quality
of
the
counterparty.
Termination
events
applicable
to
the
Fund
include
failure
of
the
Fund
to
maintain
certain
net
asset
levels
and/or
limit
the
decline
in
net
assets
over
various
periods
of
time.
In
the
event
of
default
or
early
termination,
the
ISDA
master
agreement
gives
the
non-defaulting
party
the
right
to
net
and
close-out
all
transactions
traded,
whether
or
not
arising
1.
Organization
and
Significant
Accounting
Policies
(continued)
c.
Joint
Repurchase
Agreement
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
48
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
under
the
ISDA
agreement,
to
one
net
amount
payable
by
one
counterparty
to
the
other.
However,
absent
an
event
of
default
or
early
termination,
OTC
derivative
assets
and
liabilities
are
presented
gross
and
not
offset
in
the
Statement
of
Assets
and
Liabilities.
Early
termination
by
the
counterparty
may
result
in
an
immediate
payment
by
the
Fund
of
any
net
liability
owed
to
that
counterparty
under
the
ISDA
agreement.
Collateral
requirements
differ
by
type
of
derivative.
Collateral
or
initial
margin
requirements
are
set
by
the
broker
or
exchange
clearing
house
for
exchange
traded
and
centrally
cleared
derivatives.
Initial
margin
deposited
is
held
at
the
exchange
and
can
be
in
the
form
of
cash
and/or
securities.
For
OTC
derivatives
traded
under
an
ISDA
master
agreement,
posting
of
collateral
is
required
by
either
the
Fund
or
the
applicable
counterparty
if
the
total
net
exposure
of
all
OTC
derivatives
with
the
applicable
counterparty
exceeds
the
minimum
transfer
amount,
which
typically
ranges
from
$100,000
to
$250,000,
and
can
vary
depending
on
the
counterparty
and
the
type
of
the
agreement.
Generally,
collateral
is
determined
at
the
close
of
Fund
business
each
day
and
any
additional
collateral
required
due
to
changes
in
derivative
values
may
be
delivered
by
the
Fund
or
the
counterparty
the
next
business
day,
or
within
a
few
business
days.
Collateral
pledged
and/or
received
by
the
Fund
for
OTC
derivatives,
if
any,
is
held
in
segregated
accounts
with
the
Fund's
custodian/counterparty
broker
and
can
be
in
the
form
of
cash
and/or
securities.
Unrestricted
cash
may
be
invested
according
to
the
Fund's
investment
objectives.
To
the
extent
that
the
amounts
due
to
the
Fund
from
its
counterparties
are
not
subject
to
collateralization
or
are
not
fully
collateralized,
the
Fund
bears
the
risk
of
loss
from
counterparty
non-performance.
The
Fund
entered
into
exchange
traded
futures
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk.
A
futures
contract
is
an
agreement
between
the
Fund
and
a
counterparty
to
buy
or
sell
an
asset
at
a
specified
price
on
a
future
date.
Required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Statement
of
Assets
and
Liabilities.
The
Fund entered
into
OTC
forward
exchange
contracts
primarily
to
manage
and/or
gain
exposure
to
certain
foreign
currencies.
A
forward
exchange
contract
is
an
agreement
between
the
Fund
and
a
counterparty
to
buy
or
sell
a
foreign
currency at
a
specific
exchange
rate
on
a
future
date.
The
Fund
entered
into
credit
default
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
credit
risk.
A
credit
default
swap
is
an
agreement
between
the
Fund
and
a
counterparty
whereby
the
buyer
of
the
contract
receives
credit
protection
and
the
seller
of
the
contract
guarantees
the
credit
worthiness
of
a
referenced
debt
obligation.
These
agreements
may
be
privately
negotiated
in
the
over-the-
counter
market
(OTC
credit
default
swaps)
or
may
be
executed
in
a
multilateral
trade
facility
platform,
such
as
a
registered
exchange
(centrally
cleared
credit
default
swaps).
The
underlying
referenced
debt
obligation
may
be
a
single
issuer
of
corporate
or
sovereign
debt,
a
credit
index,
a
basket
of
issuers
or
indices,
or
a
tranche
of
a
credit
index
or
basket
of
issuers
or
indices.
In
the
event
of
a
default
of
the
underlying
referenced
debt
obligation,
the
buyer
is
entitled
to
receive
the
notional
amount
of
the
credit
default
swap
contract
from
the
seller
in
exchange
for
the
referenced
debt
obligation,
a
net
settlement
amount
equal
to
the
notional
amount
of
the
credit
default
swap
less
the
recovery
value
of
the
referenced
debt
obligation,
or
other
agreed
upon
amount.
For
centrally
cleared
credit
default
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Statement
of
Assets
and
Liabilities.
Over
the
term
of
the
contract,
the
buyer
pays
the
seller
a
periodic
stream
of
payments,
provided
that
no
event
of
default
has
occurred.
Such
periodic
payments
are
accrued
daily
as
an
unrealized
appreciation
or
depreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Upfront
payments
and
receipts
are
reflected
in
the
Statement
of
Assets
and
Liabilities
and
represent
compensating
factors
between
stated
terms
of
the
credit
default
swap
agreement
and
prevailing
market
conditions
(credit
spreads
and
other
relevant
factors).
These
upfront
payments
and
receipts
are
amortized
over
the
term
of
the
contract
as
a
realized
gain
or
loss
in
the Consolidated
Statement
of
Operations.
The
Fund
entered
into
OTC
cross
currency
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk
and
certain
foreign
currencies.
A
cross
currency
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
(determined
using
either
a
fixed
or
floating
rate)
based
on
the
notional
amounts
of
two
different
1.
Organization
and
Significant
Accounting
Policies
(continued)
f.
Derivative
Financial
Instruments
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
49
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
currencies.
The
notional
amounts
are
typically
determined
based
on
the
spot
exchange
rates
at
the
opening
of
the
contract.
Cross
currency
swaps
may
require
the
exchange
of
notional
amounts
at
the
opening
and/or
closing
of
the
contract.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Upfront
payments
and
receipts
are
reflected
in
the
Statement
of
Assets
and
Liabilities
and
represent
compensating
factors
between
stated
terms
of
the
cross
currency
swap
contract
and
prevailing
market
conditions
(interest
rate
spreads
and
other
relevant
factors).
These
upfront
payments
and
receipts
are
amortized
over
the
term
of
the
contract
as
a
realized
gain
or
loss
in
the
Consolidated
Statement
of
Operations.
The
Fund
entered
into
inflation
index
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
inflation
risk.
An
inflation
index
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
whereby
one
party
makes
payments
based
on
the
percentage
change
in
an
index
that
serves
as
a
measure
of
inflation
and
the
other
party
makes
a
regular
payment
based
on
a
compounded
fixed
rate,
applied
to
a
notional
amount.
These
agreements
may
be
privately
negotiated
in
the
over-the-counter
market
(OTC
inflation
index
swap)
or
may
be
executed
on
a
registered
exchange
(centrally
cleared
inflation
index
swap).
For
centrally
cleared
inflation
index
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Typically,
an
inflation
index
swap
has
payment
obligations
netted
and
exchanged
upon
maturity.
The
Fund entered
into
interest
rate
swap
contracts
primarily
to
manage
interest
rate
risk.
An
interest
rate
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
based
on
the
difference
between
two
interest
rates,
applied
to
a
notional
amount.
These
agreements
may
be
privately
negotiated
in
the
over-the-
counter
market
(OTC
interest
rate
swaps)
or
may
be
executed
on
a
registered
exchange
(centrally
cleared
interest
rate
swaps).
For
centrally
cleared
interest
rate
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Statement
of
Assets
and
Liabilities.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
The
Fund
entered
into
OTC
total
return
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
the
interest
rate
risk
of
an
underlying
instrument
such
as
a
stock,
bond,
index
or
basket
of
securities
or
indices.
A
total
return
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
a
return
linked
to
an
underlying
instrument
for
a
floating
or
fixed
rate
payment,
both
based
upon
a
notional
amount.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
or
received
are
accrued
daily
and
recorded
as
unrealized
appreciation
or
depreciation
until
the
payments
are
made,
at
which
time
they
are
recognized
as
realized
gain
or
loss.
The
Fund
purchased
or
wrote
exchange
traded
and/or
OTC
option
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk.
An
option
is
a
contract
entitling
the
holder
to
purchase
or
sell
a
specific
amount
of
shares
or
units
of
an
asset
or
notional
amount
of
a
swap
(swaption),
at
a
specified
price.
When
an
option
is
purchased
or
written,
an
amount
equal
to
the
premium
paid
or
received
is
recorded
as
an
asset
or
liability,
respectively.
Upon
exercise
of
an
option,
the
acquisition
cost
or
sales
proceeds
of
the
underlying
investment
is
adjusted
by
any
premium
received
or
paid.
Upon
expiration
of
an
option,
any
premium
received
or
paid
is
recorded
as
a
realized
gain
or
loss.
Upon
closing
an
option
other
than
through
expiration
or
exercise,
the
difference
between
the
premium
received
or
paid
and
the
cost
to
close
the
position
is
recorded
as
a
realized
gain
or
loss.
The
Fund
invests
in
value
recovery
instruments
(VRI)
primarily
to
gain
exposure
to
economic
growth.
Periodic
payments
from
VRI
are
dependent
on
established
benchmarks
for
underlying
variables.
VRI
has
a
notional
amount,
which
is
used
to
calculate
amounts
of
payments
to
holders.
Payments
are
recorded
upon
receipt
as
realized
gains
in
the
Consolidated
Statement
of
Operations.
The
risks
of
investing
in
VRI
include
growth
risk,
liquidity,
and
the
potential
loss
of
investment.
See
Note
10 regarding
other
derivative
information.
1.
Organization
and
Significant
Accounting
Policies
(continued)
f.
Derivative
Financial
Instruments
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
50
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
g.
Loan
Participation
Notes
The
Fund
invests
in
loan
participation
notes
(Participations).
Participations
are
loans
originally
issued
to
a
borrower
by
one
or
more
financial
institutions
(the
Lender)
and
subsequently
sold
to
other
investors,
such
as
the Fund.
Participations
typically
result
in
the
Fund
having
a
contractual
relationship
only
with
the
Lender
and
not
with
the
borrower.
The
Fund
has
the
right
to
receive
from
the
Lender
any
payments
of
principal,
interest
and
fees
which
the
Lender
received
from
the
borrower.
The
Fund
generally
has
no
rights
to
either
enforce
compliance
by
the
borrower
with
the
terms
of
the
loan
agreement
or
to
any
collateral
relating
to
the
original
loan.
As
a
result,
the Fund
assumes
the
credit
risk
of
both
the
borrower
and
the
Lender
that
is
selling
the
Participation.
The
Participations
may
also
involve
interest
rate
risk
and
liquidity
risk,
including
the
potential
default
or
insolvency
of
the
borrower
and/or
the
Lender.
h.
FT
Holdings
Corporation
II
(FT
Subsidiary)
Prior
to
April
27,
2021,
the
Fund
invested
in
FT
Subsidiary.
FT
Subsidiary
was
a
Delaware
Corporation,
was
a
wholly-
owned
subsidiary
of
the
Fund,
and
was
able
to
invest
in
certain
financial
instruments
consistent
with
the
investment
objective
of
the
Fund.
In
December
2020,
FT
Subsidiary’s
sole
investment,
Turtle
Bay
Resort,
liquidated
and
paid
a
final
distribution.
FT
Subsidiary,
which
is
a
tax
paying
entity,
recognized
a
realized
loss
on
its
Turtle
Bay
Resort
investment.
An
estimated
deferred
tax
asset
based
on
such
realized
loss
was
recorded.
The
estimated
benefit
was
calculated
using
the
federal
rates
applicable
at
the
time
the
tax
was
paid.
The
losses
will
be
carried-back
to
offset
prior
year
gains,
resulting
in
a
tax
refund
which
will
relieve
the
estimated
deferred
tax
asset
once
the
final
tax
filings
are
completed.
On
April
27,
2021,
the
Fund
redeemed
out
of
FT
Subsidiary.
FT
Subsidiary
ceased
operations
and
simultaneously
transferred
its
assets
and
liabilities
to
the
Fund
(including
the
deferred
tax
asset).
The
results
of
operations
of
the
FT
Subsidiary
through
April
27,
2021
have
been
consolidated
into
the
Consolidated
Statement
of
Operations,
Consolidated
Statements
of
Changes
in
Net
Assets
and
Consolidated
Financial
Highlights.
i.
Marketplace
Lending
The
Fund
invests
in
loans
obtained
through
marketplace
lending.
Marketplace
lending,
sometimes
referred
to
as
peer-to-peer
lending,
is
a
method
of
financing
in
which
a
platform
facilitates
the
borrowing
and
lending
of
money.
It
is
considered
an
alternative
to
more
traditional
forms
of
debt
financing.
Prospective
borrowers
are
required
to
provide
certain
financial
information
to
the
platform,
including,
but
not
limited
to,
the
intended
purpose
of
the
loan,
income,
employment
information,
credit
score,
debt-to-income
ratio,
credit
history
(including
defaults
and
delinquencies)
and
home
ownership
status.
Based
on
this
and
other
information,
the
platform
assigns
its
own
credit
rating
to
the
borrower
and
sets
the
interest
rate
for
the
requested
loan.
The
platform
then
posts
the
borrowing
requests
online,
giving
investors
the
opportunity
to
purchase
the
loans
based
on
factors
such
as
the
interest
rates
and
expected
yields
of
the
loans,
the
borrower
background
data,
and
the
credit
rating
assigned
by
the
platform.
When
the
Fund
invests
in
these
loans,
it
usually
purchases
all
rights,
title
and
interest
in
the
loans
pursuant
to
a
loan
purchase
agreement
directly
from
the
platform.
The
platform
or
a
third-party
servicer
typically
continues
to
service
the
loans,
collecting
payments
and
distributing
them
to
the
Fund,
less
any
servicing
fees
assessed.
The
servicer
is
typically
responsible
for
taking
actions
against
a
borrower
in
the
event
of
a
default
on
the
loan.
Servicing
fees,
along
with
other
administration
fees,
are
included
in
marketplace
lending
fees
in
the
Consolidated
Statement
of
Operations.
The Fund,
as
an
investor
in
a
loan,
would
be
entitled
to
receive
payment
only
from
the
borrower
and
would
not
be
able
to
recover
any
deficiency
from
the
platform,
except
under
very
narrow
circumstances.
The
loans
in
which
the
Fund
may
invest
are
unsecured.
j.
Mortgage
Dollar
Rolls
The
Fund
enters
into
mortgage
dollar
rolls,
typically
on
a
TBA
basis.
Mortgage
dollar
rolls
are
agreements
between
the
Fund
and
a
financial
institution
where
the
Fund
sells
(or
buys)
mortgage-backed
securities
for
delivery
on
a
specified
date
and
simultaneously
contracts
to
repurchase
(or
sell)
substantially
similar
(same
type,
coupon,
and
maturity)
securities
at
a
future
date
and
at
a
predetermined
price.
Gains
or
losses
are
realized
on
the
initial
sale,
and
the
difference
between
the
repurchase
price
and
the
sale
price
is
recorded
as
an
unrealized
gain
or
loss
to
the
Fund
upon
entering
into
the
mortgage
dollar
roll.
In
addition,
the
1.
Organization
and
Significant
Accounting
Policies
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
51
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
Fund
may
invest
the
cash
proceeds
that
are
received
from
the
initial
sale.
During
the
period
between
the
sale
and
repurchase,
the
Fund
is
not
entitled
to
principal
and
interest
paid
on
the
mortgage
backed
securities.
Transactions
in
mortgage
dollar
rolls
are
accounted
for
as
purchases
and
sales
and
may
result
in
an
increase
to
the
Fund's
portfolio
turnover
rate.
The
risks
of
mortgage
dollar
roll
transactions
include
the
potential
inability
of
the
counterparty
to
fulfill
its
obligations.
k.
Senior
Floating
Rate
Interests
The
Fund
invests
in
senior
secured
corporate
loans
that
pay
interest
at
rates
which
are
periodically
reset
by
reference
to
a
base
lending
rate
plus
a
spread.
These
base
lending
rates
are
generally
the
prime
rate
offered
by
a
designated
U.S.
bank
or
the
London
InterBank
Offered
Rate
(LIBOR).
Senior
secured
corporate
loans
often
require
prepayment
of
principal
from
excess
cash
flows
or
at
the
discretion
of
the
borrower.
As
a
result,
actual
maturity
may
be
substantially
less
than
the
stated
maturity.
Senior
secured
corporate
loans
in
which
the Fund
invests
are
generally
readily
marketable,
but
may
be
subject
to
certain
restrictions
on
resale.
l.
Income
and
Deferred
Taxes
It
is the Fund's
policy
to
qualify
as
a
regulated
investment
company
under
the
Internal
Revenue
Code. The Fund
intends
to
distribute
to
shareholders
substantially
all
of
its
taxable
income
and
net
realized
gains
to
relieve
it
from
federal
income
and if
applicable, excise
taxes.
As
a
result,
no
provision
for
U.S.
federal
income
taxes
is
required.
The Fund
may
be
subject
to
foreign
taxation
related
to
income
received,
capital
gains
on
the
sale
of
securities
and
certain
foreign
currency
transactions
in
the
foreign
jurisdictions
in
which
it
invests.
Foreign
taxes,
if
any,
are
recorded
based
on
the
tax
regulations
and
rates
that
exist
in
the
foreign
markets
in
which
the
Fund
invests.
When
a
capital
gain
tax
is
determined
to
apply,
the
Fund
records
an
estimated
deferred
tax
liability
in
an
amount
that
would
be
payable
if
the
securities
were
disposed
of
on
the
valuation
date.
The
Fund
may
recognize
an
income
tax
liability
related
to
its
uncertain
tax
positions
under
U.S.
GAAP
when
the
uncertain
tax
position
has
a
less
than
50%
probability
that
it
will
be
sustained
upon
examination
by
the
tax
authorities
based
on
its
technical
merits.
As
of
April
30,
2021,
the
Fund
has
determined
that
no
tax
liability
is
required
in
its
financial
statements
related
to
uncertain
tax
positions
for
any
open
tax
years
(or
expected
to
be
taken
in
future
tax
years).
Open
tax
years
are
those
that
remain
subject
to
examination
and
are
based
on
the
statute
of
limitations
in
each
jurisdiction
in
which
the
Fund
invests. 
m.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
Security
transactions
are
accounted
for
on
trade
date.
Realized
gains
and
losses
on
security
transactions
are
determined
on
a
specific
identification
basis.
Interest
income
and
estimated
expenses
are
accrued
daily.
Amortization
of
premium
and
accretion
of
discount
on
debt
securities
are
included
in
interest
income.
Paydown
gains
and
losses
are
recorded
as
an
adjustment
to
interest
income.
Facility
fees
are
recognized
as
income
over
the
expected
term
of
the
loan.
Dividend
income
is
recorded
on
the
ex-dividend
date
except
for
certain
dividends
from
securities
where
the
dividend
rate
is
not
available.
In
such
cases,
the
dividend
is
recorded
as
soon
as
the
information
is
received
by
the
Fund.
Distributions
to shareholders
are
recorded
on
the
ex-dividend
date.
Distributable
earnings
are
determined
according
to
income
tax
regulations
(tax
basis)
and
may
differ
from
earnings
recorded
in
accordance
with
U.S.
GAAP.
These
differences
may
be
permanent
or
temporary.
Permanent
differences
are
reclassified
among
capital
accounts
to
reflect
their
tax
character.
These
reclassifications
have
no
impact
on
net
assets
or
the
results
of
operations.
Temporary
differences
are
not
reclassified,
as
they
may
reverse
in
subsequent
periods.
Common
expenses
incurred
by
the
Trust
are
allocated
among
the
Funds
based
on
the
ratio
of
net
assets
of
each
Fund
to
the
combined
net
assets
of
the
Trust
or
based
on
the
ratio
of
number
of
shareholders
of
each
Fund
to
the
combined
number
of
shareholders
of
the
Trust.
Fund
specific
expenses
are
charged
directly
to
the
Fund
that
incurred
the
expense.
Realized
and
unrealized
gains
and
losses
and
net
investment
income,
excluding
class
specific
expenses,
are
allocated
daily
to
each
class
of
shares
based
upon
the
1.
Organization
and
Significant
Accounting
Policies
(continued)
j.
Mortgage
Dollar
Rolls
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
52
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
relative
proportion
of
net
assets
of
each
class.
Differences
in
per
share
distributions
by
class
are
generally
due
to
differences
in
class
specific
expenses.
Inflation-indexed
bonds
are
adjusted
for
inflation
through
periodic
increases
or
decreases
in
the
security's
interest
accruals,
face
amount,
or
principal
redemption
value,
by
amounts
corresponding
to
the
rate
of
inflation
as
measured
by
an
index.
Any
increase
or
decrease
in
the
face
amount
or
principal
redemption
value
will
be
included
as
interest
income
in
the
Consolidated
Statement
of
Operations.
n.
Accounting
Estimates
The
preparation
of
consolidated
financial
statements
in
accordance
with
U.S.
GAAP
requires
management
to
make
estimates
and
assumptions
that
affect
the
reported
amounts
of
assets
and
liabilities
at
the
date
of
the
consolidated
financial
statements
and
the
amounts
of
income
and
expenses
during
the
reporting
period.
Actual
results
could
differ
from
those
estimates.
o.
Guarantees
and
Indemnifications
Under
the
Trust's
organizational
documents,
its
officers
and
trustees
are
indemnified
by
the
Trust
against
certain
liabilities
arising
out
of
the
performance
of
their
duties
to
the
Trust.
Additionally,
in
the
normal
course
of
business,
the
Trust, on
behalf
of
the
Fund,
enters
into
contracts
with
service
providers
that
contain
general
indemnification
clauses.
The
Trust's
maximum
exposure
under
these
arrangements
is
unknown
as
this
would
involve
future
claims
that
may
be
made
against
the
Trust
that
have
not
yet
occurred.
Currently,
the
Trust
expects
the
risk
of
loss
to
be
remote.
1.
Organization
and
Significant
Accounting
Policies
(continued)
m.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
53
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
2.
Shares
of
Beneficial
Interest
At
April
30,
2021,
there
were
an
unlimited
number
of
shares
authorized
(without
par
value).
Transactions
in
the
Fund’s
shares
were
as
follows:
3.
Transactions
with
Affiliates
Franklin
Resources,
Inc.
is
the
holding
company
for
various
subsidiaries
that
together
are
referred
to
as
Franklin
Templeton.
Certain
officers
and
trustees
of
the
Trust
are
also
officers
and/or
directors
of
the
following
subsidiaries:
Year
Ended
April
30,
2021
Year
Ended
April
30,
2020
Shares
Amount
Shares
Amount
Class
A
Shares:
Shares
sold
a
...................................
44,940,433
$419,168,623
51,808,122
$493,501,422
Shares
issued
in
reinvestment
of
distributions
..........
10,896,555
101,560,092
13,278,919
125,575,767
Shares
redeemed
...............................
(62,539,562)
(583,045,228)
(80,974,998)
(760,983,256)
Net
increase
(decrease)
..........................
(6,702,574)
$(62,316,513)
(15,887,957)
$(141,906,067)
Class
C
Shares:
Shares
sold
...................................
4,080,529
$38,026,405
7,181,894
$68,377,407
Shares
issued
in
reinvestment
of
distributions
..........
1,553,033
14,456,669
2,436,459
23,072,271
Shares
redeemed
a
..............................
(24,428,891)
(227,422,482)
(24,298,180)
(230,053,884)
Net
increase
(decrease)
..........................
(18,795,329)
$(174,939,408)
(14,679,827)
$(138,604,206)
Class
R
Shares:
Shares
sold
...................................
1,625,591
$15,106,571
1,421,183
$13,393,410
Shares
issued
in
reinvestment
of
distributions
..........
236,633
2,195,157
332,487
3,136,111
Shares
redeemed
...............................
(2,735,323)
(25,417,358)
(3,490,157)
(32,564,655)
Net
increase
(decrease)
..........................
(873,099)
$(8,115,630)
(1,736,487)
$(16,035,134)
Class
R6
Shares:
Shares
sold
...................................
4,216,330
$39,518,885
5,527,397
$52,655,227
Shares
issued
in
reinvestment
of
distributions
..........
494,788
4,618,696
958,906
9,140,302
Shares
redeemed
...............................
(6,056,322)
(55,617,911)
(23,024,591)
(220,902,162)
Net
increase
(decrease)
..........................
(1,345,204)
$(11,480,330)
(16,538,288)
$(159,106,633)
Advisor
Class
Shares:
Shares
sold
...................................
13,810,883
$128,667,962
16,576,637
$155,346,108
Shares
issued
in
reinvestment
of
distributions
..........
2,092,114
19,511,932
2,676,518
25,356,333
Shares
redeemed
...............................
(26,597,589)
(248,340,961)
(22,833,202)
(214,281,737)
Net
increase
(decrease)
..........................
(10,694,592)
$(100,161,067)
(3,580,047)
$(33,579,296)
a
May
include
a
portion
of
Class
C
shares
that
were
automatically
converted
to
Class
A.
Subsidiary
Affiliation
Franklin
Advisers,
Inc.
(Advisers)
Investment
manager
Franklin
Templeton
Services,
LLC
(FT
Services)
Administrative
manager
Franklin
Templeton
Distributors,
Inc.
(Distributors)
Principal
underwriter
Franklin
Templeton
Investor
Services,
LLC
(Investor
Services)
Transfer
agent
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
54
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
a.
Management
Fees
The
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
For
the
year
ended
April
30,
2021,
the
gross
effective
investment
management
fee
rate
was
0.456%
of
the
Fund’s
average
daily
net
assets. 
b.
Administrative
Fees
Under
an
agreement
with
Advisers,
FT
Services
provides
administrative
services
to
the
Fund.
The
fee
is
paid
by
Advisers
based
on
the
Fund's
average
daily
net
assets,
and
is
not
an
additional
expense
of
the
Fund.
c.
Distribution
Fees
The
Board
has
adopted
distribution
plans
for
each
share
class,
with
the
exception
of
Class
R6
and
Advisor
Class
shares,
pursuant
to
Rule
12b-1
under
the
1940
Act.
Under
the
Fund’s
Class A reimbursement
distribution
plan,
the
Fund
reimburses
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
the
Fund's
shares
up
to
the
maximum
annual
plan
rate.
Under
the
Class
A
reimbursement
distribution
plan,
costs
exceeding
the
maximum
for
the
current
plan
year
cannot
be
reimbursed
in
subsequent
periods.
In
addition,
under
the
Fund’s
Class C
and
R
compensation
distribution
plans,
the
Fund
pays
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
the
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
The
plan
year,
for
purposes
of
monitoring
compliance
with
the
maximum
annual
plan
rates,
is
February
1
through
January
31.
The
maximum
annual
plan
rates,
based
on
the
average
daily
net
assets,
for
each
class,
are
as
follows:
d.
Sales
Charges/Underwriting
Agreements
Front-end
sales
charges
and
contingent
deferred
sales
charges
(CDSC)
do
not
represent
expenses
of
the
Fund.
These
charges
are
deducted
from
the
proceeds
of
sales
of
Fund
shares
prior
to
investment
or
from
redemption
proceeds
prior
to
remittance,
as
applicable.
Distributors
has
advised
the
Fund
of
the
following
commission
transactions
related
to
the
sales
and
redemptions
of
the
Fund's
shares
for
the
year:
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
Over
$15
billion,
up
to
and
including
$17.5
billion
0.380%
Over
$17.5
billion,
up
to
and
including
$20
billion
0.360%
Over
$20
billion,
up
to
and
including
$35
billion
0.355%
Over
$35
billion,
up
to
and
including
$50
billion
0.350%
In
excess
of
$50
billion
Class
A
....................................................................................
0.25%
Class
C
....................................................................................
0.65%
Class
R
....................................................................................
0.50%
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
55
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
e.
Transfer
Agent
Fees
Each
class
of
shares pays
transfer
agent
fees
to
Investor
Services
for
its
performance
of
shareholder
servicing
obligations.
The
fees
are
based
on
an
annualized
asset
based
fee
of
0.02%
plus
a
transaction
based
fee.
In
addition,
each
class reimburses
Investor
Services
for
out
of
pocket
expenses
incurred
and,
except
for
Class
R6,
reimburses
shareholder
servicing
fees
paid
to
third
parties.
These
fees
are
allocated
daily
based
upon
their
relative
proportion
of
such
classes'
aggregate
net
assets.
Class
R6
pays
Investor
Services
transfer
agent
fees
specific
to
that
class.
For
the
year
ended
April
30,
2021,
the
Fund
paid
transfer
agent
fees
of
$5,627,586,
of
which $2,515,396
was
retained
by
Investor
Services.
f.
Investments
in
Affiliated
Management
Investment
Companies
The
Fund
invests
in
one
or
more
affiliated
management
investment
companies.
As
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
fund’s
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
fund.
The
Funds
do
not
invest
for
purposes
of
exercising
a
controlling
influence
over
the
management
or
policies.
Management
fees
paid
by
the
Fund
are
waived
on
assets
invested
in
the
affiliated
management
investment
companies,
as
noted
in
the
Consolidated
Statement
of
Operations,
in
an
amount
not
to
exceed
the
management
and
administrative
fees
paid
directly
or
indirectly
by
each
affiliate.
During
the
year
ended
April
30,
2021,
the
Fund
held
investments
in
affiliated
management
investment
companies
as
follows:
g.
Waiver
and
Expense
Reimbursements
Investor
Services
has
contractually
agreed
in
advance
to
waive
or
limit
its
fees
so
that
the
Class
R6
transfer
agent
fees
do
not
exceed
0.03%
based
on
the
average
net
assets
of
the
class
until
August
31,
2021.
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/dealers
..............................
$100,911
CDSC
retained
..............................................................................
$71,635
    aa
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Franklin
Strategic
Income
Fund
Controlled
Affiliates
Dividends
Franklin
Floating
Rate
Income
Fund
$108,077,744
$149,665,093
$—
$
$
11,575,632
$
269,318,469
34,705,988
$
5,534,929
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$51,021,802
$46,965,732
$(47,186,604)
$—
$—
$50,800,930
50,800,930
$843
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.......
$—
$20,302,000
$(16,565,000)
$
$
$3,737,000
3,737,000
$19
Total
Affiliated
Securities
....
$159,099,546
$216,932,825
$(63,751,604)
$—
$11,575,632
$323,856,399
$5,535,791
3.
Transactions
with
Affiliates
(continued)
d.
Sales
Charges/Underwriting
Agreements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
56
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
h.
Interfund
Transactions
The
Fund
engaged
in
purchases
and
sales
of
investments
with
funds
or
other
accounts
that
have
common
investment
managers
(or
affiliated
investment
managers),
directors,
trustees
or
officers.
During
the
year
ended
April
30,
2021,
these
purchase
and
sale
transactions
(excluding
in-kind
transactions)
aggregated
$0
and
$40,633,306,
respectively.
4.
Expense
Offset
Arrangement
The Fund has
entered
into
an
arrangement
with
its
custodian
whereby
credits
realized
as
a
result
of
uninvested
cash
balances
are
used
to
reduce
a
portion
of
the
Fund's
custodian
expenses.
During
the
year
ended
April
30,
2021,
the
custodian
fees
were
reduced
as
noted
in
the
Consolidated
Statement
of
Operations. 
5.
Income
Taxes
For
tax
purposes,
capital
losses
may
be
carried
over
to
offset
future
capital
gains.
At
April
30,
2021,
the
capital
loss
carryforwards
were
as
follows:
The
tax
character
of
distributions
paid
during
the
years
ended
April
30,
2021
and
2020,
was
as
follows:
At
April
30,
2021,
the
cost
of
investments
and
net
unrealized
appreciation
(depreciation)
for
income
tax
purposes
were
as
follows:
Differences
between
income
and/or
capital
gains
as
determined
on
a
book
basis
and
a
tax
basis
are
primarily
due
to
differing
treatments
of
defaulted
securities,
foreign
currency
transactions,
payments-in-kind,
bond
discounts
and
premiums,
swaps,
inflation
related
adjustments
on
foreign
securities,
financial
futures
transactions
and
transfer
in-kind.
Capital
loss
carryforwards
not
subject
to
expiration:
Short
term
................................................................................
$79,106,941
Long
term
................................................................................
516,471,525
Total
capital
loss
carryforwards
...............................................................
$595,578,466
2021
2020
Distributions
paid
from:
Ordinary
income
..........................................................
$150,774,297
$198,809,927
Cost
of
investments
..........................................................................
$4,051,184,472
Unrealized
appreciation
........................................................................
$162,723,525
Unrealized
depreciation
........................................................................
(248,966,417)
Net
unrealized
appreciation
(depreciation)
..........................................................
$(86,242,892)
Distributable
earnings:
Undistributed
ordinary
income
...................................................................
$10,857,674
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
57
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
6.
Investment
Transactions
Purchases
and
sales
of
investments
(excluding
short
term
securities)
for
the
year
ended
April
30,
2021,
aggregated
$5,500,981,629
and
$6,090,226,437,
respectively.
Purchases
and
sales
of
investments
exclude
in-kind
transactions
of
$189,731,147
and
$0,
respectively.
At
April
30,
2021,
in
connection
with
securities
lending
transactions,
the
Fund
loaned
equity
investments
and
received
$4,671,302
of
cash
collateral.
The
gross
amount
of
recognized
liability
for
such
transactions
is
included
in
payable
upon
return
of
securities
loaned
in
the
Statement
of
Assets
and
Liabilities.
The
agreements
can
be
terminated
at
any
time.
7.
Credit Risk
and
Defaulted
Securities
At
April
30,
2021,
the
Fund
had
43.0%
of
its
portfolio
invested
in
high
yield,
senior
secured
floating
rate
loans,
or
other
securities
rated
below
investment
grade
and
unrated
securities.
These
securities
may
be
more
sensitive
to
economic
conditions
causing
greater
price
volatility
and
are
potentially
subject
to
a
greater
risk
of
loss
due
to
default
than
higher
rated
securities.
The
Fund
held
defaulted
securities
and/or
other
securities
for
which
the
income
has
been
deemed
uncollectible.
At
April
30,
2021,
the
aggregate
value
of
these
securities
was
$-,
representing
-%
of
the
Fund's
net
assets.
The
Fund
discontinues
accruing
income
on
securities
for
which
income
has
been
deemed
uncollectible
and
provides
an
estimate
for
losses
on
interest
receivable.
The
securities
have
been
identified
in
the
accompanying
Statement
of
Investments.
8.
Novel
Coronavirus
Pandemic 
The
global
outbreak
of
the
novel
coronavirus
disease,
known
as
COVID-19, has
caused
adverse
effects
on
many
companies,
sectors,
nations,
regions
and
the
markets
in
general, and
may
continue for
an unpredictable duration.
The
effects
of
this
pandemic
may
materially
impact
the
value
and
performance
of
the Fund, its ability
to
buy
and
sell
fund
investments
at
appropriate
valuations
and its ability
to
achieve its investment
objectives.
9.
Restricted
Securities
The
Fund
invests
in
securities
that
are
restricted
under
the
Securities
Act
of
1933
(1933
Act).
Restricted
securities
are
often
purchased
in
private
placement
transactions,
and
cannot
be
sold
without
prior
registration
unless
the
sale
is
pursuant
to
an
exemption
under
the
1933
Act.
Disposal
of
these
securities
may
require
greater
effort
and
expense,
and
prompt
sale
at
an
acceptable
price
may
be
difficult.
The Fund
may
have
registration
rights
for
restricted
securities.
The
issuer
generally
incurs
all
registration
costs.
At
April
30,
2021,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
1933
Act,
were
as
follows:
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Strategic
Income
Fund
125,940,079
K2016470219
South
Africa
Ltd.,
A
...............
2/08/13-2/01/17
$
977,123
$
12,532,821
K2016470219
South
Africa
Ltd.,
B
...............
2/01/17
9,307
Total
Restricted
Securities
(Value
is
—%
of
Net
Assets)
..............
$986,430
$—
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
58
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
10.
Other
Derivative
Information
At
April
30,
2021,
the
Fund's
investments
in
derivative
contracts
are
reflected
in
the
Statement of
Assets
and
Liabilities
as
follows:
Asset
Derivatives
Liability
Derivatives
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Franklin
Strategic
Income
Fund
Interest
rate
contracts
.......
Investments
in
securities,
at
value
$
709,665
a
Options
written,
at
value
$
717,180
Variation
margin
on
futures
contracts
1,598,129
b
Variation
margin
on
futures
contracts
2,787,044
b
Variation
margin
on
centrally
cleared
swap
contracts
2,170,716
Variation
margin
on
centrally
cleared
swap
contracts
Foreign
exchange
contracts
..
Unrealized
appreciation
on
OTC
forward
exchange
contracts
630,824
Unrealized
depreciation
on
OTC
forward
exchange
contracts
1,427,339
Unrealized
appreciation
on
OTC
swap
contracts
Unrealized
depreciation
on
OTC
swap
contracts
203,321
Credit
contracts
............
OTC
swap
contracts
(upfront
payments)
192,295
OTC
swap
contracts
(upfront
receipts)
5,344,564
Unrealized
appreciation
on
OTC
swap
contracts
2,972,41
5
Unrealized
depreciation
on
OTC
swap
contracts
277,67
9
Value
recovery
instruments
...
Investments
in
securities,
at
value
10,573,466
c
Investments
in
securities,
at
value
Total
....................
$18,847,510
$10,757,127
a
Purchased
option
contracts
are
included
in
investments
in
securities,
at
value
in
the
Statement
of
Assets
and
Liabilities.
b
This
amount
reflects
the
cumulative
appreciation
(depreciation)
of
futures
contracts
as
reported
in
the
Statement
of
Investments.
Only
the
variation
margin
receivable/
payable
at
year
end
is
separately
reported
within
the
Statement
of
Assets
and
Liabilities.
Prior
variation
margin
movements
were
recorded
to
cash
upon
receipt
or
payment.
c
VRI
are
included
in
investments
in
securities,
at
value
in
the
Statement
of
Assets
and
Liabilities.
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
59
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
For
the
year
ended
April
30,
2021,
the
effect
of
derivative
contracts
in
the
Consolidated
Statement
of
Operations
was
as
follows:
For
the year
ended
April
30,
2021,
the
average
month
end
notional
amount
of
futures
contracts
and
swap
contracts
and
options,
the
average
month
end
contract
value
for
forward
exchange
contracts
and
average
month
end
fair
value
of
VRI
were
as
follows:
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Consolidated
Statement
of
Operations
Location
Net
Realized
Gain
(Loss)
for
the
Year
Consolidated
Statement
of
Operations
Location
Net
Change
in
Unrealized
Appreciation
(Depreciation)
for
the
Year
Franklin
Strategic
Income
Fund
Net
realized
gain
(loss)
from:
Net
change
in
unrealized
  appreciation
(depreciation)
on:
Interest
rate
contracts
..........
Investments
$—
Investments
$(393,865)
a
Written
options
Written
options
365,430
Futures
contracts
4,059,344
Futures
contracts
(4,405,766)
Swap
contracts
(2,228,077)
Swap
contracts
15,279,187
Foreign
exchange
contracts
.....
Swap
contracts
(472,648)
Swap
contracts
(666,626)
Forward
exchange
contracts
(28,787,850)
Forward
exchange
contracts
2,629,854
Credit
contracts
...............
Swap
contracts
(12,650,055)
Swap
contracts
41,797,978
Value
recovery
instruments
Investments
Investments
$3,140,736
a
Total
.......................
$(40,079,286)
$57,746,928
a
Purchased
option
contracts
and
VRI
are
included
in
net
reailzed
gain
(loss)
from
investments
and
net
change
in
unreailized
appreciation
(depreciation)
on
investments
in
the
Consolidated
Statement
of
Operations.
Franklin
Strategic
Income
Fund
Futures
contracts
.........................
$569,788,281
Swap
contracts
...........................
372,543,729
Forward
exchange
contracts
.................
588,699,295
VRI
....................................
9,615,865
Options
.................................
32,184,615
10.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
60
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
At
April
30,
2021,
the
Fund's
OTC
derivative
assets
and
liabilities
are
as
follows:
At
April
30,
2021,
OTC
derivative
assets,
which
may
be
offset
against
the
Fund's
OTC
derivative
liabilities
and
collateral
received
from
the
counterparty,
are
as
follows:
Gross
Amounts
of
Assets
and
Liabilities
Presented
in
the
Statement
of
Assets
and
Liabilities
Assets
a
Liabilities
a
Franklin
Strategic
Income
Fund
Derivatives
Forward
exchange
contracts
.............................
$
630,824
$
1,427,339
Options
purchased
.....................................
709,665
Options
written
........................................
717,180
Swap
contracts
.......................................
3,164,7
10
5,825,56
4
Total
.............................................
$4,505,199
$7,970,083
a
Absent
an
event
of
default
or
early
termination,
OTC
derivative
assets
and
liabilities
are
presented
gross
and
not
offset
in
the
Statement
of
Assets
and
Liabilities.
Amounts
Not
Offset
in
the
Statement
of
Assets
and
Liabilities
Gross
Amounts
of
Assets
Presented
in
the
Statement
of
Assets
and
Liabilities
Financial
Instruments
Available
for
Offset
Financial
Instruments
Collateral
Received
a
Cash
Collateral
Received
Net
Amount
(Not
less
than
zero)
Franklin
Strategic
Income
Fund
Counterparty
BOFA
....................
$20,038
$(7,402)
$—
$—
$12,636
BZWS
...................
770,342
(223,840)
(546,502)
CITI
.....................
2,093,782
(2,093,782)
FBCO
...................
369,067
(26,357)
(330,000)
12,710
GSCO
...................
19,221
(19,221)
JPHQ
...................
1,133,655
(1,133,655)
MSCO
...................
99,094
(51,547)
47,547
Total
...................
$4,505,199
$(3,555,804)
$
(546,502)
$(330,000)
$72,893
1
10.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
61
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
At
April
30,
2021,
OTC
derivative
liabilities,
which
may
be
offset
against
the
Fund's
OTC
derivative
assets
and
collateral
pledged
to
the
counterparty,
are
as
follows:
See
Note
1(f)
regarding
derivative
financial
instruments. 
See
Abbreviations
on
page
67
.
Amounts
Not
Offset
in
the
Statement
of
Assets
and
Liabilities
Gross
Amounts
of
Liabilities
Presented
in
the
Statement
of
Assets
and
Liabilities
Financial
Instruments
Available
for
Offset
Financial
Instruments
Collateral
Pledged
Cash
Collateral
Pledged
a
Net
Amount
(Not
less
than
zero)
Franklin
Strategic
Income
Fund
Counterparty
BOFA
....................
$7,402
$(7,402)
$—
$—
$—
BZWS
...................
223,840
(223,840)
CITI
.....................
4,800,871
(2,093,782)
(2,707,089)
FBCO
...................
26,357
(26,357)
GSCO
...................
21,367
(19,221)
2,146
JPHQ
...................
2,838,699
(1,133,655)
(1,705,044)
MSCO
...................
51,547
(51,547)
Total
...................
$7,970,083
$(3,555,804)
$—
$(4,412,133)
$2,146
a
In
some
instances,
the
collateral
amounts
disclosed
in
the
table
above
were
adjusted
due
to
the
requirement
to
limit
collateral
amounts
to
avoid
of
over
collateralization.  Actual
collateral
received
and/or
pledged
may
be
more
than
the
amounts
disclosed
herein.
10.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
62
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
11.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
The
1940
Act
defines
"affiliated
companies"
to
include
investments
in
portfolio
companies
in
which
a
fund
owns
5%
or
more
of
the
outstanding
voting
securities.
Additionally,
as
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
companies’
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
company.
During
the
year
ended
April
30,
2021,
investments
in
“affiliated
companies”
were
as
follows:
12.
Transfer
In-Kind
On
March
5,
2021,
the
Fund
completed
a
non-taxable
exchange
of
securities
with
a
value
of
$149,665,093
(which
included
$40,066,054
of
net
unrealized
depreciation)
for
19,462,301
shares
(each
then
valued
at
$7.69
per
share)
of
Franklin
Floating
Rate
Income
Fund,
an
affiliated
entity.
This
is
considered
a
non-taxable
exchange
for
federal
income
tax
purposes,
with
no
gain
or
loss
recognized
by
the
Fund
or
its
shareholders.
13.
Credit
Facility
The
Fund,
together
with
other
U.S.
registered
and
foreign
investment
funds
(collectively,
Borrowers),
managed
by
Franklin
Templeton,
are
borrowers
in
a
joint
syndicated
senior
unsecured
credit
facility
totaling
$2.675
billion
(Global
Credit
Facility)
which
matures
on
February
4,
2022.
This
Global
Credit
Facility
provides
a
source
of
funds
to
the
Borrowers
for
temporary
and
emergency
purposes,
including
the
ability
to
meet
future
unanticipated
or
unusually
large
redemption
requests.
Under
the
terms
of
the
Global
Credit
Facility,
the
Fund
shall,
in
addition
to
interest
charged
on
any
borrowings
made
by
the
Fund
and
other
costs
incurred
by
the
Fund,
pay
its
share
of
fees
and
expenses
incurred
in
connection
with
the
implementation
and
maintenance
of
the
Global
Credit
Facility,
based
upon
its
relative
share
of
the
aggregate
net
assets
of
all
of
the
Borrowers,
including
an
annual
commitment
fee
of
0.15%
based
upon
the
unused
portion
of
the
Global
Credit
Facility.
These
fees
are
reflected
in
other
expenses
in
the
Consolidated
Statement
of
Operations.
During
the
year
ended
April
30,
2021,
the Fund
did
not
use
the
Global
Credit
Facility.
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares/Principal
Amount
Held
at
End
of
Year
Investment
Income
Franklin
Strategic
Income
Fund
Non-Controlled
Affiliates
Dividends
Remington
Outdoor
Co.,
Inc.
............
$
661,219
$
$
(1,686,109)
$
$
1,024,890
$
a
$
Interest
Remington
Outdoor
Co.,
Inc.,
Litigation
Units
.....
a
Total
Affiliated
Securities
(Value
is
—%
of
Net
Assets)
..........
$661,219
$—
$(1,686,109)
1,024,890
$—
$—
a
As
of
April
30,
2021,
no
longer
held
by
the
fund.
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
63
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
14.
Fair
Value
Measurements
The
Fund
follows
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the Fund's
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the
Fund's financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level
3
significant
unobservable
inputs
(including
the
Fund's
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
64
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
April
30,
2021,
in
valuing
the
Fund's
assets
and
liabilities
carried
at
fair
value,
is
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Strategic
Income
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Energy
Equipment
&
Services
.............
$
1,606,377
$
$
$
1,606,377
Machinery
............................
5,234,619
5,234,619
Media
...............................
2,919,493
34,550
2,954,043
Multiline
Retail
........................
a
Oil,
Gas
&
Consumable
Fuels
.............
14,119
21,816
35,935
Paper
&
Forest
Products
.................
600,693
600,693
Specialty
Retail
........................
821,695
821,695
Management
Investment
Companies
.........
303,927,844
303,927,844
Warrants
:
Oil,
Gas
&
Consumable
Fuels
.............
1,902
a
1,902
Paper
&
Forest
Products
.................
9,623
9,623
Software
.............................
a
Convertible
Bonds
.......................
456,954
456,954
Corporate
Bonds
:
Aerospace
&
Defense
...................
25,418,935
25,418,935
Air
Freight
&
Logistics
...................
17,711,103
17,711,103
Airlines
..............................
40,534,518
40,534,518
Auto
Components
......................
41,031,075
41,031,075
Banks
...............................
67,838,085
67,838,085
Beverages
...........................
17,620,108
17,620,108
Biotechnology
.........................
6,419,106
6,419,106
Building
Products
......................
18,551,101
18,551,101
Capital
Markets
........................
31,620,075
31,620,075
Chemicals
...........................
111,705,568
111,705,568
Commercial
Services
&
Supplies
...........
12,577,500
12,577,500
Communications
Equipment
..............
12,889,225
12,889,225
Construction
&
Engineering
...............
3,518,796
3,518,796
Consumer
Finance
.....................
27,972,051
27,972,051
Containers
&
Packaging
.................
66,276,156
66,276,156
Diversified
Financial
Services
.............
15,317,058
15,317,058
Diversified
Telecommunication
Services
.....
44,013,984
44,013,984
Electric
Utilities
........................
67,802,846
67,802,846
Electrical
Equipment
....................
9,671,520
9,671,520
Electronic
Equipment,
Instruments
&
Components
........................
15,242,940
15,242,940
Energy
Equipment
&
Services
.............
14,009,467
14,009,467
Entertainment
.........................
21,436,458
21,436,458
Equity
Real
Estate
Investment
Trusts
(REITs)
.
57,647,386
57,647,386
Food
&
Staples
Retailing
.................
7,673,904
7,673,904
Food
Products
........................
54,999,192
54,999,192
Gas
Utilities
..........................
2,780,911
2,780,911
Health
Care
Providers
&
Services
..........
52,999,404
52,999,404
Hotels,
Restaurants
&
Leisure
.............
131,399,818
131,399,818
Household
Durables
....................
23,203,019
23,203,019
Household
Products
....................
33,736,445
33,736,445
Independent
Power
and
Renewable
Electricity
Producers
..........................
59,020,292
59,020,292
Insurance
............................
10,292,421
10,292,421
Interactive
Media
&
Services
..............
16,771,403
16,771,403
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
65
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
Level
1
Level
2
Level
3
Total
Franklin
Strategic
Income
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
Corporate
Bonds:
Internet
&
Direct
Marketing
Retail
..........
$
$
12,756,349
$
$
12,756,349
IT
Services
...........................
34,946,740
34,946,740
Life
Sciences
Tools
&
Services
............
4,410,545
4,410,545
Machinery
............................
17,023,795
17,023,795
Marine
..............................
12,726,000
12,726,000
Media
...............................
113,844,248
113,844,248
Metals
&
Mining
.......................
47,156,798
47,156,798
Multiline
Retail
........................
a
Multi-Utilities
..........................
8,411,510
8,411,510
Oil,
Gas
&
Consumable
Fuels
.............
208,472,709
208,472,709
Paper
&
Forest
Products
.................
7,278,281
7,278,281
Personal
Products
.....................
5,901,008
5,901,008
Pharmaceuticals
.......................
58,119,883
58,119,883
Real
Estate
Management
&
Development
....
32,912,889
32,912,889
Road
&
Rail
..........................
21,843,143
21,843,143
Semiconductors
&
Semiconductor
Equipment
.
7,523,957
7,523,957
Software
.............................
21,393,815
21,393,815
Specialty
Retail
........................
25,440,920
25,440,920
Thrifts
&
Mortgage
Finance
...............
28,752,559
28,752,559
Tobacco
.............................
15,873,817
15,873,817
Trading
Companies
&
Distributors
..........
39,320,954
39,320,954
Wireless
Telecommunication
Services
.......
45,738,403
45,738,403
Senior
Floating
Rate
Interests
...............
46,391,119
a
46,391,119
Marketplace
Loans
......................
8,183,547
8,183,547
Loan
Participations
and
Assignments
.........
15,220,062
15,220,062
Foreign
Government
and
Agency
Securities
....
597,005,901
597,005,901
U.S.
Government
and
Agency
Securities
.......
114,019,421
114,019,421
Asset-Backed
Securities
:
Airlines
..............................
1,218,378
1,218,378
Consumer
Finance
.....................
20,171,757
20,171,757
Diversified
Financial
Services
.............
300,814,071
923,337
301,737,408
Commercial
Mortgage-Backed
Securities
......
2,103,603
2,103,603
Mortgage-Backed
Securities
................
120,356,612
120,356,612
Municipal
Bonds
.........................
80,920,407
80,920,407
Residential
Mortgage-Backed
Securities
......
341,074,185
341,074,185
Escrows
and
Litigation
Trusts
...............
37,500
45,000
a
82,500
Options
purchased
.......................
709,665
709,665
Short
Term
Investments
...................
54,537,930
39,201,955
93,739,885
Total
Investments
in
Securities
...........
$364,437,774
$3,594,486,402
$9,210,152
$3,968,134,328
Other
Financial
Instruments:
Forward
exchange
contracts
...............
$
$
630,824
$
$
630,824
Futures
contracts
........................
1,598,129
1,598,129
Swap
contracts
.........................
5,143,131
5,143,131
Total
Other
Financial
Instruments
.........
$1,598,129
$5,773,955
$—
$7,372,084
Liabilities:
Other
Financial
Instruments:
Options
written
..........................
$
$
717,180
$
$
717,180
Forward
exchange
contracts
................
1,427,339
1,427,339
Futures
contracts
........................
2,787,044
2,787,044
Swap
contracts
..........................
481,000
481,000
Total
Other
Financial
Instruments
.........
$2,787,044
$2,625,519
$—
$5,412,563
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
66
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the
year.
15.
New
Accounting
Pronouncements
In
March
2020,
the
Financial
Accounting
Standards
Board
issued
Accounting
Standards
Update
(ASU)
No.
2020-04,
Reference
Rate
Reform
(Topic
848)
Facilitation
of
the
Effects
of
Reference
Rate
Reform
on
Financial
Reporting.
The
amendments
in
the
ASU
provides
optional
temporary
financial
reporting
relief
from
the
effect
of
certain
types
of
contract
modifications
due
to
the
planned
discontinuation
of
the
London
Interbank
Offered
Rate
and
other
interbank-offered
based
reference
rates
as
of
the
end
of
2021.
The
ASU
is
effective
for
certain
reference
rate-related
contract
modifications
that
occur
during
the
period
March
12,
2020
through
December
31,
2022. Management
has
reviewed
the
requirements
and
believes
the
adoption
of
this
ASU
will
not
have
a
material
impact
on
the
consolidated
financial
statements.
16.
Subsequent
Events
The
Fund
has
evaluated
subsequent
events
through
the
issuance
of
the consolidated
financial
statements
and
determined
that
no
events
have
occurred
that
require
disclosure.
a
Includes
securities
determined
to
have
no
value
at
April
30,
2021.
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
67
franklintempleton.com
Annual
Report
Franklin
Strategic
Income
Fund
(continued)
Abbreviations
Counterparty
BOFA
Bank
of
America,
N.A.
BZWS
Barclays
Bank
plc
CITI
Citigroup,
Inc
FBCO
Credit
Suisse
Group
AG
GSCO
Goldman
Sachs
Group,
Inc.
JPHQ
JPMorgan
Chase
Bank
NA
MSCO
Morgan
Stanley
Currency
AUD
Australian
Dollar
BRL
Brazilian
Real
COP
Colombian
Peso
DOP
Dominican
Peso
EUR
Euro
IDR
Indonesian
Rupiah
JPY
Japanese
Yen
USD
United
States
Dollar
UYU
Uruguayan
Peso
ZAR
South
African
Rand
Selected
Portfolio
BZDIOVRA
Brazil
Inter-Bank
Deposit
Rate
CLO
Collateralized
Loan
Obligation
CMT
Constant
Monthly
U.S.
Treasury
Securities
Yield
Curve
Rate
Index
CVR
Contingent
Voting
Rights
ETF
Exchange-Traded
Fund
EURIBOR
Euro
Inter-Bank
Offer
Rate
FHLMC
Federal
Home
Loan
Mortgage
Corp.
FNMA
Federal
National
Mortgage
Association
FRN
Floating
Rate
Note
GDP
Gross
Domestic
Product
GNMA
Government
National
Mortgage
Association
GO
General
Obligation
LIBOR
London
InterBank
Offered
Rate
MBS
Mortgage-Backed
Security
PIK
Payment-In-Kind
SOFR
Secured
Overnight
Financing
Rate
T-Note
Treasury
Note
VRI
Value
Recovery
Instruments
Franklin
Strategic
Series
Report
of
Independent
Registered
Public
Accounting
Firm
68
franklintempleton.com
Annual
Report
To
the
Board
of
Trustees
of
Franklin
Strategic
Series
and
Shareholders
of
Franklin
Strategic
Income
Fund
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statement
of
assets
and
liabilities,
including
the
statement
of
investments,
of
Franklin
Strategic
Income
Fund
(one
of
the
funds
constituting
Franklin
Strategic
Series,
referred
to
hereafter
as
the
"Fund")
as
of
April
30,
2021,
the
related
statements
of
operations
for
the
year
ended
April
30,
2021,
the
statement
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2021,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2021
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
the
Fund
as
of
April
30,
2021,
the
results
of
its
operations
for
the
year
then
ended,
the
changes
in
its
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2021
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2021
indicated
therein
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinion
These
financial
statements
are
the
responsibility
of
the
Fund’s
management.
Our
responsibility
is
to
express
an
opinion
on
the
Fund’s
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Fund
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
April
30,
2021
by
correspondence
with
the
custodian,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinion.
PricewaterhouseCoopers
LLP
San
Francisco,
California
June
18,
2021
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
Franklin
Templeton
Group
of
Funds
since
1948.
Franklin
Strategic
Series
Board
Members
and
Officers
69
franklintempleton.com
Annual
Report
The
name,
year
of
birth
and
address
of
the
officers
and
board
members,
as
well
as
their
affiliations,
positions
held
with
the
Trust,
principal
occupations
during
at
least
the
past
five
years
and
number
of
U.S.
registered
portfolios
overseen
in
the
Franklin
Templeton
fund
complex,
are
shown
below.
Generally,
each
board
member
serves
until
that
person’s
successor
is
elected
and
qualified.
Independent
Board
Members
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Harris
J.
Ashton
(1932)
Trustee
Since
1991
125
Bar-S
Foods
(meat
packing
company)
(1981-2010).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Director,
RBC
Holdings,
Inc.
(bank
holding
company)
(until
2002);
and
President,
Chief
Executive
Officer
and
Chairman
of
the
Board,
General
Host
Corporation
(nursery
and
craft
centers)
(until
1998).
Terrence
J.
Checki
(1945)
Trustee
Since
2017
107
Hess
Corporation
(exploration
of
oil
and
gas)
(2014-present).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Member
of
the
Council
on
Foreign
Relations
(1996-present);
Member
of
the
National
Committee
on
U.S.-China
Relations
(1999-present);
member
of
the
board
of
trustees
of
the
Economic
Club
of
New
York
(2013-present);
member
of
the
board
of
trustees
of
the
Foreign
Policy
Association
(2005-present);
member
of
the
board
of
directors
of
Council
of
the
Americas
(2007-present)
and
the
Tallberg
Foundation
(2018
-
present);
and
formerly
,
Executive
Vice
President
of
the
Federal
Reserve
Bank
of
New
York
and
Head
of
its
Emerging
Markets
and
Internal
Affairs
Group
and
Member
of
Management
Committee
(1995-2014);
and
Visiting
Fellow
at
the
Council
on
Foreign
Relations
(2014).
Mary
C.
Choksi
(1950)
Trustee
Since
2014
126
Omnicom
Group
Inc.
(advertising
and
marketing
communications
services)
(2011-present)
and
White
Mountains
Insurance
Group,
Ltd.
(holding
company)
(2017-present);
and
formerly
,
Avis
Budget
Group
Inc.
(car
rental)
(2007-2020).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Founder
and
Senior
Advisor,
Strategic
Investment
Group
(investment
management
group)
(2015-2017);
Founding
Partner
and
Senior
Managing
Director,
Strategic
Investment
Group
(1987-2015);
Founding
Partner
and
Managing
Director,
Emerging
Markets
Management
LLC
(investment
management
firm)
(1987-2011);
and
Loan
Officer/Senior
Loan
Officer/Senior
Pension
Investment
Officer,
World
Bank
Group
(international
financial
institution)
(1977-1987).
Franklin
Strategic
Series
70
franklintempleton.com
Annual
Report
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Edith
E.
Holiday
(1952)
Lead
Independent
Trustee
Trustee
since
1998
and
Lead
Independent
Trustee
since
2019
126
Hess
Corporation
(exploration
of
oil
and
gas)
(1993-present),
Santander
Consumer
USA
Holdings,
Inc.
(consumer
finance)
(2016-present);
Santander
Holdings
USA
(holding
company)
(2019-present);
and
formerly
,
Canadian
National
Railway
(railroad)
(2001-April
2021),
White
Mountains
Insurance
Group,
Ltd.
(holding
company)
(2004-May
2021),
RTI
International
Metals,
Inc.
(manufacture
and
distribution
of
titanium)
(1999-2015)
and
H.J.
Heinz
Company
(processed
foods
and
allied
products)
(1994-2013).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
or
Trustee
of
various
companies
and
trusts;
and
formerly
,
Assistant
to
the
President
of
the
United
States
and
Secretary
of
the
Cabinet
(1990-1993);
General
Counsel
to
the
United
States
Treasury
Department
(1989-1990);
and
Counselor
to
the
Secretary
and
Assistant
Secretary
for
Public
Affairs
and
Public
Liaison-United
States
Treasury
Department
(1988-1989).
J.
Michael
Luttig
(1954)
Trustee
Since
2009
126
Boeing
Capital
Corporation
(aircraft
financing)
(2006-2010).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Private
investor;
and
formerly
,
Counselor
and
Senior
Advisor
to
the
Chairman,
CEO,
and
Board
of
Directors,
of
The
Boeing
Company
(aerospace
company),
and
member
of
the
Executive
Council
(May
2019-January
1,
2020);
Executive
Vice
President,
General
Counsel
and
member
of
the
Executive
Council,
The
Boeing
Company
(2006-2019);
and
Federal
Appeals
Court
Judge,
United
States
Court
of
Appeals
for
the
Fourth
Circuit
(1991-2006).
Larry
D.
Thompson
(1945)
Trustee
Since
2007
126
Graham
Holdings
Company
(education
and
media
organization)
(2011-present);
and
formerly
,
The
Southern
Company
(energy
company)
(2014-2020);
previously
2010-2012)
and
Cbeyond,
Inc.
(business
communications
provider)
(2010-2012).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
Counsel,
Finch
McCranie,
LLP
(law
firm)
(2015-present);
John
A.
Sibley
Professor
of
Corporate
and
Business
Law,
University
of
Georgia
School
of
Law
(2015-present;
previously
2011-2012);
and
formerly
,
Independent
Compliance
Monitor
and
Auditor,
Volkswagen
AG
(manufacturer
of
automobiles
and
commercial
vehicles)
(2017-2020)};
Executive
Vice
President
-
Government
Affairs,
General
Counsel
and
Corporate
Secretary,
PepsiCo,
Inc.
(consumer
products)
(2012-2014);
Senior
Vice
President
-
Government
Affairs,
General
Counsel
and
Secretary,
PepsiCo,
Inc.
(2004-2011);
Senior
Fellow
of
The
Brookings
Institution
(2003-2004);
Visiting
Professor,
University
of
Georgia
School
of
Law
(2004);
and
Deputy
Attorney
General,
U.S.
Department
of
Justice
(2001-2003).
Independent
Board
Members
(continued)
Franklin
Strategic
Series
71
franklintempleton.com
Annual
Report
Interested
Board
Members
and
Officers
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Valerie
Williams
(1956)
Trustee
Since
May
2021
107
Omnicom
Group,
Inc.
(advertising
and
marketing
communications
services)
(2016-present),
DTE
Energy
Co.
(gas
and
electric
utility)
(2018-present),
Devon
Energy
Corporation
(exploration
and
production
of
oil
and
gas)
(January
2021-present);
and
formerly
,
WPX
Energy,
Inc.
(exploration
and
production
of
oil
and
gas)
(2018-
2021).
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
of
various
companies;
and
formerly
,
Regional
Assurance
Managing
Partner,
Ernst
&
Young
LLP
(public
accounting)
(2005-2016),
various
roles
of
increasing
responsibility
at
ErNst
&
Young
(1981-2005).
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
**Gregory
E.
Johnson
(1961)
Trustee
Since
2013
137
None
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Executive
Chairman,
Chairman
of
the
Board
and
Director,
Franklin
Resources,
Inc.;
officer
and/or
director
or
trustee,
as
the
case
may
be,
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
39
of
the
investment
companies
in
Franklin
Templeton;
Vice
Chairman,
Investment
Company
Institute;
and
formerly
,
Chief
Executive
Officer
(2013-2020)
and
President
(1994-2015),
Franklin
Resources,
Inc.
**Rupert
H.
Johnson,
Jr.
(1940)
Chairman
of
the
Board
and
Trustee
Chairman
of
the
Board
and
Trustee
since
2013
and
Vice
President
since
1991
126
None
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
(Vice
Chairman),
Franklin
Resources,
Inc.;
Director,
Franklin
Advisers,
Inc.;
and
officer
and/or
director
or
trustee,
as
the
case
may
be,
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
37
of
the
investment
companies
in
Franklin
Templeton.
Alison
E.
Baur
(1964)
Vice
President
Since
2012
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Deputy
General
Counsel,
Franklin
Templeton;
and
officer
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
42
of
the
investment
companies
in
Franklin
Templeton.
Breda
M.
Beckerle
(1958)
Chief
Compliance
Officer
Since
October
2020
Not
Applicable
Not
Applicable
280
Park
Avenue
New
York,
NY
10017
Principal
Occupation
During
at
Least
the
Past
5
Years:
Chief
Compliance
Officer,
Fiduciary
Investment
Management
International,
Inc.,
Franklin
Advisers,
Inc.,
Franklin
Advisory
Services,
LLC,
Franklin
Mutual
Advisers,
LLC,
Franklin
Templeton
Institutional,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Independent
Board
Members
(continued)
Franklin
Strategic
Series
72
franklintempleton.com
Annual
Report
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Sonal
Desai,
Ph.D.
(1963)
Vice
President
Since
2018
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Director
and
Executive
Vice
President,
Franklin
Advisers,
Inc.;
Executive
Vice
President,
Franklin
Templeton
Institutional,
LLC;
and
officer
of
17
of
the
investment
companies
in
Franklin
Templeton.
Steven
J.
Gray
(1955)
Vice
President
and
Co-Secretary
Vice
President
since
2009
and
Co-Secretary
since
2019
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Associate
General
Counsel,
Franklin
Templeton;
Vice
President,
Franklin
Templeton
Distributors,
Inc.
and
FASA,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Matthew
T.
Hinkle
(1971)
Chief
Executive
Officer
Finance
and
Administration
Since
2017
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Vice
President,
Franklin
Templeton
Services,
LLC;
officer
of
42
of
the
investment
companies
in
Franklin
Templeton;
and
formerly
,
Vice
President,
Global
Tax
(2012-April
2017)
and
Treasurer/Assistant
Treasurer,
Franklin
Templeton
(2009-2017).
Robert
G.
Kubilis
(1973)
Chief
Financial
Officer,
Chief
Accounting
Officer
and
Treasurer
Since
December
2020
Not
Applicable
Not
Applicable
300
S.E.
2nd
Street
Fort
Lauderdale,
FL
33301-
1923
Principal
Occupation
During
at
Least
the
Past
5
Years:
Treasurer,
U.S.
Fund
Administration
&
Reporting
and
officer
of
39
of
the
investment
companies
in
Franklin
Templeton.
Robert
Lim
(1948)
Vice
President
AML
Compliance
Since
2016
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Vice
President,
Franklin
Templeton
Companies,
LLC;
Chief
Compliance
Officer,
Franklin
Templeton
Distributors,
Inc.
and
Franklin
Templeton
Investor
Services,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Edward
D.
Perks
(1970)
President
and
Chief
Executive
Officer
Investment
Management
Since
2018
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
President
and
Director,
Franklin
Advisers,
Inc.;
and
officer
of
eight
of
the
investment
companies
in
Franklin
Templeton
(since
December
2018).
Navid
J.
Tofigh
(1972)
Vice
President
Since
2015
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
Associate
General
Counsel
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Interested
Board
Members
and
Officers
(continued)
Franklin
Strategic
Series
73
franklintempleton.com
Annual
Report
*We
base
the
number
of
portfolios
on
each
separate
series
of
the
U.S.
registered
investment
companies
within
the
Franklin
Templeton
fund
complex.
These
portfolios
have
a
common
investment
manager
or
affiliated
investment
managers.
**Gregory
E.
Johnson
is
considered
to
be
an
interested
person
of
the
Fund
under
the
federal
securities
laws
due
to
his
position
as
an
officer
and
director
of
Franklin
Resources,
Inc.
(Resources),
which
is
the
parent
company
of
the
Fund’s
investment
manager
and
distributor.
Rupert
H.
Johnson,
Jr.
is
considered
to
be
an
interested
person
of
the
Fund
under
the
federal
securities
laws
due
to
his
position
as
an
officer
and
director
and
major
shareholder
of
Resources.
Note
1:
Rupert
H.
Johnson,
Jr.
is
the
uncle
of
Gregory
E.
Johnson.
Note
2:
Officer
information
is
current
as
of
the
date
of
this
report.
It
is
possible
that
after
this
date,
information
about
officers
may
change.
The
Sarbanes-Oxley
Act
of
2002
and
Rules
adopted
by
the
Securities
and
Exchange
Commission
require
the
Fund
to
disclose
whether
the
Fund’s
Audit
Committee
includes
at
least
one
member
who
is
an
audit
committee
financial
expert
within
the
meaning
of
such
Act
and
Rules.
The
Fund’s
Board
has
determined
that
there
is
at
least
one
such
financial
expert
on
the
Audit
Committee
and
has
designated
Mary
C.
Choksi
as
its
audit
committee
financial
expert.
The
Board
believes
that
Ms.
Choksi
qualifies
as
such
an
expert
in
view
of
her
extensive
business
background
and
experience.
She
served
as
a
director
of
Avis
Budget
Group,
Inc.
(2007-May
2020)
and
formerly,
Founder
and
Senior
Advisor,
Strategic
Investment
Group
(1987
to
2017).
Ms.
Choksi
has
been
a
Member
of
the
Fund’s
Audit
Committee
since
2014.
As
a
result
of
such
background
and
experience,
the
Board
believes
that
Ms.
Choksi
has
acquired
an
understanding
of
generally
accepted
accounting
principles
and
financial
statements,
the
general
application
of
such
principles
in
connection
with
the
accounting
estimates,
accruals
and
reserves,
and
analyzing
and
evaluating
financial
statements
that
present
a
breadth
and
level
of
complexity
of
accounting
issues
generally
comparable
to
those
of
the
Fund,
as
well
as
an
understanding
of
internal
controls
and
procedures
for
financial
reporting
and
an
understanding
of
audit
committee
functions.
Ms.
Choksi
is
an
independent
Board
member
as
that
term
is
defined
under
the
relevant
Securities
and
Exchange
Commission
Rules
and
Releases.
The
Statement
of
Additional
Information
(SAI)
includes
additional
information
about
the
board
members
and
is
available,
without
charge,
upon
request.
Shareholders
may
call
(800)
DIAL
BEN/342-5236
to
request
the
SAI.
Name,
Year
of
Birth
and
Address
Position
Length
of
Time
Served
Number
of
Portfolios
in
Fund
Complex
Overseen
by
Board
Member*
Other
Directorships
Held
During
at
Least
the
Past
5
Years
Craig
S.
Tyle
(1960)
Vice
President
Since
2005
Not
Applicable
Not
Applicable
One
Franklin
Parkway
San
Mateo,
CA
94403-1906
Principal
Occupation
During
at
Least
the
Past
5
Years:
General
Counsel
and
Executive
Vice
President,
Franklin
Resources,
Inc.;
and
officer
of
some
of
the
other
subsidiaries
of
Franklin
Resources,
Inc.
and
of
42
of
the
investment
companies
in
Franklin
Templeton.
Lori
A.
Weber
(1964)
Vice
President
and
Co-Secretary
Vice
President
since
2011
and
Co-Secretary
since
2019
Not
Applicable
Not
Applicable
300
S.E.
2nd
Street
Fort
Lauderdale,
FL
33301-
1923
Principal
Occupation
During
at
Least
the
Past
5
Years:
Senior
Associate
General
Counsel,
Franklin
Templeton;
Assistant
Secretary,
Franklin
Resources,
Inc.;
Vice
President
and
Secretary,
Templeton
Investment
Counsel,
LLC;
and
officer
of
42
of
the
investment
companies
in
Franklin
Templeton.
Interested
Board
Members
and
Officers
(continued)
Franklin
Strategic
Series
Shareholder
Information
74
franklintempleton.com
Annual
Report
Board
Approval
of
Investment
Management
Agreements
FRANKLIN
STRATEGIC
SERIES
Franklin
Strategic
Income
Fund
(Fund)
At
a
meeting
held
on
April
20,
2021
(Meeting),
the
Board
of
Trustees
(Board)
of
Franklin
Strategic
Series
(Trust),
including
a
majority
of
the
trustees
who
are
not
“interested
persons”
as
defined
in
the
Investment
Company
Act
of
1940
(Independent
Trustees),
reviewed
and
approved
the
continuance
of
the
investment
management
agreement
between
Franklin
Advisers,
Inc.
(Manager)
and
the
Trust,
on
behalf
of
the
Fund
(Management
Agreement)
for
an
additional
one-year
period.
The
Independent
Trustees
received
advice
from
and
met
separately
with
Independent
Trustee
counsel
in
considering
whether
to
approve
the
continuation
of
the
Management
Agreement.
In
considering
the
continuation
of
the
Management
Agreement,
the
Board
reviewed
and
considered
information
provided
by
the
Manager
at
the
Meeting
and
throughout
the
year
at
meetings
of
the
Board
and
its
committees.
The
Board
also
reviewed
and
considered
information
provided
in
response
to
a
detailed
set
of
requests
for
information
submitted
to
the
Manager
by
Independent
Trustee
counsel
on
behalf
of
the
Independent
Trustees
in
connection
with
the
annual
contract
renewal
process.
In
addition,
prior
to
the
Meeting,
the
Independent
Trustees
held
a
telephonic
contract
renewal
meeting
at
which
the
Independent
Trustees
conferred
amongst
themselves
and
Independent
Trustee
counsel
about
contract
renewal
matters
and,
in
some
cases,
requested
additional
information
from
the
Manager
relating
to
the
contract.
The
Board
reviewed
and
considered
all
of
the
factors
it
deemed
relevant
in
approving
the
continuance
of
the
Management
Agreement,
including,
but
not
limited
to:
(i)
the
nature,
extent
and
quality
of
the
services
provided
by
the
Manager;
(ii)
the
investment
performance
of
the
Fund;
(iii)
the
costs
of
the
services
provided
and
profits
realized
by
the
Manager
and
its
affiliates
from
the
relationship
with
the
Fund;
(iv)
the
extent
to
which
economies
of
scale
are
realized
as
the
Fund
grows;
and
(v)
whether
fee
levels
reflect
these
economies
of
scale
for
the
benefit
of
Fund
investors.
In
approving
the
continuance
of
the
Management
Agreement,
the
Board,
including
a
majority
of
the
Independent
Trustees,
determined
that
the
terms
of
the
Management
Agreement
are
fair
and
reasonable
and
that
the
continuance
of
such
Management
Agreement
is
in
the
best
interests
of
the
Fund
and
its
shareholders.
While
attention
was
given
to
all
information
furnished,
the
following
discusses
some
primary
factors
relevant
to
the
Board’s
determination.
Nature,
Extent
and
Quality
of
Services
The
Board
reviewed
and
considered
information
regarding
the
nature,
extent
and
quality
of
investment
management
services
provided
by
the
Manager
and
its
affiliates
to
the
Fund
and
its
shareholders.
This
information
included,
among
other
things,
the
qualifications,
background
and
experience
of
the
senior
management
and
investment
personnel
of
the
Manager,
as
well
as
information
on
succession
planning
where
appropriate;
the
structure
of
investment
personnel
compensation;
oversight
of
third-
party
service
providers;
investment
performance
reports
and
related
financial
information
for
the
Fund;
reports
on
expenses
and
shareholder
services;
legal
and
compliance
matters;
risk
controls;
pricing
and
other
services
provided
by
the
Manager
and
its
affiliates;
and
management
fees
charged
by
the
Manager
and
its
affiliates
to
US
funds
and
other
accounts,
including
management’s
explanation
of
differences
among
accounts
where
relevant.
The
Board
also
reviewed
and
considered
an
annual
report
on
payments
made
by
Franklin
Templeton
(FT)
or
the
Fund
to
financial
intermediaries,
as
well
as
a
memorandum
relating
to
third-
party
servicing
arrangements,
which
included
discussion
of
the
changing
distribution
landscape
for
the
Fund.
The
Board
noted
management’s
continuing
efforts
and
expenditures
in
establishing
effective
business
continuity
plans
and
developing
strategies
to
address
areas
of
heightened
concern
in
the
mutual
fund
industry,
such
as
cybersecurity
in
the
current
work-from-home
environment
and
liquidity
risk
management.
The
Board
also
reviewed
and
considered
the
benefits
provided
to
Fund
shareholders
of
investing
in
a
fund
that
is
part
of
the
FT
family
of
funds.
The
Board
noted
the
financial
position
of
Franklin
Resources,
Inc.
(FRI),
the
Manager’s
parent,
and
its
commitment
to
the
mutual
fund
business
as
evidenced
by
its
reassessment
of
the
fund
offerings
in
response
to
the
market
environment
and
project
initiatives
and
capital
investments
relating
to
the
services
provided
to
the
Fund
by
the
FT
organization.
The
Board
specifically
noted
FT’s
commitment
to
enhancing
services
and
controlling
costs,
as
reflected
in
its
outsourcing
of
certain
administrative
functions,
and
growth
opportunities,
Franklin
Strategic
Series
Shareholder
Information
75
franklintempleton.com
Annual
Report
as
evidenced
by
its
recent
acquisition
of
the
Legg
Mason
companies.
The
Board
also
noted
FT’s
attention
focused
on
expanding
the
distribution
opportunities
for
all
funds
in
the
FT
family
of
funds.
Following
consideration
of
such
information,
the
Board
was
satisfied
with
the
nature,
extent
and
quality
of
services
provided
by
the
Manager
and
its
affiliates
to
the
Fund
and
its
shareholders.
Fund
Performance
The
Board
reviewed
and
considered
the
performance
results
of
the
Fund
over
various
time
periods
ended
January
31,
2021.
The
Board
considered
the
performance
returns
for
the
Fund
in
comparison
to
the
performance
returns
of
mutual
funds
deemed
comparable
to
the
Fund
included
in
a
universe
(Performance
Universe)
selected
by
Broadridge
Financial
Solutions,
Inc.
(Broadridge),
an
independent
provider
of
investment
company
data.
The
Board
received
a
description
of
the
methodology
used
by
Broadridge
to
select
the
mutual
funds
included
in
a
Performance
Universe.
The
Board
also
reviewed
and
considered
Fund
performance
reports
provided
and
discussions
that
occurred
with
portfolio
managers
at
Board
meetings
throughout
the
year.
A
summary
of
the
Fund’s
performance
results
is
below.
The
Performance
Universe
for
the
Fund
included
the
Fund
and
all
retail
and
institutional
multi-sector
income
funds.
The
Board
noted
that
the
Fund’s
annualized
income
return
for
the
five-year
period
was
below
the
median
of
its
Performance
Universe,
but
for
the
one-,
three-
and
10-year
periods
was
above
the
median
of
its
Performance
Universe.
The
Board
also
noted
that
the
Fund’s
annualized
total
return
for
the
one-,
three-,
five-
and
10-year
periods
was
below
the
median
of
its
Performance
Universe.
The
Board
considered
that
the
income-oriented
investment
objective
of
the
Fund
is
the
primary
focus
for
the
Fund’s
portfolio
management
team
and
that
the
evaluation
of
the
Fund’s
performance
relative
to
the
Fund’s
peers
on
an
annualized
income
return
basis
is
consistent
with
investor
expectations
and
the
Fund’s
investment
goals.
Given
the
Fund’s
income-oriented
investment
objective,
the
Board
concluded
that
the
Fund’s
performance
was
satisfactory.
Comparative
Fees
and
Expenses
The
Board
reviewed
and
considered
information
regarding
the
Fund’s
actual
total
expense
ratio
and
its
various
components,
including,
as
applicable,
management
fees;
transfer
agent
expenses;
underlying
fund
expenses;
Rule
12b-1
and
non-Rule
12b-1
service
fees;
and
other
non-
management
fees.
The
Board
also
noted
the
quarterly
and
annual
reports
it
receives
on
all
marketing
support
payments
made
by
FT
to
financial
intermediaries.
The
Board
considered
the
actual
total
expense
ratio
and,
separately,
the
contractual
management
fee
rate,
without
the
effect
of
fee
waivers,
if
any
(Management
Rate)
of
the
Fund
in
comparison
to
the
median
expense
ratio
and
median
Management
Rate,
respectively,
of
other
mutual
funds
deemed
comparable
to
and
with
a
similar
expense
structure
to
the
Fund
selected
by
Broadridge
(Expense
Group).
Broadridge
fee
and
expense
data
is
based
upon
information
taken
from
each
fund’s
most
recent
annual
report,
which
reflects
historical
asset
levels
that
may
be
quite
different
from
those
currently
existing,
particularly
in
a
period
of
market
volatility.
While
recognizing
such
inherent
limitation
and
the
fact
that
expense
ratios
and
Management
Rates
generally
increase
as
assets
decline
and
decrease
as
assets
grow,
the
Board
believed
the
independent
analysis
conducted
by
Broadridge
to
be
an
appropriate
measure
of
comparative
fees
and
expenses.
The
Broadridge
Management
Rate
includes
administrative
charges,
and
the
actual
total
expense
ratio,
for
comparative
consistency,
was
shown
for
Class
A
shares
for
the
Fund
and
Class
A
shares
for
each
other
fund
in
its
Expense
Group.
The
Board
received
a
description
of
the
methodology
used
by
Broadridge
to
select
the
mutual
funds
included
in
an
Expense
Group.
The
Expense
Group
for
the
Fund
included
the
Fund
and
nine
other
multi-sector
income
funds.
The
Board
noted
that
the
Management
Rate
and
actual
total
expense
ratio
for
the
Fund
were
below
the
medians
and
in
the
first
quintile
(least
expensive)
of
its
Expense
Group.
The
Board
concluded
that
the
Management
Rate
charged
to
the
Fund
is
reasonable.
Profitability
The
Board
reviewed
and
considered
information
regarding
the
profits
realized
by
the
Manager
and
its
affiliates
in
connection
with
the
operation
of
the
Fund.
In
this
respect,
the
Board
considered
the
Fund
profitability
analysis
provided
by
the
Manager
that
addresses
the
overall
profitability
of
FT’s
US
fund
business,
as
well
as
its
profits
in
providing
investment
management
and
other
services
to
each
of
the
individual
funds
during
the
12-month
period
ended
September
30,
2020,
being
the
most
recent
fiscal
year-
end
for
FRI.
The
Board
noted
that
although
management
continually
makes
refinements
to
its
methodologies
used
in
calculating
profitability
in
response
to
organizational
and
product-related
changes,
the
overall
methodology
has
remained
consistent
with
that
used
in
the
Fund’s
profitability
report
presentations
from
prior
years.
The
Board
further
noted
management’s
representation
that
the
profitability
analysis
excluded
the
impact
of
the
recent
acquisition
of
the
Legg
Mason
companies
and
that
management
expects
to
incorporate
the
legacy
Legg
Mason
companies
into
the
profitability
analysis
beginning
next
year.
The
Board
also
Franklin
Strategic
Series
Shareholder
Information
76
franklintempleton.com
Annual
Report
noted
that
PricewaterhouseCoopers
LLP,
auditor
to
FRI
and
certain
FT
funds,
has
been
engaged
by
the
Manager
to
periodically
review
and
assess
the
allocation
methodologies
to
be
used
solely
by
the
Fund’s
Board
with
respect
to
the
profitability
analysis.
The
Board
noted
management’s
belief
that
costs
incurred
in
establishing
the
infrastructure
necessary
for
the
type
of
mutual
fund
operations
conducted
by
the
Manager
and
its
affiliates
may
not
be
fully
reflected
in
the
expenses
allocated
to
the
Fund
in
determining
its
profitability,
as
well
as
the
fact
that
the
level
of
profits,
to
a
certain
extent,
reflected
operational
cost
savings
and
efficiencies
initiated
by
management.
As
part
of
this
evaluation,
the
Board
considered
management’s
outsourcing
of
certain
operations,
which
effort
has
required
considerable
up-front
expenditures
by
the
Manager
but,
over
the
long
run
is
expected
to
result
in
greater
efficiencies.
The
Board
also
noted
management’s
expenditures
in
improving
shareholder
services
provided
to
the
Fund,
as
well
as
the
need
to
implement
systems
and
meet
additional
regulatory
and
compliance
requirements
resulting
from
recent
US
Securities
and
Exchange
Commission
and
other
regulatory
requirements.
The
Board
also
considered
the
extent
to
which
the
Manager
and
its
affiliates
might
derive
ancillary
benefits
from
fund
operations,
including
revenues
generated
from
transfer
agent
services,
potential
benefits
resulting
from
personnel
and
systems
enhancements
necessitated
by
fund
growth,
as
well
as
increased
leverage
with
service
providers
and
counterparties.
Based
upon
its
consideration
of
all
these
factors,
the
Board
concluded
that
the
level
of
profits
realized
by
the
Manager
and
its
affiliates
from
providing
services
to
the
Fund
was
not
excessive
in
view
of
the
nature,
extent
and
quality
of
services
provided
to
the
Fund.
Economies
of
Scale
The
Board
reviewed
and
considered
the
extent
to
which
the
Manager
may
realize
economies
of
scale,
if
any,
as
the
Fund
grows
larger
and
whether
the
Fund’s
management
fee
structure
reflects
any
economies
of
scale
for
the
benefit
of
shareholders.
With
respect
to
possible
economies
of
scale,
the
Board
noted
the
existence
of
management
fee
breakpoints,
which
operate
generally
to
share
any
economies
of
scale
with
the
Fund’s
shareholders
by
reducing
the
Fund’s
effective
management
fees
as
the
Fund
grows
in
size.
The
Board
considered
the
Manager’s
view
that
any
analyses
of
potential
economies
of
scale
in
managing
a
particular
fund
are
inherently
limited
in
light
of
the
joint
and
common
costs
and
investments
the
Manager
incurs
across
the
FT
family
of
funds
as
a
whole.
The
Board
noted
that
the
Fund
had
experienced
a
decrease
in
assets
and
would
not
be
expected
to
demonstrate
additional
economies
of
scale
in
the
near
term,
but
concluded
that
to
the
extent
economies
of
scale
may
be
realized
by
the
Manager
and
its
affiliates,
the
Fund’s
management
fee
structure
provided
a
sharing
of
benefits
with
the
Fund
and
its
shareholders
as
the
Fund
grows.
Conclusion
Based
on
its
review,
consideration
and
evaluation
of
all
factors
it
believed
relevant,
including
the
above-described
factors
and
conclusions,
the
Board
unanimously
approved
the
continuation
of
the
Management
Agreement
for
an
additional
one-year
period.
Proxy
Voting
Policies
and
Procedures
The
Fund’s
investment
manager
has
established
Proxy
Voting
Policies
and
Procedures
(Policies)
that
the
Fund
uses
to
determine
how
to
vote
proxies
relating
to
portfolio
securities.
Shareholders
may
view
the
Fund’s
complete
Policies
online
at
franklintempleton.com.
Alternatively,
shareholders
may
request
copies
of
the
Policies
free
of
charge
by
calling
the
Proxy
Group
collect
at
(954)
527-
7678
or
by
sending
a
written
request
to:
Franklin
Templeton
Companies,
LLC,
300
S.E.
2nd
Street,
Fort
Lauderdale,
FL
33301,
Attention:
Proxy
Group.
Copies
of
the
Fund’s
proxy
voting
records
are
also
made
available
online
at
franklintempleton.com
and
posted
on
the
U.S.
Securities
and
Exchange
Commission’s
website
at
sec.gov
and
reflect
the
most
recent
12-month
period
ended
June
30.
Quarterly
Statement
of
Investments
The
Trust,
on
behalf
of
the
Fund,
files
a
complete
statement
of
investments
with
the
U.S.
Securities
and
Exchange
Commission
for
the
first
and
third
quarters
for
each
fiscal
year
as
an
exhibit
to
its
report
on
Form
N-PORT.
Shareholders
may
view
the
filed
Form
N-PORT
by
visiting
the
Commission’s
website
at
sec.gov.
The
filed
form
may
also
be
viewed
and
copied
at
the
Commission’s
Public
Reference
Room
in
Washington,
DC.
Information
regarding
the
operations
of
the
Public
Reference
Room
may
be
obtained
by
calling
(800)
SEC-0330.
Householding
of
Reports
and
Prospectuses
You
will
receive,
or
receive
notice
of
the
availability
of,
the
Fund's
financial
reports
every
six
months.
In
addition,
you
will
receive
an
annual
updated
summary
prospectus
(detail
prospectus
available
upon
request).
To
reduce
Fund
expenses,
we
try
to
identify
related
shareholders
in
a
household
and
send
only
one
copy
of
the
financial
reports
Franklin
Strategic
Series
Shareholder
Information
77
franklintempleton.com
Annual
Report
(to
the
extent
received
by
mail)
and
summary
prospectus.
This
process,
called
“householding,”
will
continue
indefinitely
unless
you
instruct
us
otherwise.
If
you
prefer
not
to
have
these
documents
householded,
please
call
us
at
(800)
632-2301.
At
any
time
you
may
view
current
prospectuses/
summary
prospectuses
and
financial
reports
on
our
website.
If
you
choose,
you
may
receive
these
documents
through
electronic
delivery.
194
A
06/21
©
2021
Franklin
Templeton
Investments.
All
rights
reserved.
Authorized
for
distribution
only
when
accompanied
or
preceded
by
a
summary
prospectus
and/or
prospectus.
Investors
should
carefully
consider
a
fund’s
investment
goals,
risks,
charges
and
expenses
before
investing.
A
prospectus
contains
this
and
other
information;
please
read
it
carefully
before
investing.
To
help
ensure
we
provide
you
with
quality
service,
all
calls
to
and
from
our
service
areas
are
monitored
and/or
recorded.
Annual
Report
and
Shareholder
Letter
Franklin
Strategic
Income
Fund
Investment
Manager
Distributor
Shareholder
Services
Franklin
Advisers,
Inc.
Franklin
Templeton
Distributors,
Inc.
(800)
DIAL
BEN
®
/
342-5236
franklintempleton.com
(800)
632-2301
Item 2. Code of Ethics.
 
(a) The Registrant has adopted a code of ethics that applies to its principal executive officers and principal financial and accounting officer. 
 
(c) N/A
 
(d) N/A
 
(f) Pursuant to Item 13(a)(1), the Registrant is attaching as an exhibit a copy of its code of ethics that applies to its principal executive officers and principal financial and accounting officer.
 
 
Item 3. Audit Committee Financial Expert.
 
(a)(1) The Registrant has an audit committee financial expert serving on its audit committee.
 
(2) The audit committee financial expert is Mary C. Choksi and she is "independent" as defined under the relevant Securities and Exchange Commission Rules and Releases.
 
 
Item 4.
Principal Accountant Fees and Services.
(a)      Audit Fees
The aggregate fees paid to the principal accountant for professional services rendered by the principal accountant for the audit of the registrant’s annual financial statements or for services that are normally provided by the principal accountant in connection with statutory and regulatory filings or engagements were $313,135 for the fiscal year ended April 30, 2021 and $337,873 for the fiscal year ended April 30, 2020.
 
(b)      Audit-Related Fees
There were no fees paid to the principal accountant for assurance and related services rendered by the principal accountant to the registrant that are reasonably related to the performance of the audit of the registrant's financial statements and are not reported under paragraph (a) of Item 4.
 
There were no fees paid to the principal accountant for assurance and related services rendered by the principal accountant to the registrant's investment adviser and any entity controlling, controlled by or under common control with the investment adviser that provides ongoing services to the registrant that are reasonably related to the performance of the audit of their financial statements. 
 
(c)      Tax Fees
There were no fees paid to the principal accountant for professional services rendered by the principal accountant to the registrant for tax compliance, tax advice and tax planning.
 
The aggregate fees paid to the principal accountant for professional services rendered by the principal accountant to the registrant’s investment adviser and any entity controlling, controlled by or under common control with the investment adviser that provides ongoing services to the registrant for tax compliance, tax advice and tax planning were $0 for the fiscal year ended April 30, 2021 and $232,351 for the fiscal year ended April 30, 2020. The services for which these fees were paid included tax compliance services related to year-end, and
professional fees in connection with tax treatment of equipment lease transactions.
 
(d)      All Other Fees
The aggregate fees paid to the principal accountant for products and services rendered by the principal accountant to the registrant not reported in paragraphs (a)-(c) of Item 4
were $0 for the fiscal year ended April 30, 2021 and $6,311 for the fiscal year ended April 30, 2020. The services for which these fees were paid included review of materials provided to the fund Board in connection with the investment management contract renewal process.
 
The aggregate fees paid to the principal accountant for products and services rendered by the principal accountant to the registrant’s investment adviser and any entity controlling, controlled by or under common control with the investment adviser that provides ongoing services to the registrant not reported in paragraphs (a)-(c) of Item 4 were $36,800 for the fiscal year ended April 30, 2021 and $194,566 for the fiscal year ended April 30, 2020. The services for which these fees were paid included compliance examination for Investment Advisor Act rule 204-2 and 206-4(2), professional fees in connection with determining the feasibility of a U.S. direct lending structure, for the issuance of an Auditor’s Certificate for South Korean regulatory shareholders disclosures, valuation services related to a fair value engagement, and benchmarking services in connection with the ICI TA survey, and assets under management certification.
 
(e) (1) The registrant’s audit committee is directly responsible for approving the services to be provided by the auditors, including:
 
        (i)     pre-approval of all audit and audit related services;
 
        (ii)    pre-approval of all non-audit related services to be provided to the Fund by the auditors;
 
        (iii)   pre-approval of all non-audit related services to be provided to the registrant by the auditors to the registrant’s investment adviser or to any entity that controls, is controlled by or is under common control with the registrant’s investment adviser and that provides ongoing services to the registrant where the non-audit services relate directly to the operations or financial reporting of the registrant; and
 
        (iv)    establishment by the audit committee, if deemed necessary or appropriate, as an alternative to committee pre-approval of services to be provided by the auditors, as required by paragraphs (ii) and (iii) above, of policies and procedures to permit such services to be pre-approved by other means, such as through establishment of guidelines or by action of a designated member or members of the committee; provided the policies and procedures are detailed as to the particular service and the committee is informed of each service and such policies and procedures do not include delegation of audit committee responsibilities, as contemplated under the Securities Exchange Act of 1934, to management; subject, in the case of (ii) through (iv), to any waivers, exceptions or exemptions that may be available under applicable law or rules.
 
(e) (2) None of the services provided to the registrant described in paragraphs (b)-(d) of Item 4 were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of regulation S-X.
 
(f) No disclosures are required by this Item 4(f).
 
(g) The aggregate non-audit fees paid to the principal accountant for services rendered by the principal accountant to the registrant and the registrant’s investment adviser and any entity controlling, controlled by or under common control with the investment adviser that provides ongoing services to the registrant were $36,800 for the fiscal year ended April 30, 2021 and $433,228 for the fiscal year ended April 30, 2020.
 
(h) The registrant’s audit committee of the board has considered whether the provision of non-audit services that were rendered to the registrant’s investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant’s independence.


 
Item 5. Audit Committee
 
of Listed Registrants.        N/A
 
 
Item 6. Schedule of Investments.                      N/A

 
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.      N/A
 
 
Item 8. Portfolio Managers of Closed-End Management Investment Companies.                                       N/A
 
 
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and
Affiliated Purchasers.   N/A
 
 
Item 10. Submission of Matters to a Vote of Security Holders.
 
There have been no changes to the procedures by which shareholders may recommend nominees to the Registrant's Board of Trustees that would require disclosure herein.
 
 
Item 11. Controls and Procedures.
 
(a)
  Evaluation of Disclosure Controls and Procedures
The Registrant maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the Registrant’s filings under the Securities Exchange Act of 1934, as amended, and the Investment Company Act of 1940 is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Registrant’s management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. The Registrant’s management, including the principal executive officer and the principal financial officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
 
Within 90 days prior to the filing date of this Shareholder Report on Form N-CSR, the Registrant had carried out an evaluation, under the supervision and with the participation of the Registrant’s management, including the Registrant’s principal executive officer and the Registrant’s principal financial officer, of the effectiveness of the design and operation of the Registrant’s disclosure controls and procedures. Based on such evaluation, the Registrant’s principal executive officer and principal financial officer concluded that the Registrant’s disclosure controls and procedures are effective.
 
(b)   Changes in Internal Controls
There have been no changes in the Registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect the internal control over financial reporting.
 
 
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Company.              N/A
 
 
Item 13. Exhibits.
 
(a) (1) Code of Ethics
 
 
(a) (2) Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Matthew T. Hinkle, Chief Executive Officer - Finance and Administration, and
Robert G. Kubilis, Chief Financial Officer and Chief Accounting Officer
 
 
(b)   Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Matthew T. Hinkle, Chief Executive Officer - Finance and Administration, and
Robert G. Kubilis, Chief Financial Officer and Chief Accounting Officer
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
FRANKLIN
STRATEGIC SERIES
 
 
 
By S\Matthew T. Hinkle_________________________
  Matthew T. Hinkle
  Chief Executive Officer – Finance and Administration
Date June 25, 2021
 
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
 
 
By S\Matthew T. Hinkle_________________________
  Matthew T. Hinkle
  Chief Executive Officer – Finance and Administration
Date June 25, 2021
 
 
 
By S\Robert G. Kubilis___________________________
     Robert G. Kubilis
     Chief Financial Officer and Chief Accounting Officer
Date June 25, 2021
EX-99.CODE ETH 2 coe.htm
Code of Ethics for Principal Executives
&
Senior Financial
Officers
 
 
Procedures            
Revised December 10, 2018
 
 
 

FRANKLIN
TEMPLETON
FUNDS

 
CODE OF ETHICS
FOR
PRINCIPAL
EXECUTIVES
AND
SENIOR FINANCIAL OFFICERS
 

I.
            
Covered
Officers and Purpose of the Code

 
This
code
of
ethics
(the
"Code")
applies
to
the
Principal
Executive
Officers,
Principal
Financial
Officer
and
Principal
Accounting
Officer
(the
"Covered
Officers,"
each
of
whom
is
set
forth in
Exhibit
A)
of
each investment
company
advised by
a
Franklin
Resources
subsidiary
and
that
is
registered
with
the
United
States
Securities
&
Exchange
Commission
(“SEC”)
(collectively,
"FT
Funds")
for
the
purpose
of
promoting:
 
·
        
Honest
and
ethical
conduct,
including
the
ethical
resolution
of
actual
or
apparent
conflicts
of
interest
between
personal
and
professional
relationships;
·
        
Full,
fair,
accurate,
timely
and
understandable
disclosure
in
reports
and
documents
that
a
registrant
files
with,
or
submits
to,
the
SEC
and
in
other
public
communications
made
by
or
on
behalf
of
the
FT
Funds;
·
        
Compliance
with
applicable
laws
and
governmental
rules
and
regulations;
·
        
The
prompt
internal
reporting
of
violations
of
the
Code
to
an
appropriate
person
or
persons
identified
in
the
Code;
and
·
        
Accountability
for
adherence
to
the
Code.
 
Each
Covered
Officer
will
be
expected
to
adhere
to
a
high
standard
of
business
ethics
and
must
be
sensitive
to
situations
that
may
give
rise
to
actual
as
well
as
apparent
conflicts
of
interest.
 
 
 
 
*
Rule 38a-1
under
the
Investment
Company
Act of 1940
(“1940
Act”)
and
Rule
206(4)-7
under
the
Investment
Advisers
Act
of
1940 (“Advisers Act”)
(together
the “Compliance Rule”)
require registered
investment
companies
and
registered
investment
advisers
to,
among other
things, adopt and implement
written
policies
and
procedures reasonably
designed to
prevent
violations
of the
federal
securities
laws
(“Compliance
Rule
Policies
and
Procedures”).
 
CONFIDENTIAL
INFORMATION.
 
This
document
is
the
proprietary
product
of
Franklin
Templeton
Investments.
It
may
NOT
be
distributed
outside
the
company
unless
it is
made subject to
a
non-disclosure agreement
and/or
such
release
receives
authorization
by
an FTI
Chief Compliance
Officer.
 
Any
unauthorized
use,
reproduction
or
transfer
of this
document
is strictly
prohibited.
Franklin
Templeton
Investments
©
2014.
All
Rights Reserved.
 

II.
            
Other Policies and Procedures
 
This
Code
shall
be
the
sole
code
of
ethics
adopted
by
the
Funds
for
purposes
of
Section
406
of
the
Sarbanes-Oxley
Act
and
the
rules
and
forms
applicable
to
registered
investment
companies
thereunder.
 
Franklin
Resources,
Inc.
has
separately
adopted
the
Code
of
Ethics
and
Business
Conduct
(“Business
Conduct”),
which
is
applicable
to
all
officers,
directors
and
employees
of
Franklin
Resources,
Inc.,
including
Covered
Officers.
It
summarizes
the
values,
principles
and
business
practices
that
guide
the
employee’s
business
conduct
and
also
provides a set of basic
principles
to
guide
officers,
directors
and
employees  regarding  the
minimum
ethical
requirements
expected
of
them.
It
supplements
the
values,
principles
and
business
conduct
identified
in
the
Code
and
other
existing
employee
policies.
 
Additionally,
the
Franklin
Templeton
Funds
have
separately
adopted
the
FTI
Personal
Investments
and
Insider
Trading
Policy
governing
personal
securities
trading
and
other
related
matters.
The
Code
for
Insider
Trading
provides
for
separate
requirements
that
apply
to
the
Covered
Officers
and
others,
and
therefore
is
not
part
of
this
Code.
 
Insofar
as
other
policies
or
procedures
of
Franklin
Resources,
Inc.,
the
Funds,
the
Funds’
adviser,
principal
underwriter,
or
other
service
providers
govern
or
purport
to
govern
the
behavior
or
activities
of
the
Covered Officers
who
are subject
to this Code, they are
superceded
by
this
Code
to
the
extent
that
they
overlap
or
conflict
with
the
provisions
of
this
Code.
Please
review these other documents or consult with
the
Legal
Department
if have questions regarding
the
applicability
of
these
policies
to
you.
 

III.
            
Covered Officers Should Handle
Ethically
Actual and
Apparent
Conflicts of
Interest

 
Overview.
A
"conflict
of
interest"
occurs
when
a
Covered
Officer's
private
interest
interferes
with
the
interests
of,
or
his
or
her
service
to,
the
FT
Funds.
For
example,
a
conflict
of
interest
would
arise
if
a
Covered
Officer,
or
a
member
of
his
family,
receives
improper
personal
benefits
as
a
result
of
apposition
with
the
FT
Funds.
 
Certain
conflicts
of
interest
arise
out
of
the
relationships
between
Covered
Officers
and
the
FT
Funds
and
already
are
subject
to
conflict
of
interest
provisions
in
the
Investment
Company
Act
of
1940
("Investment
Company
Act")
and
the
Investment
Advisers
Act
of
1940
("Investment
Advisers
Act").
For
example,
Covered
Officers
may
not
individually
engage
in
certain
transactions
(such
as
the
purchase
or
sale
of
securities
or
other
property)
with
the
FT
Funds
because
of
their
status
as
"affiliated
persons"
of
the
FT
Funds.
The
FT
Funds’
and
the
investment
advisers’
compliance
programs
and
procedures
are
designed
to
prevent,
or
identify
and
correct,
violations
of
these
provisions.
This
Code
does not,
and
is not
intended
to,
repeat
or replace
these
programs
and
procedures,
and
such
conflicts
fall
outside
of
the
parameters
of
this
Code.
 
Although
typically
not
presenting
an
opportunity
for
improper
personal
benefit,
conflicts
arise
from,
or
as
a
result
of,
the
contractual
relationship
between
the
FT
Funds,
the
investment
advisers
and
the
fund
administrator
of
which
the
Covered
Officers
are
also
officers
or
employees.
As
a
result,
this
Code
recognizes
that
the
Covered
Officers
will,
in
the
normal
course
of
their
duties
(whether
formally
for
the
FT
Funds,
for
the
adviser,
the
administrator,
or

 

for
all
three),
be
involved
in
establishing
policies
and
implementing
decisions
that
will
have
different
effects
on
the
adviser,
administrator
and
the
FT
Funds.
The
participation
of
the
Covered
Officers
in
such
activities
is
inherent
in
the
contractual
relationship
between
the
FT
Funds,
the
adviser,
and
the
administrator
and
is
consistent
with
the
performance
by
the
Covered
Officers
of
their
duties
as
officers
of
the
FT
Funds.
Thus,
if
performed
in
conformity
with
the
provisions
of
the
Investment
Company
Act
and
the
Investment
Advisers
Act,
such
activities
will
be
deemed
to
have
been
handled
ethically.
In
addition,
it
is
recognized
by
the
FT
Funds'
Boards
of
Directors
("Boards")
that
the
Covered
Officers
may
also
be
officers
or
employees
of
one
or
more
other
investment
companies
covered
by
this
or
other
codes.
 
Other
conflicts
of
interest
are
covered
by
the
Code,
even
if
such
conflicts
of
interest
are
not
subject
to
provisions
in
the
Investment
Company
Act
and
the
Investment
Advisers
Act.
The
following
list
provides
examples
of
conflicts
of
interest
under
the
Code,
but
Covered
Officers
should
keep
in
mind
that
these
examples
are
not
exhaustive.
The
overarching
principle
is
that
the
personal
interest
of
a
Covered
Officer
should
not
be
placed
improperly
before
the
interest
of
the
FT
Funds.
 
Each
Covered
Officer
must:
·
        
Not
use
his
or
her
personal
influence
or
personal
relationships
improperly
to
influence
investment
decisions
or
financial
reporting
by
the
FT
Funds
whereby
the
Covered
Officer
would
benefit
personally
to
the
detriment
of
the
FT
Funds;
·
        
Not
cause
the
FT
Funds
to
take
action,
or
fail
to
take
action,
for
the
individual
personal
benefit
of
the
Covered
Officer
rather
than
the
benefit
the
FT
Funds;
·
        
Not
retaliate
against
any
other
Covered
Officer
or
any
employee
of
the
FT
Funds
or
their
affiliated
persons
for
reports
of
potential
violations
that
are
made
in
good
faith;
·
        
Report
at
least
annually
the
following
affiliations
or
other
relationships:
1
o
   
all
directorships
for
public
companies
and
all
companies
that
are
required
to
file
reports
with
the
SEC;
o
   
any
direct
or
indirect
business
relationship
with
any
independent
directors
of
the
FT
Funds;
o
   
any
direct
or
indirect
business
relationship
with
any
independent
public
accounting
firm
(which
are
not
related
to
the
routine
issues
related
to
the
firm’s
service
as
the
Covered
Persons
accountant);
and
o
   
any
direct
or
indirect
interest
in
any
transaction
with
any
FT
Fund
that
will
benefit
the
officer
(not
including
benefits
derived
from
the
advisory,
sub-advisory,
distribution
or
service
agreements
with
affiliates
of
Franklin
Resources).
These
reports
will
be
reviewed
by
the
Legal
Department
for
compliance
with
the
Code.
There
are
some
conflict
of
interest
situations
that
should
always
be
approved
in
writing
by
Franklin
Resources
General
Counsel
or
Deputy
General
Counsel,
if
material.
Examples
of
these
include
2
:
·
        
Service
as
a
director
on
the
board
of
any
public
or
private
Company.
 
 
1
Reporting
of
these
affiliations
or
other
relationships
shall
be
made
by
completing
the
annual
Directors
and
Officers
Questionnaire
and
returning
the
questionnaire
to
Franklin
Resources
Inc,
General
Counsel
or
Deputy
General
Counsel.
2
 
Any
activity
or
relationship
that
would
present
a
conflict
for
a
Covered
Officer
may
also
present
a
conflict
for
the
Covered
Officer
if
a
member
of
the
Covered
Officer's
immediate
family
engages
in
such
an
activity
or
has
such
a
relationship.
The
Cover
Person
should
also
obtain
written
approval
by
FT’s
General
Counsel
in
such
situations.
·
        
The
receipt
of
any
gifts
in
excess
of
$100
from
any
person,
from
any
corporation
or
association.
·
        
The
receipt
of
any
entertainment
from
any
Company
with
which
the
FT
Funds
has
current
or
prospective
business
dealings
unless
such
entertainment
is
business
related,
reasonable
in
cost,
appropriate
as
to
time
and
place,
and
not
so
frequent
as
to
raise
any
question
of
impropriety.
Notwithstanding
the
foregoing,
the
Covered
Officers
must
obtain
prior
approval
from
the
Franklin
Resources
General
Counsel
for
any
entertainment
with
a
value
in
excess
of
$1000.
·
        
Any
ownership
interest
in,
or
any
consulting
or
employment
relationship
with,
any
of
the
FT
Fund’s
service
providers,
other
than
an
investment
adviser,
principal
underwriter,
administrator
or
any
affiliated
person
thereof.
·
        
A
direct
or
indirect
financial
interest
in
commissions,
transaction
charges
or
spreads
paid
by
the
FT
Funds
for
effecting
portfolio
transactions
or
for
selling
or
redeeming
shares
other
than
an
interest
arising
from
the
Covered
Officer's
employment,
such
as
compensation
or
equity
ownership.
·
        
Franklin
Resources
General
Counsel
or
Deputy
General
Counsel
will
provide
a
report
to
the
FT
Funds
Audit
Committee
of
any
approvals
granted
at
the
next
regularly
scheduled
meeting.
 

IV.
            
Disclosure and Compliance

 
·
        
Each
Covered
Officer
should
familiarize
himself
with
the
disclosure
requirements
generally
applicable
to
the
FT
Funds;
·
        
Each
Covered
Officer
should
not
knowingly
misrepresent,
or
cause
others
to
misrepresent,
facts
about
the
FT
Funds
to
others,
whether
within
or
outside
the
FT
Funds,
including
to
the
FT
Funds’
directors
and
auditors,
and
to
governmental
regulators
and
self-regulatory
organizations;
·
        
Each
Covered
Officer
should,
to
the
extent
appropriate
within
his
or
her
area
of
responsibility,
consult
with
other
officers
and
employees
of
the
FT
Funds,
the
FT
Fund’s
adviser
and
the
administrator
with
the
goal
of
promoting
full,
fair,
accurate,
timely
and
understandable
disclosure
in
the
reports
and
documents
the
FT
Funds
file
with,
or
submit
to,
the
SEC
and
in
other
public
communications
made
by
the
FT
Funds;
and
·
        
It
is
the
responsibility
of
each
Covered
Officer
to
promote
compliance
with
the
standards
and
restrictions
imposed
by
applicable
laws,
rules
and
regulations.
 

V.
            
Reporting
and Accountability

 
Each
Covered
Officer
must:
·
        
Upon
becoming
a
covered
officer
affirm
in
writing
to
the
Board
that
he
or
she
has
received,
read,
and
understands
the
Code
(see
Exhibit
B);
·
        
Annually
thereafter
affirm
to
the
Board
that
he
has
complied
with
the
requirements
of
the
Code;
and
·
        
Notify
Franklin
Resources’
General
Counsel
or
Deputy
General
Counsel
promptly
if
he
or
she
knows
of
any
violation
of
this
Code.
Failure
to
do
so
is
itself
is
a
violation
of
this

 

Code.
Franklin
Resources’
General
Counsel
and
Deputy
General
Counsel
are
responsible
for
applying
this
Code
to
specific
situations
in
which
questions
are
presented
under
it
and
have
the
authority
to
interpret
this
Code
in
any
particular
situation.
3
 
However,
the
Independent
Directors
of
the
respective
FT
Funds
will
consider
any
approvals
or
waivers
4
sought
by
any
Chief
Executive
Officers
of
the
Funds.
 
The
FT
Funds
will
follow
these
procedures
in
investigating
and
enforcing
this
Code:
 
·
        
Franklin
Resources
General
Counsel
or
Deputy
General
Counsel
will
take
all
appropriate
action
to
investigate
any
potential
violations
reported
to
the
Legal
Department;
·
        
If,
after
such
investigation,
the
General
Counsel
or
Deputy
General
Counsel
believes
that
no
violation
has
occurred,
The
General
Counsel
is
not
required
to
take
any
further
action;
·
        
Any
matter
that
the
General
Counsel
or
Deputy
General
Counsel
believes
is
a
violation
will
be
reported
to
the
Independent
Directors
of
the
appropriate
FT
Fund;
·
        
If
the
Independent
Directors
concur
that
a
violation
has
occurred,
it
will
inform
and
make
a
recommendation
to
the
Board
of
the
appropriate
FT
Fund
or
Funds,
which
will
consider
appropriate
action,
which
may
include
review
of,
and
appropriate
modifications
to, applicable
policies
and
procedures;
notification
to
appropriate
personnel
of
the
investment
adviser
or
its
board;
or
a
recommendation
to
dismiss
the
Covered
Officer;
·
        
The
Independent
Directors
will
be
responsible
for
granting
waivers,
as
appropriate;
and
·
        
Any
changes
to
or
waivers
of
this
Code
will,
to
the
extent
required,
are
disclosed
as
provided
by
SEC
rules.
5

VI.
            
Other Policies and Procedures

 
This
Code
shall
be
the
sole
code
of
ethics
adopted
by
the
FT
Funds
for
purposes
of
Section
406
of
the
Sarbanes-Oxley
Act
and
the
rules
and
forms
applicable
to
registered
investment
companies
thereunder.
Insofar
as
other
policies
or
procedures
of
the
FT
Funds,
the
FT
Funds'
advisers,
principal
underwriter,
or
other
service
providers
govern
or
purport
to
govern
the
behavior
or
activities
of
the
Covered
Officers
who
are
subject
to
this
Code,
they
are
superseded
by
this
Code
to
the
extent
that
they
overlap
or
conflict
with
the
provisions
of
this
Code.
The
FTI
Personal
Investments
and
Insider
Trading
Policy,
adopted
by
the
FT
Funds,
FT
investment
advisers
and
FT
Fund’s
principal
underwriter
pursuant
to
Rule
17j-1
under
the
Investment
Company
Act,
the
Code
of
Ethics
and
Business
Conduct
and
more
detailed
policies
and
procedures
set
forth
in
FT’s
Employee
Handbook
are
separate
requirements
applying
to
the
Covered
Officers
and
others,
and
are
not
part
of
this
Code.
 
 
 
 
3
Franklin
Resources
General
Counsel
and
Deputy
General
Counsel
are
authorized
to
consult,
as
appropriate,
with
members
of
the
Audit
Committee,
counsel
to
the
FT
Funds
and
counsel
to
the
Independent
Directors,
and
are
encouraged
to
do
so.
4
Item
2
of
Form
N-CSR
defines
"waiver"
as
"the
approval
by
the
registrant
of
a
material
departure
from
a
provision
of
the
code
of
ethics"
and
"implicit
waiver,"
which
must
also
be
disclosed,
as
"the
registrant's
failure
to
take
action
within
a
reasonable
period
of
time
regarding
a
material
departure
from
a
provision
of
the
code
of
ethics
that
has
been
made
known
to
an
executive
officer"
of
the
registrant.
See
Part
X.
5
 
See
Part
X.

 

VII.
            
Amendments

 
Any
amendments
to
this
Code,
other
than
amendments
to
Exhibit
A,
must
be
approved
or
ratified
by
a
majority
vote
of
the
FT
Funds’
Board
including
a
majority
of
independent
directors.

VIII.
            
Confidentiality

 
All
reports
and
records
prepared
or
maintained
pursuant
to
this
Code
will
be
considered
confidential
and
shall
be
maintained
and
protected
accordingly.
Except
as
otherwise
required
by
law or
this Code,
such matters
shall
not
be disclosed
to anyone
other than
the FT
Funds’ Board
and
their
counsel.

IX.
            
Internal Use

 
The
Code
is
intended
solely
for
the
internal
use
by
the
FT
Funds
and
does
not
constitute
an
admission,
by
or
on
behalf
of
any
FT
Funds,
as
to
any
fact,
circumstance,
or
legal
conclusion.
 
X.
                 
Disclosure
on
Form
N-CSR
 
Item
2
of
Form
N-CSR
requires
a
registered
management
investment
company
to
disclose
annually
whether,
as
of
the
end
of
the
period
covered
by
the
report,
it
has
adopted
a
code
of
ethics
that
applies
to
the
registrant's
principal
executive
officer,
principal
financial
officer,
principal
accounting
officer
or
controller,
or
persons
performing
similar
functions,
regardless
of
whether
these
officers
are
employed
by
the
registrant
or
a
third
party.
If
the
registrant
has
not
adopted
such
a
code
of
ethics,
it
must
explain
why
it
has
not
done
so.
The
registrant
must
also:
(1)
file
with
the
SEC
a
copy
of
the
code
as
an
exhibit
to
its
annual
report;
(2)
post
the
text
of
the
code
on
its
Internet
website
and
disclose,
in
its
most
recent
report
on
Form
N-CSR,
its
Internet
address
and
the
fact
that
it
has
posted
the
code
on
its
Internet
website;
or
(3)
undertake
in
its
most
recent
report
on
Form
N-CSR
to
provide
to
any
person
without
charge,
upon
request,
a
copy
of
the
code
and
explain
the
manner
in
which
such
request
may
be
made.
Disclosure
is
also
required
of
amendments
to,
or
waivers
(including
implicit
waivers)
from,
a
provision
of
the
code
in
the
registrant's
annual
report
on
Form
N-CSR
or
on
its
website.
If
the
registrant
intends
to
satisfy
the
requirement
to
disclose
amendments
and
waivers
by
posting
such
information
on
its
website,
it
will
be
required
to
disclose
its
Internet
address
and
this
intention.
The
Legal
Department
shall
be
responsible
for
ensuring
that:
·
        
a
copy
of
the
Code
is
filed
with
the
SEC
as
an
exhibit
to
each
Fund’s
annual
report;
and
·
        
any
amendments
to,
or
waivers
(including
implicit
waivers)
from,
a
provision
of
the
Code
is
disclosed
in
the
registrant's
annual
report
on
Form
N-CSR.
In
the
event
that
the
foregoing
disclosure
is
omitted
or
is
determined
to
be
incorrect,
the
Legal
Department
shall
promptly
file
such
information
with
the
SEC
as
an
amendment
to
Form
N-CSR.
In
such
an
event,
the
Fund
Chief
Compliance
Officer
shall
review
the
Code
and
propose
such
changes
to
the
Code
as
are
necessary
or
appropriate
to
prevent
reoccurrences.
 

EXHIBIT
A

 
Persons
Covered
by
the
Franklin
Templeton
Funds
Code
of
Ethics
December
2018
 
 
 

FRANKLIN GROUP
OF FUNDS

 
Edward
Perks                            President
and
Chief Executive Officer
Investment
Management
Rupert H. Johnson, Jr.                             Chairman
of the Board and
Vice President– Investment
Management
Don
Taylor                                                President
and
Chief Executive Officer
Investment
Management
Sonal
Desai)                             President
and
Chief
Executive
Officer
Investment
Management
Matthew Hinkle                          Chief Executive Officer
Finance
and Administration
 
 
 

FRANKLIN MUTUAL
SERIES FUNDS

 
Peter Langerman                       Chief Executive Officer
Investment Management
Matthew Hinkle                                       Chief Executive Officer
Finance
and Administration
Robert G. Kubilis                                      Chief Financial Officer and Chief Accounting Officer
 
 

FRANKLIN ALTERNATIVE STRATEGIES FUNDS

 
Mat S. Gulley                            Chief Executive Officer
Investment
Management
Matthew Hinkle                                       Chief Executive
Officer
Finance
and Administration
Robert G. Kubilis                                      Chief Financial Officer and Chief Accounting
Officer
 
 
 

TEMPLETON
GROUP
OF FUNDS

 
Manraj S. Sekhon                      President and
Chief Executive Officer
Investment
Management
Michael
Hasenstab,
Ph.D.
President and Chief Executive Officer
Investment
Management
Norman
Boersma                                                     President
and
Chief Executive Officer
Investment
Management
Matthew Hinkle                                       Chief Executive Officer
Finance
and Administration
Robert G. Kubilis                       Chief Financial Officer, Chief Accounting Officer and Treasurer

 

Exhibit
B
ACKNOWLEDGMENT FORM

 

Franklin
Templeton
Funds
Code
of
Ethics

For
Principal
Executives
and
Senior
Financial
Officers
 
 
Instructions:
1.
     
Complete
all
sections
of
this
form.
2.
     
Print
the
completed
form,
sign,
and
date.
3.
 
Submit
completed
form
to
FT’s
General
Counsel
c/o
Code
of
Ethics
Administration
within
10
days
of
becoming
a
Covered
Officer
and
by
February
15
th
of
each
subsequent
year.
 
Inter-office
mail:
Code
of
Ethics
Administration,
Global
Compliance
SM-920/2
Fax:                       
(650)
312-5646
E-mail:                  
Code
of
Ethics
Inquiries
&
Requests
(internal
address);
lpreclear@franklintempleton.com
(external
address)
 
 
Covered
Officer’s
Name:
 
Title:
 
Department:
 
Location:
 
Certification
for
Year
Ending:
 
 
 
To:   
 
Franklin
Resources
General
Counsel,
Legal
Department
 
I
acknowledge
receiving,
reading
and
understanding
the
Franklin
Templeton
Fund’s
Code
of
Ethics
for
Principal
Executive
Officers
and
Senior
Financial
Officers
(the
“Code”).
I
will
comply
fully
with
all
provisions
of
the
Code
to
the
extent
they
apply
to
me
during
the
period
of
my
employment.
I
further
understand
and
acknowledge
that
any
violation
of
the
Code
may
subject
me
to
disciplinary
action,
including
termination
of
employment.
 
 
 
 
 
                                                                 
Signature                                                               Date signed
EX-99.CERT 3 fss302.htm
I, Robert G. Kubilis, certify that:
 
1. I have reviewed this report on Form N-CSR of Franklin Strategic Series;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
6/25/2021
 
 
 
S\ROBERT G. KUBILIS
 
Robert G. Kubilis
Chief Financial Officer and Chief Accounting Officer
 
 
 
 
I, Matthew T. Hinkle, certify that:
 
1. I have reviewed this report on Form N-CSR of Franklin Strategic Series;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
6/25/2021
 
 
 
S\MATTHEW T. HINKLE
 
Matthew T. Hinkle
Chief Executive Officer - Finance and Administration
 
 
EX-99.906 CERT 4 fss906.htm
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 
I, Robert G. Kubilis, Chief Financial Officer of the Franklin Strategic Series (the “Registrant”), certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1.
                  
The periodic report on Form N-CSR of the Registrant for the period ended 4/30/2021 (the “Form N-CSR”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
                  
The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
Dated:  6/25/2021
 
                                                S\ROBERT G. KUBILIS
                                                                                                           
                                                Robert G. Kubilis
Chief Financial Officer and Chief Accounting Officer
                        

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 
I, Matthew T. Hinkle, Chief Executive Officer of the Franklin Strategic Series (the “Registrant”), certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1.
                  
The periodic report on Form N-CSR of the Registrant for the period ended 4/30/2021 (the “Form N-CSR”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
1.
                  
The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
Dated:  6/25/2021
 
                                                S\MATTHEW T. HINKLE
                                                                                                           
                                                Matthew T. Hinkle
Chief Executive Officer - Finance and Administration
                        
GRAPHIC 5 word8263517077504.gif begin 644 word8263517077504.gif M1TE&.#EA! (" '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y M! $ + $ 0 # @$ @ (61(ZIR^T/HYRTVHNSWKS[#X;B2%I # 0 [ end GRAPHIC 6 word8263517077505.gif begin 644 word8263517077505.gif M1TE&.#EA<0(! '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y M! $ + !Q @$ @ (81(ZIR^T/HYRTVHNSWKS[#X;B2);F %&0(% #L! end GRAPHIC 7 word8263517077506.gif begin 644 word8263517077506.gif M1TE&.#EAP0 ! '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y G! $ + #! $ @ (-1(ZIR^T/HYRTVHL#* [ end GRAPHIC 8 word8263517077507.gif begin 644 word8263517077507.gif M1TE&.#EAZ@ # '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y M! $ + $ #H , @ (:1(ZIR^T/HYRTVHNSWKS[#X8B"!CC 'B:;JNA8 .P$! end GRAPHIC 9 word8263517077508.gif begin 644 word8263517077508.gif M1TE&.#EA&0$$ '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y M! $ + $ 7 00 @ )&A(^IR^T/HYP4!7 SWKKS[X7@*';! MB:;JRK;N"Z=83-?VC>?ZSO?^#\3-@L2B\8A,*I>L(1-)BI:DU*FUBKUJL]RM &MPLN [ end